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ABSTRACT 
 
 
The research described characterises pH signalling in the human pathogen Aspergillus 
fumigatus. Normal functioning of this regulatory system in Aspergillus species requires the integrity 
of seven genes, including the DNA binding transcription factor PacC, which responds to an alkaline 
pH signal transmitted by PalA, B, C, F, H and I. Two protein complexes are proposed to sense and 
transmit the pH signal, the first of which is plasma membrane-localised and composed of two 
putative pH signal receptors, PalH and PalI, plus a cytoplasmic non-metazoan member of the 
arrestin family, PalF. Using A. fumigatus transcriptional profiling, Saccharomyces cerevisiae 
phenotypic screening and the split-ubiquitin MYTH technology, A. fumigatus functions, likely to 
moderate, or be moderated by the PacC transcription factor, were sought.  
Two independent A. fumigatus ∆pacC strains have been phenotypically characterised and 
assessed for virulence in a neutropenic murine model of pulmonary aspergillosis. Of the two, one 
mutant was further characterised using transcriptional profiling in order to elucidate functions under 
PacC control during murine infection. The results of this analysis underline the physiological 
importance of alkaline adaptation during initiation of infection, especially with respect to impacts 
upon cellular homeostasis, transport and nutrient availability.  
A S. cerevisiae membrane two-hybrid system has been developed to investigate A. 
fumigatus plasma membrane protein-protein interactions. Applying the technology, the network of 
interactions between the components of the A. fumigatus plasma membrane pH signalling complex 
was explored, and the interaction between the pH-sensing PalH protein and the cytoplasmic arrestin 
PalF and likely the homodimerisation of PalH were identified. A screen for novel interactors of 
PalH was also performed, providing 5 candidates for further validation. 
The S. cerevisiae ∆rim101 null mutant and another 80 cation-sensitive null mutants were 
analysed. An epistacy screen to address the impact of activated Rim101p upon cation sensitivity 
was performed supporting the identification of putative novel Rim101p/PacC regulators. In parallel 
the activity of a synthetic Rim101p-regulatable promoter was examined identifying 10 mutants 
suffering aberrant Rim101p processing and/or transcriptional activity.  
Finally two A. fumigatus strains have been constructed to functionally express the firefly 
luciferase gene. Preliminary tests indicate this as a powerful resource to follow murine infection in 
real time with bioluminescence assays.  
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 CHAPTER I 
 
INTRODUCTION 
 
  A significant change in the epidemiology of invasive fungal infection has occurred in 
the past 30 years due to the increasing practice of transplantation as a remedy to organ 
dysfunction, the intensification of chemotherapy for cancer and the sudden outbreak of 
Acquired Immune Deficiency Syndrome (AIDS). All of these conditions involve acute 
immunosuppressive states, either induced by, or as a consequence of the infection, exposing 
the patients to a broad range of invasive mycoses. Only two hundred of the estimated 
thousands of fungal species present in the environment have been identified as causative 
agents of disease in humans (Samson and Varga, 2009). Twenty of these belong to the genus 
Aspergillus, which remains the most common cause of mould infections in humans, although 
recent increases in infections have been observed due to other moulds, for example 
Scedosporium apiospermum, Fusarium species and various zygomycetes such as Rhizopus 
and Mucor (Kauffman, 2006). Epidemiological data indeed shows a dramatic change from the 
beginning of the century when Aspergillus infections in humans were defined as “so rare as to 
be of a little practical importance” (Henrici, 1939). A detailed understanding of Aspergillus 
biology, particularly of mechanisms involved in pathogenicity, is therefore crucial to the 
development of novel and more effective therapies.  
Environmental adaptation is particularly interesting, considering it is crucial for all 
microbes, but especially for those inhabiting mammalian niches during infection. pH is a 
negative logarithmic measurement of hydrogen ion activity. In all circumstances where 
metabolism is active, a steady flux of protons goes in and out of the cytoplasm of the cells, 
which have therefore evolved several mechanisms to maintain ion balance and guarantee 
optimal activity of major metabolic pathways, whose function would be otherwise damaged 
by large deviations of intracellular pH. One aspect of this adaptation is the ability to 
appropriately express genes involving functions at the cell surface or in the environment. 
Among these genes, there are permeases, secreted enzymes, enzymes involved in synthesis of 
exported metabolites (i.e. toxins and antibiotics) and enzymes post-translationally modifying 
secreted proteins. The genetic regulatory system involved in ambient pH regulation is 
widespread in the fungal kingdom and depends on the transcription factor Rim101p/PacC. 
Since its first discovery more than 20 years ago (Caddick et al., 1986c), ambient pH 
regulation of gene expression has been extensively studied, especially in the model 
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ascomycete Aspergillus nidulans (Caddick and Arst, 1986; Caddick et al., 1986a; Caddick et 
al., 1986b; Arst, 2003; Arst Jr and Peñalva, 2003; Penalva and Arst Jr, 2002; Peñalva and 
Arst Jr, 2004; Peñalva et al., 2008). Appropriate response to ambient pH is fundamental for 
fungal virulence in plants, insects and animals, as initially demonstrated in Candida albicans 
(Davis, 2003; Davis et al., 2000a) and recently in Aspergillus (Bignell et al., 2005). In A. 
nidulans, PacC activates genes expressed preferentially at alkaline ambient pH and represses 
genes expressed preferentially at acidic pH (Caddick et al., 1986c). The discovery that murine 
aspergillosis requires functionality of A. nidulans pacC has given new insights into the 
importance of this crucial regulatory pathway (Bignell et al., 2005). Alkaline adaptation, a 
mechanism not essential for Aspergillus viability, but critical for its virulence, might provide 
a useful target for prevention of fungal growth in vivo. 
 
1.1 Invasive aspergillosis 
 
Aspergillosis includes a broad range of diseases caused by members of the Aspergillus 
genus, affecting almost any organ or system principally in immunocompromised individuals, 
the most high-risk category of patients (Baddley, 2010). Non-respiratory infections are 
infrequent, but other sites of infections, either in immunocompetent or immunocompromised 
individuals, have been described, i.e. the skin, peritoneum, kidneys, bones, eyes and 
gastrointestinal tract (Denning, 1998).  
 
1.1.1 Clinical symptoms and diagnosis of respiratory aspergillosis 
 
Due to the small diameter of spores, the major portal of entry and site of infection for 
Aspergillus is the respiratory tract. Inhalation of conidiospores can lead to several types of 
pulmonary aspergillosis, classified according to the site of the disease within the respiratory 
tract and the presence and extent of mycelial colonisation (Bodey and Vartivarian, 1989; 
Dixon and Walsh, 1992), which are all conditions influenced by the immune status of the 
patient. Asthma and allergic sinusitis occur without mycelial colonisation as a consequence of 
the repeated exposure to conidia or Aspergillus antigens. On the contrary, there are several 
diseases involving mycelial growth that usually require therapeutic treatment.  
Allergic Bronchopulmonary Aspergillosis (ABPA) represents the most severe 
hypersensitivity reaction caused by Aspergillus species and it is usually seen in patients with 
long-standing asthma (1-2%) or cystic fibrosis (7-35%), particularly in patients taking oral 
corticosteroids for a long period (Basich et al., 1981; Knutsen and Slavin, 1992; Knutsen and 
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Slavin, 1991; Krasnick et al., 1995). Commencing as classic asthma with transient pulmonary 
infiltrates, ABPA is typified by the unique T-cell mediated cellular immune response that 
could lead to the fatal destruction of the lungs. The disease is therefore very difficult to 
diagnose in the early stages and if not treated can eventually progress to pulmonary fibrosis 
and respiratory failure (Greenberger and Patterson, 1987; Wardlaw and Geddes, 1992). 
Diagnosis is based on patient history, imaging tests, immediate skin reactivity to Aspergillus 
antigenic extracts and the measurement of IgE levels and Aspergillus-specific antibodies. 
Treatment consists of corticosteroids or itraconazole (Lazarus et al., 2008). 
 Pulmonary aspergilloma (mycetoma) refers to the mass formed when fungal spores 
settle into or colonize pre-existing pulmonary cavities originated as a consequence of previous 
diseases (10-15% of patients), such as tuberculosis and prior pneumonia (Addrizzo-Harris et 
al., 1997; Israel et al., 1982; Kirsten et al., 1992; Wollschlager and Khan, 1984). 
Aspergillomas are detected by chest radiography, appearing as spherical masses surrounded 
by a radiolucent corona. Patients are usually asymptomatic but they present a high level of 
Aspergillus-specific antibodies. At present, there is no established consensus therapy, but 
recent evidence has demonstrated amphotericin B as an effective candidate against 
aspergillomas, if administered subcutaneously (Zmeili and Soubani, 2007).  
Invasive Pulmonary Aspergillosis (IPA) refers to rare cases in which the fungus 
spreads from the lungs throughout the body via the blood stream and invades other organs, 
particularly the lungs, heart and kidneys. With an associated mortality of 70-90% (Denning, 
1998), IPA is recognised as the most serious type of Aspergillus infection. This is principally 
due to the difficulty of diagnosing IPA, especially in the early stages of infection, when the 
symptoms, such as fever, a cough, chest pain or breathlessness, are usually not specific 
enough to exclude many other illnesses. There is no established consensus diagnosis but the 
principal methods include a positive CT (computerised tomography) scan, culture and/or 
microscopic evidence of the disease and detection of Aspergillus antigens in serum. Fungal 
pathogens of humans are classified either as primary pathogens, if able to cause infection in 
an immunocompetent host, or as secondary (or opportunistic) pathogens, if some defects 
(often in the immune system) are required for the establishment of the infection (Casadevall 
and Pirofski, 1999). IPA occurs mostly in immunocompromised or critically ill patients 
(Patterson, 2005) and it is therefore classified as an opportunistic infection. 
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1.1.2 Host defence mechanisms against Aspergillus species and the role of 
immunosuppression in the development of IPA  
 
Between the severely immunocompromised patients, the categories at highest risk 
include individuals with haematological malignancies (such as leukaemia), solid-organ and 
hematopoietic stem cell transplant patients, patients on prolonged corticosteroid therapy, 
individuals with genetic immunodeficiencies (such as chronic granulomatous disease, CGD) 
and AIDS patients (Denning, 1998; Marr et al., 2002; Mikulska et al., 2009; Pagano et al., 
2001; Post et al., 2007; Wiederhold et al., 2003). Aspergillosis is estimated to afflict 10-15% 
of patients with solid or allogeneic hematopoietic stem cells transplants and with leukaemia. 
Also it is not an uncommon infection for advanced AIDS, affecting 3% of the patients 
(Baddley, 2010; Denning, 1998). For these patients the overall mortality when developing 
aspergillosis varies between 45-90%, depending on factors such as the host immune status, 
the site of infection and the treatment regimen (Lin et al., 2001). Among the human 
pathogenic species of Aspergillus, A. fumigatus is responsible for 90% of human infections 
(Kauffman, 2006), followed by A. flavus, A.terreus, A. niger and the model organism A. 
nidulans (Denning, 1998). A. fumigatus has become the most important airborne fungal 
pathogen worldwide, resulting in a significant increase in fatal IPA, a disease which was quite 
unknown 30 years ago. 
Every day, as indicated by environmental surveys, most humans inhale at least several 
hundred A. fumigatus conidia, but inhalation of conidia in immunocompetent persons rarely 
has negative effects because the conidia are efficiently eliminated by the innate immune 
system (Chazalet et al., 1998; Hospenthal et al., 1998). In immunocompetent individuals, 
inhaled airborne conidia are either removed through the ciliary action of the mucous 
epithelium or encounter epithelial cells and alveolar macrophages. Alveolar macrophages 
represent the primary resident phagocytes of the lungs and are not only responsible for the 
elimination of Aspergillus conidia, but also of the initiation of the pro-inflammatory response, 
recruiting neutrophils to the infection site. If the macrophages are unable to clear the inhaled 
conidia, these germinate to produce hyphae, the elimination of which requires infiltrating 
neutrophils, a type of polymorphonuclear cell (PMN). The risk of developing IPA is therefore 
correlated with a dysfunction of one of these two lines in the host defence system and the 
pattern of pulmonary injury and the outcome of the infection are strictly related to the form of 
immunosuppression involved, either corticosteroid-induced immunosuppression or 
neutropenia, as shown in Fig. 1.1 (Dagenais and Keller, 2009; Ibrahim-Granet et al., 2003; 
Philippe et al., 2003).  
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Fig. 1.1: Infectious life cycle of A. fumigatus. In immunosuppressed patients, the inhalation of conidia 
and their establishment and germination in the lung is followed by a specific outcome depending on the immune 
state of the host. In corticosteroid-induced immunosuppression, the infection is characterised by PMN-mediated 
fungal control with significant inflammation, whereas in a neutropenic scenario, uncontrolled hyphal growth 
with a lack of PMN infiltrates may lead, in severe cases, to dissemination. From Dagenais and Keller, 2009. 
 
Corticosteroid therapy is generally used in allogenic transplant patients and 
significantly impairs macrophages functional abilities such as phagocytosis, phagocyte 
oxidative burst, production and secretion of cytokines and chemokines and cellular migration 
(Lionakis and Kontoyiannis, 2003). IPA in these patients is characterised by limited fungal 
development, but excessive inflammation and tissue necrosis as a consequence of the massive 
recruitment of neutrophils in situ. Neutropenia is often caused by highly cytotoxic therapies 
such as cyclophosphamide, a DNA alkylating agent, used for haematological diseases or 
transplants. Cyclophosphamide binds to DNA, interfering with cellular replication and 
depleting circulating white blood cells. In these patients, IPA is characterised by low levels of 
inflammation, thrombosis and haemorrhages result from the rapid and extensive invasive 
hyphal growth (Chiang et al., 2008; Stergiopoulou et al., 2007).    
 
1.1.3 Current treatment available for IPA   
  
Once established, invasive fungal infections are extremely difficult to cure and, as a 
result, the associated death rate is extremely high and although systemic antifungals have 
been available for more than 50 years, the drugs initially available for the treatment of 
aspergillosis were characterised by several limitations (as reviewed in(Ghannoum and Rice, 
1999; Ostrosky-Zeichner et al., 2010). Initially only Amphotericin B and early formulations 
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of triazoles were available to treat aspergillosis but these drugs showed low efficacy in vivo, 
despite their activity in vitro (Denning, 1995; Denning, 1996a; Denning, 1996b; Denning, 
1998; De Pauw, 1997; Gallis et al., 1990; Kauffman, 2006). Antifungal treatments were 
unable to kill A. fumigatus rapidly and without toxicity for patients. Moreover, they had a 
limited spectra of activity and sometimes cross-react with other treatments (Kauffman, 2006). 
There was also a problem of emerging resistance (Chryssanthou, 1997; Denning et al., 1997a; 
Denning et al., 1997b; Verweij et al., 1998).  
Amphotericin B has represented for more than 30 years the standard antifungal 
therapy for IPA (Brajtburg and Bolard, 1996). The antifungal action of amphotericin B is due 
to its ability to differentially bind fungal and human membrane sterols, targeting 
preferentially ergosterol in the fungal membrane rather than cholesterol found in mammalian 
membranes. As a consequence of this binding, transmembrane channels are formed in the 
membranes and its permeability to monovalent cations is increased (Bolard, 1986). Other 
effects of amphotericin B are the inhibition of proton ATPase pumps, decreasing cellular 
energy reserves, and the promotion of lipid peroxidation, increasing membrane fragility and 
causing Ca
2+
 leakage (Brajtburg et al., 1985; Ramos et al., 1989; Surarit and Shepherd, 1987). 
The disadvantages of the use of amphotericin B include its insolubility in water and the severe 
side effects, such as nephrotoxicity (Clements and Peacock, 1990; Pathak et al., 1998; 
Patterson, 1998). The reformulation of amphotericin B with lipid compounds in the 1990s 
considerably overcame these limitations, reducing renal toxicity and improving bioavailability 
(Juliano et al., 1987; Payne et al., 1987).  
Another category of antifungal agents used against Aspergillus is triazoles, initially 
developed in the 1980s and further developed in the 1990s, with compounds such as 
fluconazole, voriconazole and itraconazole. The mechanism of action of triazoles is based on 
the competition for oxygen between the free azole nitrogen in these molecules and the 
catalytic heme iron atom of cytochrome P-450 enzymes (De Beule, 1996; Vanden Bossche et 
al., 1980; Vanden Bossche et al., 1983; Vanden Bossche et al., 1988; Vanden Bossche et al., 
1989; Vanden Bossche et al., 1990). Inhibition of the cytochrome P-450 enzymes prevents the 
synthesis of ergosterol in fungal membranes, whose fluidity is therefore increased, and causes 
the cytosolic accumulation of other membrane components, like phospholipids and 
unsaturated fatty acids. Itraconazole is the most frequently used of the triazoles, because it 
binds only weakly to mammalian cytochrome P-450 and this reduces drastically its toxicity in 
humans. Unfortunately, there is no intravenous preparation available and absorption of 
itraconazole varies between patients. A new generation of triazoles (posaconazoles, 
isavuconazole, ravuconazole and albaconazole) is characterised by a broad spectrum of 
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activity and is thought to represent the future therapeutic alternative to overcome resistance 
(De Sarro et al., 2008). 
For decades, amphotericin B has been the standard therapy for IPA, even if responses 
were less than 40% in severely immunosuppresed patients (Denning, 1998; Stevens and 
Forgac, 1997; Patterson, 1998). In a non-comparative study, voriconazole has shown a 48% 
response rate among patients with IPA. An open, randomised trial comparing the efficacy, 
safety, and tolerability of amphotericin B and voriconazole to treat IPA in almost 400 
immunocompromised patients has shown 60% and 71% survival rate respectively for patients 
at 12 weeks of therapy (Herbrecht, 2002; Herbrecht et al., 2002). The underlying condition 
for the selection of patients with IPA for the trials was allogeneic hematopoietic-cell 
transplantation, acute leukemia, or other hematologic diseases and the study demostrated that 
in these, initial therapy with voriconazole yield better responses and improved survival, with 
less severe side effects than the standard therapy with amphotericin B. 
In addition, new antifungal treatments have been recently approved to proceed to 
clinical trials or have become available. As an alternative to the traditional therapies, 
caspofungin has now been approved for IPA treatment (Letscher-Bru and Herbrecht, 2003). 
Caspofungin belongs to the echinocandins, a new family of antifungal molecules acting on the 
fungal cell wall by inhibiting glucan synthesis, and more specifically it blocks the synthesis of 
β-(1,3)-D-glucan, by non-competitive inhibition of the enzyme β-(1,3)-D-glucan synthase. 
Caspofungin potential has been demonstrated in several trials with patients refractory or 
intolerant to previuos therapy, with a favourable response rate of 45% of 83 patients and 
infrequent drug-related nephrotoxicity and hepatotoxicity (Maertens et al., 2004). Also in a 
comparative clinical trial involving over 1000 patients with persistent fever and neutropenia, 
caspofungin has been demonstrated to be as effective and generally better tolerated in 
comparison with liposomal amphotericin B (Walsh et al., 2004).  
Despite the advances in therapy, there is a critical and urgent need for the development 
of new antifungal therapeutic agents. Infection burden remains high because of the difficulty 
to diagnose Aspergillus infections especially in the early stages of infection.    
 
1.1.4 Murine models of invasive aspergillosis 
 
Immunosuppressive regimens differentially impact fungal development and host 
response (Balloy et al., 2005), highlighting the importance of studying Aspergillus fumigatus 
pathogenesis in multiple relevant contexts of host immune status. For this reason, there are 
several different models of invasive fungal infection in use, but even considering the 
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heterogeneity in the animal models in use, it has been shown that there is a direct correlation 
between the dosage of conidia and the lethality observed, as for other fungal pathogens. Also, 
following the typical pattern in humans, different immunosuppressive regimens in animal 
models result in a different development and different characteristics of infection (Stephens-
Romero et al., 2005). The most commonly used animal models of IPA involve induction of 
neutropenia or corticosteroid-induced immunosuppression to reproduce the pre-existing 
conditions necessary for the development of the infection in humans. To explain the 
importance of the use of different immunosuppressive drugs, the most appropriate example is 
the case of the gliotoxin null mutant, which shows a completely different outcome of 
infection in different host immune status scenarios (Bok et al., 2006; Spikes et al., 2008; 
Sugui et al., 2007b; Dagenais and Keller, 2009). This mutant is characterised by wild type 
virulence in a neutropenic model, but reduced virulence in a non-neutropenic model, 
identifying gliotoxin as an important A. fumigatus virulence factor in the context of non 
neutropenic hosts. Other variables, which have been established as crucial in the context of 
the application of animal models, are the amount of spores inoculated, the route of infection 
and the type of analysis to perform (Dixon et al., 1989). Fungal infection may be performed 
following different routes such as intratracheally, intravenously or via inhalation chamber but 
the intranasal inoculation is commonly used as it mimics human infection (Sheppard et al., 
2004; Steinbach et al., 2004). Possible applications of animal models include survival 
analysis, organ pathology or histology examination, fungal burden quantification or 
measurement of host cellular response.  
The murine model of infection in use at Imperial College and utilised in this study has 
been extensively used for over 15 years (Smith et al., 1994). CD1 male mice are 
immunosuppresed by intraperitoneal injections of cyclophosphamide and by a single 
subcutaneous dose of hydrocortisone acetate. This treatment causes neutropenia in mice, 
closely mimicking the condition required to develop IPA in humans (Schrettl et al., 2004). 
Also A. fumigatus conidia are inoculated intranasally to mimic the natural route of infection. 
The resulting IPA has a clinical pattern and outcome similar to what is observed in humans, 
with a mortality greater than 80%.  
 
1.2 Aspergillus fumigatus  
 
A. fumigatus belongs to the genus Aspergillus (phylum Ascomycota) comprising 
almost 200 species of ubiquitous, saprophytic fungi. Aspergillus species are primarily 
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involved in global carbon and nitrogen recycling, and their typical niche is soil, food, 
decaying vegetation and air vents. They produce small, hydrophobic conidia, dispersed into 
the air and able to survive a wide range of environmental conditions. For this reason, the 
impact of these species on public health is of enormous importance. Several Aspergillus 
species are used in industry for the production of food and pharmaceuticals, such as A. niger, 
A. terreus and A.oryzae. Other species, particularly A. flavus and A. parasiticus are well 
known as contaminants of crops, for their production of aflatoxin, a highly toxic carcinogen 
with immunosuppressive properties (Wild, 2007). Among the human pathogenic species of 
Aspergillus, A. fumigatus is responsible for 90% of human infections, followed by A. flavus, 
A. terreus, A. niger and the model organism A. nidulans (Denning, 1998; Morgan et al., 
2005). Species are differentiated on the basis of formation, colour, shape and texture of the 
spores. In the last 30 years, A. fumigatus has emerged as one of the most important causes of 
infection related death in immunocompromised patients (Wiederhold et al., 2003). Its first 
description however appeared in 1863 in the book „Nova plantarum genera juxta Tournafortii 
methodum disposita‟ by the Italian priest and biologist Pier Antonio Micheli, who named the 
species after the instrument used for the dispersion of holy water in catholic churches, called 
aspergillum, for the similarity in shape with the fungus.   
  
1.2.1 Morphology and reproductive cycle  
 
 
 
 
 
 
 
 
 
Fig. 1.2: Morphological features of A.fumigatus (A) Microscopic morphology of Aspergillus 
fumigatus. (B) On Czapek dox agar showing typical blue-green surface pigmentation with a suede-like surface 
consisting of a dense felt of conidiophores. (C) Grocott‟s methenamine silver (GMS) stained tissue sections 
showing Aspergillus fumigatus in lung tissue, note conidial heads forming in an alveolus. From 
www.mycology.adelaide.edu.au. 
 
 A. fumigatus (Fig. 1.2) is a cosmopolitan and saprophytic fungus, essential for 
recycling of environmental carbon and nitrogen. The organism survives and grows on organic 
debris. Identification of A. fumigatus is based predominantly upon the morphology of the 
conidia and conidiophores. The green echinulate conidia are produced in chains basipetally 
A B C 
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from green phialides about 6 to 8 µm. Conidia are simply released in the air and they have a 
diameter small enough (2-3 µm) to reach the lung alveoli. A few pigmentless isolates of A. 
fumigatus producing white conidia have been discovered (Latge, 1999). The chains of conidia 
originate directly from broadly clavate vesicles (20 to 30 µm in diameter) in the absence of 
metulae. A. fumigatus grows fast and the colonies can reach 4 ± 1 cm within a week when 
grown on Czapek dox agar (CZA) at 25°C (Raper, 1965). The species is thermophilic and 
capable of growth at 37°C (human body temperature), but growth occurs at temperatures as 
high as 55°C and survival is maintained at temperatures up to 70°C (Samson, 1994). 
Differently to the original classification describing A. fumigatus as a single homogenous 
species (Raper, 1965), strains have been demonstrated to differ in cultural conditions and 
micro-morphologic characteristics, such as branched conidiophores, elongate or septate 
phialides and size or shape difference in conidia (Leslie et al., 1988; Rinyu et al., 1995).    
Conidial germination starts in the presence of water, carbon, phosphate and nitrate 
sources, and oxygen (Fortwendel et al., 2004), whereas it is inhibited under anaerobic 
conditions (Taubitz et al., 2007). Water uptake, with rehydration and growth of the cell wall, 
determines a first stage of swelling or isotropic growth. Subsequently, in preparation for DNA 
replication and mitosis, nuclear decondensation occurs and polar growth starts with the 
formation of a germ tube (Momany and Taylor, 2000). These initial steps are the same in the 
case of development in soil or within the host.      
A. fumigatus has a stable haploid genome and it sporulates abundantly, with every 
conidial head generating thousands of conidia. For many years A. fumigatus was thought to 
only reproduce asexually, because neither mating nor meiosis had ever been observed. 
However, there were various lines of evidence to support the possible occurrence of sexual 
reproduction (Dyer and Paoletti, 2005; Paoletti et al., 2005). Population genetic analyses had 
revealed a high degree of genetic variation within natural population of A. fumigatus, possibly 
as a result of sexual reproduction and recombination (Chazalet et al., 1998; Paoletti et al., 
2005; Pringle et al., 2005; Rydholm et al., 2006). The sequencing of A. fumigatus clinical 
isolate Af293 and successive studies had demonstrated the presence and expression of 
apparently functional genes required for sexual development in other ascomycete fungi 
(Galagan et al., 2005; Nierman et al., 2005; Paoletti et al., 2005). Mating types, whose role as 
transcriptional activators is crucial in governing the mating process in ascomycete fungi, had 
also been identified (Paoletti et al., 2005; Casselton, 2002; Galagan et al., 2005) and shown to 
be distributed in a homogenous 1:1 ratio of MAT1-1 and MAT1-2 in geographic areas 
(O'Gorman et al., 2009). In 2008 it was finally demonstrated that A. fumigatus possesses a 
fully functional sexual reproductive cycle (O'Gorman et al., 2009).   
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1.2.2 Genome  
 
The sequencing of the A. fumigatus genome represents a crucial milestone for the 
fungal community. The project for the whole genome shotgun sequence analysis of the A. 
fumigatus Af293 wild type isolate was started in the late 90‟s as a collaboration between the 
Sanger Institute at the University of Cambridge (www.sanger.ac.uk) and the Institute of 
Genome Research (TIGR) (www.jcvi.org). The genome sequence was finished and published 
in 2005 (Nierman et al., 2005), together with a comprehensive comparative analysis with the 
A. nidulans strain FGSC A4 and the A. oryzae RIB40 (Galagan et al., 2005; Machida et al., 
2005). The Af293 wild type isolate contains eight chromosomes, whose sizes vary from 1.8 to 
4.9 Mb for a total of 29.4 Mb with a 49.9% G + C content. The comparison with A. nidulans 
and A. oryzae indicates about 500 genes as unique to A. fumigatus (Galagan et al., 2005). 
Initially, the number of predicted protein-coding genes was estimated to be 9926 and one 
third of these, 3288, had an unknown function (Ronning et al., 2005). According to the last 
version available from February 2008, the genome of A. fumigatus contains 9630 genes. More 
recently the genome sequence of the strain A1163, a derivative of the A. fumigatus wild-type 
CEA17, has been published by TIGR, showing 99.8% identity, at the nucleotide level, with 
the Af293 wild type isolate (Fedorova et al., 2008). Currently the genomes of seven of the 
closest phylogenetic relatives of A. fumigatus have been sequenced, permitting in more detail 
the determination of A. fumigatus specific and non specific genes and families. The sequenced 
genomes include A. flavus (12,587 genes), A. oryzae (12,063 genes), A. terreus (10,406 
genes), A. niger (8,592 genes), Neosartorya fisheri (10,407 genes), A. clavatus (9,124 genes) 
and A. nidulans (10,701 genes) (Nierman et al., 2005; Baker, 2006; Galagan et al., 2005; 
Machida et al., 2005; Payne et al., 2006). Between these species, about 2% of each genome is 
specific to the Aspergillus species and there is a variability ranging from 4 to 11% for species-
specific genes.   
 
1.2.3 Putative virulence factors  
 
A. fumigatus virulence has been defined as a polygenic trait (Askew, 2008; Hohl and 
Feldmesser, 2007), being due to the unique combination of multiple contributing basic traits. 
IPA pathogenesis depends on the equilibrium between the ability of the host to overcome 
fungal invasion and the various ways by which the fungus can inactivate or escape the host‟s 
defence systems. Infection is facilitated because of the versatile nature of this organism that 
can withstand the nutritional, oxidative and other physiological stresses exerted by the host 
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niche. A. fumigatus relies on the combined and coordinated expression of genes involved in 
fungal growth, such as conidial germination, cell wall assembly, hyphal growth, nutrient 
acquisition and resistance to host-imposed stresses (Askew, 2008; Hohl and Feldmesser, 
2007).  
One aspect of this adaptation is A. fumigatus thermotolerance. Deletion of the cgrA
1
 
gene, encoding a nucleolar protein involved in ribosome biogenesis, results in the impairment 
of growth at 37°C and in the attenuation of virulence in a murine model of IPA (Bhabhra et 
al., 2004).  
Following inhalation, A. fumigatus needs to adhere to and penetrate the human 
respiratory epithelia and overcome surrounding cells response, in particular from phagocytic 
cells. The conidial surface contains protrusions, called rodlets, essential to maintain conidial 
hydrophobicity (Thau et al., 1994), but also sialic acid residues. Sialidase treatment causes 
spore agglutination and for this reason sialic acid residues exposed on the conidial surface are 
thought to be important for the dispersion of conidia and pulmonary colonisation (Warwas et 
al., 2007; Wasylnka and Moore, 2000). Accordingly, it has been shown that pathogenic 
species of Aspergillus, including A. fumigatus, contain more sialic acid residues on the 
conidia surface than other non-pathogenic species (Wasylnka and Moore, 2000). The cell wall 
in A. fumigatus is composed predominantly of α-(1,3) glucan, β-(1,3) glucan, some of which 
contains β-(1,6) branches, linear β-(1,3), β-(1,4) glucan, chitin and galactomannan (Latge et 
al., 2005). Fungal cell wall composition has also been demonstrated to play a crucial role in 
A. fumigatus virulence in immunocompromised mice (Hohl and Feldmesser, 2007), as gene 
deletions for fungal cell wall components causing an increased growth rate yield 
hypervirulent Aspergillus strains (Beauvais et al., 2005; Chabane et al., 2006; Maubon et al., 
2006; Romano et al., 2006). Cell wall maintenance and homeostasis are ensured through the 
redundancy of proteins involved in the synthesis of structural polysaccharides. In addition, 
like many other fungi, the A. fumigatus cell wall contains melanin, a protective barrier against 
UV radiation. In the context of the infection, pigment biosynthesis is useful in resisting 
phagocytosis and increasing resistance to reactive oxygen species (Brakhage and Liebmann, 
2005). A. fumigatus wild type strains deficient in pigment production have been demonstrated 
to be less pathogenic than strains with green conidia (Latge, 1999).    
                                                 
1
Following A. nidulans nomenclature, A. fumigatus gene names are italicized; complete, partial loss-of-function 
and gain-of-function (constitutive) mutants using superscripts and proteins non-italicized starting with an upper 
case letter.  
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A. fumigatus relies on crucial biosynthetic pathways evolved to counter hostility in 
ecological niches, in particular by the production of several toxic secondary metabolites (Cui 
et al., 1996a; Cui et al., 1996b; Frisvad et al., 2009). As introduced previously, gliotoxin is 
the most extensively studied secondary metabolite, especially after the elucidation of its role 
as a crucial A. fumigatus virulence factor in the context of non-neutropenic hosts. Gliotoxin, a 
metabolite of the epipolythiodioxopiperazine family (Mullbacher and Eichner, 1984; 
Mullbacher et al., 1985), is acutely toxic and has immunosuppressive properties, blocking 
phagocytosis (Waring et al., 1988) and the release of inflammatory mediators by leukocytes 
(Pahl et al., 1996), and inducing the apoptosis of neutrophils and monocytes (Frame and 
Carlton, 1988; Waring et al., 1988; Stanzani et al., 2005). Environmental A. fumigatus strains 
defective in the production of gliotoxin have been demonstrated to be less virulent than strains 
producing this secondary metabolite efficiently (Sutton et al., 1996). Deletion of gliotoxin 
differentially affects A. fumigatus virulence depending on the immunosuppressive regimen of 
the host, in particular the gliotoxin mutant is characterised by wild type virulence in a 
neutropenic model, but reduced virulence in a non-neutropenic model. Other secondary 
metabolites are fumagillin, helvolic acid and verruculogen, able, at higher concentrations, to 
damage human respiratory epithelial cells and slow ciliary beat frequency (Amitani et al., 
1995a; Amitani et al., 1995b; Botterel et al., 2002; Cody et al., 1997; Khoufache et al., 2007). 
Secondary metabolite production is strongly affected by the disruption of the predicted 
methyltransferase LeaA (Bok et al., 2005). LaeA regulates 10% of the A. fumigatus genome 
and deletion results in the attenuation of the mutant strain in mice (Sugui et al., 2007a; Perrin 
et al., 2007).  
Once overcame the resident pulmonary defences, A. fumigatus germination and hyphal 
growth ensues depending upon regulatory pathways sensing and responding to stress 
conditions, nutrient availability and other environmental conditions within the host. A. 
fumigatus can express a broad range of degradative enzymes, such as elastases and proteases, 
for the invasion of host and nutrient acquisition. For example, since elastin and collagen 
constitute  major components of lung tissues, a direct correlation has been described between 
elastase production in A. fumigatus strains and their virulence, because strains not producing 
elastase showed few germinated spores and no destruction of alveoli in murine lungs 
(Kothary et al., 1984). In general, A. fumigatus produces and secretes a series of catabolic 
enzymes, especially peptidases, to degrade macromolecular complexes and derive nutrients 
(Alp and Arikan, 2008). Acquisition of essential nutrients within the host environment, such 
as calcium, iron, zinc and nitrogen, is necessary to support sufficient growth and is therefore 
required for invasive growth. 
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Calcium (Ca
2+
) is an ubiquitous second messenger involved in many signal 
transduction pathways in eukaryotic cells (Carafoli, 2005; Cyert, 2003). In particular, in 
filamentous fungi, Ca
2+
 is important for hyphal morphogenesis (Fox and Heitman, 2002). 
Two mediators, the Ca
2+
- binding protein calmodulin and the Ca
2+
-calmodulin-activated 
protein phosphatase calcineurin, are involved in calcium signalling: (Carafoli, 2005). 
Calcineurin consists of a catalytic subunit A and a Ca
2+
-calmodulin binding domain and the 
association between these two domains is essential for functioning (da Silva Ferreira et al., 
2007; Steinbach et al., 2006; Fox and Heitman, 2002). Deletion of cnaA, the catalytic subunit 
of calcineurin, determines the attenuation of virulence in mutant strains (Steinbach et al., 
2006; da Silva Ferreira et al., 2007). As well, mutants lacking the calcineurin-dependent 
transcription factor CrzA are attenuated for virulence (Soriani et al., 2008).  
Iron is involved in many biosynthetic pathways, acting as a cofactor in many 
enzymatic reactions, and as a catalyst in electron transport systems. Its availability in the host 
environment is limited, because of the instability and toxicity of free iron and its retention as 
chelates to deprive microbes. A. fumigatus, as many other pathogens, possesses systems able 
to ensure iron acquisition in the host, the storage and the detoxification of iron, and these 
systems are crucial and necessary virulence determinants. A fumigatus utilizes two different 
mechanisms for iron acquisition: siderophore-mediated iron uptake and reductive iron 
assimilation (Schrettl et al., 2004). Siderophores are small ferric-iron-specific chelators and A. 
fumigatus produces four known siderophores. Fusaricine C and triacetylfusaricine C are 
secreted and responsible for chelation of extracellular iron, whereas ferricrocin and 
hydroxyferricrocin permit the intracellular storage of iron in hyphae and conidia, respectively 
(Eisendle et al., 2004; Haas et al., 2008). Multiple genes involved in A. fumigatus siderophore 
biosynthesis have been identified and characterised (Hissen et al., 2005; Schrettl et al., 2004), 
establishing the requirement for both the extracellular and intracellular siderophores for the 
acquisition and the storage of iron during infection (Schrettl et al., 2007).    
It has been estimated that over 300 enzymes use zinc as a catalytic or structural 
component. Zinc has also a limited bio-availability in vivo. Zinc uptake is mediated by the 
zinc-responsive transcriptional activator ZafA (Vicentefranqueira et al., 2005) and the 
regulation of zinc homeostasis has been shown to be essential for A. fumigatus pathogenicity 
in a murine model of IPA (Moreno et al., 2007). Interestingly, the interplay between iron and 
zinc metabolism in A. fumigatus has been demonstrated recently, whereby the expression of 
various genes involved in zinc homeostatic maintenance is increased as a consequence of iron 
starvation (Schrettl et al., 2008; Yasmin et al., 2009). Zinc availability is also influenced by 
pH, because the solubility of zinc decreases gradually with neutral pH.         
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Aspergillus species can use a variety of nitrogen sources and are actively involved in 
global nitrogen recycling by nitrate assimilation. In this process, environmental nitrate is 
converted into ammonium and subsequently to glutamine and glutamate. The transcription 
factor responsible for nitrate transport and assimilation is AreA. Differences in growth rate 
are evident between areA mutants and wild type strains on poor nitrogen media, and for areA 
mutants delayed growth is also observed in host tissue, although virulence is similar to that 
one of the wild type strains (Hensel et al., 1998; Krappmann et al., 2004; Krappmann and 
Braus, 2005).  
Recently, the transcriptional analysis of A. fumigatus in the early stages of infection in 
a neutropenic murine model of IPA has been performed to identify genes preferentially 
expressed during adaptation to the mammalian host niche (McDonagh et al., 2008a). This 
analysis permitted the measurement of more than 9,000 A. fumigatus genes and identified iron 
limitation, nitrogen limitation and alkaline stress as prominent stresses imposed by the host in 
the early stages of infection. In addition, it demonstrated the physical clustering of genes 
involved in infection and their preferential localisation near the chromosomes termini, in the 
telomeres. As a crucial component of this study, alkaline stress will be described in detail in 
the following paragraphs but it represents one of the host-imposed stresses A. fumigatus must 
face to adapt to the host niche, together with temperature (discussed previously) and oxygen 
limitation.  
 Several genes have been shown to be involved in A. fumigatus oxidative stress 
tolerance, such as catalases (catA, cat1 and cat2) (Calera et al., 1997; Paris et al., 2003), the 
PKA regulatory subunit PkaR (Zhao et al., 2006), the MAPK pathway (Ma et al., 2008; 
Valiante et al., 2008) and two transcription factors Yap1 and Skn7 (Lessing et al., 2007). The 
role of anti-oxidant mechanisms in A. fumigatus pathogenicity is still debated because only 
some null mutants of the aforementioned genes have shown an attenuation of virulence. Also, 
in the previously cited study of A. fumigatus adaptation in a murine model of IPA, it was not 
possible to demonstrate a significant overlap between genes differentially expressed in vivo in 
the early-stages of infection and in vitro in anaerobic conditions (McDonagh et al., 2008a).   
  
1.3 The PacC/Rim101p signalling pathway for adaptation to environmental 
pH stress  
 
All microorganisms, in particular those inhabiting mammalian niches during infection, 
need to be able to adapt to the pH of the surrounding environment. Especially for organisms 
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growing over a wide pH range, adaptation implies the maintenance of internal pH 
homeostasis but also the appropriate expression of genes involving functions at the cell 
surface or in the environment. These genes include permeases, secreted enzymes, enzymes 
involved in synthesis of exported metabolites (i.e. toxins and antibiotics) and enzymes post-
translationally modifying secreted proteins. The main genetic regulatory system involved in 
ambient pH regulation is widespread in the fungal kingdom and was first recognised more 
than 20 years ago (Caddick et al., 1986c). Since then, ambient pH regulation of gene 
expression has been extensively studied (Caddick and Arst, 1986; Caddick et al., 1986a; 
Caddick et al., 1986b; Arst, 2003; Arst Jr and Peñalva, 2003; Penalva and Arst Jr, 2002; 
Peñalva and Arst Jr, 2004; Peñalva et al., 2008), especially in the ascomycete A. nidulans, 
where genetic manipulations are easily achievable (Pontecorvo et al., 1953; Dorn, 1965b; 
Dorn, 1965a; Arst, 1967; Arst et al., 1980; Arst et al., 1994), in contrast to A. fumigatus.  
The system for the regulation of gene expression according to environmental pH is an 
essential requisite for microorganisms growing over a broad range pH. A. nidulans, which 
grows over a range of pH from 2.5 to 9.0, is the fungal species where the pH regulatory 
system was identified in the first instance (Caddick et al., 1986c). In 1965, some A. nidulans 
mutants defective in the production of phosphatases were isolated (Dorn, 1965b; Dorn, 
1965a). Some of these mutants were called pal and other pac, missing respectively alkaline 
phosphatase or acid phosphatase activities. The link between these mutants and the regulation 
of gene expression by ambient pH was not demonstrated until 1986, when the mutations in 
the pal and pac genes were attributed to a defective regulation of gene expression by pH 
(Caddick et al., 1986c). In the same study, it was also shown that pH regulation is not only 
limited to phosphatase genes, but it is important for other genes and activities such as γ-
amino-n-butyric acid (GABA) uptake by the GABA permease gene, gabA, and sensitivity to 
neomycin and molybdate (Caddick et al., 1986c). Mutations affecting pH regulation were 
categorised mainly into two categories, according to their phenotypic effects: alkalinity-
mimicking and acidity-mimicking mutations. The alkalinity-mimicking mutations, 
irrespective of ambient pH, show a pattern of gene expression similar to the wild type 
growing under alkaline conditions, for example with the reduction of GABA transport and 
acid phosphatase levels, the increase of alkaline phosphatase, molybdate resistance and 
neomycin hypersensitivity. The opposite phenotype, with the prevention or the reduction of 
growth at alkaline pH, the increase of GABA transport and acid phosphatase levels, the 
decrease of alkaline phosphatase, molybdate hypersensitivity and neomycin resistance, is 
shown by the acidity-mimicking mutations. These mutations lead, irrespective of ambient pH, 
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to a pattern of gene expression similar to the wild type growing under acidic conditions 
(Caddick et al., 1986c; Mingot et al., 1999; Tilburn et al., 1995).   
The genes involved in pH regulation were named pacC and palA, palB, palC, palF, 
palH and palI; pacC was proposed to encode a transcriptional regulatory factor, activator of 
alkaline-expressed genes and repressor of acid-expressed genes (Caddick et al., 1986c; 
Tilburn et al., 1995).  
 
1.3.1 pH regulation in Aspergillus nidulans   
 
In the model developed in A. nidulans, seven genes are involved in pH regulation (Fig. 
1.3): pacC, encoding a transcription factor which activates genes expressed in alkaline 
conditions and represses those expressed in acid conditions, and palA, palB, palC, palF, palH 
and palI, whose products transmit the alkaline ambient pH signal to PacC (Arst et al., 1994; 
Caddick et al., 1986c; Denison et al., 1995; Denison et al., 1998; Fernández-Martinez et al., 
2003; Maccheroni et al., 1997; Negrete-Urtasun et al., 1997; Negrete-Urtasun et al., 1999; 
Tilburn et al., 1995). Normal functioning of the A. nidulans pH regulatory system requires the 
integrity of all these genes, as confirmed by phenotypic consequences of loss-of-function 
mutations. Null mutations in any of the pal genes of the pH signal transduction pathway, and 
in some pacC mutants, have an acidity-mimicking phenotype (Arst et al., 1994; Caddick et 
al., 1986c; Denison et al., 1995; Denison et al., 1998; Fernández-Martinez et al., 2003; 
Maccheroni et al., 1997; Negrete-Urtasun et al., 1997; Negrete-Urtasun et al., 1999; Tilburn 
et al., 1995). 
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Fig. 1.3: Schematic representation of pH regulation in A. nidulans. The shift to alkaline pH causes 
the signal for PacC processing to be transmitted from the plasma membrane to the endosomal membrane 
complex involving the endocytosis of PalH and/or PalF and the participation of PalC. The full-lenght PacC 
protein (PacC
72
), bound by PalA, undergoes signalling proteolysis by the cysteine protease PalB, which removes 
the negatively acting C-terminus to form the intermediate-lenght (PacC
53
). PacC
53
 conformation is recognised by 
the pH-independent processing protease, likely the proteasome, which forms PacC
27
. This form of PacC is the 
activator of alkaline-expressed genes and repressor of acid-expressed genes. Modified from Peñalva et al., 2008. 
 
The 72-kD translation product PacC
72
 contains 674 amino acids (Mingot et al., 1999; 
Tilburn et al., 1995). Translation starts at the Methionine codon 5 of the open reading frame 
(Mingot et al., 1999), but residues are counted from the first Met codon 1 to avoid 
inconsistency between the publications. This 674-residue full-length form of PacC (PacC
72
) is 
predominant at acidic conditions. Three interacting regions keep PacC
72
 in an apparently inert 
“closed” form, preventing proteolytic processing (Espeso et al., 2000). In neutral-to-alkaline 
conditions, PacC
72 
is processed by two successive proteolytic cleavages, although the 
formation of a small amount of the processed form occurs independently of pH signal. The 
first (signalling) proteolysis is dependent on pH-signal transduction and occurs within the 
conserved 24-residue “signalling protease box” removing ~180 C-terminal residues and 
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yielding the intermediate PacC
53 
(Diez et al., 2002). The second (processing) proteolysis is 
pH-independent and catalysed by the proteasome (Hervas-Aguilar et al., 2007), removing 
further ~245 C-terminal residues; this cleavage leaves the zinc-finger region intact and yields 
the processed PacC
27
 form, repressor of acid-expressed genes and activator of alkaline-
expressed genes (Diez et al., 2002; Orejas et al., 1995; Mingot et al., 1999). Within the 
PacC
27
 processed form lies the DNA binding domain (DBD) composed of three Cys2His2 zinc 
fingers; among these only the second and the third contact the DNA-binding site (consensus 
5‟ –GCCARG) (Espeso et al., 1997; Fernández-Martinez et al., 2003; Tilburn et al., 1995). A 
nuclear localisation signal overlaps with the third zinc finger (Fernández-Martinez et al., 
2003) and both PacC
27
  and PacC
53
, but not PacC
72
, are preferentially localised in the nucleus 
(Mingot et al., 1999; Fernández-Martinez et al., 2003). 
Acidity-, alkalinity- and neutrality-mimicking mutations have been isolated for pacC 
(Arst et al., 1994; Caddick et al., 1986c; Diez et al., 2002; Espeso et al., 1997; Espeso et al., 
2000; Fernández-Martinez et al., 2003; Mingot et al., 1999; Orejas et al., 1995; Tilburn et al., 
1995; Vincent et al., 2003). Alkaline-mimicking pacC
c
 (PacC constitutive) mutations remove 
or inactivate, by amino acid(s) substitution, one or more of the interacting regions, leading to 
PacC processing independently of ambient pH. Acidity-mimicking pacC
-
 mutations include 
frameshift and polypeptide chain termination mutations truncating PacC upstream of, or 
within, the DBD or single amino acids substitutions preventing DNA binding, or gene 
replacement removing the entire coding region (Espeso and Penalva, 1996; Espeso et al., 
2000; Vincent et al., 2003). pacC
- 
mutations also demonstrate cryosensitivity, poor growth 
and reduced conidiation at permissive temperatures (Tilburn et al., 1995).  
In the model established for A. nidulans, establishment of the ambient pH signal 
involves the connection between two complexes, the first one of which comprises the two 
plasma membrane proteins PalH and PalI and an arrestin-like protein PalF and the other is 
composed of PacC, a cysteine protease PalB, a scaffold PalA, PalC and endosomal 
components (Peñalva et al., 2008).  
The plasma membrane signalling complex contains a seven-transmembrane domain 
(TMD) protein PalH, the arrestin PalF and, very likely, the three-TMD protein PalI 
(Calcagno-Pizarelli et al., 2007; Herranz et al., 2005; Negrete-Urtasun et al., 1999).  
palH encodes the predicted transmembrane protein PalH, candidate for sensor protein 
of ambient pH. PalH contains seven transmembrane domains and a long, hydrophilic C-
terminus located in the cytosol. These analogies have raised the possibility of the involvement 
in pH signalling of G-protein coupled receptors (GPCRs) (Herranz et al., 2005), a group of 
transmembrane receptors involved in transmitting outside stimuli inside the cells.   
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palF encodes the non-metazoan arrestin protein PalF, representing the first of its kind 
identified in fungi (Herranz et al., 2005). Metazoan arrestins are known to down-regulate or 
facilitate the signalling from seven-TMD receptors to downstream regulatory proteins 
(Lefkowitz and Shenoy, 2005). The hydrophilic C-terminal part of PalH interacts strongly 
with the arrestin-like protein PalF. palF and palH mutations preventing this interaction 
prevent pH signalling as well (Herranz et al., 2005). These findings strongly indicate PalH as 
one, perhaps the only, essential component of a plasma membrane receptor.  
palI encodes the predicted transmembrane protein PalI, as well candidate for sensor 
protein of ambient pH, which contains three putative membrane-spanning domains with an N-
terminal signal peptide and the basic C-terminus facing the cytosol (Calcagno-Pizarelli et al., 
2007). Unlike the null mutants of other pal genes, null palI mutants grow, though poorly, at 
alkaline pH (Denison et al., 1995), suggesting an important, but not essential role for PalI in 
pH signalling. The function of PalI is suggested as assisting the plasma membrane localisation 
of PalH (Calcagno-Pizarelli et al., 2007) by three possible mechanisms, which are still under 
investigation, namely down-regulation of PalH endocytosis, up-regulation of PalH recycling 
or assistance of PalH exit from the Golgi. Co-overexpression of PalI redirects GFP-tagged 
PalH (PalH-GFP) to the plasma membrane which otherwise, when overexpressed, it is 
predominantly assembled in internal punctate structures (Calcagno-Pizarelli et al., 2007). 
Overexpression of PalH also allows almost wild type growth of palI mutants at alkaline pH, 
as expected if in these mutants the physiological quantity of PalH is unable to populate 
sufficiently the plasma membrane without the assistance of PalI (Calcagno-Pizarelli et al., 
2007). Each of the three possibilities could require an interaction between PalH and PalI, 
either direct or indirect, but this has not been investigated (Peñalva et al., 2008).  
Recent work has shown an unexpected role in pH signal transduction for most, but not 
all, the components of the multivesicular body pathway cargo-sorting protein complexes. 
Endocytosis is a process, occurring in every eukaryotic cell, by which cells internalize 
portions of their lipid membrane with embedded proteins. After the internalisation in 
endocytic vesicles, membrane proteins (e.g. plasma membrane receptors, ion channels or 
nutrient uptake systems) are recycled from endosomal compartments to the plasma 
membrane, or sent to the vacuole, the fungal equivalent of the metazoan cell lysosome, for 
proteolytic degradation. Initially this mechanism was associated with the down-regulation of 
plasma membrane receptors, but plasma membrane receptors do not always reach the vacuole 
but instead stay in the endosome suggesting this association could promote, rather than 
prevent, signalling, as shown by a growing number of examples. Among these, there is the 
pH-signalling pathway, where the positive-acting association between endocytosis and 
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signalling putatively connects two spatially separated complexes, located at the plasma 
membrane and on endosomal membranes (Di Fiore PP, 2001; Katzmann et al., 2002).  
The proposed endosomal membrane complex comprises PacC, a cysteine protease of 
the calpain family PalB (Denison et al., 1995), a scaffold PalA (Peñalva and Arst Jr, 2004) 
and endosomal components. palB encodes the protease PalB, showing similarity to calpains 
(Denison et al., 1995). Calpains are calcium-activated cysteine proteases, catalysing the 
modifications of substrates, such as transcription factors (Hirai et al., 1991). Although it 
shows no similarities with other domains in conventional calpains (Sorimachi et al., 1997), at 
the time of its discovery, PalB was the first example of a calpain involved in a specific signal 
transduction pathway. palA encodes the protein PalA, whose mammalian homologue 
AIP1/Alix interacts with the apoptosis-linked protein ALG-2, recognising the protein-protein 
binding motif called YPXL/I (Vincent et al., 2003). PacC contains two of these motifs next to 
the signalling protease cleavage site (Vincent et al., 2003). palC encodes the protein PalC, the 
last component of the ambient pH signalling pathway to be characterised (Galindo et al., 
2007). PalC is distantly related to Saccharomyces cerevisiae pheripheral endosomal sorting 
complexes required for transport III (ESCRT-III) protein Bro1p.  
pH signal transduction, culminating with PacC cleavage by the signalling protease, 
requires the binding of PalA to the two YPXL/I motifs at either side of the signalling box in 
PacC
72 
(Vincent et al., 2003). The Bro1 domain-containing protein PalA, like its mammalian 
homologue AIP1/Alix, interacts also with Vps32p/Snf7p
2
, a component of the endosomal 
complex required at a late stage in the multivesicular body pathway (Vincent et al., 2003). 
Work with S. cerevisiae suggests a role for this protein in the pH signal transduction pathway. 
PalA might serve as an adapter to link PacC to a multiprotein complex on the cytosolic side of 
the endosomal membrane (Xu and Mitchell, 2001; Xu et al., 2004). PalB is a cysteine 
protease of the calpain family, most likely the signalling protease, which removes the 
negatively acting C-terminus to form PacC
53
 (Mingot et al., 1999; Denison et al., 1995; 
Sorimachi et al., 1997). PalB has been excluded as the protease effecting the second 
(processing) proteolysis of PacC, since a palB
- 
mutant is not able to prevent the processing of 
a pacC
- 
mutant lacking the 214 C-terminal residues (Denison et al., 1995). In S. cerevisiae, a 
demonstrated interaction between Vps32p and the yeast PalB homologue Rim13p suggests 
                                                 
2
 Following S. cerevisiae nomenclature, S. cerevisiae gene names are instead italicized and in upper case, loss-
of-function mutants in lower case and italicized and proteins non-italicized, starting with an upper case letter and 
ending with „p‟.   
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that Vps32p might act like a scaffold in the protein complex in which Rim20p/PalA recruit 
the protease Rim13p/PalB to its Rim101/PacC substrate (Ito et al., 2001).  
Understanding the links between the two complexes has been possible with the recent 
works on PalF and PalC, until then the most enigmatic of the pH-signalling proteins (Herranz 
et al., 2005; Galindo et al., 2007). PalF is phosphorylated and multi-ubiquitinated depending 
on alkaline ambient pH in a PalH- and partially PalI- but not PalA-, PalB-, PalC-dependent 
manner (Herranz et al., 2005). The participation of the arrestin-like protein PalF in this 
pathway strongly supports the involvement of endocytosis for pH-signal transduction, 
because mammalian arrestins specifically bind to the seven-TMD receptors promoting their 
endocytosis (Lefkowitz and Shenoy, 2005). As demonstrated by PalC-GFP localisation 
experiments, in alkaline conditions PalC is recruited and assembled in puntate structures 
associated with the plasma membrane; these cortical punctuate structures have been shown to 
depend on the presence of PalH but not of PalA and therefore hypothesised to be the sites of 
PalH-PalF signal-dependent interactions (Galindo et al., 2007). PalC is therefore likely to act 
later in the pH signalling pathway than PalH but earlier, or concomitant with PalA action. As 
shown by two-hybrid interaction assays, PalC contains a Bro1-like domain supporting its 
interaction with Vps32 and this interaction has been demonstrated to be essential for pH 
signalling (Tilburn et al., 1995; Galindo et al., 2007). Given its ability to localize in cortical 
puntate structures and to bind to Vps32, PalC has the expected characteristics required to link 
the two complexes involved in pH regulation. As recently suggested in Peñalva et al., 2008, 
an attractive hypothesis is that, after PalF-mediated internalisation, the plasma membrane 
complex recruits PalC, which functions as a guide to the endosomal membranes containing 
PalA and PalB.  
PacC
27 
binds to target sites in the promoter of genes expressed preferentially at 
alkaline ambient pH to activate their expression and to target sites of those genes 
preferentially expressed at acidic ambient pH to prevent their expression (Espeso and 
Penalva, 1996; Espeso and Arst Jr, 2000; Tilburn et al., 1995). The main categories in which 
identified ambient pH-regulated A. nidulans genes are classified are three: those encoding 
secreted enzymes (pacA, xlnA, xlnB, abfB), those encoding permeases (gabA), and those 
encoding enzymes involved in the synthesis of exported metabolites (ipnA) (Penalva and Arst 
Jr, 2002; Peñalva and Arst Jr, 2004). Two new categories have been added recently: enzymes 
involved in transcriptional modification of secreted enzymes and enzymes catalysing 
reactions to yield energy (Peñalva et al., 2008). Each of these genes contains multiple 
consensus sites in the promoter region for the recognition by PacC. The regulation of the 
genes ipnA and gabA has been studied extensively in A. nidulans, demonstrating the ability of 
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PacC of acting either as an activator or a repressor of gene expression. ipnA encodes the 
isopenicillin N synthetase, whose expression is directly activated by PacC in alkaline 
conditions (Espeso and Penalva, 1996). gabA encodes the GABA permease, whose expression 
is instead repressed by PacC as consequence of the competitive binding for overlapping target 
sites with the transcription factor IntA, positive regulator of the expression of ω-amino acids 
(Espeso and Arst Jr, 2000).  
Significantly, pacC is itself preferentially expressed at alkaline pH, following a 
mechanism of positive feedback that amplifies the response to alkaline conditions (Tilburn et 
al., 1995). Recent works include also genes involved in the siderophore biosynthesis pathway 
(Eisendle et al., 2004). The expression of the genes sidA, mirA and mirB, involved in 
siderophore biosynthesis and iron uptake, has been demonstrated to depend both on iron and 
pH control. The consensus sites for PacC and SreA, the iron regulator, do not overlap in these 
genes, indicating the independence of the two regulatory pathways, because the two 
transcription factor do not compete for the same binding site (Eisendle et al., 2004).    
 
1.3.2 What is known about pH signalling in the other fungal species and its role in fungal 
virulence? 
 
Homologues of A. nidulans pacC have been identified in numerous filamentous 
ascomycetes, such as A. niger (MacCabe et al., 1996), A. oryzae (Machida et al., 2005), A. 
fumigatus (Nierman et al., 2005), Penicillum chrysogenum (Suarez and Penalva, 1996), 
Acremonium chrysogenum (Schmitt et al., 2001) and Sclerotinia sclerotiorum (Rollins and 
Dickman, 2001). The regulatory system has also been demonstrated to be present in the 
budding yeast S. cerevisiae (Su and Mitchell, 1993a; Su and Mitchell, 1993b) and in the two 
dimorphic yeast Candida albicans (Davis et al., 2000b) and Yarrowia lipolytica (Lambert et 
al., 1997), where pacC homologue is called RIM101. In fungi, one of the main conserved 
transduction pathway involved in adaptation to environmental pH is focused on the 
proteolytical activation of PacC/Rim101p. Fungal pathogens share the necessity to respond to 
chemical and physical stresses to accomplish infection and the appropriate response to 
ambient pH is fundamental for fungal virulence in plants, insects and animals.  
Initially, the importance of pH adaptation during mammalian infection was shown in 
C. albicans (De Bernardis et al., 1998; Davis et al., 2000a; Davis, 2003). It was demonstrated 
that C. albicans virulence is attenuated according to the pH of the host niche (systemic or 
vaginal colonisation are possible) in the absence of the pH regulated cell surface 
glycoproteins Phr1 and Phr2, which are functionally redundant but essential for growth (De 
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Bernardis et al., 1998). For this opportunistic pathogen, the ability to shift between the two 
different morphological forms is essential for virulence and environmental pH has been 
demonstrated to function as a powerful signal for morphological differentiation. Yeast growth 
is favoured at acidic pH, whereas hyphal growth is favoured in alkaline or neutral conditions 
(Davis, 2003). Highlighting the role of CaRIM101 in C. albicans pathogenesis, the Δrim101 
mutant shows significant reduction in virulence in a mouse model of systemic candidiasis and 
impaired kidney damage compared to the wild type. Since this pathway is not present in 
mammals, it could represent not only an important contribution to fungal virulence but also a 
novel target for the development of antifungal therapies. To support the targeting of pH 
adaptation aiming to inhibit fungal growth in the host, studies in S. cerevisiae have shown that 
the perturbation of the pH regulatory system determines the hypersensitivity to fluconazole 
(Parsons et al., 2004).   
As previously introduced, Aspergillus pathogenicity is the result of a multitude of 
attributes that the causative fungi possess to deal successfully with the physical conditions 
within the host and its defences. A significant role is likely played by adaptation to 
physiological pH, over the wide range of changes infections Aspergillus species have to face, 
not only within the pulmonary niche but also as a result of phagocytosis by macrophages or 
ingestion by neutrophils and exposure to their vacuole contents (Ibrahim-Granet et al., 2003; 
Levitz et al., 1999; Newman, 1999; Reeves et al., 2002). First evidence of the coupling of 
virulence and pH signal transduction was provided by studies of murine intraperitoneal 
administration of A. nidulans, marking the correlation between the production of alkaline 
phosphatase and virulence (Purnell and Martin, 1971). This species is of clinical importance 
for patients with CGD, an inherited condition characterised by the inability of the phagocytes 
to generate reactive antimicrobial oxidants (Dotis et al., 2003; Dotis and Roilides, 2004; 
Johnston, 2001; Segal et al., 1998). Recently it has been demonstrated that murine 
aspergillosis requires integrity of A. nidulans pacC (Fig. 1.4): elimination of A. nidulans PacC 
strongly attenuates virulence in neutropenic mice (Bignell et al., 2005). Not only the presence 
of A. nidulans pacC, but also its proteolytic processing and the upstream Pal proteins 
mediating pH-sensing are essential for murine pathogenicity. Mutants where the ambient pH 
signal transduction pathway is blocked or PacC proteolytic processing is prevented are 
attenuated for virulence and the infection in neutropenic mice is characterised by reduced 
growth in vivo and reduction of inflammatory infiltrate (Bignell et al., 2005). On the contrary, 
constitutive activation of PacC determines extensive tissue invasion by the fungal mycelia, 
leading to an increased murine mortality (Bignell et al., 2005). 
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Fig. 1.4: Histological analysis to compare the growth of A. nidulans wild type strain (pacC
+
), pacC
-
, palB
-
, and pacC
c
 mutants in the neutropenic murine lung. Murine lung sections sampled at 40 h post-
infection, paraffin-embedded and stained with Grocott‟s Methenamine Silver. (E) bronchiolar epithelium. From 
Peñalva et al., 2008. 
 
The components for alkaline adaptation in A. nidulans are highly conserved in A. 
fumigatus (Arst, 2003; Bignell et al., 2005; Peñalva and Arst Jr, 2004). However, the 
mechanism leading to the activation of this regulatory pathway has not yet been characterised 
extensively in A. fumigatus and especially the elucidation of its role during infection is still 
unexplored by the current literature. Because of the conserved nature of the pathway 
throughout the fungal kingdom, proteins involved in pH adaptation in A. fumigatus might 
indeed represent novel targets for the development of antifungal drugs, in particular if 
localised in the plasma membrane or involved in plasma membrane protein-protein 
interactions.     
 
1.4 Fungal DNA microarray studies  
 
Microarrays are a powerful instrument to monitor relative expression levels for a 
multitude of genes at the same time and permit therefore the characterisation of various 
processes. Thus, the development of microarray represents one of the most important and 
innovative scientific invention in the 1990s (Schena et al., 1995; Shalon et al., 1996). DNA 
microarrays consist of grids of nucleic acids (probes), synthesised and immobilised on a solid 
substrate (slide) as discrete features or spots. Each slide is therefore composed of tens of 
thousands of spots, each containing tens of millions of identical DNA molecules. According 
to the microarray terminology, the target is the sequence of interest, fluorescently labelled and 
hybridised to the probe slide. The hybridisation results in an increase in fluorescence over the 
background level measured by a fluorescent scanner (Miller and Tang, 2009). Microarrays 
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differ according to the nature of the probe, the support used and the method for hybridisation 
and detection. mRNA level detection relies upon the hybridisation of two complementary 
single-stranded nucleic acid molecules (either DNA or RNA). In the microarray analysis, this 
principle is applied on a large scale permitting the analysis of thousands of gene transcripts in 
parallel. DNA microarrays have been utilised for a variety of applications, including 
quantitative (gene expression) and qualitative (diagnostic) ones. The most popular use is 
probably for the comparison of gene expression levels in two different samples or the same 
sample in two different conditions via differential labelling (usually with the fluorochromes 
Cy3 and Cy5) and competitive hybridisation to the same slide.  
DNA microarray analysis is in general a complicated process, articulated in multiple 
stages, all requiring a high level of organisation, skills and time to assure the best results in 
measuring, comparing and interpreting gene expression levels properly. A typical DNA 
experiment consists of two major stages: material processing and data collection, and 
information processing. The first stage involves the array preparation, the sample extraction 
and labelling, the hybridisation of the labelled extracts to the array, and the image acquisition. 
The second stage is basically the interpretation of the results, with the conversion of the 
image(s) in quantitative measurements of fluorescent intensities, the data normalisation and 
integration, and the analysis.  
 
1.4.1 Review of the relevant fungal DNA microarray studies   
 
Since the development of DNA microarrays, multiple studies in filamentous fungi 
have been based on the comparison of gene expression levels. In 2007 the number of these 
studies was estimated to be fifty (Breakspear and Momany, 2007), but further studies are now 
frequent due to the recent completion of several fungal genomes. The first reported 
application of DNA microarrays for the fungal kingdom was for the budding yeast S. 
cerevisiae (DeRisi et al., 1997; Lashkari et al., 1997), but since then studies in filamentous 
fungi have covered a variety of biological processes, such as metabolism and secretion of 
secondary metabolites, development and pathogenesis (Breakspear and Momany, 2007).  
Within the context of A. fumigatus biology and pathogenicity, some interesting studies 
have focused on the mechanisms of adaptation to the physical conditions within the host and 
its defences. For example, as already mentioned, the secretion of secondary metabolites is an 
important virulence factor for the Aspergillus species. Because of its crucial role in the 
regulation of secondary metabolite production (Bok et al., 2005), LaeA has been the subject 
of multiple DNA microarray studies. The transcriptional profiles of the ΔlaeA mutant in 
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comparison with the respective wild type have been studied both in vitro (Perrin et al., 2007) 
and in vivo using a neutropenic murine model of IPA (Cairns et al., unpublished). In 
particular, the in vitro transcriptional profiling analysis has indicated that LaeA influences the 
expression of at least 9.5% of A. fumigatus genome and between 20 and 40% of the genes 
involved in secondary metabolite production (Perrin et al., 2007). Among other aspects 
crucial for A. fumigatus adaptation to the host, thermotolerance has also been investigated, 
comparing A. fumigatus transcriptional profiling for temperatures typical of pathogenic 
(37°C) and non-pathogenic (30°C and 48°C) environments (Do et al., 2009; Nierman et al., 
2005). Host temperature has been excluded as the only determinant of virulence-related genes 
expression, as no genes previously identified as necessary for virulence were demonstrated to 
be up-regulated at 37°C (Nierman et al., 2005). Interestingly, an inverse correlation between 
heat-shock and central metabolic pathway genes has been revealed, i.e. regulation of 
metabolic genes by heat shock proteins appear stronger at 37°C than at 48°C, suggesting a 
feed-forward loop of regulation by the first category on the second one (Do et al., 2009). 
Accordingly, exit from dormancy was associated with the change from fermentative to 
respiratory metabolism (Lamarre et al., 2008). Finally, an interesting DNA microarray 
analysis focused on A. fumigatus response to the attack by host cells, comparing gene 
expression from conidia and hyphae exposed to neutrophils, both from healthy donors and 
from patients with CGD and identifying oxidative stress, reductive iron assimilation and 
metabolic reprogramming as crucial in the context of adaptation to and surviving host attack 
(Sugui et al., 2008). DNA microarray analyses of A. fumigatus during murine infection are 
emerging as a consequence of overcoming the difficulties in obtaining RNA from the sites of 
infection in sufficient quantity. The most interesting application for the purpose of this study 
is the previously cited transcriptional analysis of A. fumigatus in the early stages of infection 
in a neutropenic murine model of IPA (McDonagh et al., 2008a). Measuring more than 9,000 
A. fumigatus genes, this study identified iron limitation, nitrogen limitation and alkalinity as 
prominent stresses imposed by the host in the early stages of infection and it has showed the 
preferential clustering of genes involved in infection and their preferential localisation in the 
telomeres.  
Adaptation to environmental pH for fungal species and the role of this pathway in 
virulence have been extensively studied via DNA microarrays especially in S. cerevisiae and 
C. albicans. Time course analyses have followed temporal scale gene expression during 
transitions from normal pH to mid-alkaline (pH 7.6) (Serrano et al., 2002) and alkaline 
conditions (pH 7.9-8.0) (Causton et al., 2001) in S. cerevisiae and from normal pH to alkaline 
(pH 7.9-8.0) (Bensen et al., 2004) conditions in C. albicans. Several genes involved in pH 
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homeostasis were up-regulated, but also genes involved in cell wall biogenesis and in the 
uptake, mobilisation and utilisation of important ions such as calcium, iron and copper, to 
counter the limited bioavailability of nutrients. Recently, a similar study has been performed 
in A. fumigatus, delineating the temporal response of this species to an alkaline shift in vitro 
and comparing it to high concentration of Ca
2+
 (Loss et al., unpublished).        
 
1.5 Saccharomyces cerevisiae: a model organism for fungal research 
 
The yeast S. cerevisiae has been largely used as a model system to investigate 
biological processes such as cell cycle, signalling, DNA replication and protein translation. In 
the context of this study, it has been also demonstrated to be an important tool for the 
investigation of protein-protein interactions.  
The ascomycete S. cerevisiae was first described by Hansen in 1883 and is commonly 
isolated from human, mammals, birds, wine, beer, fruits, trees, plants and soil. The name 
"Saccharomyces" from Latinised Greek combines the words “saccharo” for sugar and 
“myces” for fungus and means "sugar mold" or "sugar fungus", whereas cerevisiae comes 
from Latin and means "of beer". This microorganism conducts the most common type of 
fermentation and for this reason has been, since ancient time, the most useful yeast because of 
its application in baking and brewing. Thus, it is also known as “baker‟s” or “brewer‟s” yeast. 
The shape of S. cerevisiae cells is round to ovoid and the diameter varies from 5 to 10 µm. S. 
cerevisiae can exist in the haploid or diploid form, with one or two copies of the genome 
respectively. In either case, it reproduces by forming buds by mitosis and from this derives 
the denomination “budding yeast”. In the haploid form, cells can occur in two different 
mating types (a or α) and the type depends on the expression of genes in the active mating 
type locus. Haploid cells can survive indefinitely in this form. However, in case of contact 
with cells of opposite mating types, haploid cells can fuse to enter the diploid phase of the cell 
cycle. Diploid cells are more resistant to stressful conditions or nutrient starvation and 
undergo meiosis with the formation of four haploid spores contained in asci. In more 
favourable conditions, the germination of the spores generates four haploid yeast cells, two 
for each mating type.  
S. cerevisiae possesses several traits required for a good model organism, such as 
small size, short generation time, easy of manipulation and genetics, and conservation of 
mechanisms with higher organisms. In addition, S. cerevisiae can be easily cultured on 
defined media at low cost. In its haploid form, S. cerevisiae is small and has a short 
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generation time (doubling time 1.5–2 hours at 30°C). The simple life cycle is ideal for 
classical genetic analysis; detailed genetic maps of the haploid set of sixteen chromosomes 
are therefore available. S. cerevisiae was the first eukaryotic organism whose genome was 
completely sequenced (Goffeau et al., 1996). The genomic sequence was released on April 
24, 1996 and since then continuously updated in the Saccharomyces Genome Database 
(SGD). This database is highly annotated and cross-referenced and represents an important 
resource for the scientific community. Another important S. cerevisiae database is held by the 
Munich Information Center for Protein Sequences (MIPS). S. cerevisiae genome is one of the 
smallest among well studied eukaryotes; it is composed of about 12.2 Mb, encoded on 16 
chromosomes. The 16 chromosomes contain 6,275 genes but only about 5,800 of these are 
believed to be functional genes. The percentage of homology with human genes is estimated 
to be about 23%, therefore many proteins important in human biology were first discovered 
by studying their homologues in yeast. Interestingly, it can be transformed permitting the 
addition or deletion of genes of interest through homologous recombination. An interesting 
example of the easy genetic manipulation achievable in S. cerevisiae is the construction of 
multiple genome-wide gene knock out (KO) collections (Winzeler et al., 1999; Winzeler et 
al., 2000). Of particular interest for this study is the Saccharomyces Genome Deletion Project 
(SGDP) knockout library that contains 4811 disruption mutants for most of the non-essential 
S. cerevisiae genes. Furthermore, S. cerevisiae presents the same complex internal cell 
structure of plants and animals but without the high percentage of non-coding DNA typical in 
higher eukaryotes.  
S. cerevisiae has also been the organism of choice for methods that detect novel 
protein-protein interactions. Indeed, for the purpose of this study, S. cerevisiae is confirmed 
as a crucial model organism for studying conserved features of fungal pH regulatory pathway. 
As introduced in the previous paragraphs, important contributions to the understanding of the 
pH regulation were achieved by studies in S. cerevisiae. Among these, there is the first 
demonstration of a PalA family member to interact with a PacC family member and the first 
evidence of the involvement of the endocytic pathway in pH transduction and in particular of 
Vps32p/Snf7p (Arst, 2003; Xu and Mitchell, 2001; Xu et al., 2004; Hayashi et al., 2005).   
 
1.5.1 pH regulation in S. cerevisiae 
 
Rim101p, formerly known as Rim1p (regulator of Ime2p) is the S. cerevisiae 
homologue of PacC and has been demonstrated to be a positive regulator of sporulation, 
invasive growth, ion tolerance and acquisition, alkaline pH adaptation and certain cell wall 
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characteristics (Denison, 2000; Hayashi et al., 1998; Lamb et al., 2001; Lamb and Mitchell, 
2003; Li and Mitchell, 1997). Rim101p was first discovered as a positive regulator of meiosis, 
via stimulation of the transcription of Ime1p. IME1 encodes a positive-acting transcription 
factor, which activates numerous meiotic genes, such as the kinase-encoding gene IME2 (Su 
and Mitchell, 1993a; Su and Mitchell, 1993b). Like its A. nidulans homologue, Rim101p 
contains three zinc fingers (Su and Mitchell, 1993b). Similarly to the PacC regulatory 
pathway, in S. cerevisiae the gene products are called Rim13p (the S. cerevisiae calpain-like 
protease) (Futai et al., 1999; Su and Mitchell, 1993a), Rim20p (the protease scaffold) (Xu and 
Mitchell, 2001), Rim9p and Rim21p (the putative transmembrane proteins PalI and PalH) 
(Denison et al., 1998; Li and Mitchell, 1997) and Rim8p (the arrestin-like protein)(Su and 
Mitchell, 1993a). Recently a PalC homolog has been identified in yeast, likely to be 
YGR122wp (Barwell et al., 2005; Rothfels et al., 2005). Deletion of RIM101, RIM13 or 
RIM20 impairs  growth at alkaline pH, confirming the essential role of this pathway in yeast 
alkaline adaptation (Futai et al., 1999; Lamb et al., 2001; Xu and Mitchell, 2001). rim101, 
rim8, rim9 and rim13 mutations exhibit the same phenotype at neutral conditions, 
characterised by reduced expression of Ime1p and Ime2p and therefore poor sporulation, poor 
growth at low temperature and altered colony morphology with smooth colonies (Su and 
Mitchell, 1993a; Su and Mitchell, 1993b). In addition the same mutants, together with rim20, 
prevented haploid invasive growth (Li and Mitchell, 1997; Xu and Mitchell, 2001).  
Rim101p-mediated pH regulation shows some notable differences from the PacC 
system (Fig. 1.5). First, the proteolytic activation of PacC ortholog Rim101p is mediated by a 
single cleavage. The processing is executed by the signalling protease Rim13p and eliminates 
approximately 100 residues from the C-terminus of the protein (Diez et al., 2002; Xu and 
Mitchell, 2001). As in A. nidulans, mutations in the Pal homologues, RIM8, RIM9, RIM13 
and RIM20 prevent the activation of Rim101p, whereas if Rim101p is truncated a constitutive 
phenotype results which is epistatic to mutations in RIM8, RIM9 and RIM13 (Lamb et al., 
2001; Li and Mitchell, 1997; Xu and Mitchell, 2001). In addition to Rim9p and Rim21p, in S. 
cerevisiae another transmembrane protein is involved in pH signalling. Dfg16p is predicted to 
be a seven transmembrane domain protein with a hydrophilic C-terminus and it has been 
hypothesised to be a GPCR (Barwell et al., 2005). The activation of Rim101p is suggested to 
occur by Rim8-directed endocytosis either of Dfg16p or Rim21p or of both (Boysen and 
Mitchell, 2006). Recent findings in S. cerevisiae indicate the intersection between the 
Rim101p and the ESCRT pathways. Eight ESCRT subunits (Snf7p/Vps32p, Vps20p, 
Snf8p/Vps22p, Vps25p, Vps36p, Vps23p, Vps28p and Vps37p) participate in Rim101 
processing. In particular Vps32p has been demonstrated to interact both with Rim20p and 
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Rim13p and for this reason hypothesised to act as a scaffold, bringing in close proximity all 
of the components required for Rim101p cleavage (Barwell et al., 2005).  
 
Fig. 1.5: Schematic representation of pH regulation in S. cerevisiae. The components for alkaline 
adaptation in A. nidulans are highly conserved in S. cerevisiae. However, some differences between the two 
microorganisms have been demonstrated. The signal for the activation of Rim101p is transmitted from the 
plasma membrane to the endosomal membrane complex by a process probably involving the Rim8-directed 
endocytosis of Rim21 and/or Dfg16p and the participation of the product of the gene YGR122W, only recently 
identified as palC homologue in S. cerevisiae. At alkaline pH, Rim101p is activated by a one step C-terminal 
proteolytic cleavage corresponding to the first step in PacC processing. Modified from Peñalva et al., 2008. 
 
Environmental pH not only influences S. cerevisiae growth, but also its differentiation, 
invasive growth and meiotic sporulation. The main effect of external alkalinity is the 
disruption of membrane proton gradients supplying energy for transmembrane transport and 
the consequent nutrient and ion limitation. Rim101p is therefore principally required for 
general ion homeostasis. Yeast cells grow faster at acidic than neutral or alkaline pH (Lamb et 
al., 2001) and in alkaline conditions the maintenance of homeostasis is ensured by the 
expression of PMA1, which encodes a plasma membrane H
+
-ATPase, which hydrolyses ATP 
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to exclude protons and thereby neutralize the cytoplasm (van der Rest et al., 1995). The 
proton gradient is necessary for acquisition of solutes from the environment and for the 
transport of amino acids, nucleotide bases, phosphate and other molecules in symport 
reactions. The Na
+
-ATPase Ena1p, also called Pmr2p, expels Na
+
 to generate a gradient 
utilised for the uptake of other cations (Rodriguez-Navarro et al., 1994). Ena1p is a Na
+
-
ATPase responsible of the efflux of Na
+
, Li
+ 
and K
+ 
by exchange with proton and is crucial 
for environmental pH adaptation as demonstrated by the high increase of its expression in 
response to lithium, saline and alkaline pH stress (Ruiz and Arino, 2007) and by the 
phenotype of the ena1 mutants. These mutants are sensitive to Na
+
 and Li
+
 cations and show 
impaired growth at alkaline pH (Garciadeblas et al., 1993; Haro et al., 1991). Finally the 
vacuolar H
+
-ATPase Vma4p is necessary for vacuolar acidification (Stevens and Forgac, 
1997). The essential role of these homeostatic mechanisms is highlighted by the inability of 
null mutants lacking these pumps to grow in alkaline conditions and/or in presence of high 
concentrations of extracellular cations (Lamb and Mitchell, 2003). Coherent with the 
necessity for pH homeostasis, a new role for the Rim101p pathway has been identified in S. 
cerevisiae i.e. the tolerance to weak acid-induced stress at constant pH (pH 4.0) (Mira et al., 
2008), where the analysis of genes susceptible to inhibitory concentrations of propionic acid 
has revealed a correlation between the resistance to propionic acid and other weak acid, and 
Rim101p processing; the deletion of each of the genes participating to Rim101p processing 
leads to strains sensitive to propionic acid.  
RIM101p directs the adaptation to environmental pH in S. cerevisiae, via a conserved 
regulatory pathway homologous to that described for PacC in A. nidulans. Whereas PacC acts 
both as a transcriptional activator for alkaline-expressed genes (Tilburn et al., 1995) and as a 
transcriptional repressor for acidic-expressed genes (Espeso and Arst Jr, 2000), Rim101p 
appears to function only as a repressor, acting in an indirect manner by repressing the 
expression of genes encoding transcriptional repressors, particularly NRG1 and SMP1 (Lamb 
et al., 2001; Lamb and Mitchell, 2003). The action of Rim101p on the two repressors is 
demonstrated by the ability of nrg1
-
 mutations to rescue the sensitivity to alkaline pH, NaCl 
and LiCl of the rim101
-
 mutant, as well as smp
-
 mutations to rescue the sporulation and 
invasion phenotype in the rim101
-
 mutant (Lamb and Mitchell, 2003). In particular, Nrg1p is 
a repressor involved in the control of the expression of several glucose-repressed genes and 
invasive growth (Vyas et al., 2005). The rescue of the alkaline-, NaCl- and LiCl- sensitive 
phenotype in the nrg1
-
 rim101
-
 mutant has been hypothesised as due to the de-repression of 
the sodium pump ENA1p (Haro et al., 1991; Tenney and Glover, 1999), whose expression 
levels are increased in nrg1
-
 mutants, even in absence of stress (Lamb and Mitchell, 2003). 
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Confirming the link between Rim101p, Nrg1p and Ena1p, several binding sites have been 
identified in the promoter region of the Ena1p, in particular two for Ngr1p and one for 
Rim101p (Ruiz and Arino, 2007). Rim101p has been therefore demonstrated as a regulator of 
pump expression and the reduction of ion pump activity may explain the phenotype observed 
for rim101
-
 in neutral conditions (Lamb et al., 2001). As demonstrated by the evidence that 
ENA1 expression is also induced by NaCl, the regulation the Na
+
-ATPase is not only 
Rim101p mediated but it involves other pathways such as the HOG (high osmolarity glycerol) 
osmoresponsive pathway and the calcium-calcineurin-Crz1p-mediated pathway (Ruiz and 
Arino, 2007). 
An interesting study using open reading frame macroarray hybridisation identified 71 
genes whose transcripts were at least 2.1-fold more abundant when cells were shifted from 
neutral to alkaline pH rather than to acidic pH (Lamb et al., 2001). Among these, several 
genes are involved in phosphate, iron or copper uptake and utilisation (CTR3, FRE1, 
PHO11/12, PHO84, ARN4/ENB1) and significantly the two ion pump genes ENA1 and 
VMA1, confirming the correlation between ion homeostasis and alkaline adaptation. CTR3 
and FRE1 are targets of the copper-responsive transcription factor Mac1p (Jungmann et al., 
1993; Pena et al., 1998); PHO11/PHO12 and PHO84 are targets of the phosphate-responsive 
transcription factor Pho4p (Ogawa et al., 1995a; Ogawa et al., 1995b). In general, these genes 
were classified according to their transcriptional dependence upon RIM101, to demonstrate 
that in yeast alkaline adaptation is not only mediated by the PacC homologue, but by other 
mechanisms such as the calcium-calcineurin-Crz1p-mediated response (Lamb and Mitchell, 
2003; Serrano et al., 2002). Three classes of alkaline response genes have been identified: 
genes independent of the Rim101p pathway (PHO11/12, PHO84, CTR3, FRE1 and TIS11), 
weakly dependent on Rim101p (ENA1 and NRG1) and strictly dependent on Rim101p (ARN4, 
YAR068W/ YHR214W, YOL154W and WMA4) (Lamb et al., 2001). Arn4p is involved in iron 
uptake and in particular imports a bacterial siderophores-iron complex, facilitating 
competition with bacteria in alkaline conditions (Heymann et al., 2000; Lamb et al., 2001). 
YOR154W is a target of the zinc-responsive transcription factor Zap1p (Lyons et al., 2000). 
 Unlike pacC, RIM101 does not seem to be alkaline-expressed (Lamb and Mitchell, 
2003). To avoid an increasing response to alkaline pH, S. cerevisiae Rim8 expression is 
subjected to a negative-feedback loop by the processed form of Rim101p (Lamb and Mitchell, 
2003), as  recently demonstrated for A. nidulans palF (Munera-Huertas, PhD thesis).  
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1.6 Membrane protein-protein interactions: biological roles, limits of 
available detention techniques and a new innovative investigative approach   
 
Protein-protein interactions are intrinsic to and crucial for almost every cellular 
process within a cell and the formation of most cellular structures result from complex 
interactions between many different proteins. Crucial membrane proteins are pumps, 
channels, pores and transporters involved in exchange of membrane-impermeable molecules 
between the cellular compartments and the extracellular environment. Transmembrane 
receptors are involved in the sensing of environmental changes to activate specific cellular 
adaptation responses, usually via intermediate intracellular proteins. Thus, membrane protein-
protein interactions are hugely involved in the organisation of living cells. Often identification 
of interacting partners permits inference of function of the protein itself. Because of their 
essential role and accessibility as potential drug targets, membrane protein-protein 
interactions have been among the most difficult aspects of biology to be investigated. It was 
estimated that around 50% (500) of the current known drug targets are either membrane 
receptors or ion channels (Reiss, 2001).   
Genome analyses surprisingly revealed that approximately a third of the predicted 
proteins of an organism are localised or anchored to the plasma membrane (Auerbach et al., 
2002; Goffeau et al., 1996). Many biological issues can be addressed by studying protein-
protein interactions, such as the identification and characterisation of novel gene products or 
the discovery of structural and functional motifs. Traditionally, the tools available to analyze 
protein-protein interactions in multicellular organisms have been restricted to biochemical 
approaches. Much has been learned through biochemical methods, such as 
coimmunoprecipitation, and cross-linking proteins and thereafter cofractionation by 
chromatography. However, these approaches can be difficult to set up and time-consuming to 
carry out, generally requiring extensive optimisation. In addition they are characterised by 
some limitations i.e. they are destructive methods and consequently do not give live-cell 
dynamics. Besides membrane proteins are very unsuitable for biochemical studies due to their 
hydrophobic nature, which makes protein isolation difficult and so complicates the 
determination of protein complex composition. Several interacting proteomic techniques have 
been developed in the recent years to detect membrane protein-protein interactions, such as 
Fluorescence Resonance Energy Transfer (FRET) (Miyawaki et al., 1997), β-lactamase 
protein fragment complementation assay (Galarneau et al., 2002) and β-galactosidase 
complementation assay (Rossi et al., 1997). In addition, the combination of conventional 
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affinity tagging methods and mass spectrometry (MS) has been demonstrated to be adaptable 
to the high-throughput analysis of yeast protein complexes (Gavin et al., 2002; Ho et al., 
2002).   
The limits of biochemical methods have been partially circumvented with the 
development of protein library screening techniques such the yeast two-hybrid system (Fields 
and Song, 1989). The analysis of protein-protein interactions through genetic selection in 
yeast has several important advantages. First, no optimisation of binding or washing 
conditions is required, because the interactions are detected in vivo. In addition, proteins of 
interest do not need to be purified. But more interestingly for the purposes of this study, novel 
protein-protein interactions can be relatively easily selected from a pool of potential 
interaction partners (e.g. a cDNA expression library) and genetic screening systems yield not 
only information on the interaction itself but also directly provide the cDNA encoding the 
novel interaction partner (e.g. they give information on the region of the protein specifically 
involved in the exposed interaction). Genetic selection for protein-protein interactions in yeast 
was initially developed by Fields and Song (1989) with the yeast two-hybrid system (Fields 
and Song, 1989). To test for protein interactions, this method employs the modular nature of 
transcription factors that can be separated into a DNA-binding domain and a transcriptional 
activation domain. If two interacting proteins are fused to these separated domains, the 
protein interaction will bring the two portions of the transcription factor together and hence 
reconstitute its activity. The interaction between the two proteins takes the transcription factor 
to a specific sequence of DNA upstream of a reporter gene, whose expression is therefore 
activated. Since its invention, this method has rapidly become the choice for identifying novel 
protein-protein interactions. However, the limitation of the two-hybrid technique is that the 
set of detectable protein interactions only occur in the nucleus, near to the reporter gene, so 
the method is not useful for the study of membrane proteins (Fields and Song, 1989). The 
features that make membrane proteins unsuitable for the two-hybrid system include not only 
their propensity to aggregate if not in the lipid bilayer, but also the presence of either specific 
post-translational modification (such as glycosylation and disulfide bond formation) or intra-
membraneous ligand-binding pockets and the possibility of oligomerisation. To overcome the 
limitation in the yeast two-hybrid assay, a wide range of similar screening systems have 
followed and one of them is the split-ubiquitin Membrane Yeast Two Hybrid (MYTH), also 
commercially called DUALmembrane system (Johnsson and Varshavsky, 1994).   
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1.6.1 The split-ubiquitin Membrane Yeast Two Hybrid (MYTH): an innovative 
system to investigate membrane protein-protein interactions  
 
As previously described, an intense network of protein-protein interactions is 
established in fungi for pH sensing and adaptation (for a review(Peñalva et al., 2008). These 
interactions, in particular those taking place in the plasma membrane, might be required for 
the initial contact between host and fungus and therefore could provide a way to interfere with 
the first stages of fungal growth. For example, in the absence of either PalH or PalI pH 
signalling is blocked and PacC is not proteolytically processed (Denison et al., 1998; Negrete-
Urtasun et al., 1999).  
The split-ubiquitin Membrane Yeast Two Hybrid (MYTH) is based on the 
complementation between separable domains of ubiquitin (Ub) (Fetchko and Stagljar, 2004; 
Johnsson and Varshavsky, 1994; Stagljar et al., 1998). This assay has been applied 
successfully in various studies i.e. to investigate how mutations affect the assembly of 
fragments of presenilin in the development of the Alzheimer disease (Cervantes et al., 2001) 
or the interaction between the two yeast proteins α1,2-mannosidase Mns1p and Rer1p in the 
endoplasmic reticulum (Massaad and Herscovics, 2001) or the intra- and intermolecular 
interactions between plant sucrose transporters (Reinders et al., 2002). Recently the approach 
has also been extended to the screening of libraries of NubG-fused inserts to identify novel 
protein–protein interactions for specific membrane proteins both of yeast and mammalian 
origin (Snider et al., 2010b; Thaminy et al., 2003).  
Ub is a conserved protein of 76 residues that is present in cells both free and 
covalently linked to other proteins and plays a role in many processes, primarily through 
protein degradation (Hershko and Ciechanover, 1992), whereby it is usually attached to the 
N-terminus of proteins as a signal for their degradation by the 26S proteosome. While the 
target protein is degraded by the 26S proteosome, the ubiquitin motifs are saved from 
degradation by cellular ubiquitin-specific proteases (UBPs), which cleave ubiquitin from the 
target protein after the C-terminal residue (Gly76), hence recycling the ubiquitin back to the 
cytoplasm. The inventors of this system (Fig. 1.6) found that yeast ubiquitin can be divided 
into two halves, called Nub (for N-terminal ubiquitin) and Cub (for C-terminal ubiquitin) and 
that their strong affinity can be abolished by a single amino acid exchange in the N-terminal 
portion (mutated Nub is termed NubG) (Fetchko and Stagljar, 2004; Johnsson and 
Varshavsky, 1994; Stagljar et al., 1998).  
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Fig. 1.6: The split-ubiquitin Membrane Yeast Two-Hybrid (MYTH) system. (A) A point mutation 
in the N-terminal part, therefore called NubG from the amino acidic substitution obtained, completely abolishes 
the affinity between the two halves of the ubiquitin. A membrane protein of interest X is fused to Cub and the 
hybrid transcriptional factor LexA-VP16, whereas another protein Y, either membrane or cytoplasmic, is fused 
to the NubG moiety. (B) If interaction occurs between X and Y, split-ubiquitin is reconstituted and the hybrid 
transcription factor LexA-VP16 is released. From(Kittanakom et al., 2009).  
 
A membrane protein of interest, termed the bait, is fused to the C-terminal half of Ub, 
Cub. A second protein of interest, termed the prey, is fused to the mutated N-terminal half of 
ubiquitin, NubG. If the two proteins are in sufficiently close proximity, NubG and Cub are 
forced to reconstitute split-ubiquitin, which is immediately recognised by the UBPs. The 
polypeptide chain is therefore cleaved between Cub and the reporter protein LexA-VP16, the 
latter being released from the membrane and translocated to the nucleus where it binds the 
LexA operators situated upstream of reporter genes. The reporter protein LexA-VP16 is a 
hybrid transcription factor, composed of the bacterial LexA protein and the Herpes simplex 
VP16 transactivator protein. Thus, the reconstitution of the split-ubiquitin converts the protein 
interaction into a transcriptional output. 
As well as for small-scale and specific membrane protein-protein interaction studies, 
the methodology can be adapted for high-throughput screening of cDNA prey libraries, as 
recently demonstrated (Gisler et al., 2008; Lissanu Deribe et al., 2009; Scheper et al., 2003b; 
Thaminy et al., 2003; Paumi et al., 2007).   
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1.7 In vivo bioluminescence imaging (BLI) 
 
The Split-ubiquitin MYTH assay cannot inform on the dynamics of protein 
interactions in the native organism A. fumigatus, or on the relevance of tested interactions 
during infection. Bioluminescence imaging (BLI) can allow the in vivo study of 
establishment and manifestation of infection, providing information on its inception and 
progress in real time. BLI has been successfully applied to a multitude of microorganisms, 
including several bacteria species (Glomski et al., 2007; Karsi and Lawrence, 2007; Sjolinder 
and Jonsson, 2007), viruses (Hutchens and Luker, 2007) and eukaryotic parasites like 
Toxoplasma, Leishmania, and Plasmodium species (Dellacasa-Lindberg et al., 2007; Franke-
Fayard et al., 2006; Hutchens and Luker, 2007; Saeij et al., 2005). Successful imaging of 
fungal species during infection provides real time data on location and distribution of 
infectious particles, which is currently unobtainable. In addition, repetitive imaging of single 
mice dramatically reduces the number of animals required for experimentation.  
 
1.7.1 Definition of bioluminescence and in vivo bioluminescence imaging (BLI) 
 
The application of an internal biological source of light, called luciferase, as a marker 
for cells, pathogens or genes, represents a resourceful approach to gain biological information 
in vivo, but externally in a non-invasive way (Doyle et al., 2004). In the case of animal 
models of infectious disease, BLI gives not only insights into the establishment and the 
development of the disease, but also about the means by which pathogens avoid host 
defences during the infection. Bioluminescence is a naturally occurring enzyme reaction 
whereby light is produced by enzyme-mediated chemical conversion of a substrate usually 
through an intermediate highly energised state. This process occurs in multiple organisms 
from different genera and for various aims, such as to facilitate location of food or for 
identifying mates (Hastings, 1996). Independent evolution has originated different luciferases 
and substrates with different colours of emission but in general, these enzymes require 
energy, oxygen and a specific substrate (commonly known as luciferin) and may also require 
cofactors for light production. Briefly, to monitor infectious diseases in animal models by 
BLI, cells are engineered to express a bioluminescent marker; after the induction of light 
emission through the administration of the appropriate substrates, the bioluminescent photons 
emitted are able to pass through the tissues and to be detected on the surface of the animal. 
This provides indication of spatial and temporal localisation, because the signal is detectable 
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externally using sensitive proton detectors, such as cooled or intensified charge-coupled 
device (CCD) cameras (Rice et al., 2001).  
The first application of bioluminescence to quantify pathogen loads in a non-invasive 
way was conducted with the bacteria Salmonella enterica and the lux operator, which does 
not require the addition of any substrate (Contag et al., 1995). Subsequently, multiple studies 
reported the use of luciferase genes from Photinus pyralis and Renilla reniformis, the latter of 
which has however been demonstrated to be effective only for cells near to the surface of the 
animals in analysis (Bhaumik and Gambhir, 2002; Contag et al., 2000; Contag and 
Stevenson, 2001; Rice et al., 2001; Zhang et al., 2001). Respect to fluorescent markers such 
as GFP or near-infra red fluorescent dyes, bioluminescence drastically reduces the 
background due to the intrinsic fluorescence of the animal tissues (Becker et al., 2001; 
Chishima et al., 1997; Rudin and Weissleder, 2003; Weissleder et al., 1999; Yang et al., 
2000).  
Photinus pyralis (Firefly) is one of the most well-recognised bioluminescent 
organisms: the male uses bioluminescence as a way to attract potential mates (Wood et al., 
1989). The firefly luciferase (FLuc) is a single polypeptide (550 aa; 62 kDa) and uses the 
benzothiazole luciferin as substrate along with ATP as energy source and oxygen and Mg
2+
 
as cofactor (de Wet et al., 1985; de Wet et al., 1987). Light emission for cells expressing this 
enzyme and provided with luciferin is yellow-green with an emission peak at 560 nm. 
Luciferin can be administered to the animal before imaging via intraperitoneal or intravenous 
injection or oral delivery and it is able to passively diffuse into cells, to spread quickly in the 
body (Contag et al., 1997), to cross the blood-brain (Rehemtulla et al., 2000; Rehemtulla et 
al., 2002) and placental barriers (Lipshutz et al., 2001) with no adverse reactions for the 
animals. Other bioluminescent markers recently tested are the luciferase from the sea pansy 
Renilla reniformis and the marine copepod Gaussia princeps. Renilla luciferase (RLuc) 
derives from the sea pansy (Renilla reniformis) and is a monomeric, bioluminescent protein 
(311 aa, 34 kDa) emitting blue light with a peak at 480 nm, using coelenterazine as substrate 
and not requiring ATP as energy source (Bhaumik and Gambhir, 2002; Grentzmann et al., 
1998; Lorenz et al., 1996; Stables et al., 1999). However, the emission colour is not suitable 
for its application in vivo (Contag and Bachmann, 2002). Gaussia luciferase (GLuc) from the 
marine copepod Gaussia princeps is the smallest luciferase known (185 aa, 19.9 kDa); it 
emits blue light at a broad peak extending from 480 to 600 nm, uses coelenterazine as 
substrate and is secreted, therefore does not require ATP as energy source (Tannous et al., 
2005; Verhaegent and Christopoulos, 2002).  
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1.7.2 Interesting applications of BLI for the detection of fungal pathogens 
 
Within the fungal kingdom, BLI was firstly applied to the pathogenic yeast C. 
albicans, to study the difference between vaginal and systemic infection (Doyle et al., 2006). 
In particular C. albicans cells were engineered to express the firefly luciferase by its stable 
integration in a transcriptionally silent region of the genome, to generate strains with identical 
pathogenicity and growth rate to the parental isolates (Doyle et al., 2004). The substrate was 
supplied externally, by virtue of the ability of C. albicans cells to uptake luciferin without 
any treatment and the presence of enough intracellular ATP to catalyze light emission. 
However, luciferin availability in the cytoplasm is a limiting factor for the BLI, because 
hyphal cells are less able to absorb the substrate and therefore when C. albicans switches to 
the hyphal form (e.g. during systemic infection) light emission is significantly reduced 
(Doyle et al., 2006). Because luciferin is thought to enter the cells via passive diffusion, this 
difference may be a consequence of changes in the cell wall composition. In contrast with the 
application of GFP for C. albicans imaging (Cormack et al., 1997), firefly luciferase was 
demonstrated to be detectable within an hour after the addition of the substrate and to have a 
relatively short half-time (3 hours in mammalian cells). In addition, the study included the 
use of the Renilla luciferase and has revealed the instability of the substrate coelenterazine in 
aqueous solution and a significant level of background (Doyle et al., 2004).  
In concomitance with our study, BLI has been developed for A. fumigatus, using the 
firefly luciferase under the control of the glyceraldehde-3-phosphate dehydrogenase gene 
(gpdA) promoter. The gpdA promoter was chosen because it is constitutively active, with 
some variations depending on the carbon source, but is actively expressed when the 
mycelium is growing invasively in the host tissue. In contrast to observation in C. albicans, 
the bioluminescent signal generated by the A. fumigatus engineered strain during infection 
shows a good correlation with fungal biomass, permitting the evaluation of the fungal burden 
in infected tissues and providing a means to test antifungal treatments for efficiency. Light 
emission can be directly correlated with the copies of luciferase gene present in the 
engineered strain (Brock et al., 2008). The same study demonstrated that the A. fumigatus 
strain expressing firefly luciferase is a powerful tool for drug efficiency testing and in vivo 
monitoring of IPA, allowing the assessment of infection parameters such as the levels of 
tissue colonisation and invasion (Brock et al., 2008). In addition, the A. fumigatus strain 
expressing firefly luciferase has been used to monitor fungal progression and location during 
the infection in mice with different types of immunosuppressive regimens, affecting either 
macrophages or neutrophils functions. In particular bioluminescent imaging of infected mice 
69 
 
and histopathologic analysis have correlated light emission and fungal invasion for the 
cyclophosphamide-treated murine model, where neutrophil function is depleted (Ibrahim-
Granet et al., 2010). Instead, in murine models where the neutrophil function is not depleted, 
there is no correlation between light emission and fungal invasion, because of the extensive 
tissue damage and consequent tissue hypoxia occurring in the other murine model of 
infection as a consequence of the action of neutrophils. Firefly luciferase requires oxygen as 
substrate for light emission and it has been demonstrated that oxygen saturation below 5% 
decreases significantly the efficiency of the reaction (Robertson et al., 2008). Under 
conditions of high inflammation, therefore, the intensity of bioluminescent signal reflects 
properly only the early stages of infection, because at later stages it declines as a consequence 
of the progressive hypoxia (Ibrahim-Granet et al., 2010). This study demonstrated the 
applicability of BLI for A. fumigatus to monitor fungal germination, tissue invasion and 
inflammatory response.     
 
1.8 Objectives of this study  
 
Environmental-sensing proteins are particularly interesting from a therapeutic 
perspective because they are important at the earliest stage of the development of the fungus 
in the host and they are more accessible to inhibitory agents due to their membrane 
localisation. Alkaline adaptation, a mechanism not essential for Aspergillus viability, but 
critical for its virulence, might therefore provide a useful target for prevention of fungal 
growth in vivo. Using A. fumigatus transcriptional profiling during murine infection, 
phenotypic screening in S. cerevisiae, and a yeast-based A. fumigatus split-ubiquitin screen, 
novel virulence-essential A. fumigatus functions acting upstream of the transcription factor 
PacC, central regulator of Aspergillus virulence, have been investigated.  
The mechanism leading to the activation of PacC regulatory pathway has not yet been 
characterised extensively in A. fumigatus and especially the elucidation of its role during 
infection is still unexplored by the current literature. This study presents therefore the   
characterisation of an A. fumigatus ΔpacC mutant in terms of phenotype, virulence and tissue 
invasion to determine the physiological requirement for pH signaling during A. fumigatus 
virulence (Chapter III). In addition, transcriptional profiling of the A. fumigatus ΔpacC in 
comparison with the respective parental isolate was performed to identify functions under 
PacC transcriptional control during murine infection (Chapter IV).   
An intense network of protein-protein interactions has been demonstrated to be 
established in fungi for pH sensing and adaptation. These interactions, in particular those 
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taking place in the plasma membrane, are required during initial contact between host and 
fungus and therefore could provide a way to interfere with the first stages of fungal 
growth.The innovative split-ubiquitin Membrane Yeast Two-Hybrid (MYTH) system was 
applied to characterise A. fumigatus membrane protein interactions involved in pH perception 
(Chapter V).In addition, the system was optimised and adapted to a high-throughput format to 
discover novel protein interactors for A. fumigatus PalH from a full-length A. fumigatus 
cDNA prey library (Chapter VI).  
In virtue of the conservation of the PacC/Rim101 pathway between the Aspergillus 
species and S. cerevisiae, novel upstream components of the Rim101 regulatory pathway 
were identified in yeast through an epistacy screen using S. cerevisiae null mutants, having 
Δrim101-like phenotype and showing cation hypersensitivity as the rim101 mutant (Chapter 
VII). The epistacy screen was based upon the reversal of lithium toxicity by an activated 
RIM101 allele, which would strongly suggest a PacC regulating role for these genes. In 
addition, a synthetic Rim101p promoter fused to a lacZ reporter was used to isolate mutants 
suffering aberrant Rim101p processing and transcriptional activity among the S. cerevisiae 
Δrim101-like mutants (Chapter VII);  
Finally, for the ultimate purpose of transposing protein interaction assays into tissue 
cultures and murine models of infection, an A. fumigatus strain expressing firefly luciferase 
under the control of the glyceraldehde-3-phosphate dehydrogenase gene (gpdA) promoter has 
been constructed and tested for its potential use in the murine model (Chapter VIII).  
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CHAPTER II 
 
MATERIAL AND METHODS 
 
2.1 Chemicals, reagents and enzymes 
 
Chemicals and reagents were purchased from Sigma UK or Fisher Chemicals unless 
otherwise stated. Restriction enzymes, ligases, phosphatases, kinases and other modifying 
enzymes were purchased from New England Biolabs (USA). Taq DNA polymerase enzymes 
were purchased from KAPABiosystems (UK), Bioline (UK) and Invitrogen (UK) unless 
otherwise stated.  
 
2.2 Bacterial and fungal strains  
 
All bacterial and fungal strains used in this study are listed in the respective Chapters 
and in Appendix A.  
 
2.3 Media 
 
Unless otherwise stated, all ingredients were purchased from Oxoid Ltd (UK), BDH 
(UK), or Sigma (UK). All media were sterilised by autoclaving at 121°C for 15 minutes.  
 
2.3.1 Bacterial cultures 
 
XL-10 Escherichia coli [F- mcrA ∆(mrr-hsdRMS-mcrBC) Φ80lacZ∆M15 ∆lacΧ74 
recA1 araD139 ∆(araleu) 7697 galU galK rpsL (StrR) endA1 nupG] (Stratagene) were 
grown in Luria Bertani (LB) medium (1% (w/v) tryptone, 0.5% (w/v) yeast extract, 1% (w/v) 
NaCl) at 37°C, 180 rpm. Solid LB was produced by addition of 2% (w/v) agar prior to 
autoclaving. When required, after autoclaving the media was supplemented with 100 μg/ml 
ampicillin or 30 µg/ml kanamycin or, for β-galactosidase assays, 0.5 mM IPTG and 80 μg/ml 
X-Gal. Strains were stored for up to 1 week at 4°C. For longer term storage, strains were 
stored in 25% (w/v) glycerol at -80°C.  
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2.3.2 Fungal cultures  
 
S. cerevisiae strains, constructed in the genetic background BY4741 [MATa his3_1 
leu2_0 met15_0 ura3_0], were grown in yeast extract peptone dextrose (YPD) media (1% 
(w/v) yeast extract, 2% (w/v) peptone, 2% (w/v) glucose), or in appropriate synthetic drop-out 
(SD) media (0.17% (w/v) yeast nitrogen base (YNB) without amino acids, 2% (w/v) glucose 
and 0.08% (w/v) drop out mix [Formedium, UK]) according to specific nutritional or 
experimental requirements. S. cerevisiae strains, constructed in the genetic background 
NMY51 [MATa his3delta200 trp1-901 leu2-3,112 ade2 LYS2::(lexAop)4-HIS3 
ura3::(lexAop)8-lacZ (lexAop)8-ADE2 GAL4] were grown in yeast extract peptone adenine 
dextrose (YPAD) media (1% (w/v) yeast extract, 2% (w/v) peptone, 2% (w/v) glucose, 
0.004% adenine sulfate), or in appropriate SD media as previously described. Solid YPD, 
YPAD or SD media was produced by addition of 2% (w/v) agar prior to autoclaving. Liquid 
cultures were agitated by orbital shaking at 180 rpm unless otherwise specified. S. cerevisiae 
strains were cultured for 2-3 days at 30°C. Strains were either stored at 4°C for up to 4 weeks 
on solid agar plates or for long term storage in 25% (w/v) glycerol at -80°C.  
A. fumigatus strains used in this study were the wild type strain CEA10, a clinical 
isolate, obtained at a Paris hospital in 1989 (D'Enfert et al., 1996), the wild type strain 
ATCC46645 (Hearn and Mackenzie, 1980) and the PyrG Δku80 which has a non-homologous 
end joining deficiency (da Silva Ferreira et al., 2006). Recipes for solid and liquid media were 
identical, save the addition of 1% (w/v) agar to solid media. Liquid cultures were agitated by 
orbital shaking at 150 rpm unless otherwise specified. A. fumigatus strains were cultured at 
37°C in Aspergillus Minimal Media (AMM) (20 ml/l Aspergillus salt solution [26 g/l KCl, 26 
g/l MgSO4.7H2O, 76 g/l KH2PO4], 10 ml/l vitamin solution [400 mg/l 4-aminobenzoic acid, 
50 mg/l aneurin, 1 mg/l biotin, 24 g/l mesoinositol, 100 mg/l nicotinic acid, 200 mg/l DL-
pantothenic acid (hemicalcium salt), 250 mg/l pyridoxine monohydrochloride, 100 mg/l 
riboflavin, 1.4 mg/l choline chloride], 20 ml/l 50% glucose, 10 ml/l 500 mM ammonium 
tartrate) or Aspergillus Complete Media (ACM) (1% (w/v) glucose, 0.1% (w/v) yeast extract, 
0.1% (w/v) casamino acids, 0.2% (w/v) peptone, 75 mg/l adenine, 20 ml/l Aspergillus salt 
solution, 10 ml/l vitamin solution). The pH of ACM was adjusted to 6.5 using 10 M NaOH, 
whereas AMM was buffered using 100 mM MES (2-(N-Morpholino) ethanesulfonic acid 
hemisodium salt) pH 6.5. Strains were either stored at 4°C for up to 4 weeks on solid agar 
plates or for long term storage in 20% (w/v) glycerol at -20°C.  
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2.3.3 Fungal phenotypic assays 
 
Media conditions used for fungal phenotypic assays in this study are listed in the 
respective chapters.  
S. cerevisiae cell density was calculated by assessing OD600 using an UltroSpec II 
(Biochrom, LRB) spectrophotomer and assuming that an OD600 equivalent to 1.0 corresponds 
to 3.0 x 10
7
 cells/ml. Serial dilutions of 1.0x10
6
, 1.0x10
5
, 1.0x10
4
 and 1.0x10
3
 cells were 
plated in the test conditions. Plates were incubated for 2-4 days at 30°C and photographed 
without magnification using a Nikon Coolpix 990 digital camera.  
A. fumigatus conidia were harvested in sterile H2O and filtered on MIRACLOTH 
(Calbiochem). Spores were counted using a haemocytometer and resuspended at a 
concentration of 2 x 10
6
 cfu/ml in sterile H2O prior to serial dilutions of 1x10
4
, 1x10
3
, 1x10
2
, 
1x10
1
 spores. Each serial dilution was plated 3 times and plates were incubated for 2 days at 
37°C. Plates were photographed without magnification using a Nikon Coolpix 990 digital 
camera. For counting, Aspergillus spores were visualised using a Nikon Eclipse 80i 
microscope.  
 
2.4 Oligonucleotide primer synthesis  
 
All primers used in this study are summarised in the respective Chapters and in 
Appendix B. Oligonucleotides were purchased from Sigma-Genosys and designed to contain, 
where necessary, an appropriate restriction site for cloning.   
 
2.5 Plasmids 
 
Full details regarding plasmids used during this study are given in the respective 
Chapters. 
 
2.6 General molecular techniques  
 
2.6.1 Preparation of competent cells 
 
E. coli XL10 cells were grown in 15 ml of LB media overnight at 37°C. The following 
day 5 ml of the culture was inoculated in 100 ml of LB (pre-warmed to 37°C) and grown at 
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37°C until the A550 of the culture reached 0.48. The culture was subsequently transferred to 50 
ml falcon tubes, chilled for 5 minutes on ice and then centrifuged in a Sorvall centrifuge at 
3660 rpm for 10 minutes at 4°C. Cells were resuspended in 40 ml ice-cold TfbI (30 mM KAc, 
100 mM KCl, 10 mM CaCl2, 50 mM MnCl2, Glycerol 15%, pH 5.8 with 0.2 M acetic acid), 
chilled on ice for 5 minutes and centrifuged as before. Finally cells were resuspended in 4 ml 
ice-cold TfbII (10 mM MOPs or PIPES, 10 mM CaCl2, 10 mM KCl, Glycerol 15%, pH to 6.5 
with 3 M KOH), left on ice for 15 minutes and aliquoted into cryotubes to be stored at -80°C.  
 
2.6.2 Bacterial Transformation    
 
Bacterial transformation was performed using the CaCl2 heat shock method (Mandel 
and Higa, 1970). 50 μl of E. coli XL-10 competent cells were mixed with 10-100 ng of 
plasmid DNA. The suspension was left on ice for 30 minutes and then heat-shocked in a 42°C 
H2O bath for 40 seconds. Cells were resuspended in 500 μl of LB without any selective drug 
and left at 37°C for 45 minutes to allow cells to express drug resistance. Cells were 
subsequently plated on LB plates containing the selective antibiotic and incubated overnight 
at 37°C. The day after, single colonies were transferred to 3 ml of LB broth supplemented 
with the appropriate antibiotic to be grown overnight at 37°C, 180 rpm.         
 
2.6.3 Plasmid DNA extraction 
 
According to the manufacturer‟s instructions, plasmids were extracted from 3 ml 
overnight E. coli LB culture (supplemented with the appropriate antibiotic) with the 
commercial kit NucleoSpin Plasmid (Macherey-Negen, Germany), specifically designed to 
extract plasmid DNA for a variety of routine applications (i.e. restriction enzyme digestion, 
sequencing, ligation and transformation). The procedure is based on alkaline lysis of bacterial 
cells followed by adsorption of DNA onto silica in the presence of high salt.  
 
2.6.4 Separation of DNA fragments by electrophoresis  
 
DNA fragments were visualised by electrophoretic separation on 1% agarose gel (w/v) 
(Electran). In order to facilitate sample loading and to visualize the migration of the samples, 
6X Loading Dye Solution (10mM Tris-HCl (pH 7.6), 0.03% bromophenol blue, 60% 
glycerol, 60mM EDTA) was added to the DNA in a ratio 1:5. To prepare and run the gel, 
TBE 1X buffer (Tris-borate 0.09 M, EDTA 1 mM, pH 8.0) was used and 4 μl of the dye 
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SYBR Safe DNA gel stain (Invitrogen) was added to each 50 ml gel for DNA vizualisation 
using the UV transilluminator AlphaImager (Alpha Innotech, USA). To define the size of 
DNA fragments, 500 ng of various molecular ladders (Marker λ, Marker 1Kb and Marker 100 
bp, New England Biolabs) were used.  
For specific applications, the DNA was purified directly after the electrophoretic 
separation by excising the DNA band of interest from the agarose gel with a clean, sharp 
scalpel and using the commercial kit QIAquick Gel extraction Kit (QIAGEN) according to 
the manufacturer‟s instructions.  
 
2.6.5 Nucleic acid quantification  
 
Nucleic acid concentration and purity were assayed with a Nanodrop ND-1000 
Spectrophotometer (Nanodrop, Wilmington, USA).  
 
2.6.6 Dephosphorylation of vector 
 
To prevent re-ligation of digested vectors, dephosphorylation was achieved using 
enzyme calf intestinal alkaline phosphatase (CIP) (New England BioLabs) that catalyzes the 
removal of 5‟ phosphate groups from DNA, RNA, ribo- and deoxyribonucleoside 
triphosphates. 0.1-10 µg of DNA was mixed with 3 μl of NEBuffer 3 and 2 μl of enzyme to a 
final volume of 30 μl and the reaction was incubated for 3 h at 37°C.  
After this treatment, the samples were purified according to the manufacturer‟s 
specifications with the commercial kit QIAquick PCR purification Kit (QIAGEN), designed 
for rapid cleanup of DNA from amplification reactions and other enzymatic reactions such as 
treatment with alkaline phosphatase and restriction digestions to avoid interference with 
subsequent downstream applications.  
 
2.6.7 Restriction enzyme digests  
 
Restriction digestion of DNA was performed using restriction enzymes purchased 
from New England Biolabs and according to the manufacturer‟s specifications. The 
appropriate NEBuffer was used at a final concentration of 1X and when needed, bovine serum 
albumin (BSA) was supplied at the final concentration of 100 µg/ml. To remove the enzymes 
and buffer following restriction digests, the QIAquick PCR Purification Kit (QIAGEN) was 
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used according to the manufacturer‟s specifications.   
 
2.6.8 Polymerase chain reaction (PCR)   
 
PCRs were performed following standard procedures described by manufacturers and 
using one of three enzymes: BIO-X-ACT-Long (Bioline), BD-ADVANCED (BD 
Advantage™ 2 Polymerase Mix, Takara) and Platinum Taq DNA Polymerase High Fidelity 
(Invitrogen). For colony PCR initial incubation at 95 °C was extended to 10 minutes. PCR 
amplification of probes for digoxigenin-labelled Southern analysis was performed following 
the manufacturer‟s instructions (Roche Diagnostics Ltd, UK). PCR products were purified 
with QIAquick PCR purification kit (QIAGEN) according to the manufacturer‟s 
specifications.  
 
2.6.9 Treatment of PCR products  
 
DNA Polymerase I, Large (Klenow) Fragment (New England BioLabs) was used to 
fill-in 5‟ overhangs to form blunt ends. 0.1-5 µg of DNA was mixed with 4 μl of NEBuffer 2, 
13 μl of dNTPs (100 μM) and 3 μl of enzyme and the reaction was incubated for 30 minutes 
at 37°C.  
T4 Polynucleotide Kinase (PNK) (New England BioLabs) was used for the addition of 
5´-phosphates to oligonucleotides to allow subsequent ligation. 0.1-5 µg of DNA was mixed 
with 4 μl of T4 DNA ligase buffer in a total volume of 21 μl. The reaction was incubated for 5 
minutes at 70°C and immediately cooled on ice. Subsequently 1.5 μl of enzyme was added 
and the reaction was incubated for 30 minutes at 37°C.  
To purify DNA after each of these treatments the QIAquick PCR Purification Kit 
(QIAGEN) was used according to the manufacturer‟s specifications.  
 
2.6.10 Ligation 
 
The ligations were performed using T4 DNA Ligase (New England BioLabs), 
catalyzing the formation of a phosphodiester bond between juxtaposed 5' phosphate and 3' 
hydroxyl termini in duplex DNA joining blunt end and cohesive end termini. The overall 
concentration of vector + insert was between 1-10 μg/ml for efficient ligation. The volume of 
DNA to use for each reaction was determined by comparison with the molecular ladder in a 
1% agarose gel and Nanodrop quantification. A ratio 1 : 3 of vector : insert was routinely used 
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to avoid self-ligation of the vectors. The total volume used was 10 μl using 1 μl of the enzyme 
(400000 units/ml) and the reaction was incubated overnight at 16°C. 
  
2.6.11 Sequencing  
  
Every plasmid obtained was verified by sequencing with the Sanger‟s method using a 
3730 capillarity electrophoresis sequencer (Applied Biosystems Warrington Cheshire). For 
each reaction, the mix was comprised of 200-500 ng of the plasmid to sequence, 2 μl of the 
primer (20 μM) in a final volume of 10 μl. DNA sequencing was performed at the DNA Core 
Laboratory, Medical Research Council, Imperial College London. The oligonucleotides used 
to sequence (listed in the respective Chapters and in Appendix B) were purchased from 
Sigma-Genosys and appropriately co-ordinated for maximal coverage of the region of 
interest.   
 
2.6.12 Western blotting analysis  
 
To assay for the expression of fusion proteins by western blotting (Towbin et al., 
1979), S. cerevisiae strains were inoculated in liquid SD medium and grown overnight to 
prepare total extracts as described in Section 2.10.  
Protein samples were run on 8% SDS-PAGE gels in a XCell-SureLock Mini Cell 
electrophoresis tank (Invitrogen) with SDS-PAGE running buffer (25 mM Tris-HCl, 192 mM 
glycine, 0.1 % (v/v) SDS) at 150V until samples reached the end of the gel. Gels were 
transferred to nitrocellulose membrane (Amersham) in transfer buffer (25mM Tris base, 
192mM glycine, 20% (v/v) methanol) using Invitrogen‟s XCell-SureLock Mini Cell XII Blot 
module. Membranes were blocked overnight in 5 % (w/v) milk (Marvel) PBS-Tween (137 
mM NaCl, 1.47 mM KH2PO4, 2.68 mM KCl, 8.1 mM Na2HPO4.12H2O, 0.001 % (v/v) 
Tween-20) and incubated for 4 hours with primary antibody in 1 % (w/v) milk PBS-Tween. 
Membranes were washed 3 x 10 minutes with PBS-Tween, incubated with secondary 
antibody in 1 % (w/v) milk PBS-Tween for an hour and washed 3 x 10 minutes with PBS-
Tween. Membranes were developed using the ECL solution (Amersham) and exposed onto 
Hyper film from Kodax. During all incubations and washings, the membrane was maintained 
in continuous agitation. 
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2.6.13 Southern blotting analysis 
 
Southern analysis was performed by using a slightly modified version of the original 
one (Southern, 1975). Briefly, 20 μg of A. fumigatus genomic DNA was digested with the 
appropriate restriction enzyme and digested DNA was separated on a 1% (w/v) agarose gel, 
stained for 30 minutes in 100 ml TBE with 20 μl of SYBR Safe DNA gel stain (Invitrogen), 
and photographed. Following depurination (250 mM HCl), denaturation (0.5 M NaOH, 1.5 M 
NaCl), neutralisation (0.5 M Tris-HCl, pH 7.5, 1.5 M NaCl) and equilibration in 20 x SSC (3 
M NaCl, 300 mM sodium citrate, pH 7), the gel was blotted overnight onto a positively 
charged nylon membrane (Roche Diagnostics). After transfer, the DNA was fixed to the 
membrane using the autocrosslink function on a Stratagene UV Stratalinker 1800. The DIG 
Easy Hyb solution, hybridisation solution for nucleic acid blots with digoxigenin-labeled 
probes (Roche) was pre-warmed to the hybridisation temperature (Thyb) of the probe. Thyb was 
calculated using the following equations: 
Tm = 49.82 + 0.41 (% G+C) – 600/l 
Thyb = Tm – (20°C to 25°C) 
where Tm = melting point of probe-target hybrid, % (G+C) = % of G and C residues in probe 
sequence, Thyb = optimal temperature of hybridisation of probe to target in DIG Easy Hyb and 
l = length of the probe in base pairs. The membrane was pre-hybridised at the Thyb in DIG 
Easy Hyb solution for 1-3 hours with gentle agitation. The probes were generated using the 
PCR DIG Probe Synthesis Kit (Roche) for production of highly sensitive probes labeled with 
DIG-dUTP (alkali-labile) according to the manufacturer‟s instructions. 50 ng of the probe was 
denatured in a final volume of 50 μl of H20 at 100°C for 5 minutes before chilling 
immediately on ice. The probe was added to 10 ml pre-warmed DIG Easy Hyb solution, 
mixed and the membrane was incubated overnight at the Thyb with agitation. The membrane 
was then washed in low stringency buffer (2 x SSC, 0.1% (w/v) SDS) at 25°C, high 
stringency buffer (0.5 x SSC, 0.1 % (w/v) SDS) at 65°C and washing buffer (0.1 M maleic 
acid, 0.15 M NaCl (pH 7.5), 0.3% (v/v) Tween 20). The membrane was blocked in blocking 
solution (1% (w/v) blocking powder [Roche Diagnostics] in 0.1 M maleic acid, 0.15 M NaCl, 
pH 7.5) for 1-3 hours at 25°C. The antibody, Anti-Digoxigenin-AP Fab fragments (Roche), 
was centrifuged at 10000 rpm for 5 minutes and used at a dilution of 1 in 10000 in 30 ml 
blocking solution for an incubation of 30 minutes with gentle agitation. The membrane was 
washed in washing buffer and equilibrated in detection buffer (0.1 M Tris-HCl, 0.1 M NaCl, 
pH 9.5) for 3 minutes. CDP-Star (Roche) was added to the membrane and incubated for 5 
minutes before the membrane was exposed onto Hyper film (Kodax).  
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2.7 Aspergillus fumigatus techniques   
 
2.7.1 A. fumigatus genomic DNA extraction  
 
DNA was extracted from A. fumigatus following two different protocols according to 
the requirements of the planned experiment.  
For colony PCR, spores were picked from a colony using a loop and mixed in 200 µl 
of breaking buffer (2% Triton X-100, 1% SDS, 100 mM NaCl, 10 mM Tris-HCl pH 8.0, 1 
mM EDTA pH 8.0). After the addition of 300 mg of glass beads (0.4-0.6 mm diameter, 
Sartorius UK), samples were incubated for 30 minutes at 70°C, vortexing every 10 minutes. 
200 µl phenol:chloroform:isoamyl alcohol 25:24:1 was added and the samples were vortexed 
for 5 minutes and subsequently centrifugated for 8 minutes at 13000 rpm. The supernatant 
was precipitated by adding an equal volume of isopropanol and incubated for 1 hour at 4°C. 
After centrifugation at 13000 rpm for 10 minutes, the pellet was washed in 70 % (v/v) ethanol 
and air-dried before resuspension in 20 µl of sterile H2O.  
For large scale genomic DNA preparations, A. fumigatus genomic DNA was extracted 
from mycelia following the modified method of Raeder and Broda (Raeder and Broda, 2008). 
Mycelia from an overnight culture in ACM (37°C, 180 rpm) were harvested, frozen in liquid 
nitrogen and ground with a mortar and pestle. Then, 1.5 ml of Aspergillus extraction buffer 
(300 mM Tris-HCl, 375 mM NaCl, 37.5 mM EDTA, 2% (v/v) sarkosyl) was added to 300 mg 
of mycelia reduced to a fine powder. Following addition of a half volume of phenol and a half 
volume of chloroform:isoamyl alcohol 24:1 (Sigma), tubes were mixed on a tube rotator for 
15 minutes at room temperature and then centrifuged at 13000 rpm for 1 hour. The 
supernatant was transferred to a microcentrifuge tube containing 400 μl of chloroform, 
centrifuged for 15 minutes, and the aqueous phase transferred to a new eppendorf tube where 
400 μl of chloroform was added. After 15 minutes of centrifugation, the aqueous phase was 
mixed with an equal volume of isopropanol. The tube was left at 4°C for 1 hour, centrifuged 
at 13000 rpm for 10 minutes and the pellet was washed in 70 % (v/v) ethanol and air-dried. 
Finally, the pellet was resuspended in 50 μl of TE containing RNace-It ribonuclease cocktail 
(Stratagene). 
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2.7.2 Transformation of A. fumigatus  
 
Transformation of DNA into A. fumigatus was conducted by electroporation. 
Electrocompetent spores were made according to the Sanchez and Aguirre protocol (Sanchez 
and Aguirre, 1996). Aspergillus spores were plated on ACM and incubated for 5 days, then 
harvested in sterile H2O and filtered through Miracloth (Calbiochem). Spores were 
centrifuged for 10 minutes at 4000 g, washed 5 times with H2O and counted. 250 ml YG 
broth (0.5% Yeast Extract, 2% Glucose) was inoculated with 5 x 10
9
 spores and grown at 
37°C for 2-4 hours. Spores were then centrifuged for 10 minutes at 4000 g, washed in cold 
H2O, and resuspended in 20 ml YED (1% Yeast Extract, 1% Glucose, 20 mM Hepes, pH 8 
with NaOH). Spores were grown at 30°C for 1 hour, and then resuspended in cold EB (10 
mM Tris HCl pH 7.5, 270 mM Sucrose, 1 mM LiAc).  
For the transformation, 2 μg of DNA was mixed with 50 μl of electrocompetent spores 
and incubated on ice for 15 minutes. Electroporation was then performed by application of a 
pulse of 1 kV, 400 OHM and 25 F. After incubation on ice for 15 minutes in presence of 
YED, spores were incubated at 30°C for 90 minutes. Resulting transformant spores were 
plated on AMM (- aneurin) supplemented with the optimal concentration of 0.5 μg/ml 
Pyrithiamine (Takara), as selective agent, and then incubated for 3 days at 37°C. 
 
2.8 Saccharomyces cerevisiae techniques  
 
2.8.1 DNA extraction  
 
Plasmid DNA extraction was performed using a modification of the standard protocol 
described previously (Sambrook and Russell, 2001). Plasmids were extracted from 10 ml 
overnight yeast SD cultures with the commercial kit NucleoSpin Plasmid (Macherey-Negen, 
Germany) but an additional step was introduced to disrupt yeast cells with acid-washed glass 
beads (425-600 µm diameter, Sigma). After resuspension of yeast cells according to the 
manufacturer‟s instructions, 300 mg of glass beads were added and the mixture was 
vigorously agitated for 30 minutes.  
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2.8.2 Protein extraction  
 
S. cerevisiae strains were inoculated in 10 ml of liquid SD medium supplemented with 
the appropriate drop-out mixture and grown overnight at 30°C, 180 rpm. Cells were then 
centrifuged at 700 g for 5 minutes and the pellets were washed once in 1 mM EDTA/water. 
200 µl of 2 M NaOH was added to cells and the mixture was transferred to eppendorf tubes to 
be incubated on ice for 10 minutes. Following the addition of 200 µl of 50 % TCA and 2 
hours of incubation on ice, cells were centrifuged at 14000 g for 20 minutes at 4°C. The 
supernatant was discarded and 200 µl ice-cold acetone was added to the pellet, gently broken 
up using a pipette tip. Samples were centrifuged at 14000 g for 20 minutes at 4°C and the 
supernatants were discarded. 200 µl of 5 % SDS was added to the pellet to resuspend and later 
an equal volume of 2X SDS Loading Buffer (65.5M Tris-HCl (pH 6.8), 2% (w/v) SDS, 5% 
(v/v) β-mercaptoethanol, 6 M Urea and bromophenol blue in distilled/deionized water). 
was added. If the colour of the sample was yellow several drops of 2 M Tris-Cl pH 9 
were added until the colour changed from yellow to blue. Samples were stored at -20°C and 
prior to western blotting analysis they were incubated at 37°C for 15 minutes and then 
centrifuged at 14000 g for 5 minutes.  
Total protein quantification of the samples was performed using the Bicinchoninic 
Acid Protein Assay Kit (Sigma) according to the manufacturer‟s instructions. The principle of 
the bicinchoninic acid (BCA) assay relies on the formation of a Cu
2+
-protein complex under 
alkaline conditions, followed by reduction of the Cu
2+
 to Cu
1+
, where the amount of reduction 
is proportional to the protein present. Unless otherwise stated, 30 µg of protein extract was 
loaded on 8% SDS-PAGE gels. 
 
2.8.3 Yeast transformation  
 
Lithium acetate protocol 
 
S. cerevisiae cells were transformed using a modification of the lithium acetate 
protocol described by Gietz and Woods (Gietz et al., 1992). Briefly, yeast cells were grown at 
30°C overnight in 5 ml of YPD and then centrifuged, washed once with 1 ml of H2O and 
incubated for 15 minutes at 30°C in 1 ml 100 mM lithium acetate. After centrifugation, 360 µl 
of transformation mix (33% (w/v) polyethylene glycol (PEG) 3350, 0.1 M LiAc, 0.3 mg/ml 
boiled and chilled salmon sperm DNA, 200-500 ng DNA per transformation) was added. 
Following the incubation for 30 minutes at 30°C and heat-shock at 42°C for 20 minutes, cells 
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were centrifuged and 400 µl of H2O was added. After an incubation of 5 minutes at room 
temperature, cells were resuspended, spread onto SD plates and incubated for 3 days at 30°C. 
 
Lithium acetate protocol for 96-wells plate 
 
The lithium acetate transformation method (Gietz et al., 1992) was adapted to the 96-
well plate format as follows: S. cerevisiae cells were grown at 30°C overnight in 100 µl of 
YPD. Cells were centrifuged, washed once with 150 µl of H2O and incubated for 15 minutes 
at 30°C in 150 µl 100 mM lithium acetate. Cells were then centrifuged and 20 µl of mix 1 (9 
µl TE buffer, 10.5 µl of 2 mg/ml boiled and chilled salmon sperm DNA, 5 µl of 180 ng/µl 
plasmid) was added. After mixing, 55 µl of mix 2 (48 µl 50% (w/v) PEG 3350, 7 µl 1 M 
lithium acetate) was added. After incubation for 30 minutes at 30°C followed by 30 minutes 
of incubation at 42°C, cells were centrifuged and 100 µl of H2O was added. After incubation 
for 5 minutes at room temperature, cells were resuspended in H2O, spread onto SD plates and 
incubated for 3 days at 30°C. For each strain, three transformants were selected, and cultured 
in 150 µl of SD in a 96-wells plate overnight at 30°C. 
 
Split-ubiquitin modified lithium acetate protocol  
 
Another modified version of the lithium acetate transformation method (Gietz et al., 
1992) was utilised for split-ubiquitin experiments. 50 ml of YPAD was inoculated with 
several colonies of NMY51 taken from a fresh plate and grown overnight at 30°C with 
shaking. The OD546 of the culture was measured and the yeast cells were diluted to OD546 = 
0.2 and re-grown to OD546 = 0.6. 50 ml of culture was centrifuged for 5 minutes at 2500 g and 
resuspended in 2.5 ml of H2O. PEG/LiOAc mix (sufficient for 5 reactions) was prepared with 
1.2 ml 50 % PEG 3350, 180 µl 1 M LiOAc and 125 µl of boiled and chilled salmon sperm 
DNA and added to 1.5 µg of the transforming plasmid. After vigorous shaking, 100 µl of 
resuspended yeast cells was added, followed by vortexing for 1 min. Samples were incubated 
in a 42°C water bath for 45 minutes and centrifuged for 5 minutes at 700 g. Each pellet was 
dissolved in 150 µl 0.9 % NaCl and spread onto SD plates. Plates were incubated for 4 days at 
30°C. 
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2.8.4 Quantitative β-galactosidase assay 
 
The β-galactosidase activity of S. cerevisiae strains was measured using the non-stop 
protocol for 96-well plate recommended by the yeast β-galactosidase assay kit (Pierce) 
manufacturers. Briefly, overnight broth cultures were diluted (1/10) and grown to an OD660 of 
approximately 0.6. The OD660 was then recorded and 100 μl of working solution (50 μl 2X 
ONPG and 50 μl Y-PER Reagent) was added to each well. After 20-30 minutes the 
absorbance at 420 nm was measured and the β-galactosidase activity was calculated applying 
the following formula:  
(1000 x A420)/ T x V x OD660 = β-galactosidase activity 
where T = reaction time= 20 min, V = total volume= 200 μl and A420 = Absorbance at 420 
nm.  
 
2.9 In vivo virulence analysis  
 
Murine infections were conducted under UK Home Office Project Licence 
PPL/70/6487 in a dedicated facility at Imperial College London, where individually vented 
cages with free access to food and H2O were used to house outbred male mice (strain CD1, 18 
– 22 g, Harlan Ortech). H2O was supplemented with 1 g/l tetracycline hydrochloride and 64 
mg/L ciprofloxacin as prophylaxis against bacterial infection. For a neutropenic model of 
infection, immunosuppression of mice was performed by intraperitoneal injections of 
cyclophosphamide (150 mg/kg) on days –3, –1, +2, and subsequently every third day for the 
duration of the experiment and by a single subcutaneous dose of hydrocortisone acetate 
(112.5 mg/kg) on day –1 (Schrettl et al., 2004). A. fumigatus spores were grown on ACM, 
supplemented with 1 % (w/v) glucose and 5 mM ammonium tartrate, for 5 days prior to 
harvesting the conidia using sterile saline (Baxter Healthcare Ltd, UK) and filtering them 
through MIRACLOTH.  
For survival analysis, conidial suspensions were centrifuged for 5 minutes at 5000 
rpm, washed twice with sterile saline, counted using a haemocytometer and resuspended at a 
concentration of 1.25x10
6
-1.5x10
7
 (respectively for low and high dose) cfu/ml. The 
determination of viable counts for the administered inocula was performed by serial dilution 
on ACM plates supplemented with 1 % (w/v) glucose and 5 mM ammonium tartrate and 
incubated for 3 days at 37°C. Mice were anaesthetised by isofluorane inhalation and infected 
by intranasal instillation of 5.0x10
4
-6.0x10
5
 (respectively for low and high dose) conidia in 40 
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μl of saline solution. Mice were weighed every 24 hours from day -3 and inspected twice 
daily. For survival analysis, in the majority of instances, the end of the experimentation 
corresponded to a 20% reduction in body weight measured from the day 0, at which point 
mice were culled.  
For the transcriptional time course comparison between ATCC466645 ΔpacC and the 
respective parental isolate throughout murine infection, spores, prepared as before, were 
resuspended at a concentration of 2.5x10
9
 cfu/ml and mice, anaesthetised by isofluorane 
inhalation, were infected by intranasal instillation of 1x10
8
 conidia in 40 μl of saline solution. 
Groups of infected mice were culled and processed collectively during a 2 hour window 
corresponding to time points 4, 8 and 16 hours post-infection. Bronchoalveolar lavages 
(BALs) were performed using three 0.5 ml aliquots of sterile saline. BAL fluids (BALFs) 
were snap frozen immediately following harvesting using liquid nitrogen.  
Lungs were removed immediately after sacrifice or after BALFs were obtained and 
fixed in 4 % (w/v) formaldehyde (Sigma) for histological sectioning. Lungs were embedded 
in paraffin prior to being sectioned and stained with hemotoxylin and eosin (H&E) or light 
green and Grocott‟s Methenamine Silver (GMS).  
 
2.10 DNA microarray techniques 
 
2.10.1 Fungal RNA extraction from BALFs 
 
BALF samples were centrifuged at 14000 rpm for 5 minutes and the pellet was 
washed with 500 µl ice cold H2O to lyse host cells. Seven BALFs were pooled, resuspended 
in 450 µl ME-RLC buffer (QIAGEN) and ground in liquid nitrogen with a pestle and mortar. 
RNA was then extracted using RNeasy® Kit (QIAGEN). Quality of RNA used for microarray 
analysis was checked by Nanodrop ND-1000 Spectrophotometer (Nanodrop, Wilmington, 
USA). Only RNA with an A260/280 and an A260/230 ratio > 1.9 was used for the experiments. 
 
2.10.2 Reverse transcription and fluorescent labelling of RNA  
 
Labelled cDNA samples were synthesised at the J. Craig Venter Institute (JCVI), 
Rockville, Maryland, USA, as described previously (McDonagh et al., 2008a). Protocols for 
direct labelling and hybridisation of cDNA probes can be found on the JCVI website 
(pfgrc.jcvi.org/index.php/microarray/protocols.html).  
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2.10.3 Data capture for cDNA microarrays  
 
The GenePix 4000b (Axon Instruments, Foster City, CA) semiconfocal microarray 
scanner was used to measure the intensities of hybridised probes. Fluorescence was measured 
with the associated GenPix Pro 3.0 software, setting pixel size at 10 μm and lines to average 
at 2. The photomultiplier tube (PMT) voltage for each channel (532 nm and 635 nm) was 
adjusted to give an overall intensity ratio across each slide of around 1, a background intensity 
at 532 nm of around 100, and a maximal intensity at around saturation (65536 or 216 i.e. 16 
bit scanning resolution). Datasets were exported as GenePix Results (GPR) files. Images were 
saved as .TIF files and TIGR Spotfinder (Saeed et al., 2003) was used to quantify 
fluorescence intensities. Poor quality spots were identified manually and flagged. 
 
2.10.4 Manipulation and analysis of microarray data  
 
After Spotfinder analysis, results were exported as TIGR software-compatible MEV 
files. Data normalisation was performed with TIGR TM4 freeware (www.tm4.org/) for 
locally-weighted scatter plot smoothing (LOWESS). After LOWESS normalisation, the flip 
dye pairs were analysed in a consistency check to remove any outlier spots (defined as those 
falling beyond the standard deviation of the array-wide average log2 ratio of the fluorescence 
values for spot intensity). The resulting data was averaged taking a total of 6 intensity data 
points for each gene (triplicate copies of the genes printed on each array and the duplicate 
flip-dye arrays for each experiment). The phase- or strain-specific comparative analysis of 
gene expression datasets was conducted in Genespring GX 11.02 (Aligent). Normalised log2 
expression ratios were filtered on expression level and differentially regulated transcripts were 
defined as having log2 (Cy5/Cy3) greater than the arbitrary thresholds of ± 1.5 or ±2, as 
appropriate. Clustering was performed using the software STEM (Short Time-series 
Expression Miner), designed for clustering, comparing, and visualizing gene expression data 
from short time series microarray experiments (Ernst and Bar-Joseph, 2006).  
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CHAPTER III  
 
PHYSIOLOGICAL REQUIREMENT FOR PH SIGNALING DURING 
A. FUMIGATUS STRESS ADAPTATION AND VIRULENCE 
  
3.1 Overview  
 
A. fumigatus virulence has been defined as a polygenic trait (Askew, 2008; Hohl and 
Feldmesser, 2007), originating from a combination of several contributing basic traits, which 
allows the fungus to inactivate or escape host defence systems and to withstand the 
nutritional, oxidative and other physiological stresses exerted by the host niche. The 
mammalian immune system is usually depicted as the primary impediment to fungal 
colonisation and subsequently infection, but in this context it is also necessary to consider the 
dramatic differences between a saprophytic lifestyle in the natural environment and a parasitic 
lifestyle as a mammalian pathogen (Cooney and Klein, 2008). Host-related abiotic stresses 
include elevated temperature, heightened ambient pH, and low availability of metal ions, 
usually sequestered by the host to support its own metabolism. Accordingly, transcriptional 
profiling of A. fumigatus in the early stages of infection identifies differentially expressed 
genes involved in environmental pH adaptation and in iron uptake, utilisation and 
mobilisation in a neutropenic murine model of IPA (McDonagh et al., 2008a). This study 
demonstrated that, together with various types of other stresses such as iron and nitrogen 
limitation and temperature, alkaline stress is indeed one of the host-imposed stresses A. 
fumigatus must face to adapt to the host niche. All microorganisms, but in particular those 
inhabiting mammalian niches during infection, must adapt to the pH of the surrounding 
environment. In fact, within a human or murine host, the pH shifts to slightly alkaline; 
adaptation to which requires therefore, not only the maintenance of internal pH homeostasis 
but also the appropriate expression of genes involving functions at the cell surface or in the 
extracellular environment, especially to ensure supply of the necessary nutrients, whose 
bioavailability is altered as a function of ambient pH.  
The conserved PacC/Rim101p signal transduction pathway mediates fungal pH 
adaptation. Due to the easy genetic manipulation achievable in A. nidulans (Pontecorvo et al., 
1953), this model ascomycete has represented the organism of choice for the extensive 
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characterisation of the PacC/Rim101p pathway, since its first discovery more than 20 years 
ago (Caddick et al., 1986c). Findings that murine aspergillosis requires functionality of A. 
nidulans pacC highlights the importance of fungal PacC-mediated alkaline adaptation in the 
pathogenesis of murine pulmonary aspergillosis (Bignell et al., 2005). For murine 
pathogenicity, A. nidulans PacC must be present, and proteolytically processed via pH-
sensing Pal proteins (Bignell et al., 2005). The mechanism leading to the activation of this 
regulatory pathway has not yet been characterised extensively in A. fumigatus and its precise 
role during infection is still unexplored by the current literature. In this study two A. 
fumigatus ΔpacC mutants, constructed in different genetic backgrounds, were characterised in 
terms of phenotype, virulence and tissue invasion. Concordant with studies in A. nidulans, 
these findings underline the physiological requirement for PacC-mediated pH signaling 
during A. fumigatus alkaline stress adaptation.   
 
3.2 Methods  
 
3.2.1 A. fumigatus strains  
 
Two A. fumigatus strains, the clinical isolates CEA10 and ATCC46645 (see Appendix 
A), were used for ΔpacC mutant construction. Both mutants were constructed by gene 
replacement using a split-marker strategy by a collaborator Markus Schrettl (Hubertus Haas 
laboratory at Innsbruck Medical University). To propagate ΔpacC mutants, AMM (- aneurin) 
was supplemented with 0.5 μg/ml Pyrithiamine (PTR, Takara) as selective agent. PTR is 
thiamine antagonist, inhibiting thiamine pyrophosphorylation and therefore inducing thiamine 
deficiency (Liu et al., 2006). Hence, the use of PTR in culturing media requires omission of 
aneurin.  
Gene replacement was confirmed by PCR and by Southern Blotting for both mutants. 
In the case of the ATCC46645 ΔpacC mutant, this was conducted in the Haas laboratory. For 
the CEA10 ΔpacC mutant, the integrity of the pacC coding region was tested in 3 
independent transformants, supplied by Markus Schrettl, using the oligonucleotides pF-
PacCint1 and pR-PacCint1 (see Appendix B), designed to amplify a region of 1100 bp of the 
pacC gene (nucleotides +543 to +1593 with respect to the ATG). Clones from which the pacC 
genetic locus could not be amplified were further analysed by Southern blotting using two 
DIG probes. A pacC-specific probe, obtained by PCR with the oligonucleotides PacCSB1 and 
PacCSB2 (see Appendix B), which amplify a region of 1250 bp of the 5‟ flanking region of 
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pacC gene (nucleotides -1266 to -24 with respect to the ATG) was used to differentiate 
between wild type and mutant pacC genetic loci. A second ptrA-specific probe, obtained by 
PCR using the oligos LucPtrAF and LucPtrAR (see Appendix B), which amplify a region of 
580 bp of the ptrA gene (nucleotides +638 to +1137 with respect to the ATG) was used to 
determine between single and multiple insertions of the gene replacement cassette. Genomic 
DNA was extracted from the mycelia and digested overnight with the enzyme SalI.  
 
3.2.2 A. fumigatus phenotypic testing  
 
As summarised in Table 3.1, the phenotype of the A. fumigatus ΔpacC mutants was 
examined in AMM pH 6.5, AMM pH 8.0 (buffered with 100 mM Tris-HCl pH 8.0) and 
AMM pH 7.2 (buffered with 100 mM Tris-HCl pH 7.2).  
 
Media Test Condition Comments 
AMM pH 6.5  Neutral pH  Buffered with 100 mM MES pH 6.5  
AMM pH 7.2  Physiological (host) pH  Buffered with 100 mM Tris-HCl pH 7.2  
AMM pH 8.0  Alkaline stress  Buffered with 100 mM Tris-HCl pH 8.0  
 
Table 3.1: Media and buffers used for A. fumigatus phenotypic screening. The composition of the 
media is described in Section 2.3.2.  
 
An alternative buffering system, using phosphate, was also used to test the response to 
alkaline conditions and was composed of 2.7 mM NaH2PO4, 50 mM Na2HPO4, and 20 ml/ 
phosphate-free salt solution (26 g/l KCl, 26 g/l MgSO4, 40 mg/l Na2B4O7.10H2O, 400 mg/l 
CuCl2.5H2O, 800 mg/l FeCl3.H2O, 800 mg/l MnSO4.4H2O, 800 mg/l Na2MoO4.2H2O, 8 g/l 
ZnSO4.7H2O).  
A. fumigatus was cultured for 4 days on ACM at 37°C. Spores were harvested from a 
single plate and serially diluted prior to plating (1x10
4
, 1x10
3
, 1x10
2
, 1x10
1
 spores). Each 
dilution of 1x10
4
, 1x10
3
, 1x10
2
, 1x10
1
 spores was plated in triplicate as individual spots on 
the same plate. Plates were incubated for 2 days at 37°C. Plates were photographed without 
magnification using a Nikon Coolpix 990 digital camera. Aspergillus spores were visualised 
using a Nikon Eclipse 80i microscope.  
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3.2.3 Murine infections  
 
Murine infections were performed under UK Home Office project Licence 
PPL/70/6487 in dedicated facilities at Imperial College London. Outbred male mice (strain 
CD1, 18-22 g, Harlan Ortech) were housed in individually vented cages. Mice were 
immunosuppressed as previously described (Schrettl et al., 2004). A. fumigatus spores for 
inoculation were grown on ACM for 5 days prior to infection. Conidia were freshly harvested 
using sterile saline (Baxter Healthcare) and filtered through Miracloth (Calbiochem, UK) and 
conidial suspensions were spun for 10 min at 3,000 rpm, washed twice with sterile saline and 
counted using a hemocytometer.  
For the high dose-survival analysis, conidia were resuspended at a concentration of 
1.5x10
7
 cfu/ml and viable counts from administered inocula were determined by serial 
dilutions on ACM plates incubated for 3 days at 37ºC. Mice were anaesthetised by isofluorane 
inhalation and infected by intranasal instillation of 6.0x10
5
 conidia in 40 μl of saline. For the 
low dose-survival analysis, conidia were resuspended at a concentration of 1.25x10
6
 cfu/ml 
and viable counts from administered inocula were determined by serial dilutions on ACM 
plates incubated for 3 days at 37ºC. Mice were infected by intranasal instillation of 5.0x10
4
 
conidia in 40 μl of saline. Mice were weighed every 24 hours from the day of infection and 
visual inspection was made twice daily. In the majority of cases, the end point for survival 
experimentation was a 20% reduction in body weight measured from day of infection, at 
which point mice were sacrificed.  
Histological analysis was performed on samples obtained during infections for 
transcriptional analysis of the ATCC46645 ΔpacC mutant and the respective parental isolate. 
Mice were culled and processed at 4, 8 and 16 hours post-infection. Lungs were removed 
immediately after sacrifice and fixed in 4% (w/v) formaldehyde (Sigma). Lungs were 
embedded in paraffin prior to being sectioned and stained with hemotoxylin and eosin (H&E) 
or light green and Grocott‟s Methenamine Silver (GMS).  
 
3.3 Results  
 
3.3.1 Phenotypic characterisation of A. fumigatus ΔpacC mutants   
 
The two A. fumigatus ΔpacC mutants (ATCC46645 and CEA10 genetic backgrounds) 
provided by Markus Schrettl (Hubertus Haas‟s laboratory) were analysed to verify gene 
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replacement by PCR and by Southern Blotting. In the case of the ATCC46645 ΔpacC mutant, 
this was conducted in the Haas laboratory.  
For the CEA10 ΔpacC mutant, the integrity of the pacC coding region was initially 
tested in three independent transformants using the oligonucleotides pF-PacCint1 and pR-
PacCint1 (see Appendix B). Because these oligonucleotides were designed to amplify a 
region of 1100 bp of the pacC gene, no PCR product was expected if the pacC gene had been 
efficiently deleted and substituted with the split-pyrithiamine cassette. Using this approach, 
no amplification product resulted for the clone represented in Fig. 3.1A, which was therefore 
further analysed by Southern blotting using two DIG probes (Fig.3.1B). A pacC-specific 
probe, obtained by PCR with the oligonucleotides PacCSB1 and PacCSB2 (see Appendix B) 
was used to differentiate between wild type and mutant pacC genetic loci. The expected 
signals were 7883 bp for the wild type and 3355 bp for the ΔpacC mutant. A second ptrA-
specific probe, obtained by PCR using the oligos LucPtrAF and LucPtrAR (see Appendix B) 
was used to determine between single and multiple insertions of the gene replacement 
cassette. No signal was expected for the wild type, whereas for a single, homologous 
integration of the deletion cassette the expected signal was 3355 bp.  
 
Fig. 3.1: Verification of ΔpacC mutant in the A. fumigatus CEA10 genetic background by PCR 
and Southern blotting. (A) PCR results showing the CEA10 ΔpacC mutant in comparison to the CEA10 wild 
type. 1 Kb DNA ladder (10.0, 8.0, 6.0, 5.0, 4.0, 3.0, 2.0, 1.5, 1.0 and 0.5 Kb). (B) Southern Blotting results 
showing the CEA10 ΔpacC mutant in comparison to the CEA10 wild type for pacC-specific and ptrA-specific 
probes.   
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The phenotype of ΔpacC mutants in the A. fumigatus ATCC46645 and CEA10 genetic 
backgrounds were analysed and compared to those of the respective parental strains at neutral 
(pH 6.5), host physiological pH (pH 7.4: supposed murine lung pH) and alkaline conditions 
(pH 8.0). Each strain was tested in serial dilutions of 1x10
4
, 1x10
3
, 1x10
2
, 1x10
1
 spores. Tests 
were performed in triplicate (data not shown). Fig. 3.2 shows the results of the phenotypic test 
for A. fumigatus ΔpacC mutants and the respective parental strains. In addition to a 
morphological defect and poor conidiation at pH 6.5, A. fumigatus ΔpacC mutants exhibit 
reduced or complete prevention of growth at pH 8.0 compared to the wild type. Significantly, 
the growth of A. fumigatus ATCC46645 ΔpacC is prevented at pH 7.2, the physiological 
conditions expected in mouse lungs. Alkaline sensitivity was less extreme in the case of 
CEA10 ΔpacC.   
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Fig. 3.2: Phenotypic analysis of the A. fumigatus ΔpacC. A. fumigatus ΔpacC mutants in the 
ATCC46645 (bottom left) and CEA10 genetic backgrounds (bottom right) compared to respective parental 
isolates ATCC46645 (top right) and CEA10 (top left). Each strain was plated in serial dilutions of 1x10
4
, 1x10
3
, 
1x10
2
 and 1x10
1
 spores from left to right. For each strain, the conditions tested were AMM 6.5, AMM 7.2, 
AMM pH 8.0 (pH 8.0 a) and phosphate-buffered pH 8.0 media (pH 8.0 b). Plates were incubated for 2 days at 
37°C.  
 
3.3.2 Effect of pacC deletion on A. fumigatus virulence in a neutropenic murine model of 
infection 
 
The virulence of A. fumigatus ΔpacC mutants was compared to that of the parental 
wild type strains using a neutropenic murine model of invasive pulmonary aspergillosis. For 
the neutropenic model of infection, immunosuppression of mice was performed by 
intraperitoneal injections of cyclophosphamide (150 mg/kg) on days –3, –1, +2, and 
subsequently every third day for the duration of the experiment and by a single subcutaneous 
dose of hydrocortisone acetate (112.5 mg/kg) on day –1 (Schrettl et al., 2004). Initially four 
groups of 8 neutropenic male mice were inoculated intranasally with 6x10
5
 spores of the 
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ATCC46645 ΔpacC and CEA10 ΔpacC mutants and the respective parental isolates. To 
verify the administered inocula in mice, the determination of viable counts was performed 
using serial dilution on solid ACM culture. Mice were weighed daily and inspected regularly. 
For survival analysis, in the majority of instances, the end of the experimentation 
corresponded to a 20% reduction in body weight measured from the day of the infection, at 
which point mice were culled. As shown in Fig. 3.3, infection with ATCC46645 ΔpacC 
mutant resulted in 50% mortality within 13.5 days compared to infection with the wild type 
ATCC46645 strain which resulted in 50% mortality within 5 days (p<0.0001, Kaplan-Meier 
log rank analysis). This demonstrates that, in comparison with the wild type strain, A. 
fumigatus ATCC46645 ΔpacC is attenuated in a murine model of pulmonary aspergillosis. 
 
Fig. 3.3: Comparative survival of neutropenic mice infected with ATCC46645 and ATCC46645 
ΔpacC. Mice were inoculated with 6x105 spores for each strain (n=8). Median survival was 5 and 13.5 days for 
ATCC46645 and ATCC46645 ΔpacC respectively. A Kaplan-Meier survival curve and a log rank test were used 
to compare survival levels among the strain groups, demonstrating significant difference between the survival 
curves for ATCC46645 and ATCC46645 ΔpacC (p<0.0001).   
 
A different result was observed following infection with an A. fumigatus CEA10 
ΔpacC mutant. As shown in Fig. 3.4, infection with CEA10 ΔpacC and the wild type CEA10 
strain resulted, in both cases, in 50% mortality within 5 days (p=0.3774, Kaplan-Meier log 
rank analysis). This suggests that, in comparison with the wild type strain, the A. fumigatus 
CEA10 ΔpacC mutant is not attenuated in a murine model of pulmonary aspergillosis. 
94 
 
 
 
 
Fig. 3.4: Comparative survival of neutropenic mice infected with CEA10 and CEA10 ΔpacC. Mice 
were inoculated with 6x10
5
 spores for each strain (n=8). Median survival was, for both strains, 5 days. A 
Kaplan-Meier survival curve and a log rank test were used to compare survival levels among the strain groups, 
showing no significant difference between the survival curves for CEA10 and CEA10 ΔpacC (p=0.3774).   
 
The differential virulence observed for the ATCC46645 ΔpacC and CEA10 ΔpacC 
mutants correlates with the observed differential alkaline pH sensitivity of the strains (Fig. 
3.2). At pH 7.2, ATCC46645 ΔpacC is almost unable to grow, whereas CEA10 ΔpacC is 
reduced for growth but not entirely impaired, possibly explaining the differential virulence 
data obtained in the murine model. Relating the phenotypic data to those obtained in model 
infections, an inoculum of 10
4 
is ten times lower than the concentration usually used to infect 
a single mouse.  
Hypothesising that the infectious dose of 6x10
5
 spores masked a possible virulence 
defect, the experiment was repeated with a lower infectious dose. Two groups of 8 
neutropenic male mice were inoculated with 5x10
4
 spores of CEA10 ΔpacC and CEA10 
reconstituted via ectopic insertion of the pacC gene. As before, the determination of viable 
counts was performed using serial dilution on solid ACM culture to verify the administered 
inocula in mice. Mice were weighed daily and inspected regularly. For survival analysis, in 
the majority of instances, the end of the experimentation corresponded to a 20% reduction in 
body weight measured from the day of the inoculum, at which point mice were sacrificed. As 
shown in Fig. 3.5, infection with low doses of CEA10 ΔpacC resulted in 50% mortality 
within 17 days, compared to 50% mortality within 4 days for the reconstituted CEA10 strains. 
This demonstrates that, in comparison with the respective wild type strain, A. fumigatus 
CEA10 ΔpacC is attenuated in a low-dose murine model of pulmonary aspergillosis 
(p<0.0001, Kaplan-Meier log rank analysis). 
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Fig. 3.5: Survival of neutropenic mice infected with low dose CEA10 ΔpacC. Mice were inoculated 
with 5.0x10
4
 spores for the CEA10 ΔpacC strain and ectopically reconstituted CEA10. Median survival was 17 
and 4 days for CEA10 ΔpacC and reconstituted CEA10 (CEA10RC) respectively. A Kaplan-Meier survival curve 
and a log rank test were used to compare survival levels among the strain groups, demonstrating a significant 
difference between survival curves (p < 0.0001).  
 
3.3.3 Histopathological analysis of A. fumigatus ATCC46645 ΔpacC mutant in 
neutropenic mice  
 
To examine comparative growth of the highly attenuated ATCC46645 ΔpacC mutant, 
and a fully virulent parental strain, tissues were recovered from a further murine infection 
experiment, which explored the A. fumigatus transcriptome during initiation of infection 
(Chapter IV). Fig. 3.6 shows a time course of histological samples (4, 8 and 16 hrs) for the 
wild type strain ATCC46645 (top row) and the ATCC46645 ΔpacC mutant (bottom row). 
Minimal differences between the wild type and mutant isolates are visible in the earlier 
stages, corresponding to 4 and 8 hrs, of infection (Fig 3.5A, B, D and E). Although, at 8 hours 
post infection, wild type spores are visibly swollen and beginning to germinate (Fig. 3.5B). In 
addition, some slight differences in the level of inflammation were associated with the wild 
type infection, as visible from the comparison between panels B and E in Fig. 3.6. The 
difference becomes clearly visible from the comparison at 16 hours between the wild type 
strain and the ATCC46645 ΔpacC, as shown in panels C and F of Fig. 3.6. The ΔpacC mutant 
seems unable to progress beyond primary hyphal morphotypes, whereas the parental isolate 
revealed extensively branched invasive growth. 
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Fig. 3.6: Comparative lung histopathology in neutropenic mice infected with ATCC46645 and 
ATCC46645 ΔpacC. Mice were infected with 1x108 A. fumigatus spores. Lung sections were stained with 
Grocott's Methenamine silver and light green. Host tissue stains green and fungal material stains black. Pictures 
were taken with 50x magnification. (A) ATCC466645, 4 hours; (B) ATCC466645, 8 hours; (C) ATCC466645, 
16 hours; (D) ATCC466645 ΔpacC, 4 hours; (E) ATCC466645 ΔpacC, 8 hours; (F) ATCC466645 ΔpacC, 16 
hours. 
 
3.4 Discussion  
 
The role of the Rim101p/PacC family members in virulence has been extensively 
studied, highlighting how this regulatory pathway is able to affect, in different ways, the 
success of fungal pathogens in their host niche. In mice, C. albicans Rim101p (Davis et al., 
2000a) and A. nidulans PacC (Bignell et al., 2005) are necessary for the establishment of 
disseminated candidiasis and IPA respectively. In plants, the homologue of PacC in 
Sclerotinia sclerotiorum (Pac1) (Rollins, 2003) and Colletotrichum acutatum (Klap2) (You et 
al., 2007) are also required for virulence; however, no specific role in plant infection has been 
identified for Ustilago maydis Rim101 (Arechiga-Carvajal and Ruiz-Herrera, 2005). On the 
contrary, in the plant pathogen Fusarium oxysporum PacC has been demonstrated to act as a 
negative regulator of virulence (Caracuel et al., 2003b). Certain components required for 
alkaline adaptation of Aspergillus species are highly conserved between A. nidulans and A. 
fumigatus, as shown by the alignments presented in Appendix F. Due to the existence of 
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sexual and parasexual stages in the A. nidulans life cycle, this organism has been widely used 
as a model for A. fumigatus.  
The recent development of new molecular tools for A. fumigatus genetic manipulation, 
and considerable progress in the comprehension of its genetic and molecular biology 
(Brakhage and Langfelder, 2002), have facilitated investigation of the pH regulatory 
mechanism directly in this pathogen. Pertinent publications are extremely recent (Amich et 
al., 2009; Amich et al., 2010), representing the first experimental studies on A. fumigatus 
PacC. The construction and phenotypical characterisation of A. fumigatus PacC mutants 
confirmed strong parallels with PacC function in A. nidulans (Amich et al., 2009) and 
revealed the role of the transcription factor in repressing, under neutral, zinc-limiting 
conditions, the ZfrA and ZfrB transporters. As in A. nidulans, growth of the pacC
+/-
 mutant 
was almost identical to that of the wild type at acid pH, but impaired as a consequence of pH 
increase. Growth of the pacC
c 
mutant was impaired at acid pH, but not at alkaline pH, where 
the growth was identical to the wild type. The behaviour of the two mutants therefore reflects 
that expected on the basis of experimental evidence in A. nidulans for acidity- (pacC
+/-
) and 
alkalinity-mimicking (pacC
c
) phenotypes. In addition, similarly to A. nidulans (Tilburn et al., 
1995), pacC gene expression is slightly increased as a consequence of alkalinisation. A. 
fumigatus PacC has been demonstrated to be involved in regulation of zinc uptake, in 
particular by repressing under neutral, zinc-limiting conditions the ZfrA and ZfrB 
transporters, in order to economise cellular resources. Considering the proximity between the 
PacC consensus site and the TATA box in zfrB, the mechanism by which PacC is 
hypothesised to repress zfrB transcription involves the physical blockage of efficient RNA 
polymerase binding. The link between pH regulation and zinc homeostasis is crucial, 
considering zinc solubility decreases around neutral pH. A. fumigatus PacC has also been 
linked to the regulation of expression of two other genes required for fungal growth in 
alkaline and extreme zinc-limiting conditions zrfC and asp2 (Amich et al., 2010). 
Interestingly, in this case, the mode of action of PacC contrasts with the accepted model of 
PacC function, which supposes that in alkaline conditions PacC activates the transcription of 
alkaline-expressed genes and represses the expression of acid-expressed genes. In fact, PacC 
derepresses the transcription of the zrfC and asp2 at alkaline pH but represses it at acidic pH.    
The zinc studies extensively focused on the role of A. fumigatus PacC on zinc uptake 
but no biological clues were provided on its role during infection, which is still unreported in 
the current literature. The analysis of phenotype, virulence and tissue invasion of the A. 
fumigatus ΔpacC mutants presented in this study has highlighted (as for numerous fungal 
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species such as A. nidulans, S. cerevisiae and C. albicans), the importance of PacC for A. 
fumigatus virulence and its requirement for pH tolerance in alkaline environments.   
 
3.4.1 pacC deletion prevents A. fumigatus adaptation to alkaline stress in vitro 
 
Our collaborators at Innsbruck Medical University generated two ΔpacC mutants 
using a split-pyrithiamine marker in the A. fumigatus ATCC46645 genetic background and in 
the sequenced A. fumigatus isolate CEA10. The choice of these genetic backgrounds align 
with other mutant constructions in the Bignell laboratory which had previously used both 
backgrounds and with the previous cited publications from(Amich et al., 2009)where the 
pacC
+/- 
mutant was constructed in CEA17, the auxotrophic pyrG
-
 version of CEA10. These 
genetic backgrounds are also routinely used for collaborations with the Haas laboratory, 
which has extensively characterised the role of siderophores in fungal physiology and 
virulence (for a comprehensive review see(Haas et al., 2008; Haas, 2003). 
These ΔpacC mutants were verified for the correct and single insertion of the split-
pyrithiamine marker in the pacC genomic locus and subsequently their phenotypes were 
analysed and compared to that of the respective parental strains at pH 6.5, 7.2 and 8.0. 
Specific phenotypes are associated with pacC null mutants in A. nidulans which extend 
beyond growth defects in alkaline conditions. The phenotype of A. nidulans pacC deletants 
includes cryosensitivity of growth in neutral conditions, a low growth rate at the permissive 
temperature, poor conidiation and overproduction of a brown pigment, presumed to be 
melanin (Tilburn et al., 1995). The same phenotypic alterations were revealed for the two A. 
fumigatus ΔpacC mutants in the ATCC46645 and CEA10 backgrounds (Fig. 3.2). In neutral 
conditions, A. fumigatus ΔpacC mutants in both backgrounds show morphological defects, 
i.e. poor conidiation (Fig. 3.2). As reported for A. nidulans pacC null mutations (Tilburn et 
al., 1995), the A. fumigatus ΔpacC mutants also exhibit reduced, or lack of growth, compared 
to the wild type when pH is increased. These findings align with the characterisation of the A. 
fumigatus pacC
+/-
 mutant recently presented by(Amich et al., 2009)which shows an acidity-
mimicking phenotype whereby growth of the pacC
+/-
 mutant impaired gradually as a 
consequence of increasing pH. However, in neutral conditions only minor defects was 
associated with this mutant, which was constructed by replacing the pacC ORF with a 
truncated version deleted for residues L471 to H556, therefore leading to the inability of PacC 
to undergo proteolytic processing (similarly to the A. nidulans pacC
+/-
 20205 mutant 
presented in(Mingot et al., 1999). The difference in phenotype at neutral pH between the 
ΔpacC mutants characterised in this study and the pacC+/- mutant presented by(Amich et al., 
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2009)probably derives from the salt composition of the media itself, which slightly differ in 
iron concentration. The importance of the salt composition was confirmed in the present 
study, where two different alkaline media were used to assess fungal growth. In fact, alkaline 
media buffered with phosphate-free solution affects significantly more the growth of ΔpacC 
mutants (Fig. 3.2). 
pH is a negative logarithmic measure of hydrogen ion activity (Sörensen, 1909), used 
to express the wide variation in H
+
 concentration occurring in aqueous solution. According to 
an established scale, the term acidity is associated with pH from 1 to 6.9 and the term 
alkalinity with pH from 7.1 to 14. As a consequence of active metabolism, there is always a 
movement of protons inside and outside the cytoplasm of cells. Cells have therefore evolved 
several mechanisms to maintain ion balance and guarantee optimal activity of major 
metabolic pathways, whose functioning would be otherwise damaged by large deviations of 
intracellular pH. In fact, proteins have an optimal pH at which their activity is maintained and 
outside this range their functioning is strongly impaired. In addition, most cellular nutrients 
uptake systems are driven by the electrochemical gradient. As a consequence of pacC 
deletion, many, as opposed to few, functions are likely to be impaired, including the control 
of the synthesis of secreted proteins (mainly enzymes), permeases and (intracellular) enzymes 
involved in the synthesis of exported metabolites (Arst, 2003; Peñalva and Arst Jr, 2004) to 
the synthesis of enzymes implicated in post-translational modifications of secreted enzymes 
and enzymes catalyzing energy-yielding reactions. Accordingly, it is not surprising that a 
specific phenotype is associated with pacC deletion not only in alkaline, but also in neutral 
conditions, as observed in previous studies for A. nidulans and in this study for A. fumigatus.   
Transcriptional expression is likely to be profoundly modified in pacC mutants, as 
extensively studied in the budding yeast S. cerevisiae, where Rim101p has been associated 
with a multitude of biological processes, other than alkaline pH adaptation, such as 
sporulation, invasive growth, ion tolerance and acquisition, and certain cell wall 
characteristics (Denison, 2000; Hayashi et al., 1998; Lamb et al., 2001; Lamb and Mitchell, 
2003; Li and Mitchell, 1997). As for A. nidulans and A. fumigatus, Δrim101 mutants exhibit 
specific phenotypes in neutral conditions including reduced growth, poor sporulation, poor 
growth at low temperature and altered colony morphology (Su and Mitchell, 1993a; Su and 
Mitchell, 1993b) and defective haploid invasive growth (Li and Mitchell, 1997; Xu and 
Mitchell, 2001). The predicted immediate effect of the alkalinisation of the external 
environment is the disruption of membrane proton gradients supplying energy for 
transmembrane transport and consequent nutrient and ion limitation (Lamb and Mitchell, 
2003). Rim101p has been associated principally with general ion homeostasis, through 
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control of the transcriptional expression of a series of protein pumps. The essential role of 
these transporters at alkaline pH is evidenced by phenotypes of null mutants lacking these 
pumps, which are unable to grow in alkaline conditions and/or cation sensitivity (Lamb and 
Mitchell, 2003). The plasma membrane pump Pma1p neutralises the cytoplasm by pumping 
protons out of the cell in an ATP-dependent manner (van der Rest et al., 1995). The proton 
gradient generated from its action is utilised to support symport activitites acquiring solutes 
from the extracellular environment, such as amino acids, nucleotide bases, phosphate and 
other molecules. The plasma membrane-localised Ena1p sodium/H
+
 ATPase expels Na
+
 from 
the cytoplasm to generate a gradient utilised for the uptake of other cations (Rodriguez-
Navarro et al., 1994) and the vacuolar H
+ 
ATPase Vma4p is necessary for vacuolar 
acidification (Stevens and Forgac, 1997). Reduction of such ion pump activity may clearly 
explain the phenotype observed for rim101
-
 in neutral conditions (Lamb et al., 2001). A 
similar set of targets for the regulatory action of PacC might be hypothesised for the 
Aspergillus species, but currently only a limited number of PacC-dependent genes have been 
identified and anyway mostly for A. nidulans (Espeso and Penalva, 1996; Tilburn et al., 
1995).  
In the context of adaptation to the host niche and its relationship with virulence, it is 
important to remember that the pH of different cellular compartments, body fluids, and organs 
is usually tightly regulated by the acid-base homeostatic process. In humans, the pH of blood 
is usually slightly basic with a value of pH 7.4, often referred to as physiological pH. Other 
pH values in human body fluids range from pH 1 for the gastric acid to pH 8.1 for pancreas 
secretions, through pH 6 for urine. Within the mammalian cell, different pHs are represented 
too, ranging from pH 4.5 in the lysosomes to pH 7.2 in the cytosol and pH 7.5 in the 
mitochondrial matrix. Enzymes and other proteins have an optimum pH range and can 
become inactivated or denatured outside this range. The most common disorder in acid-base 
homeostasis is acidosis, an acid overload in the body which is generally defined by pH falling 
below pH 7.35. Physiological pH of murine lungs has been defined as pH 7.2 (Song et al., 
2003) and interestingly, the A. fumigatus ΔpacC mutants already exhibit reduced or prevented 
growth, compared to the wild type, when pH is increased to this slightly-alkaline value. 
An unexpected and significant difference was found between the mutants constructed 
in two different A. fumigatus genetic backgrounds whereby pacC deletion in the ATCC46645 
genetic background was more sensitive to alkaline pH than in the CEA10 background. 
However, from our phenotypic analysis, a different growth rate was visible already when 
comparing the two wild type isolates. Considering ATCC46645 and CEA10 in neutral 
conditions, it looks likely that the CEA10 wild type strain produces slightly more conidia or 
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sporulates earlier and it would be therefore interesting to quantitatively assess radial growth 
and conidiation rate for the two different wild type strains. The differential response to 
alkalinisation of the media might be due to an altered modification of the media pH as a 
consequence of fungal growth. Originally A. fumigatus had been defined as a single 
homogenous species (Raper, 1965); however, different strains have been demonstrated to 
differ in growth requirements and micromorphology, having branched conidiophores, 
elongate or septate phialides and size or shape differences in conidia (Leslie et al., 1988; 
Rinyu et al., 1995). At present, the morphological and molecular differences between the 
numerous A. fumigatus strains are poorly understood: in the literature, there are few 
occurrences where mutants have been constructed and characterised at the same time and in 
the same differential genetic backgrounds used in this study. A ΔsidA mutant was constructed 
in both the A. fumigatus ATCC46645 and the CEA10 genetic backgrounds (Schrettl et al., 
2004), to study the siderophore biosynthetic pathway in A. fumigatus. sidA encodes the L-
ornithine-N
5
-monooxygenase, which catalyzes the first step of the hydroxamate-type 
siderophore biosynthesis (Haas, 2003; Haas et al., 2008). The phenotypic tests performed and 
the additional quantitative analysis of radial growth and conidiation of the strains did not 
show any significant difference between A. fumigatus genetic backgrounds. The phenotypic 
difference between the A. fumigatus ΔpacC mutants in two different genetic backgrounds 
might indicate a differential regulation of a function(s) under PacC regulatory control, which 
supports alkaline adaptation in vitro, for instance of certain pumps or transporters. 
Unfortunately, only for the CEA10 strain the sequence is publicly available (Nierman et al., 
2005), so it is not possible to infer which PacC-related function(s) might differ between the 
strains. Another explanation might be the redundancy of genes encoding for specific 
functions. An example is the Ena1p transporters: S. cerevisiae S288c has three ENA, but this 
number varies in other yeasts strains. According to the redundancy of a function in a specific 
strain and the extent by which this function is regulated by PacC, pacC deletion in different 
genetic backgrounds could differentially affect alkaline adaptation. However, a growth 
difference was notable also in the wild type strains on alkaline medium suggesting loss of a 
PacC-independent function, which may be worsened in the absence of PacC-mediated 
alkaline adaptation. 
 
3.4.2 A. fumigatus ΔpacC mutants are attenuated for virulence  
 
One of the most important applications of the study of ambient pH regulation in fungi 
is derived from its impact on fungal virulence, especially for the most prominent airborne 
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pathogen A. fumigatus (Latge, 1999). The importance of the A. nidulans PacC-mediated pH 
response in the pathogenesis of pulmonary aspergillosis was firstly shown using mutational 
analysis to demonstrate that, in neutropenic mice, the virulence is acutely attenuated when 
eliminating the A. nidulans transcription factor PacC, blocking the ambient pH signal 
transduction pathway or preventing PacC proteolytic processing (Bignell et al., 2005). pacC 
and palB loss of function mutants are attenuated for virulence in a respiratory model of 
murine infection, indicating that A. nidulans Pal-mediated pH signalling and PacC-regulated 
gene expression are essential for the development of infection in the host. In stark contrast, 
constitutive activation of PacC leads to increased mortality, even in a palB loss of function 
mutant. These data (Bignell et al., 2005) link A. nidulans pathogenicity with PacC action, 
which is required for, and able to, enhance virulence.  
Similar results were observed for A. fumigatus, when comparing the virulence of A. 
fumigatus ΔpacC null mutants in the ATCC46645 and the CEA10 genetic backgrounds to the 
respective wild type strains using a neutropenic murine model of invasive pulmonary 
aspergillosis. Following the high dose-survival protocol routinely used in our laboratory, A. 
fumigatus ATCC46645 ΔpacC virulence was attenuated in a murine model of pulmonary 
aspergillosis, in comparison with the respective wild type strain. The outcomes of the 
infection with ATCC46645 ΔpacC mutant and ATCC46645 wild type strain were 
significantly different, with associated medial survival of 13.5 days and 5 days respectively 
(p<0.0001, Kaplan-Meier log rank analysis). According to the same protocol, a different 
result was observed for the A. fumigatus CEA10 ΔpacC mutant where median survival 
following infection with either A. fumigatus CEA10 ΔpacC or CEA10 wild type strain 
corresponded to 5 days (p=0.3774, Kaplan-Meier log rank analysis). The differential 
virulence observed for the ATCC46645 ΔpacC and CEA10 ΔpacC mutants was attributed to 
the differential pH sensitivity between the strains, which had been demonstrated to behave 
differently with the progressive alkalinisation of the pH media. This difference was evident in 
slightly alkaline conditions in vitro, where the ATCC46645 ΔpacC mutant was almost unable 
to grow, whereas CEA10 ΔpacC mutant was only reduced for growth (Fig. 3.2). A difference 
between the two A. fumigatus ΔpacC mutants was observed at a concentration of 104 cells 
concentration at pH 8.0 in vitro (Fig. 3.2). This concentration is ten times lower than the 
concentration usually used to infect a single mice. This link between phenotypic and virulence 
data was further maintained in comparing the virulence of the A. fumigatus CEA10 ΔpacC 
mutant to the respective reconstituted strain using a low dose-survival protocol in a 
neutropenic murine model of invasive pulmonary aspergillosis. Inoculating a concentration of 
spores ten times lower than that used in the standard high dose-survival protocol, A. fumigatus 
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CEA10 ΔpacC was demonstrated to be attenuated in comparison with the respective 
reconstituted strain (Fig. 3.5).  
In the A. nidulans study, demonstrating the importance of PacC-mediated pH 
responses in the pathogenesis of pulmonary aspergillosis, a specific pathology was associated 
with infection caused by the ΔpacC mutant. Not only was the virulence acutely attenuated as 
a consequence of eliminating A. nidulans PacC, blocking of the ambient pH signal 
transduction pathway or preventing PacC proteolytic processing (Bignell et al., 2005), but in 
addition the infection resulting from alkaline-sensitive mutants was characterised by limited 
fungal growth in mice and a reduction of inflammatory cell infiltration. In stark contrast, the 
constitutive activation of PacC led to increased mortality and extensive fungal invasive 
growth. A similar pathology was identified in this study for the A. fumigatus ATCC466645 
ΔpacC mutant in comparison to the respective parental isolate throughout early stages of 
murine infection in a neutropenic model. The histological time course analysis (4, 8 and 16 
hrs) for ATCC46645 wild type strain and the ATCC46645 ΔpacC mutant revealed a dramatic 
impairment in hyphal growth, as a consequence of pacC deletion. Minimal differences were 
visible in the earliest studied stages of infection; however, at 8 hours post infection, the 
ATCC46645 wild type spores appear swollen and begin to germinate. Also, some slight 
differences in the level of inflammation were associated with the wild type infection (Fig. 
3.6).  
From the evidence presented here, it is clear that the PacC pathway plays a crucial role 
in A. fumigatus virulence. However, this provides only limited indications of the mechanisms 
involved and more detailed information will follow in Chapter IV, where the transcriptional 
profiling of an A. fumigatus ΔpacC mutant and the respective parental isolate is described. 
Several hypotheses can be formulated at this stage, considering the demonstrated links of the 
PacC pathway with several other biological pathways, and will be validated by evidence 
obtained in subsequent chapters.  
In the first instance, PacC/Rim101p has been demonstrated to be involved in the 
regulation of the transport across the plasma membrane of essential nutrients (Amich et al., 
2009; Arino et al., 2010a; Caracuel et al., 2003a), among which iron is essential for virulence 
of pathogenic fungi, and specifically of A. fumigatus (Haas, 2003; Haas et al., 2008; Schrettl 
et al., 2004; Schrettl et al., 2007). Siderophore biosynthesis but not reductive iron assimilation 
is essential for A. fumigatus virulence (Schrettl et al., 2004). Elimination of both intra- and 
extracellular siderophores causes the attenuation of A. fumigatus virulence in a murine model 
of invasive aspergillosis, indicating the importance of iron acquisition for A. fumigatus 
virulence, as also supported by the transcriptional profiling of A. fumigatus during initiation 
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of murine infection (McDonagh et al., 2008a), which highlighted the abundant upregulation 
of genes involved in siderophore biosynthesis relative to a laboratory culture.  
Increasing evidence suggests PacC/Rim101p might mediate pathogenic interaction 
through cell wall functions (Nobile et al., 2008; O'Meara et al., 2010; Villar et al., 2007). For 
C. albicans, several hypothesised PacC-mediated virulence strategies collaborate for the 
establishment of colonisation and tissue invasion of mucosal tissues (for a recent rewiew 
see(Davis, 2009), such as the degradation of E-cadherin in epithelial adherens junctions 
mediated by Sap5, a secreted aspartyl proteinase (Villar et al., 2007). C. albicans rim101
-
/rim101
-
 mutant was found unable to invade the mucosal tissues as a consequence of its 
inability to degrade E-cadherin, therefore suggesting the possible involvement of Rim101p in 
the regulation of the Sap proteases, which was confirmed by reverse transcription-PCR data 
(Villar et al., 2007).(Nobile et al., 2008)also demonstrated that Rim101p-dependent cell wall 
alterations affect C. albicans pathogenic interaction with oral epithelial cells using an over-
expression rescue approach. The over-expression of four genes, the functions of which are 
related to cell wall structure, were identified as Rim101p targets, being able to partially 
restore the pathogenic interactions of a C. albicans rim101Δ/Δ mutant with the oral epithelial 
cells (Nobile et al., 2008). Finally, in Cryptococcus neoformans, the rim101Δ mutant (which 
is slightly more virulent than the wild-type) is characterised by major defects in the 
polysaccharide capsule (O'Meara et al., 2010), an important virulence factor for this species 
(Granger et al., 1985). However, few genes involved in capsule biosynthesis were 
transcriptionally regulated by Rim101p, suggesting the phenotype observed was more likely 
due to defects in the attachment of the capsule to the cell wall (O'Meara et al., 2010). 
Interestingly, transcriptional profiling of the C. neoformans rim101Δ mutant also revealed the 
Rim101p-mediated regulation of ENA1 and various genes involved in iron homeostasis.  
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CHAPTER IV  
 
TRANSCRIPTIONAL PROFILING OF A. FUMIGATUS 
ATCC46645 AND AN ISOGENIC ΔpacC MUTANT DURING 
INITIATION OF MURINE INFECTION 
 
4.1 Overview 
 
The characterisation of A. fumigatus ΔpacC mutants, and associated pathogenicity 
presented in Chapter III, has validated a fundamental role for PacC in A. fumigatus adaptation 
to environmental pH and virulence in the murine host. The profound defects of growth in 
vitro at alkaline pH and the impairment of virulence in a murine model of IPA, are likely to 
be due to aberrant transcriptional regulation in A. fumigatus ΔpacC mutants. In addition to 
alkaline adaptation, S. cerevisiae Rim101p has been demonstrated as involved in a variety of 
other biological processes, such as sporulation, invasive growth, ion tolerance and acquisition, 
and cell wall structure and modification (Denison, 2000; Hayashi et al., 1998; Lamb et al., 
2001; Lamb and Mitchell, 2003; Li and Mitchell, 1997). Considering the high level of 
conservation of PacC/Rim101p pathway components within the fungal kingdom, a similar set 
of targets for the regulatory action of PacC might be hypothesised for the Aspergillus species, 
but currently only a limited number of PacC-dependent genes have been identified, mostly in 
A. nidulans (for a recent review please refer to(Peñalva et al., 2008).  
DNA microarray technology is a powerful tool for analysis of gene expression and 
fungal adaptation to environmental pH (Bensen et al., 2004; Causton et al., 2001; Serrano et 
al., 2002; Viladevall et al., 2004) as well as adaptation to the murine host (McDonagh et al., 
2008a) have been extensively studied using this methodology. In S. cerevisiae and C. 
albicans, genes whose expression is up-regulated in alkaline conditions include those 
encoding functions with direct relevance to pH homeostasis and also those involved in cell 
wall biogenesis and in the uptake, mobilisation and utilisation of essential ions such as 
calcium, iron and copper (Bensen et al., 2004; Causton et al., 2001; Serrano et al., 2002; 
Viladevall et al., 2004). To elucidate the transcriptional response to alkaline conditions, a 
microarray study performed by our research group has recently delineated the temporal 
response of A. fumigatus to an alkaline shift in vitro and compared it to that induced by high 
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extracellular concentrations of Ca
2+
 (Loss et al., unpublished). However, beyond this 
unpublished dataset there are no available pH-responsive transcriptome data for Aspergillus 
species. Besides, PacC is highly responsive to the extracellular environment and as such in 
vitro investigations of its function can not be directly extrapolated to the murine niche. 
DNA microarray analyses of A. fumigatus transcriptional profiling during murine 
infection have been limited by the difficulty in obtaining RNA from the sites of infection in 
sufficient quantity. Our research group recently performed transcriptional profiling analysis 
during initiation of murine infection, identifying many genes whose expression is up-
regulated or down-regulated with respect to a laboratory culture (McDonagh et al., 2008a). 
This analysis identified pH, oxygen, iron and nitrogen limitation as host-imposed 
combinatorial stresses during early-stage A. fumigatus infection and revealed a biased 
distribution of induced genes (relative to a laboratory culture) in subtelomeric regions of 
chromosomes (McDonagh et al., 2008a). 
To identify functions under PacC transcriptional control during murine infection, the 
transcriptional profiling comparison between an A. fumigatus ΔpacC mutant and the 
respective parental isolate was performed. The ΔpacC mutant in the ATCC46645 genetic 
background, having the most severely pH-sensitive phenotype (Chapter III, Fig. 3.2), was 
used for the analysis. 
    
4.2 Methods 
 
4.2.1 A. fumigatus strains  
 
A. fumigatus strains used in this chapter are the wild type isolates ATCC46645 and the 
ATCC46645 ΔpacC mutant (see Appendix A), obtained using a split-pyrithiamine marker 
and kindly provided from our collaborator Markus Schrettl (Hubertus Haas‟s laboratory at 
Innsbruck Medical University). To propagate the ATCC46645 ΔpacC mutant, AMM was 
supplemented with 0.5 μg/ml Pyrithiamine (Takara).  
 
4.2.2 Murine infection 
 
Murine infections were conducted under UK Home Office Project Licence 
PPL/70/6487 in a dedicated facility at Imperial College London, where individually vented 
cages, providing free access to food and H2O were used to house outbred male mice (strain 
CD1, 18 – 22 g, Harlan Ortech). H2O was supplemented with 1 g/l tetracycline hydrochloride 
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and 64 mg/L ciprofloxacin as prophylaxis against bacterial infection. For a neutropenic model 
of infection, immunosuppression of mice was performed by intraperitoneal injections of 
cyclophosphamide (150 mg/kg) on days –3, –1, +2, and subsequently every third day for the 
whole time of the experiment and by a single subcutaneous dose of hydrocortisone acetate 
(112.5 mg/kg) on day –1 (Schrettl et al., 2004). A. fumigatus spores were grown on ACM, 
supplemented with 1 % (w/v) glucose and 5 mM ammonium tartrate, for 5 days prior to 
infection. Spores were harvested on the day of infection, using sterile saline (Baxter 
Healthcare Ltd, UK), and filtered through MIRACLOTH. Conidial suspensions were 
centrifuged for 5 minutes at 5000 rpm, washed twice with sterile saline, counted using a 
haemocytometer and resuspended at a concentration of 2.5x10
9
 cfu/ml. Mice were 
anaesthetised by isofluorane inhalation and infected by intranasal instillation of 1x10
8
 conidia 
in 40 μl of saline solution. The determination of viable counts for the administered inocula 
was performed using serial dilution on ACM plates supplemented with 1 % (w/v) glucose and 
5 mM ammonium tartrate and incubated for 3 days at 37°C.  
For the transcriptional time course comparison between ATCC466645 ΔpacC and the 
respective parental isolate during murine infection, groups of infected mice were culled and 
processed, as previously described (McDonagh et al., 2008a) at time points corresponding to 
4, 8 and 16 hours post-infection. Bronchoalveolar lavage (BAL) was performed using three 
0.5 ml aliquots of sterile saline per mouse. Once collected, BAL fluids (BALFs) were snap 
frozen immediately in liquid nitrogen. Lung samples for histological analysis were protected 
from BAL by suturing. These were removed subsequent to BALF, and snap frozen.  
For A. fumigatus RNA extraction, mRNA amplification and hybridisation of 
fluorescently labelled cDNA to DNA microarray and microarray data capture, normalisation 
and analysis please consult Chapter 2.10.  
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4.3 Results 
 
4.3.1 Microarray analysis of A. fumigatus during early stages of infection in a 
neutropenic murine model 
 
Six groups of 8 neutropenic male mice were inoculated intranasally with 1x10
8
 spores 
of ATCC46645 ΔpacC and the respective parental isolate. One group of infected mice for 
each strain were culled and processed for each of three time points (4, 8 and 16 hours post-
infection) to harvest BALF and tissue for histological analysis. Fungal RNA extracted from 
the BALF samples was sent to the J. Craig Venter Institute (JCVI), Rockville, Maryland, 
USA, for amplification and labelling as described previously (McDonagh et al., 2008a).  
Three sets of hybridisations were performed to obtain the greatest amount of 
biological information as possible from the experiment, as displayed in Fig. 4.1. To 
investigate the biological functions crucial for A. fumigatus ATCC46645 wild type virulence, 
the transcriptional profile of the strain during initiation of murine infection was performed 
comparing the three time points (4, 8 and 16 hrs) to a common reference of RNA extracted 
from ATCC46645 spores (Fig. 4.1A). To analyse which virulence functions are affected by 
pacC deletion, the A. fumigatus ATCC46645 ΔpacC mutant transcriptional profile during 
initiation of murine infection was performed comparing the three time points (4, 8 and 16 hrs) 
to a common reference of RNA extracted from ATCC46645 ΔpacC spores (Fig. 4.1B). 
Finally, to directly compare gene expression of the two strains at each time point of infection 
a comparative analysis of A. fumigatus ATCC46645 ΔpacC mutant transcript profile relative 
to the parental isolate ATCC46645 was also performed (Fig. 4.1C).  
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Fig. 4.1: Schematic representation of hybridisations performed to analyse pacC-mediated 
virulence functions in A. fumigatus. (A) A. fumigatus ATCC46645 transcriptional profile during initiation of 
murine infection compares three time points (4, 8 and 16 hrs) to a common reference of RNA extracted from 
ATCC46645 spores. (B) A. fumigatus ATCC46645 ΔpacC transcriptional profile during initiation of murine 
infection compares three time points (4, 8 and 16 hrs) to a common reference of RNA extracted from 
ATCC46645 ΔpacC spores. (C) A. fumigatus ATCC46645 ΔpacC transcript profile relative to the parental 
isolate ATCC46645 during initiation of murine infection compares transcript abundance between ATCC46645 
ΔpacC and the parental isolate ATCC46645 for each time point (4, 8 and 16 hrs) of infection.   
 
For each of the analyses, a total of two microarray hybridisations were included for 
significance testing, including a dye swapped technical replicate. Data were normalised with 
TIGR TM4 freeware (www.tm4.org/) for locally-weighted scatter plot smoothing (LOWESS) 
and standard deviation regularisation and subsequently analysed using MeV software 
(www.tm4.org/). 
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4.3.2 A. fumigatus ATCC46645 transcriptional profile during initiation of murine 
infection  
 
A. fumigatus ATCC46645 transcriptional profiling during initiation of murine 
infection was performed by hybridising doubly amplified fungal RNA, extracted from BALFs 
harvested at each of the 3 time points (4, 8 and 16 hrs) of murine infection, against a common 
reference of in vitro-cultured ATCC46645 spores, as shown in Fig. 4.2.  
 
Fig. 4.2: Schematic representation of the hybridisations performed to analyse A. fumigatus 
ATCC46645 transcription during initiation of murine infection. A. fumigatus ATCC46645 transcriptional 
profile during initiation of murine infection was performed comparing the three time points (4, 8 and 16 hrs) to a 
common reference of RNA extracted from ATCC46645 spores.  
 
Poor quality spots were manually flagged when the background subtracted intensity 
was less than an arbitrary threshold of 1000. Normalisation was performed by locally-
weighted scatter plot smoothing (LOWESS) and standard deviation regularisation using TIGR 
TM4 freeware (www.tm4.org/). After LOWESS normalisation, the flip dye pairs were 
combined in a consistency check to remove spot values, from either of the two 
slides, that outlie the specific deviation of the array-wide average log2 ratio. Finally, the 
resulting data was derived as the average of six values for each gene (triplicate copies of the 
genes printed on each array and the duplicate flip-dye arrays for each experiment).  
Fig. 4.3, 4.4 and 4.5 show microarray (MA) and box plots of the datasets for each of 
the three time points studied, both before and after normalisation. The MA plots for each time 
point (A) show the distribution of data before (UN-NORMALISED) and after 
(NORMALISED) LOWESS normalisation thereby depicting the dataset adjustments 
implemented by normalisation. In MA plots the log2 ratio between red and green channels (Y-
axis) is plotted against the sum of red and green channels (X-axis). Normalisation adjusts for 
the higher measured spot intensities associated with the green dye (Cy3). Box plots (B) also 
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show dataset log2 ratio distributions for each time point, both before (UN-NORMALISED) 
and after LOWESS normalisation (NORMALISED), but on a slide specific basis. On the X-
axis, each box represents a distinct set of spots printed by a given pin. In the case of this JCVI 
amplicon array (http://pfgrc.jcvi.org/index.php/microarray/protocols.html) having ~29,952 
spots, each block consists of 624 spots arranged in a 24x26 grid and these blocks are arranged 
in 4 columns with 12 rows. The arrays are printed by a machine that has 48 metal pins 
arranged in 4 columns of 12 rows. When the robot prints the array, it drops those pins into a 
384 well plate then touches the glass slide, making 48 spots on the array. The pins get rinsed 
off and the robot then dips the pins into the 384 well plate again (moving 1 well over) and 
places another set of 48 spots adjacent to the first 48. The process is repeated for all ~9500 
genes present on the array and then repeated twice to achieve triplicate printing for all spots 
on the array. After normalisation the median values obtained for all blocks are set to zero and 
the standard deviation is regularised.   
 
 Fig. 4.3: Data normalisation plot for the ATCC46645 4 hrs in vivo versus dormant spores 
analysis. Pairwise MA (A) and box plots (B) for the 4 hour time point of ATCC46645 (mouse) versus 
ATCC46645 (dormant spores) RNA. Datasets plotted before (UN-NORMALISED) and after (NORMALISED) 
LOWESS normalisation are shown.  
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Fig. 4.4: Data normalisation plot for the ATCC46645 8 hrs in vivo versus dormant spores analysis. 
Pairwise MA (A) and box plots (B) for the 8 hour time point of ATCC46645 (mouse) versus ATCC46645 
(dormant spores) RNA. Datasets plotted before (UN-UN-NORMALISED) and after (UN-NORMALISED) 
LOWESS normalisation are shown.  
 
Fig. 4.5: Data normalisation plot for the ATCC46645 16 hrs in vivo versus dormant spores 
analysis. Pairwise MA (A) and box plots (B) for the 16 hour time point of ATCC46645 (mouse) versus 
ATCC46645 (dormant spores) RNA. Datasets plotted before (UN-UN-NORMALISED) and after (UN-
NORMALISED) LOWESS normalisation are shown.  
 
As summarised in the summary statistics for the ATCC46645 time course during 
initiation of murine infection reported in Table 4.1, among a total of 8243 genes in the slides, 
signals were detected for 8217, 8157 and 7164 genes, for the 4, 8 and 16 hr time points, 
respectively.  
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  4 hrs vs 0 hrs 8 hrs vs 0 hrs 16 hrs vs 0 hrs 
Observations 8217 8157 7164 
Missing observations 26 86 1079 
Minimum value -4.65 -6.66 -4.78 
Maximum value 6.66 7.25 7.57 
Mean 0.0173 0.0211 -9.0731E-5 
Median  -0.05 -0.08 -0.13 
Standard deviation 1.4964 1.8908 1.8854 
Outliers  179 118 112 
 
Table 4.1: Summary statistics for the ATCC46645 time course during initiation of murine 
infection.  
 
The analysis of temporal gene expression in vivo for the ATCC46645 strain was 
conducted in Genespring GX 11.02. Normalised log2 expression ratios were filtered on 
expression level and differentially regulated transcripts were defined as having averaged log2 
(Cy5/Cy3) ratios less or greater than the arbitrary thresholds of ±2. The numbers and 
classifications of differentially expressed genes are shown in Table 4.2. Among a total of 
2663 (26.8% of A. fumigatus genome,(Nierman et al., 2005) differentially expressed genes 
across the entire time course, 1364 (13.7%) were up-regulated and 1299 (13.1%) were down-
regulated in at least one time point. The complete lists of differentially expressed genes are 
attached in the Supplementary Data CD, as listed in Appendix D.  
 
 Up-regulated Down-regulated Differentially expressed 
TOTAL 1364 1299 2663 
4 hrs  787 682 1469 
8 hrs  1178 1088 2266 
16 hrs  999 974 1973 
 
Table 4.2: Number of differentially expressed genes in the ATCC46645 time course during 
initiation of murine infection.  
 
A. fumigatus genome sequences have been published relatively recently (Nierman et 
al., 2005), as well as new techniques for A. fumigatus manipulation (Brakhage and 
Langfelder, 2002). However, the status of functional genomic understanding is primitive 
when compared to better-characterised microorganisms such as S. cerevisiae where a detailed 
gene annotation is available. Often the function of A. fumigatus genes is predicted upon the 
basis of finding orthologues in S. cerevisiae by BLAST analysis, and subsequent use of gene 
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ontology (GO) tools (www.yeastgenome.org/GOContents.html) whereby, according to the 
annotation available for S. cerevisiae, differentially expressed A. fumigatus genes can be 
partially functionally characterised. 
The temporal basis of gene regulation in the ATCC46645 time course experiment is 
simply depicted in a 3-way Venn diagram in Fig. 4.6 for both up-regulated (Fig. 4.6A) and 
down-regulated (Fig. 4.6B) genes. In addition, the complex pattern of differentially expressed 
genes in the ATCC46645 time course is shown in a detailed heat map attached in the 
Supplementary Data CD, as listed in Appendix D.  
 
Fig. 4.6: Three-way Venn diagrams depicting temporal aspects of differential gene expression in 
the ATCC46645 time course experiment during initiation of murine infection. Up-regulated (A) and down-
regulated genes (B) have been identified using a fold change cut off of ±2 on a log2 scale. Analysis performed 
using Genespring GX 11.02.  
 
Among a total of 1364 up-regulated genes (13.7% of A. fumigatus genome), 617 
(6.2%) were similarly differentially regulated at all three time points. Among these, one 
hundred genes, having the highest log2 ratios are reported in Table 4.3. Across all time points, 
multiple genes involved in the uptake, mobilisation and utilisation of crucial ions and 
nutrients are up-regulated. These include at least five genes, involved in siderophore 
biosynthesis for extracellular iron acquisition (Afu3g03440, Afu3g03390, Afu7g04730, 
Afu2g07680, and Afu6g13750), several sugar permeases (Afu3g3700, Afu4g00800 and 
Afu7g05100), and also transporters for a variety of other elements, such as phosphate 
(Afu3g03010 and Afu8g01850), sodium (Afu2g01320), ammonium (Afu1g10930), choline 
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(Afu8g00840 and Afu5g02940), urea (Afu6g03200) and amino acids (Afu7g0190). In 
addition, several up-regulated genes represent functions involved cell wall biogenesis and 
organisation (Afu7g05450, Afu1g16250, Afu4g10150 and Afu2g00640). Other genes 
commonly associated with A. fumigatus pathogenicity are also up-regulated in the 
ATCC46645 time course experiment, such as a secreted peptidase (Afu4g09320) and genes 
involved in response to stress (Afu3g02280), more specifically oxidative stress (Afu1g14550 
and Afu3g07150). In addition, Tables AD.1.2-AD.1.4 in Appendix D list thirty ORFs, having 
the highest log2 ratios for each time point. Each of the categories contains up-regulated genes 
involved in transport (Afu8g0210, Afu4g14670 at 4 hrs, Afu3g01670, Afu2g03730 
Afu1g17160 at 8 hrs, Afu3g14670, Afu4g00830 at 16 hrs). Whereas the role of transport in A. 
fumigatus ATCC46645 adaptation to the murine niche is highlighted across the entire 
ACTT46645 time course, it is possible to extrapolate several phase-specific trends for the up-
regulated genes, such as the abundance of genes with oxidoreductase activity at 4 hrs post-
infection (Afu2g02810, Afu2g04560, Afu2g04060 and Afu5g02490) and of transcriptional 
regulators at 16 hrs post-infection (Afu6g12150, Afu1g02860, Afu5g13020 and 
Afu6g03800). Interestingly, the regulator of second metabolite synthesis LaeA is uniquely up-
regulated at 8 hrs post-infection.     
Of a total of 1299 down-regulated genes (13.1% of A. fumigatus genome), 556 (5.6%) 
were similarly differentially regulated at all three time points, among these, one hundred 
genes having the greatest down-regulation are reported in Table 4.4. Among the down-
regulated genes, several ORFs are involved in the regulation of transcription (Afu5g02880, 
Afu7g02620, Afu5g06140, Afu3g11330, Afu3g10120, Afu1g17360, Afu4g12390, 
Afu1g14750, Afu2g10550). In addition, to aid evaluation of phase-specific, down-regulated 
genes across the ACTT46645 time course, Tables AD.1.6-AD.1.8 in Appendix D list the 
thirty ORFs subject to the greatest degree of down-regulation at each of 4, 8 and 16 hrs time 
points. The functional trend of transcriptional repression is particularly emphasised at 4 
(Afu8g02750, Afu3g08580) and 8 hrs (Afu7g08500, Afu3g03070) post-infection.  
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Table 4.3: 100 ORFs with the highest log2 values between the up-regulated genes in common for the 3 time 
points (4, 8 and 16 hrs) of the ATCC46645 time course.  
ORF T4 vs 
T0 
T8 vs 
T0 
T16 
vs T0 
Annotation  Functional 
classification 
Predicted Function 
(Assigned from 
literature) 
Afu3g03410 6.66 7.19 7.13 enoyl-CoA 
hydratase/isomera
se family protein 
 Fatty acid degradation 
in mitochondria 
Afu1g17180 6.58 7.25 7.49 pyridine 
nucleotide-
disulphide 
oxidoreductase, 
putative 
electron carrier 
activity///nucleus///mit
ochondrion///DNA 
fragmentation involved 
in apoptosis 
Oxidative metabolism 
of fatty acids, 
mitochondria 
Afu3g03440 6.22 7.18 7.57 MFS family 
siderophore 
transporter, 
putative 
siderophore-iron 
transport///siderophore-
iron (ferrioxamine) 
uptake transmembrane 
transporter 
activity///integral to 
membrane///cellular 
iron ion homeostasis 
Transport (Iron 
acquisition) 
Afu7g05450 6.18 7.17 7.06 SUN domain 
protein (Uth1), 
putative 
autophagic cell 
death///cell wall 
organisation///barrier 
septum 
formation///fungal-type 
cell wall///response to 
oxidative stress///beta-
glucosidase 
activity///mitochondrio
n 
organisation///mitocho
ndrial outer 
membrane///apoptosis 
Cell wall 
biogenesis/CWI/mitoc
hondrial association 
Afu3g02940 6.08 6.55 6.01 allergen, putative  Immunoreactive 
Afu1g14550 5.98 6.76 6.71 Mn superoxide 
dismutase 
MnSOD 
manganese superoxide 
dismutase 
activity///oxygen and 
reactive oxygen species 
metabolic 
process///mitochondrial 
matrix///mitochondrion 
Antioxidant/mitochond
rial 
Afu3g03010 5.87 6.67 7.2 phosphate-
repressible 
phosphate 
permease 
sodium:inorganic 
phosphate symporter 
activity///plasma 
membrane///phosphate 
transport 
Phosphate transport 
Afu7g06380 5.75 6.06 5.58 maltase cellular component 
unknown///alpha-
glucosidase 
activity///maltose 
catabolic process 
Polysaccharide 
hydrolysis 
Afu3g03420 5.71 6.25 7.32 hypothetical 
protein 
  
Afu1g16250 5.68 6.62 5.96 alpha-glucosidase 
B 
alpha-glucosidase 
activity///fungal-type 
cell wall 
biogenesis///endoplasm
ic reticulum 
Polysaccharide 
hydrolysis 
Afu3g03860 5.65 5.4 4.84 3-hydroxyacyl-
CoA 
 Oxidative metabolism 
of fatty acids, 
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dehydrogenase, 
putative 
mitochondria 
Afu8g01710 5.44 5.63 6.64 antigenic 
thaumatin domain 
protein, putative 
  
Afu3g03820 5.39 4.61 5.29 MFS transporter, 
putative 
nicotinamide 
mononucleotide 
transport///nicotinamid
e mononucleotide 
permease 
activity///integral to 
plasma membrane 
Transport 
Afu3g03390 5.37 5.8 5.76 siderophore 
biosynthesis 
lipase/esterase, 
putative 
 Iron acquisition 
Afu3g03430 5.35 5.94 6.67 ABC multidrug 
transporter SitT, 
putative 
ATP-binding cassette 
(ABC) transporter 
activity///ATP 
binding///transport 
Transport 
Afu3g03700 5.29 5.74 5.68 Sugar transporter 
subfamily 
mannose 
transmembrane 
transporter 
activity///hexose 
transport///fructose 
transmembrane 
transporter 
activity///plasma 
membrane///glucose 
transmembrane 
transporter activity 
Transport 
Afu6g13750 5.26 6.73 6.51 ferric-chelate 
reductase, 
putative 
ferric-chelate reductase 
activity///transition 
metal ion 
transport///integral to 
membrane 
Iron acquisition 
Afu4g09320 5.2 5.25 6.29 antigenic 
dipeptidyl-
peptidase Dpp4 
proteolysis///serine-
type peptidase 
activity///aminopeptida
se activity 
Secreted proteinase 
Afu1g10780 5.18 5.42 5.95 glycine cleavage 
system T protein 
glycine metabolic 
process///mitochondrio
n///one-carbon 
metabolic 
process///glycine 
dehydrogenase 
(decarboxylating) 
activity 
One-carbon 
metabolism, 
mitochondrion 
Afu8g07090 5.16 5.81 6.98 extracellular 
proline-serine rich 
protein 
 Extracellular protein 
Afu3g00900 5.1 5.73 6.07 alpha-amylase 
AmyA 
 Polysaccharide 
hydrolysis 
Afu3g07910 5.05 6.29 6.15 UDP-glucose 4-
epimerase, 
putative 
cellular component 
unknown///UDP-
glucose 4-epimerase 
activity///galactose 
metabolic process 
Galactose metabolism 
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Afu1g17170 4.99 6.79 6.42 alpha-
ketoglutarate-
dependent taurine 
dioxygenase 
cellular component 
unknown///sulfur 
metabolic 
process///sulfonate 
dioxygenase 
activity///"oxidoreducta
se activity, acting on 
paired donors, with 
incorporation or 
reduction of molecular 
oxygen, 2-oxoglutarate 
as one donor, and 
incorporation of one 
atom each of oxygen 
into both donors" 
Utilization of taurine 
as sulphur source 
Afu1g11480 4.97 5.52 5.29 hypothetical 
protein 
  
Afu1g14390 4.9 5.75 5.88 zinc binding 
dehydrogenase 
family protein 
cellular component 
unknown///L-iditol 2-
dehydrogenase 
activity///fructose 
metabolic 
process///zinc ion 
binding///mannose 
metabolic process 
 
Afu4g01140 4.87 4.48 5.4 MFS multidrug 
transporter, 
putative 
drug transport///drug 
transporter 
activity///integral to 
membrane 
Transport 
Afu5g10290 4.86 4.71 4.04 fructose-
bisphosphate 
aldolase, putative 
fructose-bisphosphate 
aldolase 
activity///glycolysis 
Glycolysis 
Afu8g00850 4.86 5.36 5.49 dihydroorotase, 
homodimeric type 
dihydroorotase 
activity///pyrimidine 
nucleotide biosynthetic 
process///cytoplasm///n
ucleus 
Pyrimidine 
biosynthesis 
Afu3g03400 4.82 5.95 6.06 siderophore 
biosynthesis 
acetylase AceI, 
putative 
 Iron acquisition 
Afu8g05610 4.78 5.88 6.1 cell wall 
glucanase 
(Scw11), putative 
hydrolase activity, 
hydrolyzing O-glycosyl 
compounds///cellular 
glucan metabolic 
process///fungal-type 
cell wall///"cytokinesis, 
completion of 
separation" 
Cell wall assembly 
Afu6g03420 4.72 3.44 3.32 trehalose 
synthase, putative 
 Trehalose synthesis 
Afu4g10150 4.7 5.91 4.27 alpha-glucosidase alpha-glucosidase 
activity///fungal-type 
cell wall 
biogenesis///endoplasm
ic reticulum 
Glucosidase 
Afu6g03190 4.7 5.36 5.55 hypothetical 
protein 
  
Afu2g05800 4.64 5.43 5.23 IdgA domain 
protein 
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Afu1g17200 4.63 5 5.55 nonribosomal 
peptide synthase, 
putative 
nonribosomal peptide 
biosynthetic 
process///catalytic 
activity///amino acid 
adenylylation by 
nonribosomal peptide 
synthase 
NRPS secondary 
metabolism 
Afu3g07150 4.63 5.49 5.43 succinate-
semialdehyde 
dehydrogenase, 
putative 
response to oxidative 
stress///succinate-
semialdehyde 
dehydrogenase 
[NAD(P)+] 
activity///cytoplasm///g
lutamate catabolic 
process 
Mitochondrial 
succinate production 
Afu2g04570 4.63 4.75 4.86 BNR/Asp-box 
repeat domain 
protein 
  
Afu3g07870 4.61 5.52 5.69 extracellular 
serine-rich protein 
 Extracellular enzyme 
Afu5g14680 4.6 5.25 6.14 hypothetical 
protein 
  
Afu8g01850 4.6 4.08 5.24 phosphate-
repressible 
phosphate 
permease 
sodium:inorganic 
phosphate symporter 
activity///plasma 
membrane///phosphate 
transport 
Transport 
Afu3g02280 4.6 4.78 4.45 alpha,alpha-
trehalose 
glucohydrolase, 
putative 
fungal-type 
vacuole///trehalose 
catabolic 
process///"alpha,alpha-
trehalase 
activity"///response to 
stress 
Trehalase 
Afu8g02450 4.6 5.06 5.84 hypothetical 
protein 
  
Afu7g01090 4.57 4.87 5.67 proline permease plasma 
membrane///neutral 
amino acid 
transmembrane 
transporter 
activity///neutral amino 
acid transport///amino 
acid permease activity 
Transport 
Afu7g05070 4.56 4.14 4.38 FAD dependent 
oxidoreductase, 
putative 
cytoplasm///metabolic 
process///fumarate 
reductase (NADH) 
activity 
 
Afu4g00800 4.56 4.43 4.96 MFS 
monosaccharide 
transporter, 
putative 
response to glucose 
stimulus///plasma 
membrane///glucose 
transmembrane 
transporter 
activity///signal 
transduction///glucose 
binding///receptor 
activity 
Transport 
Afu3g07140 4.52 4.71 5.06 developmental 
regulator FluG 
 Regulation of 
development 
Afu1g10930 4.51 3.79 2.39 ammonium 
transporter 
pseudohyphal 
growth///plasma 
membrane///ammoniu
Transport 
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m 
transport///ammonium 
transmembrane 
transporter activity 
Afu7g06080 4.5 4.79 4.69 ubiE/COQ5 
methyltransferase, 
putative 
methyltransferase 
activity///metabolic 
process 
Respiratory chain 
Afu1g15330 4.48 4.95 4.94 T10O22.24   
Afu1g17190 4.47 5.67 5.98 long-chain-fatty-
acid-CoA ligase, 
putative 
peroxisomal 
membrane///peroxisom
al 
matrix///cytoplasm///A
MP binding 
Bioactivation of fatty 
acids 
Afu2g01320 4.47 5.26 5.12 P-type ATPase, 
putative 
sodium ion 
transport///plasma 
membrane///"ATPase 
activity, coupled to 
transmembrane 
movement of ions, 
phosphorylative 
mechanism" 
Transport 
Afu4g09580 4.45 6.36 6.99 major allergen 
Asp F2 
biological process 
unknown///molecular 
function unknown 
Immunoreactive and 
zinc transport 
Afu3g01370 4.43 5.55 6.08 MFS transporter, 
putative 
pantothenate 
transport///plasma 
membrane///transporter 
activity 
Transport 
Afu5g07620 4.37 5.06 5.68 DUF1212 domain 
membrane protein 
conjugation with 
cellular 
fusion///molecular 
function 
unknown///integral to 
membrane 
 
Afu1g16480 4.36 4.16 4.45 acid phosphatase, 
putative 
 Phosphate acquisition 
Afu8g02440 4.36 5.98 6.61 C-4 methyl sterol 
oxidase, putative 
plasma 
membrane///ergosterol 
biosynthetic 
process///endoplasmic 
reticulum 
membrane///C-4 
methylsterol oxidase 
activity 
Erg25 
Afu7g00700 4.36 3.99 4.32 aldo-keto 
reductase 
(AKR13), 
puatative 
aldo-keto reductase 
activity///cytoplasm///n
ucleus///cellular 
aldehyde metabolic 
process 
Oxidoreductase 
Afu6g02260 4.35 4.79 4.7 hypothetical 
protein 
  
Afu8g06470 4.34 5.86 6.03 N,N-
dimethylglycine 
oxidase 
aminomethyltransferas
e activity 
Osmostabilisation 
Afu5g11850 4.33 4.45 4.04 mitochondrial 
carrier protein 
(Pet8), putative 
S-adenosylmethionine 
transmembrane 
transporter 
activity///mitochondrial 
inner membrane///S-
adenosylmethionine 
transport///mitochondri
on 
Biotin biosynthesis and 
respiratory growth, 
mitochondrial 
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Afu3g11480 4.33 4.53 3.91 mitochondrial 
methylglutaconyl-
CoA hydratase 
(Auh), putative 
endocytosis///3-
hydroxyisobutyryl-
CoA hydrolase 
activity///mitochondrio
n///fatty acid beta-
oxidation 
Enoyl coA activity 
Afu6g12240 4.32 5.32 4.84 Glycerophosphor
yl diester 
phosphodiesterase 
family family 
  
Afu8g00840 4.27 4.42 4.6 amino acid 
permease, 
putative 
plasma 
membrane///choline 
transport///choline 
transmembrane 
transporter activity 
Transport 
Afu7g06390 4.25 4.69 4.29 maltose permease alpha-
glucoside:hydrogen 
symporter 
activity///membrane 
fraction///alpha-
glucoside transport 
Transport 
Afu5g02940 4.19 3.14 3.67 choline transport 
protein Ctr, 
putative 
plasma 
membrane///choline 
transport///choline 
transmembrane 
transporter activity 
Transport 
Afu1g02890 4.18 4.82 5.29 dUTPase (Dut), 
putaive 
pyrimidine 
deoxyribonucleoside 
triphosphate catabolic 
process///dUTP 
diphosphatase 
activity///cytoplasm///n
ucleus 
 
Afu6g03200 4.16 4.84 5.59 solute symporter 
family transporter 
plasma 
membrane///urea 
transport///urea 
transmembrane 
transporter activity 
Transport 
Afu5g09400 4.16 4.8 3.96 carbonyl 
reductase, 
putative 
oxidoreductase 
activity///metabolic 
process 
 
Afu2g01280 4.15 3.59 4.04 D-mandelate 
dehydrogenase, 
putative 
NAD or NADH 
binding///cytoplasm///n
ucleus///metabolic 
process///"oxidoreducta
se activity, acting on 
the CH-OH group of 
donors, NAD or NADP 
as acceptor" 
 
Afu6g10090 4.15 4.1 4.11 D-isomer specific 
2-hydroxyacid 
dehydrogenase 
family protein 
formate catabolic 
process///formate 
dehydrogenase 
activity///NADH 
regeneration///cytosol 
 
Afu5g13810 4.14 4.83 4 transulfuration 
enzyme family 
protein, putative 
sulfur metabolic 
process///cytoplasm///c
ystathionine beta-lyase 
activity 
 
Afu2g07680 4.13 4.69 5.01 L-ornithine N5-
oxygenase SidA 
pathogenesis Siderophore 
biosynthesis 
Afu2g00770 4.13 3.87 5.12 salicylate 
hydroxylase 
 Oxidoreductase 
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Afu4g11400 4.12 4.29 4.23 cell surface 
receptor/MFS 
transporter 
(FLVCR), 
putative 
transporter 
activity///transport 
Transport 
Afu1g05940 4.11 4.32 4.92 conserved 
hypothetical 
protein 
mediator 
complex///RNA 
polymerase II 
transcription mediator 
activity///transcription 
from RNA polymerase 
II promoter 
 
Afu5g06910 4.1 5.31 5.58 DUF636 domain 
protein 
  
Afu4g06860 4.09 4.92 5.45 conserved 
hypothetical 
protein 
  
Afu1g10800 4.09 3.83 3.72 thioesterase 
family protein 
CoA hydrolase 
activity///fatty acid 
metabolic 
process///mitochondrio
n 
Mitochondrion 
Afu1g03550 4.09 3.94 2.73 mitochondrial 
dihydroxy acid 
dehydratase, 
putative 
dihydroxy-acid 
dehydratase 
activity///branched 
chain family amino 
acid biosynthetic 
process///mitochondrio
n 
Mitochondrion 
Afu6g14330 4.08 4.5 3.95 5-oxo-L-
prolinase, putative 
5-oxoprolinase (ATP-
hydrolyzing) 
activity///cytoplasm///b
iological process 
unknown 
 
Afu3g14030 4.05 4.52 5.11 alkaline 
phosphatase 
 Phosphate acquisition 
Afu3g11640 4.04 4.3 2.85 homoserine 
dehydrogenase 
homoserine 
biosynthetic 
process///cytoplasm///n
ucleus///methionine 
metabolic 
process///threonine 
metabolic 
process///homoserine 
dehydrogenase activity 
Glycine, serine, 
threonine metabolism 
Afu6g00620 4.03 4.74 4.29 GPI anchored 
hypothetical 
protein 
  
Afu2g00640 4.03 5.32 4.43 beta-N-
hexosaminidase, 
putative 
fungal-type cell 
wall///cell wall chitin 
metabolic 
process///beta-N-
acetylhexosaminidase 
activity 
Cell wall 
assembly/degradation 
Afu6g04920 4 4.66 3.41 NAD-dependent 
formate 
dehydrogenase 
formate catabolic 
process///acetate 
metabolic 
process///formate 
dehydrogenase 
activity///NADH 
regeneration///cytosol 
 
Afu1g04300 3.99 4.1 5.14 hypothetical   
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protein 
Afu2g04590 3.98 3.64 3.35 alcohol 
dehydrogenase, 
putative 
cytoplasm///fermentati
on///zinc ion 
binding///alcohol 
dehydrogenase (NAD) 
activity///ethanol 
metabolic process 
 
Afu5g09140 3.97 3.41 3.41 amidase, putative aerobic 
respiration///amidase 
activity///mitochondrio
n 
 
Afu2g07810 3.96 4.17 4.41 cytosolic 
hydroxymethyltra
nsferase, putative 
glycine 
hydroxymethyltransfer
ase 
activity///mitochondrio
n///one-carbon 
metabolic process 
One-carbon 
metabolism, 
mitochondrion 
Afu6g08630 3.94 4.62 4.35 hypothetical 
protein 
mitochondrion///biolog
ical process 
unknown///molecular 
function unknown 
 
Afu2g11010 3.93 4.22 4.16 dihydroorotate 
reductase PyrE, 
putative 
pyrimidine 
ribonucleotide 
biosynthetic 
process///dihydroorotat
e oxidase activity 
Pyrimidine 
biosynthesis 
Afu1g12290 3.93 4.46 4.54 possible NADH-
ubiquinone 
oxidoreductase 
  
Afu6g02470 3.92 3.68 4.21 fumarate 
hydratase, 
putative 
tricarboxylic acid 
cycle///fumarate 
hydratase 
activity///fumarate 
metabolic 
process///cytosol///mito
chondrial matrix 
 
Afu7g02340 3.92 4.74 4.97 L-PSP 
endoribonuclease 
family protein 
(Hmf1), putative 
cytoplasm///cytosol///n
ucleus///biological 
process 
unknown///molecular 
function unknown 
 
Afu7g04730 3.92 4.43 4.76 siderochrome-iron 
transporter, 
putative 
endosome///siderophor
e-iron 
transport///cytoplasmic 
membrane-bounded 
vesicle///siderophore-
iron (ferrioxamine) 
uptake transmembrane 
transporter 
activity///cellular iron 
ion homeostasis 
Iron acquisition 
Afu6g08640 3.92 4 4.12 metallopeptidase 
Mip1 
metallopeptidase 
activity///mitochondrio
n///mitochondrial 
protein processing 
during import///cellular 
iron ion homeostasis 
Mitochondrial 
respiration 
Afu7g05100 3.92 3.82 3.22 hexose transporter 
protein 
mannose 
transmembrane 
transporter 
activity///hexose 
transport///fructose 
Transport 
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Table 4.4: 100 ORFs with the lowest log2 values between the down-regulated genes in common for the 3 
time points (4, 8 and 16 hrs) of the ATCC46645 time course.  
ORF T4 vs 
T0 
T8 vs 
T0 
T16 vs 
T0 
Annotation  Functional 
classification 
Predicted Function 
(Assigned from 
literature) 
Afu6g00770 -4.65 -6.66 -4.74 extracellular 
arabinanase, 
putative 
hydrolase activity, 
hydrolyzing N-glycosyl 
compounds///metabolic 
process 
Secreted enzyme 
Afu1g10950 -4.56 -5.45 -4.78 conserved 
hypothetical 
protein 
extrinsic to 
membrane///cytoplasmi
c membrane-bounded 
vesicle///vesicle-
mediated 
transport///molecular 
function 
unknown///negative 
regulation of 
gluconeogenesis 
 
Afu5g02880 -4.49 -5.59 -4.51 C6 
transcription 
factor, 
putative 
transcription factor 
activity///regulation of 
transcription 
Transcription 
Afu7g06840 -4.43 -5.85 -4.75 class III 
aminotransfera
se 
arginine catabolic 
process///cytoplasm///n
ucleus///ornithine-oxo-
acid transaminase 
activity 
 
Afu8g05120 -4.41 -5.51 -4.77 hypothetical 
protein 
  
Afu7g04930 -4.4 -5.37 -4.34 alkaline serine 
protease 
(PR1), 
putative 
protein catabolic 
process///cellular 
component 
unknown///peptidase 
activity 
Proteinase 
Afu2g00200 -4.35 -6.14 -4.73 catalase, 
putative 
oxygen and reactive 
oxygen species 
metabolic 
process///peroxisomal 
Oxidative stress 
transmembrane 
transporter 
activity///plasma 
membrane///glucose 
transmembrane 
transporter activity 
Afu6g10080 3.9 4.45 4.97 conserved 
hypothetical 
protein 
  
Afu2g01040 3.9 4.52 3.84 formaldehyde 
dehydrogenase 
formaldehyde 
dehydrogenase 
(glutathione) 
activity///cytoplasm///f
ormaldehyde 
assimilation 
 
Afu1g13500 3.89 4.14 3.55 transketolase 
TktA 
cytoplasm///pentose-
phosphate 
shunt///transketolase 
activity 
Pentose-phosphate 
pathway 
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matrix///response to 
oxidative 
stress///catalase activity 
Afu3g00810 -4.35 -4.68 -3.87 cholestenol 
delta-
isomerase, 
putative 
  
Afu2g06290 -4.21 -4.35 -3.95 nuclear 
division rft1 
protein 
protein amino acid N-
linked 
glycosylation///oligosa
ccharide 
transmembrane 
transporter 
activity///oligosacchari
de 
transport///endoplasmic 
reticulum membrane 
Protein N-
glycosylation 
Afu1g06350 -4.21 -4.85 -3.52 virulence 
related protein 
(Cap20), 
putative 
  
Afu1g06190 -4.2 -5.69 -4.59 hnrnp arginine 
n-
methyltransfer
ase 
mRNA export from 
nucleus///peptidyl-
arginine 
modification///nucleus/
//protein-arginine N-
methyltransferase 
activity 
Protein arginine 
methylation 
Afu2g14330 -4.16 -5.06 -3.97 hypothetical 
protein 
  
Afu8g02290 -4.13 -5.48 -4.08 conserved 
hypothetical 
protein 
  
Afu6g04390 -4.09 -5.44 -4.66 conserved 
hypothetical 
protein 
chromatin silencing at 
telomere///ubiquitin-
protein ligase 
activity///histone 
ubiquitination///protein 
monoubiquitination///n
ucleus///histone 
methylation 
Chromatin silencing 
Afu2g03950 -4.02 -5.31 -4.66 serine/threonin
e protein 
phosphatase, 
putative 
cellular component 
unknown///cellular 
sodium ion 
homeostasis///protein 
serine/threonine 
phosphatase activity 
 
Afu7g05500 -4.01 -4.8 -3.78 theta class 
glutathione S-
transferase 
regulation of nitrogen 
utilisation///soluble 
fraction///transcription 
corepressor activity 
 
Afu7g05490 -3.95 -5.16 -2.76 hypothetical 
protein 
  
Afu8g02270 -3.94 -4.84 -4.01 dihydrodipicol
inate 
synthetase 
family protein 
  
Afu4g11960 -3.91 -4.37 -3.34 Iron only 
hydrogenase 
large subunit, 
C-terminal 
domain 
cellular component 
unknown///iron 
hydrogenase 
activity///biological 
process unknown 
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containing 
protein 
Afu5g00800 -3.89 -4.29 -3.98 conserved 
hypothetical 
protein 
  
Afu3g06770 -3.89 -4.76 -4.08 zinc knuckle 
domain 
protein 
pre-mRNA splicing 
factor 
activity///spliceosomal 
complex///"nuclear 
mRNA splicing, via 
spliceosome"///protein 
binding 
 
Afu7g06890 -3.88 -4.72 -3.51 Dyp-type 
peroxidase 
family protein 
  
Afu5g12630 -3.86 -3.95 -3.71 hypothetical 
protein 
  
Afu5g05610 -3.85 -4.78 -3.74 cell cycle 
control protein 
Cwf14, 
putative 
nucleus///cellular bud 
site 
selection///molecular 
function unknown 
Cell cycle control 
Afu4g14630 -3.85 -5.52 -3.51 FAD binding 
domain 
protein 
  
Afu4g11480 -3.83 -4.35 -3.66 C2H2 finger 
domain 
protein, 
putative 
DNA 
binding///nucleus///zinc 
ion binding 
Transcription 
Afu7g06260 -3.81 -3.22 -3.02 alcohol 
dehydrogenase
, zinc-
containing 
oxidoreductase 
activity///zinc ion 
binding///metabolic 
process 
 
Afu5g05480 -3.8 -4.37 -3.88 Rheb GTPase 
RhbA 
detection of 
nutrient///extrinsic to 
plasma 
membrane///pathogene
sis///nitrogen 
utilisation///RHEB 
small monomeric 
GTPase activity 
Nitrogen utilisation 
Afu2g13850 -3.77 -5.46 -4.17 protein 
phosphatase 
regulatory 
subunit 
(Gac1), 
putative 
 Glycogen synthesis 
Afu6g10150 -3.76 -4.03 -3.35 hypothetical 
protein 
  
Afu7g00270 -3.75 -4.64 -3.95 FAD binding 
monooxygena
se, putative 
cellular aromatic 
compound metabolic 
process///monooxygena
se activity 
 
Afu8g06040 -3.75 -5.08 -3.52 hypothetical 
protein 
  
Afu3g14550 -3.73 -4.27 -3.71 DNA repair 
protein 
(Rex1), 
putative 
  
Afu6g10790 -3.73 -4.55 -4.06 MFS amine 
transporter, 
putative 
 Transport 
Afu5g02400 -3.72 -4.71 -4.36 catabolite cytoplasm///nucleus///  
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degradation 
protein, 
putative 
molecular function 
unknown///negative 
regulation of 
gluconeogenesis 
Afu5g12150 -3.72 -4.16 -3.87 PH domain 
protein 
  
Afu7g02620 -3.7 -4.17 -4.24 DNA-directed 
RNA 
polymerases 
N/8 kDa 
subunit 
superfamily 
DNA-directed RNA 
polymerase III 
complex///DNA-
directed RNA 
polymerase I 
complex///transcription 
from RNA polymerase 
II 
promoter///transcriptio
n from RNA 
polymerase III 
promoter///DNA-
directed RNA 
polymerase 
activity///transcription 
from RNA polymerase 
I promoter///"DNA-
directed RNA 
polymerase II, core 
complex" 
Transcription 
Afu6g03370 -3.7 -5.45 -4.29 oxidoreductas
e, short-chain 
dehydrogenase
/reductase 
family 
lipid 
particle///cytoplasm///e
ndoplasmic 
reticulum///acylglycero
ne-phosphate reductase 
activity///phosphatidic 
acid biosynthetic 
process 
 
Afu3g10530 -3.68 -5.16 -4.49 protein 
serine/threonin
e kinase 
(Ran1), 
putative 
protein serine/threonine 
kinase activity///G1/S 
transition of mitotic 
cell 
cycle///cytoplasm///prot
ein amino acid 
phosphorylation///prote
in kinase activity 
 
Afu5g11520 -3.66 -4.49 -3.91 serine/threonin
e protein 
kinase (Nrc-
2), putative 
cytoplasm///protein 
kinase activity 
 
Afu5g06140 -3.65 -4.41 -3.56 histone 
acetyltransfera
se, putative 
DNA-directed RNA 
polymerase II, 
holoenzyme///transcript
ion elongation factor 
complex///RNA 
polymerase II 
transcription elongation 
factor 
activity///regulation of 
transcription from 
RNA polymerase II 
promoter///histone 
acetyltransferase 
activity 
 
Afu7g03770 -3.65 -5.22 -3.43 hypothetical 
protein 
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Afu3g02550 -3.64 -3.29 -4.02 conserved 
hypothetical 
protein 
  
Afu6g02020 -3.63 -4.7 -4.27 hypothetical 
protein 
  
Afu3g12530 -3.63 -4.74 -3.74 sensor 
histidine 
kinase/respons
e regulator, 
putative 
protein histidine kinase 
activity///plasma 
membrane///protein 
amino acid 
phosphorylation///two-
component sensor 
activity 
Signalling 
Afu2g14110 -3.63 -3.81 -3.24 sulfur 
metabolite 
repression 
control protein 
SconB, 
putative 
SCF ubiquitin ligase 
complex///protein 
ubiquitination///sulfur 
metabolic 
process///ubiquitin-
dependent protein 
catabolic process///cell 
cycle///protein 
binding///nuclear 
ubiquitin ligase 
complex 
Sulphur metabolism 
Afu5g04260 -3.6 -4.88 -3.9 arginine 
transporter, 
putative 
basic amino acid 
transmembrane 
transporter 
activity///arginine 
permease 
activity///lysine 
permease 
activity///basic amino 
acid transport///plasma 
membrane 
Transporter 
Afu4g11710 -3.6 -5.55 -4.61 oxidoreductas
e, zinc-binding 
dehydrogenase 
family 
superfamily 
cellular component 
unknown///biological 
process 
unknown///molecular 
function unknown 
 
Afu3g11330 -3.59 -4.73 -4.26 bZIP 
transcription 
factor (AtfA), 
putative 
RNA polymerase II 
transcription factor 
activity///negative 
regulation of 
transcription from 
RNA polymerase II 
promoter///cytosol///nu
cleus 
Transcription: 
Response to oxidative 
and osmotic stress 
Afu6g02640 -3.59 -3.86 -3.96 hypothetical 
protein 
  
Afu5g14350 -3.57 -3.87 -4.04 c-24(28) sterol 
reductase 
delta24(24-1) sterol 
reductase 
activity///endoplasmic 
reticulum///ergosterol 
biosynthetic process 
Erg4 homologue 
(which catalyses final 
step in ergosterol 
biosynthesis) 
Afu5g12100 -3.57 -4.04 -3.16 pmt2 
methyltransfer
ase 
RNA methyltransferase 
activity///nucleolus///rR
NA 
processing///nucleus 
 
Afu2g09510 -3.54 -4.35 -3.82 hypothetical 
protein 
  
Afu3g00500 -3.51 -5.18 -4 integral 
membrane 
protein 
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Afu6g02680 -3.49 -4.81 -3.84 ankyrin repeat 
and  
BTB/POZ 
domain 
protein 
cytoplasm///biological 
process 
unknown///molecular 
function unknown 
 
Afu3g13470 -3.49 -3.56 -3.22 sulfate 
transporter, 
putative 
endoplasmic reticulum  
Afu4g05870 -3.48 -4.55 -3.55 oxidoreductas
e, short-chain 
dehydrogenase
/reductase 
family 
cytoplasm///biological 
process 
unknown///molecular 
function unknown 
 
Afu2g02390 -3.46 -3.89 -3.51 hypothetical 
protein 
  
Afu1g00910 -3.45 -4.16 -2.98 conserved 
hypothetical 
protein 
  
Afu5g11690 -3.45 -4.44 -3.89 related to 
protein 
tyrosine 
phosphatase 
PPS1 
cellular component 
unknown///regulation 
of S phase of mitotic 
cell cycle///vitamin 
B12 reduction///protein 
tyrosine/threonine 
phosphatase activity 
 
Afu3g10120 -3.45 -5.43 -4.53 TATA-box 
binding 
protein 
DNA binding///RNA 
polymerase I 
transcription factor 
activity///transcription 
initiation from RNA 
polymerase II 
promoter///RNA 
polymerase I 
transcription factor 
complex///general 
RNA polymerase II 
transcription factor 
activity///nucleus///tran
scription factor TFIIIB 
complex///transcription 
factor TFIID 
complex///transcription 
initiation from RNA 
polymerase III 
promoter///transcriptio
n from RNA 
polymerase I 
promoter///RNA 
polymerase III 
transcription factor 
activity 
Transcription 
Afu6g10500 -3.44 -4.36 -2.72 conserved 
hypothetical 
protein 
  
Afu3g03040 -3.43 -4.95 -3.86 conserved 
hypothetical 
protein 
  
Afu3g13160 -3.43 -4.11 -3.08 hypothetical 
protein 
  
Afu8g01340 -3.43 -3.9 -4.13 MFS sugar 
transporter, 
putative 
alpha-
glucoside:hydrogen 
symporter 
Transport 
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activity///membrane 
fraction///alpha-
glucoside transport 
Afu3g06400 -3.42 -4.28 -3.98 hypothetical 
protein 
  
Afu3g02140 -3.42 -3.9 -2.89 large 
conductance 
mechanosensit
ive channel, 
putative 
nonselective channel 
activity///ion channel 
activity///transport 
Transport 
Afu5g10590 -3.42 -3.21 -2.13 stress response 
RCI peptide, 
putative 
cytoplasm///response to 
stress///molecular 
function 
unknown///integral to 
membrane 
 
Afu7g01850 -3.41 -3.56 -3.66 RNA 
polymerase 
Rpc34 subunit 
superfamily 
  
Afu1g16570 -3.39 -3.59 -3.38 G4P04 protein chromosome 
segregation 
 
Afu8g02260 -3.39 -4.4 -3 neutral amino 
acid permease 
 Transport 
Afu3g06540 -3.36 -4.71 -3.99 3'-
phosphoadeno
sine-5'-
phosphosulfat
e reductase 
intracellular///phosphoa
denylyl-sulfate 
reductase (thioredoxin) 
activity///sulfate 
assimilation///methioni
ne metabolic process 
 
Afu1g11720 -3.36 -3.83 -3.61 conserved 
hypothetical 
protein 
  
Afu1g11930 -3.36 -3.81 -3.13 protein kinase, 
putative 
proteolysis///cytoplasm
///protein kinase 
activity 
 
Afu1g16450 -3.35 -4.15 -2.92 hypothetical 
protein 
  
Afu4g06260 -3.35 -3.83 -3.35 mating-type 
switch/DNA 
repair protein 
Swi10, 
putative 
double-strand break 
repair via single-strand 
annealing, removal of 
nonhomologous 
ends///nucleotide-
excision repair factor 1 
complex///"nucleotide-
excision repair, DNA 
incision, 5'-to 
lesion"///removal of 
nonhomologous 
ends///single-stranded 
DNA specific 
endodeoxyribonuclease 
activity 
Cell cycle control 
Afu3g04310 -3.35 -4.07 -4.04 snoRNA 
binding 
protein, 
putative 
nucleus///maturation of 
SSU-rRNA///snoRNA 
binding 
 
Afu2g16180 -3.34 -4.07 -3.57 hypothetical 
protein 
  
Afu5g06060 -3.31 -3.35 -3.91 sulfur 
metabolism 
regulator 
SkpA, putative 
SCF ubiquitin ligase 
complex///ubiquitin-
dependent protein 
catabolic 
Sulphur metabolism 
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process///ubiquitin-
protein ligase 
activity///G1/S 
transition of mitotic 
cell 
cycle///cytoplasm///reg
ulation of sulfur 
metabolic 
process///protein 
binding///nucleus///nucl
ear ubiquitin ligase 
complex///G2/M 
transition of mitotic 
cell cycle///kinetochore 
Afu2g10980 -3.3 -3.57 -3.68 ADP-
ribosylation 
factor, 
putative 
soluble 
fraction///vesicle-
mediated 
transport///protein 
targeting to 
vacuole///small 
monomeric GTPase 
activity 
 
Afu5g10910 -3.3 -3.22 -4.02 hypothetical 
protein 
  
Afu5g13870 -3.3 -4.34 -4.05 mlo3 protein  mRNA export, mitotic 
chromosome 
segregation 
Afu1g17360 -3.29 -4.38 -3.26 bZIP 
transcription 
factor 
(BACH2), 
putative 
transcription///transcrip
tion factor 
activity///nucleus 
 
Afu4g08780 -3.28 -4.16 -3.29 hypothetical 
protein 
  
Afu3g10150 -3.27 -4.48 -4.27 hypothetical 
protein 
  
Afu2g05250 -3.27 -4.4 -3.49 RfeD   
Afu6g06390 -3.26 -2.45 -3.14 hypothetical 
protein 
  
Afu1g12900 -3.26 -3.67 -3.98 Leucine Rich 
Repeat 
domain 
protein 
negative regulation of 
microtubule 
depolymerisation///cell 
wall 
organisation///microtub
ule///structural 
constituent of 
cytoskeleton 
 
Afu4g12390 -3.25 -4 -2.83 cell 
differentiation 
protein 
(Rcd1), 
putative 
regulation of 
transcription from 
RNA polymerase II 
promoter///CCR4-NOT 
complex///molecular 
function unknown 
Regulator of nitrogen 
starvation-induced 
sexual differentiation 
Afu5g05600 -3.25 -3.44 -2.75 forkhead 
transcription 
factor (Sep1), 
putative 
spindle 
organisation///transcrip
tion initiation from 
RNA polymerase II 
promoter///specific 
RNA polymerase II 
transcription factor 
activity///nucleus 
Mitotic gene 
transcription 
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Afu1g14750 -3.24 -4.27 -3.89 C2H2 
transcription 
factor (Sfp1), 
putative 
regulation of 
transcription, DNA-
dependent///transcriptio
n factor 
activity///nucleus///zinc 
ion binding///regulation 
of cell size 
Transcription factor: 
Integration of nutrient 
and stress signals for 
down regulation of 
protein synthesis 
Afu6g02810 -3.24 -2.61 -3.01 Ctr copper 
transporter 
family family 
 Transport 
Afu3g06690 -3.24 -4.12 -3.73 Rho GTPase 
Rho3 
actin filament 
organisation///intracell
ular///signal transducer 
activity///Rho small 
monomeric GTPase 
activity///small GTPase 
mediated signal 
transduction///exocytos
is 
Bud formation and 
exocytosis 
Afu2g10550 -3.23 -4.15 -3.19 C2H2 
transcription 
factor (RfeC), 
putative 
regulation of 
transcription, DNA-
dependent///transcriptio
n factor 
activity///nucleus///zinc 
ion binding 
Transcription factor 
Afu4g10110 -3.23 -3.57 -3.65 homeobox 
transcription 
factor, 
putative 
cellular copper ion 
homeostasis///transcript
ion initiation from 
RNA polymerase II 
promoter///specific 
RNA polymerase II 
transcription factor 
activity///nucleus 
Transcription factor 
Afu5g00810 -3.23 -5.02 -4.03 hypothetical 
protein 
  
Afu3g01300 -3.23 -4.24 -3.39 hypothetical 
protein 
  
Afu2g11180 -3.22 -3.74 -3.94 developmental 
regulator FlbA 
regulation of 
sporulation resulting in 
formation of a cellular 
spore///pheromone-
dependent signal 
transduction involved 
in conjugation with 
cellular 
fusion///response to 
pheromone during 
conjugation with 
cellular 
fusion///response to 
stress 
Developmental 
regulator upstream of 
FluG 
Afu4g07490 -3.22 -4.35 -3.98 hypothetical 
protein 
  
Afu1g04230 -3.22 -2.75 -2.55 mitoribosomal 
protein 
YmL27 
structural constituent of 
ribosome///translation//
/mitochondrial large 
ribosomal subunit 
Essential for 
mitochondrial function 
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To identify biological categories enriched, in a stage-specific manner among the total 
population of differentially expressed genes (fold change cut off of ±2 on a log2 scale) in the 
ATCC46645 time course experiment, GO analysis was performed using Genespring GX 
11.02. Table 4.5 and Table 4.6 show the GO terms, which satisfy an arbitrarily imposed p-
value cut-off of 0.05 with respect to their occurrence in the A. fumigatus genome. Significant 
GO terms among total up-regulated genes included catalytic and oxidoreductase activities, 
and metabolism. Additionally, phase-specific GO analysis of the up-regulated genes 
partitioned functional categories according to time point of infection, revealing increased 
significance of transport functions as infection progresses. Significant GO terms among the 
down-regulated genes in the ATCC46645 time course included several members involved in 
transcription and transcriptional regulation.   
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Total up-regulated genes in the ATCC46645 time course 
GO ACCESSION GO Term p-value corrected p-
value 
Count in 
Selection 
% Count in 
Selection 
Count in 
Total 
% Count in 
Total 
GO:0003824 catalytic activity 2.6329286E-13 4.504941E-9 47 36.71875 2044 45.462635 
GO:0016491 oxidoreductase activity 6.042038E-12 5.1689636E-8 38 29.6875 472 10.49822 
GO:0006082 organic acid metabolic process 1.9514832E-9 4.7699823E-6 6 4.6875 309 6.872776 
GO:0019752 carboxylic acid metabolic process 1.9514832E-9 4.7699823E-6 6 4.6875 309 6.872776 
GO:0042180 cellular ketone metabolic process 1.0381139E-9 4.7699823E-6 6 4.6875 319 7.095196 
GO:0043436 oxoacid metabolic process 1.9514832E-9 4.7699823E-6 6 4.6875 309 6.872776 
GO:0044281 small molecule metabolic process 1.5245785E-9 4.7699823E-6 1 0.78125 483 10.742883 
GO:0022857|GO:0005386|
GO:0015646 
transmembrane transporter activity 1.6942975E-7 2.8989432E-4 1 0.78125 354 7.8736653 
GO:0006811 ion transport 2.3700125E-6 0.003119301 1 0.78125 132 2.9359431 
GO:0005886|GO:0005904 plasma membrane 1.4934758E-5 0.012776686 53 41.40625 315 7.006228 
GO:0032787 monocarboxylic acid metabolic process 1.4664228E-5 0.012776686 5 3.90625 115 2.5578291 
GO:0044242 cellular lipid catabolic process 1.5870719E-5 0.012930858 5 3.90625 32 0.7117438 
GO:0016042|GO:0006724 lipid catabolic process 2.6027752E-5 0.019362384 5 3.90625 33 0.7339858 
GO:0016616 oxidoreductase activity, acting on the CH-OH group 
of donors, NAD or NADP as acceptor 
2.981266E-5 0.021253943 4 3.125 114 2.535587 
GO:0006753 nucleoside phosphate metabolic process 6.2342755E-5 0.028829312 1 0.78125 80 1.7793595 
GO:0009062 fatty acid catabolic process 5.984095E-5 0.028829312 5 3.90625 25 0.5560498 
GO:0009117 nucleotide metabolic process 6.2342755E-5 0.028829312 1 0.78125 80 1.7793595 
GO:0016614 oxidoreductase activity, acting on CH-OH group of 
donors 
4.6860412E-5 0.028829312 4 3.125 129 2.8692172 
GO:0016054 organic acid catabolic process 7.5876196E-5 0.03245604 6 4.6875 61 1.3567616 
GO:0046395 carboxylic acid catabolic process 7.5876196E-5 0.03245604 6 4.6875 61 1.3567616 
GO:0005215|GO:0005478 transporter activity 1.1932882E-4 0.04640264 24 18.75 525 11.677046 
4 hrs up-regulated genes in the ATCC46645 time course 
GO ACCESSION GO Term p-value corrected p-
value 
Count in 
Selection 
% Count in 
Selection 
Count in 
Total 
% Count in 
Total 
GO:0042180 cellular ketone metabolic process 8.861405E-12 6.27341E-8 6 3.0456853 319 7.095196 
GO:0044281 small molecule metabolic process 4.8981244E-12 6.27341E-8 1 0.5076142 483 10.742883 
GO:0016491 oxidoreductase activity 1.8180478E-11 8.58055E-8 27 13.705584 472 10.49822 
GO:0006082 organic acid metabolic process 4.053666E-11 9.565943E-8 6 3.0456853 309 6.872776 
GO:0019752 carboxylic acid metabolic process 4.053666E-11 9.565943E-8 6 3.0456853 309 6.872776 
GO:0043436 oxoacid metabolic process 4.053666E-11 9.565943E-8 6 3.0456853 309 6.872776 
GO:0003824 catalytic activity 5.8614547E-10 1.0374007E-6 34 17.258883 2044 45.462635 
GO:0022857|GO:0005386| transmembrane transporter activity 2.8638493E-7 3.1191617E-4 1 0.5076142 354 7.8736653 
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GO:0015646 
GO:0005737 cytoplasm 9.120414E-7 6.456775E-4 146 74.11167 2039 45.351425 
GO:0006753 nucleoside phosphate metabolic process 4.487924E-6 0.0024440114 1 0.5076142 80 1.7793595 
GO:0009117 nucleotide metabolic process 4.487924E-6 0.0024440114 1 0.5076142 80 1.7793595 
GO:0044242 cellular lipid catabolic process 9.112341E-6 0.0047785626 5 2.5380712 32 0.7117438 
GO:0016042|GO:0006724 lipid catabolic process 1.3607678E-5 0.0066438084 5 2.5380712 33 0.7339858 
GO:0032787 monocarboxylic acid metabolic process 1.454998E-5 0.006867082 6 3.0456853 115 2.5578291 
GO:0008152 metabolic process 2.50623E-5 0.011446963 60 30.456852 2366 52.624554 
GO:0005739 mitochondrion 3.7388872E-5 0.015570212 46 23.350254 435 9.675267 
GO:0044444 cytoplasmic part 5.4811295E-5 0.02080657 46 23.350254 1294 28.78114 
GO:0006457|GO:0007022|
GO:0007024|GO:0007025 
protein folding 7.3481424E-5 0.026010498 13 6.5989847 48 1.0676156 
GO:0006811 ion transport 8.0210826E-5 0.027040506 1 0.5076142 132 2.9359431 
GO:0016616 oxidoreductase activity, acting on the CH-OH group 
of donors, NAD or NADP as acceptor 
9.7396965E-5 0.03134179 3 1.5228426 114 2.535587 
GO:0009062 fatty acid catabolic process 1.1876168E-4 0.036299374 5 2.5380712 25 0.5560498 
GO:0016054 organic acid catabolic process 1.2305783E-4 0.036299374 5 2.5380712 61 1.3567616 
GO:0046395 carboxylic acid catabolic process 1.2305783E-4 0.036299374 5 2.5380712 61 1.3567616 
GO:0016614 oxidoreductase activity, acting on CH-OH group of 
donors 
1.3296878E-4 0.03842242 3 1.5228426 129 2.8692172 
GO:0055086 nucleobase, nucleoside and nucleotide metabolic 
process 
1.73719E-4 0.04858762 1 0.5076142 105 2.3354092 
8 hrs up-regulated genes in the ATCC46645 time course 
GO ACCESSION GO Term p-value corrected p-
value 
Count in 
Selection 
% Count in 
Selection 
Count in 
Total 
% Count in 
Total 
GO:0003824 catalytic activity 1.7023827E-11 2.774999E-7 37 40.217392 2044 45.462635 
GO:0016491 oxidoreductase activity 3.622693E-9 2.9526173E-5 28 30.434782 472 10.49822 
GO:0044281 small molecule metabolic process 5.97662E-8 2.4355738E-4 1 1.0869565 483 10.742883 
GO:0022857|GO:0005386|
GO:0015646 
transmembrane transporter activity 3.155829E-7 8.573691E-4 1 1.0869565 354 7.8736653 
GO:0006811 ion transport 7.8666125E-7 0.001831873 1 1.0869565 132 2.9359431 
GO:0042180 cellular ketone metabolic process 9.0772875E-7 0.001849574 5 5.4347825 319 7.095196 
GO:0006082 organic acid metabolic process 2.0390244E-6 0.0030215888 5 5.4347825 309 6.872776 
GO:0019752 carboxylic acid metabolic process 2.0390244E-6 0.0030215888 5 5.4347825 309 6.872776 
GO:0043436 oxoacid metabolic process 2.0390244E-6 0.0030215888 5 5.4347825 309 6.872776 
GO:0006753 nucleoside phosphate metabolic process 1.150689E-5 0.011765132 1 1.0869565 80 1.7793595 
GO:0009062 fatty acid catabolic process 1.1548116E-5 0.011765132 5 5.4347825 25 0.5560498 
GO:0009117 nucleotide metabolic process 1.150689E-5 0.011765132 1 1.0869565 80 1.7793595 
GO:0044242 cellular lipid catabolic process 1.2443318E-5 0.011931441 5 5.4347825 32 0.7117438 
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Table 4.5: Significant GO terms among the up-regulated genes in the ATCC46645 time course. p-value represents the probability of obtaining the GO term from a list 
of random entities, corrected p-value derived from Bonferroni testing of multiple comparisons. Analysis performed using Genespring GX 11.02. 
 
Total down-regulated genes in the ATCC46645 time course 
GO ACCESSION GO Term p-value corrected p-
value 
Count in 
Selection 
% Count in 
Selection 
Count 
in Total 
% Count in 
Total 
GO:0005634 nucleus 5.5901533E-10 9.502934E-6 154 79.38145 1124 25.0 
GO:0006350 transcription 1.4846413E-9 1.2619017E-5 35 18.041237 120 2.6690392 
GO:0044428 nuclear part 3.2058924E-8 1.8166099E-4 6 3.0927835 464 10.320285 
GO:0031981 nuclear lumen 5.2097686E-8 2.2140756E-4 6 3.0927835 238 5.2935944 
GO:0016070 RNA metabolic process 1.0409707E-7 3.539179E-4 21 10.824742 372 8.274021 
GO:0044260|GO:0034960 cellular macromolecule metabolic process 3.2913212E-7 9.3250896E-4 35 18.041237 1075 23.910143 
GO:0006351 transcription, DNA-dependent 1.4624209E-6 0.0035514713 21 10.824742 87 1.9350533 
GO:0003702 RNA polymerase II transcription factor activity 2.3201442E-6 0.004323292 7 3.6082475 65 1.4457295 
GO:0032774 RNA biosynthetic process 2.5432005E-6 0.004323292 21 10.824742 93 2.0685053 
GO:0043170|GO:0043283 macromolecule metabolic process 2.4108556E-6 0.004323292 35 18.041237 1199 26.66815 
GO:0010467 gene expression 2.8524491E-6 0.004408179 35 18.041237 571 12.700178 
GO:0005488 binding 3.9904253E-6 0.0054627666 5 2.5773196 867 19.283808 
GO:0005886|GO:0005904 plasma membrane 1.6725186E-5 0.015146213 48 52.173912 315 7.006228 
GO:0016042|GO:0006724 lipid catabolic process 1.9778961E-5 0.016120521 5 5.4347825 33 0.7339858 
GO:0032787 monocarboxylic acid metabolic process 2.2823499E-5 0.016910838 5 5.4347825 115 2.5578291 
GO:0016054 organic acid catabolic process 7.7985234E-5 0.045400433 5 5.4347825 61 1.3567616 
GO:0046395 carboxylic acid catabolic process 7.7985234E-5 0.045400433 5 5.4347825 61 1.3567616 
16 hrs up-regulated genes in the ATCC46645 time course 
GO ACCESSION GO Term p-value corrected p-
value 
Count in 
Selection 
% Count in 
Selection 
Count in 
Total 
% Count in 
Total 
GO:0003824 catalytic activity 2.0177418E-9 2.8934535E-5 3 4.83871 2044 45.462635 
GO:0022891 substrate-specific transmembrane transporter activity 2.6887168E-8 1.927818E-4 1 1.6129032 317 7.0507116 
GO:0022857|GO:0005386|
GO:0015646 
transmembrane transporter activity 1.3589522E-7 3.8974907E-4 2 3.2258065 354 7.8736653 
GO:0022892 substrate-specific transporter activity 1.9675623E-7 4.0333378E-4 1 1.6129032 357 7.9403915 
GO:0006811 ion transport 9.644869E-6 0.0138308 1 1.6129032 132 2.9359431 
GO:0005342 organic acid transmembrane transporter activity 3.5586836E-5 0.03925518 1 1.6129032 59 1.3122776 
GO:0005215|GO:0005478 transporter activity 4.0179137E-5 0.039597526 19 30.64516 525 11.677046 
GO:0005886|GO:0005904 plasma membrane 4.1419837E-5 0.039597526 42 67.741936 315 7.006228 
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GO:0005654 nucleoplasm 4.3250748E-6 0.0054627666 6 3.0927835 138 3.069395 
GO:0006357 regulation of transcription from RNA polymerase II 
promoter 
4.734825E-6 0.0054627666 13 6.7010307 83 1.8460854 
GO:0050789|GO:0050791 regulation of biological process 4.820254E-6 0.0054627666 43 22.164948 512 11.3879 
GO:0003676 nucleic acid binding 5.3128256E-6 0.005644683 5 2.5773196 439 9.764235 
GO:0050794|GO:0051244 regulation of cellular process 6.974342E-6 0.006974102 39 20.103092 489 10.876334 
GO:0006366 transcription from RNA polymerase II promoter 8.355536E-6 0.007891068 21 10.824742 65 1.4457295 
GO:0044451 nucleoplasm part 1.0704729E-5 0.009577586 2 1.0309278 129 2.8692172 
GO:0019222 regulation of metabolic process 1.4490729E-5 0.012316696 43 22.164948 339 7.5400357 
GO:0016591 DNA-directed RNA polymerase II, holoenzyme 1.5400934E-5 0.012466994 1 0.5154639 37 0.82295376 
GO:0065007 biological regulation 1.8282262E-5 0.014126717 43 22.164948 618 13.745552 
GO:0043233 organelle lumen 2.69467E-5 0.018323125 6 3.0927835 365 8.118327 
GO:0070013 intracellular organelle lumen 2.69467E-5 0.018323125 6 3.0927835 365 8.118327 
GO:0080090 regulation of primary metabolic process 2.5067759E-5 0.018323125 43 22.164948 318 7.0729537 
GO:0006355 regulation of transcription, DNA-dependent 3.8250757E-5 0.02500925 25 12.886598 168 3.7366548 
GO:0032991 macromolecular complex 4.5281955E-5 0.02749167 5 2.5773196 774 17.215303 
GO:0051252 regulation of RNA metabolic process 4.5101173E-5 0.02749167 25 12.886598 169 3.7588968 
GO:0031326 regulation of cellular biosynthetic process 5.4806183E-5 0.031055769 39 20.103092 299 6.650356 
GO:0000151 ubiquitin ligase complex 5.9944836E-5 0.0318446 3 1.5463917 23 0.51156586 
GO:0006109 regulation of carbohydrate metabolic process 5.899354E-5 0.0318446 4 2.0618556 14 0.3113879 
GO:0030528 transcription regulator activity 6.48235E-5 0.033392776 8 4.123711 280 6.227758 
GO:0009889 regulation of biosynthetic process 6.930231E-5 0.03464996 39 20.103092 301 6.69484 
GO:0031323 regulation of cellular metabolic process 7.23957E-5 0.035162415 39 20.103092 322 7.1619215 
GO:0005667 transcription factor complex 7.806755E-5 0.036863964 1 0.5154639 41 0.9119217 
GO:0006367 transcription initiation from RNA polymerase II 
promoter 
8.660711E-5 0.03979109 13 6.7010307 27 0.6005338 
GO:0006139 nucleobase, nucleoside, nucleotide and nucleic acid 
metabolic process 
9.365904E-5 0.041898653 35 18.041237 660 14.679715 
4 hrs down-regulated genes in the ATCC46645 time course 
GO ACCESSION GO Term p-value corrected p-
value 
Count in 
Selection 
% Count in 
Selection 
Count 
in Total 
% Count in 
Total 
GO:0005634 nucleus 1.4105173E-6 0.008881466 83 98.809525 1124 25.0 
GO:0006350 transcription 1.3111768E-6 0.008881466 10 11.904762 120 2.6690392 
8 hrs down-regulated genes in the ATCC46645 time course 
GO ACCESSION GO Term p-value corrected p-
value 
Count in 
Selection 
% Count in 
Selection 
Count 
in Total 
% Count in 
Total 
GO:0006350 transcription 6.2399946E-10 9.384578E-6 33 19.298246 120 2.6690392 
GO:0005634 nucleus 1.2679399E-9 9.534528E-6 147 85.96491 1124 25.0 
GO:0031981 nuclear lumen 9.829524E-8 4.9276714E-4 27 15.789474 238 5.2935944 
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GO:0016070 RNA metabolic process 1.7188285E-7 6.4625376E-4 20 11.695907 372 8.274021 
GO:0006351 transcription, DNA-dependent 9.879598E-7 0.002476387 20 11.695907 87 1.9350533 
GO:0044428 nuclear part 8.6203045E-7 0.002476387 27 15.789474 464 10.320285 
GO:0032774 RNA biosynthetic process 1.4132655E-6 0.0030363807 20 11.695907 93 2.0685053 
GO:0010467 gene expression 3.1244708E-6 0.005873771 33 19.298246 571 12.700178 
GO:0003702 RNA polymerase II transcription factor activity 4.209757E-6 0.0070346915 5 2.9239767 65 1.4457295 
GO:0005634 nucleus 1.4105173E-6 0.008881466 83 98.809525 1124 25.0 
GO:0006350 transcription 1.3111768E-6 0.008881466 10 11.904762 120 2.6690392 
GO:0016591 DNA-directed RNA polymerase II, holoenzyme 6.470116E-6 0.009730667 1 0.5847953 37 0.82295376 
GO:0005488 binding 1.4964731E-5 0.01664453 5 2.9239767 867 19.283808 
GO:0006366 transcription from RNA polymerase II promoter 1.5494197E-5 0.01664453 20 11.695907 65 1.4457295 
GO:0003676 nucleic acid binding 1.8162524E-5 0.01821023 5 2.9239767 439 9.764235 
GO:0005654 nucleoplasm 3.0831856E-5 0.025549265 4 2.3391812 138 3.069395 
GO:0005730 nucleolus 3.1949843E-5 0.025549265 24 14.035088 112 2.4911032 
GO:0030528 transcription regulator activity 3.2443582E-5 0.025549265 5 2.9239767 280 6.227758 
GO:0043233 organelle lumen 3.397644E-5 0.025549265 27 15.789474 365 8.118327 
GO:0070013 intracellular organelle lumen 3.397644E-5 0.025549265 27 15.789474 365 8.118327 
GO:0044451 nucleoplasm part 4.0753133E-5 0.02918584 1 0.5847953 129 2.8692172 
GO:0006367 transcription initiation from RNA polymerase II 
promoter 
6.870035E-5 0.044922266 12 7.017544 27 0.6005338 
16 hrs down-regulated genes in the ATCC46645 time course 
GO ACCESSION GO Term p-value corrected p-
value 
Count in 
Selection 
% Count in 
Selection 
Count 
in Total 
% Count in 
Total 
GO:0005634 nucleus 8.61132E-9 1.3784424E-4 124 78.48101 1124 25.0 
GO:0006350 transcription 3.4257312E-7 0.0018278938 29 18.354431 120 2.6690392 
GO:0044260|GO:0034960 cellular macromolecule metabolic process 2.2965533E-7 0.0018278938 29 18.354431 1075 23.910143 
GO:0044428 nuclear part 4.764217E-7 0.0019065599 4 2.5316455 464 10.320285 
GO:0043170|GO:0043283 macromolecule metabolic process 7.557978E-7 0.0024196613 29 18.354431 1199 26.66815 
GO:0016070 RNA metabolic process 1.1366951E-6 0.0030325758 19 12.025316 372 8.274021 
GO:0031981 nuclear lumen 1.8273149E-6 0.0041786334 4 2.5316455 238 5.2935944 
GO:0006366 transcription from RNA polymerase II promoter 2.1125286E-6 0.0042269933 19 12.025316 65 1.4457295 
GO:0005488 binding 3.4334078E-6 0.0061066328 3 1.8987342 867 19.283808 
GO:0005622 intracellular 5.202852E-6 0.008328378 130 82.27848 2921 64.968864 
GO:0000151 ubiquitin ligase complex 5.8427418E-6 0.008502427 3 1.8987342 23 0.51156586 
GO:0003702 RNA polymerase II transcription factor activity 8.137292E-6 0.010854694 6 3.7974684 65 1.4457295 
GO:0044424 intracellular part 9.518359E-6 0.01172027 126 79.74683 2899 64.47954 
GO:0003676 nucleic acid binding 1.2039269E-5 0.013603866 3 1.8987342 439 9.764235 
GO:0050789|GO:0050791 regulation of biological process 1.3597636E-5 0.013603866 31 19.620253 512 11.3879 
GO:0065007 biological regulation 1.3079437E-5 0.013603866 31 19.620253 618 13.745552 
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GO:0006351 transcription, DNA-dependent 1.6304955E-5 0.015352872 19 12.025316 87 1.9350533 
GO:0050794|GO:0051244 regulation of cellular process 1.8027062E-5 0.016031398 31 19.620253 489 10.876334 
GO:0016591 DNA-directed RNA polymerase II, holoenzyme 1.9954921E-5 0.016148277 1 0.6329114 37 0.82295376 
GO:0032774 RNA biosynthetic process 2.0176101E-5 0.016148277 19 12.025316 93 2.0685053 
GO:0010467 gene expression 2.215825E-5 0.016890211 29 18.354431 571 12.700178 
GO:0006367 transcription initiation from RNA polymerase II 
promoter 
4.6177567E-5 0.033599075 12 7.594937 27 0.6005338 
GO:0006357 regulation of transcription from RNA polymerase II 
promoter 
6.25143E-5 0.043508135 12 7.594937 83 1.8460854 
GO:0043227 membrane-bounded organelle 7.410959E-5 0.047451865 124 78.48101 2057 45.751778 
GO:0043231 intracellular membrane-bounded organelle 7.410959E-5 0.047451865 124 78.48101 2057 45.751778 
GO:0005654 nucleoplasm 7.931446E-5 0.04883126 4 2.5316455 138 3.069395 
 
Table 4.6: Significant GO terms among the down-regulated genes in the ATCC46645 time course. p-value represents the probability of obtaining the GO term from a 
list of random entities, corrected p-value derived from Bonferroni testing of multiple comparisons. Analysis performed using Genespring GX 11.02.  
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Differentially expressed genes in the ATCC46645 transcriptome during initiation of 
murine were also analysed using the STEM (Short Time-series Expression Miner) software, 
designed for clustering, comparing, and visualizing gene expression data from short time 
series microarray experiments (Ernst and Bar-Joseph, 2006). This software utilises a novel 
method for clustering short time series expression data, differentiating between real and 
random patterns and is also integrated with the GO for a biological interpretation of the 
results. The software generates a set of distinct and representative models corresponding to 
possible patterns of gene expression over time. The expression profiles from the geneset of 
interest are then assigned to the most closely matching model profile based on correlation 
coefficient. Significant model profiles are those having a statistically significant number of 
genes assigned to them, as compared to that expected by chance. The number of genes 
expected to be assigned by chance to a profile is calculated by repeating a large number of 
random permutations, which renormalise the genes‟ expression values and then assign the 
genes to their most closely matching model profiles. After these permutations, the average 
number of genes assigned to a model profile is used as the number of genes expected to be 
assigned by chance. Statistical significance is calculated on the basis of the number of genes 
assigned to each profile versus the number randomly expected by the permutations. The 
biological significance of the set of genes assigned to the same profile or the same cluster of 
profiles can then be assessed using a GO enrichment analysis. 
Fig. 4.7 shows the STEM output profiles for the ATCC46645 time course experiment. 
Each box is a different model temporal expression profile, having a unique profile number 
(top left hand corner). The box is coloured when a statistically significant number of genes 
were assigned to the model expression profile. Model profiles of the same colour are similar 
in temporal expression characteristics and can be considered as a cluster. Model profiles can 
be ordered by various parameters, such as significance or number of genes assigned. In the 
following examples the model profiles are ordered by default to list models by similarity, 
thereby grouping similar temporal profiles together. The significance of, and the number of 
genes associated to each model profiles is indicated in the legend. As summarised in Fig 4.7, 
STEM allocated the differentially expressed genes (fold change cut off of ±2 on a log2 scale) 
of the ATCC46645 time course dataset into nine model profiles, belonging to four different 
clusters. Among these, four model profiles (0, 12, 1, 9) contain genes whose expression is 
down-regulated across the ATCC46645 time course and five (49, 48, 42, 47 and 29) contain 
genes whose expression is up-regulated across the ATCC46645 time course.  
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Fig. 4.7: STEM clustering analysis of differentially expressed genes in the ATCC46645 time 
course during initiation of murine infection. Statistically significant model profiles are coloured. Clustered 
model profiles are similarly coloured.  Profile 0, n = 395 (1e-201), Profile 12, n = 444 (2e-119), Profile 1, n = 
197 (7e-59), Profile 9, n = 85, (4e-25), Profile 49, n = 479 (6e-180), Profile 48, n = 398 (1e-142), Profile 42, n = 
114, (1e-44), Profile 47, n=122 (6e-21), Profile 29, n = 75 (2e-36). All analysed genes are indicated in red.  
 
Functional classification of the genes assigned to each model profile was performed by 
using a GO enrichment analysis. For GO analysis in STEM, the A. fumigatus annotation used 
elsewhere in this study (produced by the JCVI) was extended to include additional categories 
of interest, extrapolated from the literature or from the research performed in our laboratory. 
These categories include those located in clusters of physically-linked genes, termed by us as 
infections clusters (ICs) which were identified as differentially expressed at a single timepoint 
of A. fumigatus virulence (Af293, 14 hours) relative to laboratory culture (McDonagh et al., 
2008a), and genes having subtelomeric (300 kb from telomeres) and semi-subtelomeric 
locations (300-600 kb from telomeres). Genes specific to A. fumigatus, A. fisheri and A. 
clavatus lineage (AFFC-specific) were also collectively analysed as the latter two species are 
phylogenetically the closest (based upon sequenced Aspergillus genomes) to A. fumigatus and 
may be used as indicators of recently evolved function. In addition, genes specific to A. 
fumigatus only (AFU-SPECIFIC) were annotated. Genes involved in secondary metabolite 
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production (as predicted from in silico analyses) by(Perrin et al., 2007)(SECMET) and genes 
putatively involved in transposition were additional functional classifications. Genes 
differentially regulated during shift from low (pH=5) to high (pH=8.0) pH were also included 
(Loss et al., unpublished).  
The GO enrichment analysis for each profile is shown in Table 4.7. For each model 
profile, only GO terms with corrected p-value <0.05 are included, where the p-value, initially 
based on a hypergeometric distribution, was corrected by the software using a Bonferonni 
correction for multiple GO categories being tested simultaneously. This corrected p-value is 
the original p-value divided by the number of GO categories in which the number of genes on 
the array is above the GO analysis minimum number of genes parameter.  
Broadly speaking the STEM analysis confirmed the enrichment for transport and cell 
wall functions among up-regulated genes, whereby profiles 48 and 49 were significantly 
enriched for such terms. In addition, profiles 0, 12 and 1, representing down-regulated genes 
were significantly enriched in GO terms associated with the functional category transcription.  
 
Significant GO terms for Profile 0 (n = 395)   
Category ID Genes in 
Category 
Count  
Genes  
Genes 
Expected  
Genes 
Enriched 
p-value Corrected 
p-value 
Semi-subT 438 71.0 9.1 +61.9 2.5E-40 6.2E-38 
nucleus 221 46.0 4.6 +41.4 1.1E-31 2.8E-29 
cytoplasm 286 36.0 6.0 +30.0 1.4E-17 3.5E-15 
molecular function unknown 186 29.0 3.9 +25.1 5.7E-17 1.4E-14 
In vitro pH response genes 282 34.5 5.9 +28.6 6.1E-17 1.5E-14 
zinc ion binding 68 19.0 1.4 +17.6 1.5E-16 3.7E-14 
Subtelomeric 373 39.0 7.8 +31.2 3.9E-16 9.5E-14 
AFU-SPECIFIC 70 16.0 1.5 +14.5 1.1E-12 2.7E-10 
DNA binding 33 11.0 0.7 +10.3 4.2E-11 1.0E-8 
regulation of transcription 40 11.0 0.8 +10.2 4.4E-10 1.1E-7 
transcription factor activity 44 11.0 0.9 +10.1 1.3E-9 3.3E-7 
cellular component unknown 97 15.0 2.0 +13.0 1.9E-9 4.7E-7 
biological process unknown 151 18.0 3.2 +14.8 3.7E-9 9.0E-7 
SECMET 81 13.0 1.7 +11.3 1.4E-8 3.5E-6 
mitochondrial matrix 17 7.0 0.4 +6.6 2.8E-8 6.8E-6 
nuclear mRNA splicing 13 6.0 0.3 +5.7 1.3E-7 3.1E-5 
via spliceosome 13 6.0 0.3 +5.7 1.3E-7 3.1E-5 
IC 279 20.5 5.8 +14.7 6.2E-7 1.5E-4 
transcription 17 6.0 0.4 +5.6 8.4E-7 2.1E-4 
endoplasmic reticulum 50 9.0 1.0 +8.0 8.7E-7 2.1E-4 
negative regulation of 
transcription from RNA 
polymerase II promoter 
10 5.0 0.2 +4.8 9.2E-7 2.2E-4 
general RNA polymerase II 
transcription factor activity 
11 5.0 0.2 +4.8 1.7E-6 4.0E-4 
protein serine/threonine kinase 
activity 
11 5.0 0.2 +4.8 1.7E-6 4.0E-4 
nucleolus 29 7.0 0.6 +6.4 1.8E-6 4.4E-4 
protein amino acid 
phosphorylation 
30 7.0 0.6 +6.4 2.3E-6 5.6E-4 
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transcription initiation from 
RNA polymerase II promoter 
13 5.0 0.3 +4.7 4.4E-6 0.001 
response to stress 23 6.0 0.5 +5.5 6.2E-6 0.002 
pathogenesis 23 6.0 0.5 +5.5 6.2E-6 0.002 
protein kinase activity 15 5.0 0.3 +4.7 1.0E-5 0.002 
integral to plasma membrane 39 6.5 0.8 +5.7 1.5E-5 0.004 
DNA-dependent 17 5.0 0.4 +4.6 2.0E-5 0.005 
AFFC specific 42 7.0 0.9 +6.1 2.5E-5 0.006 
mitochondrion 79 9.0 1.7 +7.3 4.2E-5 0.010 
transport 49 6.5 1.0 +5.5 6.9E-5 0.017 
plasma membrane 74 8.0 1.5 +6.5 1.6E-4 0.039 
Significant GO terms for Profile 12 (n = 444)  
Category ID Genes in 
Category 
Count  
Genes  
Genes 
Expected  
Genes 
Enriched 
p-value Corrected 
p-value 
nucleus 221 59.0 10.2 +48.8 3.2E-28 7.8E-26 
molecular function unknown 186 47.0 8.6 +38.4 1.0E-21 2.5E-19 
cytoplasm 286 52.0 13.3 +38.7 4.0E-17 9.8E-15 
biological process unknown 151 32.0 7.0 +25.0 5.2E-13 1.3E-10 
Semi-subT 438 58.0 20.3 +37.7 1.2E-12 3.0E-10 
protein binding 36 15.0 1.7 +13.3 2.2E-11 5.3E-9 
nucleolus 29 12.0 1.3 +10.7 2.4E-9 6.0E-7 
35S primary transcript 
processing 
16 9.0 0.7 +8.3 8.4E-9 2.1E-6 
zinc ion binding 68 16.0 3.2 +12.8 6.7E-8 1.6E-5 
In vitro pH response genes 282 34.0 13.1 +20.9 4.5E-7 1.1E-4 
rRNA modification 6 5.0 0.3 +4.7 1.2E-6 3.0E-4 
cellular component unknown 97 16.0 4.5 +11.5 1.0E-5 0.002 
signal transducer activity 8 5.0 0.4 +4.6 1.1E-5 0.003 
regulation of transcription 40 10.0 1.9 +8.1 1.1E-5 0.003 
ubiquitin-dependent protein 
catabolic process 
20 7.0 0.9 +6.1 2.1E-5 0.005 
transcription factor activity 44 10.0 2.0 +8.0 2.7E-5 0.007 
Subtelomeric 373 36.0 17.3 +18.7 3.4E-5 0.008 
nucleotide-excision repair 11 5.0 0.5 +4.5 7.8E-5 0.019 
AFU-SPECIFIC 70 12.0 3.2 +8.8 8.5E-5 0.021 
endoplasmic reticulum 50 10.0 2.3 +7.7 8.6E-5 0.021 
proteolysis 13 5.0 0.6 +4.4 2.0E-4 0.049 
transcription initiation from 
RNA polymerase II promoter 
13 5.0 0.6 +4.4 2.0E-4 0.049 
Significant GO terms for Profile 1 (n = 197) 
Category ID Genes in 
Category 
Count  
Genes  
Genes 
Expected  
Genes 
Enriched 
p-value Corrected 
p-value 
Semi-subT 438 36.0 8.1 +27.9 1.8E-13 4.4E-11 
ubiquitin-dependent protein 
catabolic process 
20 10.0 0.4 +9.6 6.9E-13 1.7E-10 
nucleus 221 22.0 4.1 +17.9 2.2E-10 5.4E-8 
cytoplasm 286 25.0 5.3 +19.7 2.2E-10 5.4E-8 
biological process unknown 151 17.0 2.8 +14.2 3.7E-9 9.0E-7 
protein binding 36 9.0 0.7 +8.3 1.4E-8 3.5E-6 
molecular function unknown 186 17.0 3.4 +13.6 8.3E-8 2.0E-5 
ATPase activity 19 6.0 0.3 +5.7 8.5E-7 2.1E-4 
translational initiation 11 5.0 0.2 +4.8 8.8E-7 2.2E-4 
translation initiation factor 
activity 
11 5.0 0.2 +4.8 8.8E-7 2.2E-4 
regulation of transcription from 
RNA polymerase II promoter 
14 5.0 0.3 +4.7 3.7E-6 8.9E-4 
zinc ion binding 68 8.0 1.3 +6.7 3.6E-5 0.009 
cellular component unknown 97 9.0 1.8 +7.2 8.0E-5 0.019 
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Significant GO terms for Profile 9 (n = 85) 
Category ID Genes in 
Category 
Count  
Genes  
Genes 
Expected  
Genes 
Enriched 
p-value Corrected 
p-value 
protein amino acid 
phosphorylation 
30 6.0 0.2 +5.8 1.5E-7 3.6E-5 
cytoplasm 286 13.0 2.3 +10.7 9.5E-7 2.3E-4 
nucleus 221 10.0 1.8 +8.2 1.7E-5 0.004 
Significant GO terms for Profile 49 (n = 479) 
Category ID Genes in 
Category 
Count  
Genes  
Genes 
Expected  
Genes 
Enriched 
p-value Corrected 
p-value 
Subtelomeric 373 84.5 13.8 +70.7 1.6E-41 3.8E-39 
Semi-subT 438 86.5 16.2 +70.3 1.5E-37 3.7E-35 
IC 279 63.0 10.3 +52.7 5.5E-31 1.3E-28 
biological process unknown 151 34.0 5.6 +28.4 2.0E-17 4.8E-15 
cytoplasm 286 45.0 10.6 +34.4 3.6E-16 8.7E-14 
molecular function unknown 186 33.0 6.9 +26.1 8.7E-14 2.1E-11 
In vitro pH response genes 282 37.0 10.4 +26.6 3.6E-11 8.7E-9 
cellular component unknown 97 21.0 3.6 +17.4 5.4E-11 1.3E-8 
mitochondrion 79 19.0 2.9 +16.1 6.2E-11 1.5E-8 
fungal-type vacuole 19 9.0 0.7 +8.3 8.4E-9 2.0E-6 
plasma membrane 74 16.0 2.7 +13.3 1.0E-8 2.5E-6 
spindle pole body 11 7.0 0.4 +6.6 2.7E-8 6.6E-6 
SECMET 81 16.0 3.0 +13.0 4.0E-8 9.9E-6 
oxidoreductase activity 55 13.0 2.0 +11.0 8.0E-8 1.9E-5 
metabolic process 75 15.0 2.8 +12.2 8.9E-8 2.2E-5 
microsome 9 6.0 0.3 +5.7 1.9E-7 4.7E-5 
fatty acid beta-oxidation 9 6.0 0.3 +5.7 1.9E-7 4.7E-5 
nucleus 221 26.0 8.2 +17.8 2.4E-7 5.9E-5 
structural constituent of 
cytoskeleton 
10 6.0 0.4 +5.6 4.7E-7 1.1E-4 
cytosol 44 10.0 1.6 +8.4 3.7E-6 9.0E-4 
endoplasmic reticulum 50 10.0 1.8 +8.2 1.2E-5 0.003 
ergosterol biosynthetic process 17 6.0 0.6 +5.4 2.2E-5 0.005 
glucose transmembrane 
transporter activity 
14 5.0 0.5 +4.5 1.0E-4 0.025 
fungal-type cell wall 15 5.0 0.6 +4.4 1.5E-4 0.037 
Significant GO terms for Profile 48 (n = 398)  
Category ID Genes in 
Category 
Count  
Genes  
Genes 
Expected  
Genes 
Enriched 
p-value Corrected 
p-value 
In vitro pH response genes 282 57.0 9.0 +48.0 9.2E-29 2.2E-26 
Semi-subT 438 67.5 13.9 +53.6 8.0E-27 2.0E-24 
IC 279 54.0 8.9 +45.1 2.3E-26 5.5E-24 
Subtelomeric 373 58.5 11.9 +46.6 6.4E-24 1.6E-21 
cytoplasm 286 50.0 9.1 +40.9 1.8E-22 4.3E-20 
plasma membrane 74 17.0 2.4 +14.6 1.4E-10 3.5E-8 
mitochondrion 79 16.0 2.5 +13.5 3.5E-9 8.6E-7 
metabolic process 75 15.0 2.4 +12.6 1.3E-8 3.1E-6 
nucleus 221 25.0 7.0 +18.0 5.5E-8 1.3E-5 
arginine biosynthetic process 6 5.0 0.2 +4.8 1.9E-7 4.6E-5 
hydrolase activity 24 8.0 0.8 +7.2 4.9E-7 1.2E-4 
molecular function unknown 186 21.0 5.9 +15.1 6.3E-7 1.5E-4 
cytosol 44 10.0 1.4 +8.6 9.7E-7 2.4E-4 
oxidoreductase activity 55 11.0 1.7 +9.3 1.1E-6 2.7E-4 
transporter activity 32 8.0 1.0 +7.0 5.6E-6 0.001 
biological process unknown 151 17.0 4.8 +12.2 7.4E-6 0.002 
cellular component unknown 97 13.0 3.1 +9.9 1.3E-5 0.003 
AFFC specific 42 8.0 1.3 +6.7 4.7E-5 0.011 
cell wall organisation 23 6.0 0.7 +5.3 6.6E-5 0.016 
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membrane 24 6.0 0.8 +5.2 8.5E-5 0.021 
transport 49 8.0 1.6 +6.4 1.5E-4 0.036 
integral to plasma membrane 39 7.0 1.2 +5.8 2.1E-4 0.050 
SECMET 81 9.0 2.6 +6.4 1.1E-3 0.269 
integral to membrane 38 6.0 1.2 +4.8 1.2E-3 0.291 
endoplasmic reticulum 50 6.0 1.6 +4.4 5.0E-3 1.000 
transcription factor activity 44 5.0 1.4 +3.6 0.01 1.000 
zinc ion binding 68 5.0 2.2 +2.8 0.07 1.000 
Significant GO terms for Profile 42 (n = 122) 
Category ID Genes in 
Category 
Count  
Genes  
Genes 
Expected  
Genes 
Enriched 
p-value Corrected 
p-value 
IC 279 33.0 2.3 +30.7 1.4E-27 3.5E-25 
Subtelomeric 373 30.0 3.0 +27.0 2.5E-20 6.0E-18 
In vitro pH response genes 282 23.0 2.3 +20.7 4.4E-16 1.1E-13 
SECMET 81 11.0 0.7 +10.3 7.7E-11 1.9E-8 
Semi-subT 438 21.0 3.6 +17.4 2.0E-10 4.8E-8 
integral to plasma membrane 39 5.0 0.3 +4.7 1.7E-5 0.004 
cellular component unknown 97 6.0 0.8 +5.2 1.6E-4 0.038 
Significant GO terms for Profile 47 (n = 122) 
Category ID Genes in 
Category 
Count  
Genes  
Genes 
Expected  
Genes 
Enriched 
p-value Corrected 
p-value 
cytoplasm 286 26.0 5.0 +21.0 1.2E-11 3.0E-9 
ATP synthesis coupled proton 
transport 
6 5.0 0.1 +4.9 9.3E-9 2.3E-6 
metabolic process 75 11.0 1.3 +9.7 7.6E-8 1.9E-5 
rotational mechanism 8 5.0 0.1 +4.9 8.5E-8 2.1E-5 
oxidoreductase activity 55 9.0 1.0 +8.0 4.4E-7 1.1E-4 
mitochondrion 79 8.5 1.4 +7.1 9.9E-6 0.002 
Semi-subT 438 21.0 7.6 +13.4 3.8E-5 0.009 
Significant GO terms for Profile 29 (n = 75) 
Category ID Genes in 
Category 
Count  
Genes  
Genes 
Expected  
Genes 
Enriched 
p-value Corrected 
p-value 
IC 279 31.0 1.2 +29.8 1.3E-33 3.1E-31 
Subtelomeric 373 30.0 1.6 +28.4 2.3E-28 5.7E-26 
In vitro pH response genes 282 25.0 1.2 +23.8 6.0E-25 1.5E-22 
N-acetyltransferase activity 12 5.0 0.1 +4.9 1.0E-9 2.5E-7 
Semi-subT 438 15.0 1.9 +13.1 1.1E-9 2.8E-7 
SECMET 81 8.0 0.3 +7.7 2.5E-9 6.1E-7 
metabolic process 75 6.0 0.3 +5.7 8.9E-7 2.2E-4 
 
Table 4.7: Significant GO terms among the profiles 0, 12, 1, 9, 49, 48, 42, 47, and 29 in the 
ATCC46645 time course experiment. Table details the GO terms, whose corrected p-value based on the 
expected number of genes assigned to the profile satisfy the cut-off of <0.05.  
 
Significant model profiles can be ordered according to the enrichment of a specific 
GO term, whereby the output can offer an indication of how many ORFs associated with that 
GO term are present within a profile, and if that profile is significantly enriched for a specific 
GO term. This study, which represents the first documentation of stage-specific gene 
expression profiling during early aspergillosis was analysed in this manner to probe the 
activity of certain gene sets of interest and provide an indication of concordance with previous 
studies.   
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McDonagh et. al. (2008) studied transcription during adaptation of a clinical isolate 
Af293 to the murine host niche, finding a total of 2180 genes (22.6% of the A. fumigatus 
genome) as differentially expressed, having a fold-change in log2 intensity ratio of 2 or 
greater. Among these, 1281 were up-regulated and 897 were down-regulated, relative to 
developmentally-matched, laboratory-culterd germlings. In contrast to the present study 
which analysed ATCC46645 adaptation to the murine niche across a time course composed of 
three time points, the McDonagh study considered only one (i.e. 14 hours post-infection) 
Another difference between the studies relates to the reference samples used for the 
hybridations whereby McDonagh used lab cultured germlings (YPD) as opposed to dormant 
conidia (this study). 
Fig. 4.8 illustrates commonalities between cohorts of differentially expressed genes 
during initiation of murine infection by A. fumigatus ATCC46645 and Af293 strains. Among 
a total of 1364 and 1136 genes up-regulated, respectively, in the ATCC46645 time course and 
in the Af293 study, the overlap consists of 504 genes (Fig. 4.8A) having phase-specific 
variations as indicated (A.1, A.2, A.3). Among a total of 1299 and 726 genes down-regulated, 
respectively, in the ATCC46645 time course and in the Af293 study, the overlap consists of 
276 genes (Fig. 4.8B) having phase-specific variations as indicated (B.1, B.2, B.3).  
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Fig. 4.8: Venn diagrams illustrating commonalities between cohorts of differentially expressed 
genes during initiation of murine infection by A. fumigatus ATCC46645 and Af293 strains. Total up-
regulated genes (n=1136) for the Af293 strain (McDonagh et. al. 2009) (blue) compared to the up-regulated 
genes for the ATCC45546 (red) strain (A=total up-regulated, A.1=4 hours, A.2=8 hours and A.3=16 hours). 
Total down-regulated genes (n=726) for the Af293 strain (McDonagh et. al. 2009) (blue) compared to the down-
regulated genes for the ATCC45546 (red) strain (A=total down-regulated, A.1=4 hours, A.2=8 hours and 
A.3=16 hours). Analysis performed using Genespring GX 11.02.  
 
The previous Af293 analysis (McDonagh et al., 2008a) had revealed that many up-
regulated genes required for A. fumigatus adaptation to the murine niche and were located in 
contiguous chromosome locations (ICs). We therefore asked whether these gene clusters were 
also significant during initiation of murine infection by ATCC46645. This was addressed by 
STEM clustering analysis of the differentially expressed genes in the ATCC46645 time 
course during initiation of murine infection, ordered on the basis of the previously identified 
(McDonagh et al., 2008a) Af293 infection clusters (Fig. 4.9) (the unabridged output of this 
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analysis is reported in Appendix D). Model profiles remain coloured according to significance 
in the initial analysis, however, red traces now correspond to genes in the dataset specifically 
annotated as residing in infection clusters.  
 
Fig. 4.9: Selection of STEM clustering analyses of the differentially expressed genes in the 
ATCC46645 time course during initiation of murine infection, ordered on the basis of containing Af293 
infection cluster genes (McDonagh et al., 2008a). Values at the bottom of each profile indicate the number of 
genes (in this case genes previously identified in the Af293 infection clusters) and the significance of the 
intersect size, based upon the hypergeometric distribution of dataset genes in the respective model profiles. 
 
(McDonagh et al., 2008a)also reported that 29% of the transcripts having increased 
abundance during initiation of murine infection, relative to a laboratory culture, are localised 
in the subtelomeric region of the chromosomes. In contrast, only 11% of the down-regulated 
genes are localised within 300 kb from the telomeres. We therefore asked how many 
subtelomeric genes were differentially expressed in the ATCC46645 time course (Fig. 4.10), 
(the unabridged STEM output is reported in Appendix D). In this instance red gene profiles 
correspond to genes having subtelomerics locations.  
 
Fig. 4.10: STEM clustering analysis of the differentially expressed genes in the ATCC46645 time 
course during initiation of murine infection ordered on the basis of the subtelomeric location (McDonagh 
et al., 2008a). The two values at the bottom of each profile indicate how many specific genes (in this case genes 
with subtelomeric location) are present in the profile and the significance of the intersect size, based upon the 
hypergeometric distribution of dataset genes in the respective model profiles. 
 
Our A. fumigatus annotation was also extended for genes involved in the production of 
secondary metabolites (based on(Perrin et al., 2007) and STEM model profiles were also 
ordered depending upon the enrichment of this category. STEM clustering analysis of the 
secondary metabolite genes in the ATCC46645 time course are represented in Fig. 4.11 (the 
unabridged output is reported in Appendix D).  
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Fig. 4.11: STEM clustering analysis of the differentially expressed genes in the ATCC46645 time 
course during initiation of murine infection ordered on the basis of the involvement on secondary 
metabolite production (Perrin et al., 2007). The two values at the bottom of each profile indicate how many 
specific genes (in this case genes involved on secondary metabolite production) and the significance of the 
intersect size, based upon the hypergeometric distribution of dataset genes in the respective model profiles. 
 
To elucidate the transcriptional response to alkaline conditions, a microarray study 
performed by our research group has recently delineated the temporal response of A. 
fumigatus to an alkaline shift in vitro and compared it to that induced by high concentration of 
Ca
2+
 (Loss et al., unpublished). Specifically, this study investigated the transcriptional profile 
of A. fumigatus mycelia grown for 14 hours in AMM pH 5.0 and subsequently shifted to pH 
8.0 for 60 minutes. Samples were taken for RNA extraction after 5, 15, 30, 45 and 60 
minutes, the common reference being a sample shifted to pH 5.0 media. According to the 
resultant dataset, Fig. 4.12 illustrates the representation of alkaline-responsive A. fumigatus 
genes among those in the ATCC46645 host-responsive transcriptome. Among a total of 1364 
and 433 genes up-regulated, respectively, in the murine time course and in the in vitro study, 
the overlap consists of 127 genes (Fig. 4.12A) having phase-specific variations (A.1, A.2, 
A.3) as indicated. Among a total of 1299 and 141 genes down-regulated, respectively, in the 
murine time course and in the in vitro study, the overlap consists of 30 genes (Fig. 4.12B) 
with phase-specific variations as shown (B.1, B.2, B.3).  
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Fig. 4.12: Venn diagrams illustrating the proportions of alkaline-responsive A. fumigatus genes 
during initiation of murine infection by ATCC46645. Total up-regulated genes (n=433) following the in vitro 
shift to alkaline pH (blue) are compared to the up-regulated genes for the ATCC45546 (red) strain (A=total up-
regulated, A.1=4 hours, A.2=8 hours and A.3=16 hours). Total down-regulated genes (n=171) following the in 
vitro shift to alkaline pH (blue) are compared to the down-regulated genes for the ATCC45546 (red) strain 
(B=total down-regulated, B.1=4 hours, B.2=8 hours and B.3=16 hours). Analysis performed using Genespring 
GX 11.02.  
 
STEM clustering analyses of alkaline-responsive genes, also differentially regulated in 
the ATCC46645 time course during initiation of murine infection are shown in Fig. 4.13 and 
Fig. 4.14 (unabridged output is reported in Appendix D). As illustrated in Fig. 4.13, only 
model profiles containing up-regulated (as opposed to down-regulated) genes across the 
ATCC46645 time course (29, 48 and 42) are significantly enriched in alkaline-responsive 
genes. The comparison with down-regulated in vitro pH response genes (Fig. 4.14) revealed 
several genes in differential behaviour between the murine and in vitro niches including five 
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genes in cluster 29, which are instead up-regulated in vivo. Interestingly, among these genes 
are two ORFs involved in cell wall organisation (Afu3g08110 encoding a putative cell wall 
protein and Afu2g14490 encoding an endoglucanase). Additionally, profile 45 revealed the 
co-ordinate behaviour of three genes in the ATCC46645 time course experiment, which are 
up-regulated in vivo but down-regulated in vitro. Two of them (Afu4g06620 and 
Afu1g07380) have been linked to secondary metabolite production.  
 
Fig. 4.13: STEM clustering analysis of the differentially expressed genes in the ATCC46645 time 
course during initiation of murine infection ordered on the basis of containing genes also up-regulated in 
response to an alkaline pH shift (Loss, unpublished). The two values at the bottom of each profile indicate 
how many specific genes (in this case up-regulated genes in response to an alkaline pH shift) are present in the 
profile and the significance of the intersect size, based upon the hypergeometric distribution of dataset genes in 
the respective model profiles. 
 
 
 
 
 
 
 
 
 
 
Fig. 4.14: STEM clustering analysis of the differentially expressed genes in the ATCC46645 time 
course during initiation of murine infection ordered on the basis of the in vitro down-regulated genes in 
response to an alkaline pH shift (Loss, unpublished). Values at the bottom of each profile indicate how many  
genes (in this case down-regulated genes in response to an alkaline pH shift) are present in the profile and the 
significance of the intersect size, based upon the hypergeometric distribution of dataset genes in the respective 
model profiles. 
 
4.3.3 A. fumigatus ATCC46645 ΔpacC mutant transcriptional profile during initiation of 
murine infection 
 
The A. fumigatus ATCC46645 ΔpacC transcriptional profile during initiation of 
murine infection was performed by hybridising doubly amplified fungal RNA, extracted from 
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BALFs harvested at each of 3 time points (4, 8 and 16 hrs) post-infection against a common 
reference of RNA extracted from in vitro-cultured dormant ATCC46645 ΔpacC spores, as 
shown in Fig. 4.15.  
 
Fig. 4.15: Schematic representation of hybridisations performed to analyse the A. fumigatus 
ATCC46645 ΔpacC transcriptome during initiation of murine infection. Characterisation of the A. fumigatus 
ATCC46645 ΔpacC transcriptional profile during initiation of murine infection was performed by comparing 
transcript abundance at three time points (4, 8 and 16 hrs) to that of a common reference of dormant 
ATCC46645 ΔpacC spores.  
 
Fig. 4.16, 4.17 and 4.18 show MA and box plots of the datasets for each of the three 
time points studied, both before and after normalisation. The MA plots for each time point 
(A) show the distribution of the data before (UN-NORMALISED) and after the LOWESS 
normalisation (NORMALISED), therefore depicting the dataset adjustments implemented by 
normalisation. In MA plots the log2 ratio between red and green channels (Y-axis) is plotted 
against the sum of red and green channels (X-axis). Normalisation adjusts for the higher 
measured spot intensities associated with the green dye (Cy3). Box plots (B) also show 
dataset log2 ratio distributions for each time point before (UN-NORMALISED) and after 
LOWESS normalisation (NORMALISED) but on a slide specific basis. After normalisation 
the medians of the blocks are all equal to zero and the standard deviation is regularised.   
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Fig. 4.16: Data normalisation plot for the ATCC46645 ΔpacC 4 hrs in vivo versus dormant spores 
analysis. Pairwise MA (A) and box plots (B) for the 4 hour time point of ATCC46645 ΔpacC (mouse) versus 
ATCC46645 ΔpacC (dormant spores) RNA. Datasets plotted before (UN-NORMALISED) and after 
(NORMALISED) LOWESS normalisation are shown.  
 
Fig. 4.17: Data normalisation plot for the ATCC46645 ΔpacC 8 hrs in vivo versus dormant spores 
analysis. Pairwise MA (A) and box plots (B) for the 8 hour time point of ATCC46645 ΔpacC (mouse) versus 
ATCC46645 ΔpacC (dormant spores) RNA. Datasets plotted before (UN-NORMALISED) and after 
(NORMALISED) LOWESS normalisation are shown. 
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Fig. 4.18: Data normalisation plot for the ATCC46645 ΔpacC 16 hrs in vivo versus dormant 
spores analysis. Pairwise MA (A) and box plots (B) for the 16 hour timepoint of ATCC46645 ΔpacC (mouse) 
versus ATCC46645 ΔpacC (dormant spores) RNA. Datasets plotted before (UN-NORMALISED) and after 
(NORMALISED) LOWESS normalisation are shown. 
 
The summary statistics for the ATCC46645 ΔpacC time course dataset (Table 4.8) 
report that among a total of 8243 genes represented on the slides, 8222, 7993 and 8200, 
returned signal, for the 4, 8 and 16 hrs time points respectively.  
 
 4 hrs vs 0 hrs 8 hrs vs 0 hrs 16 hrs vs 0 hrs 
Observations 8222 7993 8200 
Missing observations 21 250 43 
Minimum value -7.28 -5.74 -6.99 
Maximum value 5.85 7.05 6.94 
Mean 0.0392 0.0162 0.0333 
Median  0.06 -0.05 -0.04 
Standard deviation 1.4328 1.5441 1.5858 
Outliers  175 160 182 
 
Table 4.8: Summary statistics for the ATCC46645 ΔpacC time course during initiation of murine 
infection.  
 
The analysis of temporal gene expression for the ATCC46645 ΔpacC strain was 
conducted in Genespring GX 11.02. Normalised log2 expression ratios were filtered on 
expression level and differentially regulated transcripts were defined as having average log2 
(Cy5/Cy3) ratios less or greater than the arbitrary thresholds of ±2. The numbers and 
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classifications of differentially expressed genes are shown in Table 4.9. Among a total of 
2515 (25.3% of A. fumigatus genome,(Nierman et al., 2005) differentially expressed genes 
across the entire time course, 1198 were up-regulated and 1317 were down-regulated in at 
least in one time point of the dataset. The complete lists of differentially expressed genes are 
attached in the Supplementary Data CD, as listed in Appendix D.  
 
 Up-regulated Down-regulated Differentially expressed 
TOTAL 1198 1317 2515 
4 hrs  788 741 1529 
8 hrs  788 654 1442 
16 hrs  969 874 1843 
 
Table 4.9: Number of differentially expressed genes in the ATCC46645 ΔpacC time course during 
initiation of murine infection.  
 
The temporal basis of gene regulation in the ATCC46645 ΔpacC time course 
experiment is simply depicted in a 3-way Venn diagram in Fig. 4.19 for both up-regulated 
(Fig. 4.19A) and down-regulated (Fig. 4.19B) genes. In addition, the complex pattern of 
differentially expressed genes in the ATCC46645 ΔpacC time course is shown in a detailed 
heat map attached in the Supplementary Data CD, as listed in Appendix D.  
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Fig. 4.19: Three-way Venn diagrams depicting temporal aspects of differential gene expression in 
the ATCC46645 ΔpacC time course experiment during initiation of murine infection. Up-regulated (A) and 
down-regulated genes (B) have been identified using a fold change cut off of ±2 on a log2 scale. Analysis 
performed using Genespring GX 11.02.  
 
Among a total of 1198 up-regulated genes (12.1% of A. fumigatus genome), 423 were 
similarly differentially regulated across all 3 time points. Among these, one hundred up-
regulated genes, having the greatest fold change relative to dormant spores, are reported in 
Table 4.10. As observed for the relative parental strain, across the ATCC46645 ΔpacC time 
course experiment, several genes involved in the uptake, mobilisation and utilisation of 
crucial ion and nutrients are up-regulated. At least three genes are involved in siderophore 
biosynthesis for the uptake of extracellular iron (Afu3g03440, Afu3g03430 and Afu7g04730) 
and were also identified as up-regulated in the ATCC46645 time course (Table 4.3). 
Likewise, several sugar permeases are included (Afu3g3700, Afu6g04270, Afu4g00800 and 
Afu2g14590), but few other transporters are up-regulated, and notable omissions, relative to 
the parental strain include Afu5g02940 and Afu1g15300 for choline and Afu4g00150 for 
maltose transport. Several up-regulated genes represent functions involved cell wall 
biogenesis and organisation, Afu7g05370, Afu8g05610, Afu1g16250 and Afu4g10150, the 
two latter of were also identified as up-regulated in the ATCC46645 time course (Table 4.3). 
To aid the evaluation of phase-specific up-regulated genes across the ACTT46645 ΔpacC 
time course, Tables AD.2.2-AD.2.4 in Appendix D list the thirty ORFs with the greatest log2 
ratios for the up-regulated genes at 4, 8 and 16 hrs post-infection respectively. 
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Of a total of 1317 down-regulated genes (13.3% of A. fumigatus genome), 376 were 
similarly differentially regulated at all 3 time points. Among these, one hundred genes having 
the greatest fold changes are reported in Table 4.11. Among the down-regulated genes, there 
are several ORFs are involved in the regulation of transcription (Afu5g02880 and 
Afu2g15680), however the most striking difference noted between the ΔpacC and parental 
profiles the abundance of ORFs putatively involved in transposition (Afu4g00820, 
Afu8g01040, Afu4g14870, Afu2g18080, Afu6g09470, Afu8g00310, Afu6g00780, 
Afu6g14660, Afu8g06290, Afu3g15370, Afu3g09430) in the ΔpacC profile. All of the 
aforementioned genes were already highly down-regulated at early stages of infection (4 hrs 
post-infection). To aid the evaluation of phase-specific down-regulated genes across the 
ACTT46645 ΔpacC time course, Tables AD.2.6-AD.2.8 in Appendix D list the thirty ORFs 
having lowest log2 ratios for 4, 8 and 16 hrs post-infection respectively. 
According to expanded A. fumigatus annotation utilised for analysis of the 
ATCC46645 analyses outlined earlier in this chapter, GO analysis of the differentially 
expressed genes in the ATCC46645 ΔpacC time course (fold change cut off of ±2 on a log2 
scale) was performed using Genespring GX 11.02. Table 4.12 and Table 4.13 show the GO 
terms, which satisfy an imposed p-value cut-off of 0.05, respectively, among the up-regulated 
and down-regulated genes, with respect to their occurrence in the A. fumigatus genome. 
Aiming to identify functional categories arsing in a stage-specific manner GO analyses on the 
total set of differentially expressed genes and also on the single time points (4, 8 and 16 hrs) 
of the analysis are reported. Significant GO terms among the up-regulated genes in the 
ATCC46645 ΔpacC time course included several members correlated with transport, uptake 
and mobilisation of crucial nutrients, especially glucose and fructose, and with lipid 
metabolism. Significant GO terms among the down-regulated genes in the ATCC46645 
ΔpacC time course include several members involved in transcription and its regulation.  
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Table 4.10: 100 ORFs having the highest log2 values among up-regulated genes across the 3 time points (4, 
8 and 16 hrs) of the ATCC46645. 
ORFs T4 vs 
T0 
T8 vs 
T0 
T16 vs 
T0 
Annotation Functional classification  
Afu3g03440 5.85 6.29 6.55 MFS family 
siderophore 
transporter, putative 
siderophore-iron transport///siderophore-
iron (ferrioxamine) uptake 
transmembrane transporter 
activity///integral to membrane///cellular 
iron ion homeostasis 
Afu7g06380 5.81 7.05 6.43 Maltase cellular component unknown///alpha-
glucosidase activity///maltose catabolic 
process 
Afu7g04730 5.74 6.46 6.78 siderochrome-iron 
transporter, putative 
endosome///siderophore-iron 
transport///cytoplasmic membrane-
bounded vesicle///siderophore-iron 
(ferrioxamine) uptake transmembrane 
transporter activity///cellular iron ion 
homeostasis 
Afu1g17180 5.7 6.51 6.73 pyridine nucleotide-
disulphide 
oxidoreductase, 
putative 
electron carrier 
activity///nucleus///mitochondrion///DN
A fragmentation involved in apoptosis 
Afu6g00260 5.59 4.13 5.19 phosphatidylserine 
decarboxylase family 
protein 
phosphatidylserine decarboxylase 
activity///phosphatidylserine catabolic 
process 
Afu3g03390 5.34 5.37 5.87 siderophore 
biosynthesis 
lipase/esterase, putative 
 
Afu1g14550 5.29 6.65 6.03 Mn superoxide 
dismutase MnSOD 
manganese superoxide dismutase 
activity///oxygen and reactive oxygen 
species metabolic 
process///mitochondrial 
matrix///mitochondrion 
Afu1g10930 5.28 3.26 2.04 ammonium transporter pseudohyphal growth///plasma 
membrane///ammonium 
transport///ammonium transmembrane 
transporter activity 
Afu3g03700 5.21 6.69 6.7 Sugar transporter 
subfamily 
mannose transmembrane transporter 
activity///hexose transport///fructose 
transmembrane transporter 
activity///plasma membrane///glucose 
transmembrane transporter activity 
Afu3g03410 5.2 6.21 6.25 enoyl-CoA 
hydratase/isomerise 
family protein 
 
Afu6g00630 5.07 5.49 6.15 MFS transporter, 
putative 
transporter activity///transport///integral 
to membrane 
Afu3g02940 5.04 5.54 5.48 allergen, putative  
Afu5g00290 5.04 4.97 5.13 C6 transcription factor, 
putative 
 
Afu5g13300 5 6.42 6.94 aspartic endopeptidase 
Pep1 
protein catabolic process///aspartic-type 
endopeptidase activity///extracellular 
region///pathogenesis 
Afu5g00300 4.94 4.59 4.18 zinc-binding 
oxidoreductase, 
putative 
oxidoreductase activity///cellular 
component unknown///zinc ion 
binding///metabolic process 
Afu4g10150 4.91 6.35 5.88 alpha-glucosidase alpha-glucosidase activity///fungal-type 
cell wall biogenesis///endoplasmic 
reticulum 
Afu3g03400 4.88 5.58 5.49 siderophore  
biosynthesis acetylase 
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AceI, putative 
Afu4g00800 4.81 4.53 4.35 MFS monosaccharide 
transporter, putative 
response to glucose stimulus///plasma 
membrane///glucose transmembrane 
transporter activity///signal 
transduction///glucose binding///receptor 
activity 
Afu5g09400 4.78 4.97 4.73 carbonyl reductase, 
putative 
oxidoreductase activity///metabolic 
process 
Afu3g03660 4.77 2.49 3.8 esterase superfamily 
protein 
hydrolase activity, acting on ester bonds 
Afu1g12690 4.75 4.03 4.06 ABC multidrug 
transporter Mdr4 
response to drug///xenobiotic-
transporting ATPase activity///ABC-type 
efflux porter activity///multidrug 
transport///integral to plasma 
membrane///multidrug efflux pump 
activity 
Afu7g04910 4.74 6.5 5.6 phosphatidylglycerol 
specific phospholipase 
C, putative 
 
Afu1g03570 4.61 5.22 5.61 acid phosphatase PHOa  
Afu2g17320 4.59 5.29 5.74 conserved hypothetical 
protein 
 
Afu1g11250 4.5 3.8 4.37 amidohydrolase, 
putative 
proteolysis///carboxypeptidase activity 
Afu6g12670 4.46 3.37 3.74 beta-alanine synthase, 
putative 
 
Afu1g13500 4.44 3.73 2.11 transketolase TktA cytoplasm///pentose-phosphate 
shunt///transketolase activity 
Afu2g07680 4.44 4.31 4.65 L-ornithine N5-
oxygenase SidA 
pathogenesis 
Afu3g03420 4.42 6.45 6.07 hypothetical protein  
Afu6g04270 4.39 2.49 2.59 fructose symporter membrane///myo-inositol 
transport///myo-inositol transmembrane 
transporter activity 
Afu3g03430 4.32 5.73 5.71 ABC multidrug 
transporter SitT, 
putative 
ATP-binding cassette (ABC) transporter 
activity///ATP binding///transport 
Afu1g12920 4.32 3.23 3.24 glycogen 
phosphorylase 1; 
possible glycogen 
phosphorylase 
cytoplasm///glycogen phosphorylase 
activity///glycogen catabolic process 
Afu7g05150 4.25 3.67 4.97 hypothetical protein  
Afu5g11240 4.23 3.84 4.06 oxidoreductase, short 
chain 
dehydrogenase/reducta
se family 
L-serine metabolic 
process///cytoplasm///nucleus///"oxidore
ductase activity, acting on the aldehyde 
or oxo group of donors, NAD or NADP 
as acceptor" 
Afu3g06530 4.2 3.4 3.43 ATP sulphurylase cytoplasm///sulfate 
assimilation///methionine metabolic 
process///sulfate adenylyltransferase 
(ATP) activity 
Afu6g00640 4.19 4.5 5.41 integral membrane 
protein 
 
Afu7g06390 4.16 5.05 5.54 maltose permease alpha-glucoside:hydrogen symporter 
activity///membrane fraction///alpha-
glucoside transport 
Afu3g00900 4.13 4.86 4.97 alpha-amylase AmyA  
Afu1g17170 4.13 4.7 5.17 alpha-ketoglutarate-
dependent taurine 
dioxygenase 
cellular component unknown///sulfur 
metabolic process///sulfonate 
dioxygenase activity///"oxidoreductase 
activity, acting on paired donors, with 
incorporation or reduction of molecular 
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oxygen, 2-oxoglutarate as one donor, 
and incorporation of one atom each of 
oxygen into both donors" 
Afu3g00740 4.12 3.88 4.14 2-dehydropantoate 2-
reductase, putative 
2-dehydropantoate 2-reductase 
activity///cytoplasm///nucleus///FAD 
binding 
Afu1g10910 4.09 3.87 3.92 tubulin beta, putative kinetochore microtubule///spindle pole 
body///cytoplasmic 
microtubule///nuclear migration during 
conjugation with cellular fusion///mitotic 
sister chromatid segregation///nuclear 
microtubule///polar 
microtubule///homologous chromosome 
segregation///structural constituent of 
cytoskeleton 
Afu4g11550 4.05 3.21 2.51 hypothetical protein  
Afu6g10660 4.05 2.85 2.64 ATP-citrat-lyase  
Afu1g17190 4.02 4.52 4.4 long-chain-fatty-acid-
CoA ligase, putative 
peroxisomal membrane///peroxisomal 
matrix///cytoplasm///AMP binding 
Afu1g11480 4.02 5.08 4.81 hypothetical protein  
Afu4g08710 4.02 3.93 4.39 short chain 
dehydrogenase, 
putative 
fatty acid catabolic process 
Afu2g02950 4.02 3.28 3.01 aldehyde reductase, 
putative 
cellular component unknown///aldo-keto 
reductase activity///cellular aldehyde 
metabolic process 
Afu1g07130 4.02 3.55 3.53 dienelactone hydrolase 
family protein 
aromatic compound catabolic 
process///cytoplasm///carboxymethylene
butenolidase activity 
Afu4g07690 4.01 2.73 2.58 phosphoribosylaminoi
midazolecarboxamide 
formyltransferase/IMP 
cyclohydrolase 
'de novo' IMP biosynthetic 
process///phosphoribosylaminoimidazole
carboxamide formyltransferase 
activity///cytosol///IMP cyclohydrolase 
activity 
Afu3g02280 4 4.74 4.77 alpha,alpha-trehalose 
glucohydrolase, 
putative 
fungal-type vacuole///trehalose catabolic 
process///"alpha,alpha-trehalase 
activity"///response to stress 
Afu7g05450 3.96 5.03 5.08 SUN domain protein 
(Uth1), putative 
autophagic cell death///cell wall 
organisation///barrier septum 
formation///fungal-type cell 
wall///response to oxidative stress///beta-
glucosidase activity///mitochondrion 
organisation///mitochondrial outer 
membrane///apoptosis 
Afu5g12480 3.95 3.5 3.74 short chain 
dehydrogenase/reducta
se family 
 
Afu5g02940 3.94 3.71 2.71 choline transport 
protein Ctr, putative 
plasma membrane///choline 
transport///choline transmembrane 
transporter activity 
Afu2g02590 3.94 2.67 2.07 aspartyl-tRNA 
synthetase 
translation///cytoplasm///aspartate-tRNA 
ligase activity 
Afu4g13900 3.93 2.78 2.37 MFS transporter, 
putative 
nicotinamide mononucleotide 
transport///nicotinamide mononucleotide 
permease activity///integral to plasma 
membrane 
Afu7g06810 3.93 5.21 5.51 L-amino acid oxidase 
LaoA, putative 
 
Afu4g00150 3.93 4.5 4.84 MFS maltose 
transporter, putative 
carbohydrate transmembrane transporter 
activity///carbohydrate 
transport///plasma membrane///maltose 
porter activity 
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Afu3g08290 3.9 2.73 2.24 aspartyl 
aminopeptidase 
cytoplasm///biological process 
unknown///molecular function unknown 
Afu1g17700 3.89 4.32 4.52 short chain 
dehydrogenase, 
putative 
oxidoreductase activity///metabolic 
process 
Afu1g16250 3.87 5.94 5.07 alpha-glucosidase B alpha-glucosidase activity///fungal-type 
cell wall biogenesis///endoplasmic 
reticulum 
Afu6g11340 3.86 3 3.75 peroxisomal AMP 
binding enzyme, 
putative 
peroxisomal membrane///peroxisomal 
matrix///cytoplasm///biological process 
unknown///AMP binding 
Afu1g02550 3.85 3.76 3.39 tubulin alpha-1 subunit kinetochore microtubule///spindle pole 
body///cytoplasmic 
microtubule///nuclear migration (sensu 
Saccharomyces)///nuclear migration 
during conjugation with cellular 
fusion///mitotic sister chromatid 
segregation///nuclear microtubule///polar 
microtubule///homologous chromosome 
segregation///structural constituent of 
cytoskeleton 
Afu3g03670 3.85 3.34 4.08 ABC multidrug 
transporter, putative 
ATP-binding cassette (ABC) transporter 
activity///ATP binding///transport 
Afu2g11540 3.83 2.18 2.48 ketoreductase, putative endoplasmic reticulum///ketoreductase 
activity///fatty acid elongation///integral 
to membrane 
Afu3g03860 3.82 3.43 4.91 3-hydroxyacyl-CoA 
dehydrogenase, 
putative 
 
Afu6g07490 3.81 2.55 2.69 WD repeat protein cytoplasm///biological process 
unknown///molecular function unknown 
Afu8g01710 3.8 4.74 5.37 antigenic thaumatin 
domain protein, 
putative 
 
Afu1g02880 3.8 2.84 3.5 Phosphotransferase 
enzyme family domain 
protein 
transferase activity, transferring 
phosphorus-containing groups 
Afu1g17200 3.76 4.16 4.37 nonribosomal peptide 
synthase, putative 
nonribosomal peptide biosynthetic 
process///catalytic activity///amino acid 
adenylylation by nonribosomal peptide 
synthase 
Afu7g05550 3.76 3.81 4.43 sugar transporter 
family protein 
lactate transmembrane transporter 
activity///lactate transport///plasma 
membrane 
Afu2g03830 3.74 3.92 4.19 allergen Asp F4 pathogenesis 
Afu6g14440 3.73 5.03 5.13 MFS monosaccharide 
transporter, putative 
response to glucose stimulus///plasma 
membrane///glucose transmembrane 
transporter activity///signal 
transduction///glucose binding///receptor 
activity 
Afu2g08300 3.7 3.07 2.66 DnaJ domain protein, 
putative 
endoplasmic reticulum lumen///co-
chaperone activity///protein folding 
Afu5g09140 3.7 3.91 3.71 amidase, putative aerobic respiration///amidase 
activity///mitochondrion 
Afu5g04250 3.67 3.38 2.73 homocysteine synthase, 
putative 
cysteine synthase activity///O-
acetylhomoserine 
aminocarboxypropyltransferase 
activity///cytoplasm///methionine 
metabolic process 
Afu3g11640 3.66 3.56 4.17 homoserine 
dehydrogenase 
homoserine biosynthetic 
process///cytoplasm///nucleus///methioni
ne metabolic process///threonine 
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metabolic process///homoserine 
dehydrogenase activity 
Afu3g03820 3.66 4.09 5.47 MFS transporter, 
putative 
nicotinamide mononucleotide 
transport///nicotinamide mononucleotide 
permease activity///integral to plasma 
membrane 
Afu1g10020 3.65 4.68 3.93 reverse transcriptase, 
RNaseH 
 
Afu8g01580 3.63 4.33 4.68 aminotransferase, 
classes I and II family 
arylformamidase 
activity///cytoplasm///mitochondrion///N
AD biosynthetic process 
Afu6g06770 3.62 2.67 2.26 enolase phosphopyruvate hydratase 
complex///cytoplasm///pathogenesis///ph
osphopyruvate hydratase 
activity///gluconeogenesis///glycolysis 
Afu5g02850 3.62 4.17 4.49 conserved hypothetical 
protein 
 
Afu5g13170 3.61 2.42 2.6 MATE efflux family 
protein subfamily, 
putative 
cellular component 
unknown///biological process 
unknown///molecular function unknown 
Afu3g00680 3.6 3.18 3.39 copper amine oxidase  
Afu1g03630 3.6 5.62 5.83 GPI anchored serine-
threonine rich protein 
 
Afu5g10320 3.59 2.33 3.94 toxin biosynthesis 
protein (GliH), putative 
 
Afu5g10020 3.59 3.7 4.82 sensor histidine 
kinase/response 
regulator, putative 
 
Afu1g15300 3.58 3.3 3.17 choline transport 
protein, putative 
plasma membrane///choline 
transport///choline transmembrane 
transporter activity 
Afu2g09810 3.58 3.56 2.81 mandelate 
racemase/muconate 
lactonizing enzyme 
family protein 
 
Afu5g03550 3.55 2.57 2.87 plasma membrane 
H(+)ATPase, putative 
hydrogen-exporting ATPase activity, 
phosphorylative mechanism///regulation 
of pH///plasma membrane///fungal-type 
vacuole///endoplasmic 
reticulum///proton transport 
Afu2g14590 3.54 2.54 2.22 MFS monosaccharide 
transporter, putative 
response to glucose stimulus///plasma 
membrane///glucose transmembrane 
transporter activity///signal 
transduction///glucose binding///receptor 
activity 
Afu6g00620 3.53 4.82 4.95 GPI anchored 
hypothetical protein 
 
Afu6g02600 3.53 2.93 3.09 phosphoglycerate 
mutase family protein 
cytoplasm///nucleus///biological process 
unknown///molecular function unknown 
Afu7g05370 3.52 2.83 2.35 septin AspB cell wall organisation///prospore 
membrane///axial cellular bud site 
selection///phosphatidylinositol 
binding///cytokinesis///structural 
constituent of cytoskeleton///mating 
projection///ascospore wall///cell 
morphogenesis 
Afu1g03550 3.52 2.75 2.52 mitochondrial 
dihydroxy acid 
dehydratase, putative 
dihydroxy-acid dehydratase 
activity///branched chain family amino 
acid biosynthetic 
process///mitochondrion 
Afu4g13580 3.51 3.91 3.44 gamma-  
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Table 4.11: 100 ORFs with the lowest log2 values among down-regulated genes common to all 3 time 
points (4, 8 and 16 hrs) of the ATCC46645 ΔpacC time course.  
ORFs T4 vs 
T0 
T8 vs 
T0 
 T16 vs 
T0 
Annotation Functional classification  
Afu5g02880 -7.28 -5.53 -6.46 C6 transcription factor, putative transcription factor 
activity///regulation of 
transcription 
Afu5g00810 -6.76 -5.33 -6.4 hypothetical protein  
Afu2g10130 -6.69 -4.64 -5.2 phase-specific adhesin, putative  
Afu3g00810 -6.16 -4.5 -6.19 cholestenol delta-isomerase, 
putative 
 
Afu4g00820 -6.07 -2.45 -4.18 reverse transcriptase, RNaseH  
Afu8g01040 -6.05 -2.92 -4.56 reverse transcriptase, RNaseH  
Afu5g00790 -5.99 -4.5 -5.44 ABC multidrug transporter, 
putative 
ATP-binding cassette (ABC) 
transporter activity///ATP 
binding///transport 
Afu2g14330 -5.97 -4.81 -5.97 hypothetical protein  
Afu3g03040 -5.97 -3.53 -4.34 conserved hypothetical protein  
Afu4g14870 -5.9 -2.83 -4.46 LINE-1 class reverse 
transcriptase, RNaseH, putative 
 
Afu3g01300 -5.81 -4.65 -5.26 hypothetical protein  
Afu2g00200 -5.8 -5.74 -6.99 catalase, putative oxygen and reactive oxygen 
species metabolic 
process///peroxisomal 
matrix///response to oxidative 
stress///catalase activity 
Afu2g18080 -5.78 -2.7 -4.36 LINE-1 class reverse 
transcriptase, RNaseH, putative 
 
Afu4g14760 -5.77 -3.33 -4.46 ABC multidrug transporter, 
putative 
 
Afu6g09470 -5.73 -2.67 -3.9 reverse transcriptase, RNaseH, 
putative 
 
Afu3g11880 -5.7 -2.28 -2.24 hypothetical protein  
Afu3g02140 -5.63 -4.47 -4.52 large conductance 
mechanosensitive channel, 
putative 
nonselective channel 
activity///ion channel 
activity///transport 
Afu3g01400 -5.59 -3.77 -4.06 ABC multidrug transporter, 
putative 
response to drug///xenobiotic-
transporting ATPase 
activity///plasma membrane 
Afu8g00310 -5.54 -2.6 -4.08 LINE-1 class reverse  
glutamyltranspeptidase 
Afu6g03060 3.5 4.2 4.15 monosaccharide 
transporter 
response to glucose stimulus///plasma 
membrane///glucose transmembrane 
transporter activity///signal 
transduction///glucose binding///receptor 
activity 
Afu8g05610 3.5 4.71 4.51 cell wall glucanase 
(Scw11), putative 
hydrolase activity, hydrolyzing O-
glycosyl compounds///cellular glucan 
metabolic process///fungal-type cell 
wall///"cytokinesis, completion of 
separation" 
Afu5g11850 3.49 3.48 3.83 mitochondrial carrier 
protein (Pet8), putative 
S-adenosylmethionine transmembrane 
transporter activity///mitochondrial inner 
membrane///S-adenosylmethionine 
transport///mitochondrion 
Afu7g04500 3.48 3.46 3.84 ATP 
phosphoribosyltransfer
ase 
cell///ATP phosphoribosyltransferase 
activity///histidine biosynthetic process 
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transcriptase, RNaseH, putative 
Afu2g13060 -5.54 -3.22 -3.54 calcineurin binding protein, 
putative 
 
Afu1g14000 -5.49 -3.48 -3.71 hypothetical protein  
Afu6g00780 -5.48 -2.79 -4.18 LINE-1 class reverse 
transcriptase, RNaseH, putative 
 
Afu4g11710 -5.43 -4.92 -5.94 oxidoreductase, zinc-binding 
dehydrogenase family 
superfamily 
cellular component 
unknown///biological process 
unknown///molecular function 
unknown 
Afu6g14660 -5.41 -2.64 -3.95 reverse transcriptase, RNaseH  
Afu7g06840 -5.4 -5.39 -5.98 class III aminotransferase arginine catabolic 
process///cytoplasm///nucleus/
//ornithine-oxo-acid 
transaminase activity 
Afu8g06290 -5.39 -2.74 -4.07 LINE-1 class reverse 
transcriptase, RNaseH, putative 
 
Afu3g15370 -5.37 -2.77 -4.01 LINE-1 class reverse 
transcriptase, RNaseH, putative 
 
Afu1g16450 -5.36 -3.33 -4.18 hypothetical protein  
Afu7g05490 -5.31 -4.11 -5.03 hypothetical protein  
Afu3g09430 -5.3 -2.82 -4.23 LINE-1 class reverse 
transcriptase, RNaseH, putative 
 
Afu3g12000 -5.26 -3.57 -3.18 hypothetical protein  
Afu4g00730 -5.14 -5.1 -6.21 HHE domain protein  
Afu6g03210 -5.13 -3.77 -5.61 conidiation-specific protein 10  
Afu7g04930 -5.13 -4.92 -4.84 alkaline serine protease (PR1), 
putative 
protein catabolic 
process///cellular component 
unknown///peptidase activity 
Afu3g14620 -5.12 -3.67 -3.7 extracellular endo-1,5-alpha-L-
arabinase, putative 
hydrolase activity, 
hydrolyzing N-glycosyl 
compounds///metabolic 
process 
Afu1g00170 -4.99 -3.59 -4.58 hypothetical protein  
Afu8g01400 -4.96 -3.57 -3.66 mitochondrial carrier protein 
(Pet8), putative 
S-adenosylmethionine 
transmembrane transporter 
activity///mitochondrial inner 
membrane///S-
adenosylmethionine 
transport///mitochondrion 
Afu2g03150 -4.87 -2.81 -2.04 kinesin family protein kinesin 
complex///microtubule motor 
activity///establishment of 
mitotic spindle 
orientation///cytoplasmic 
microtubule///microtubule 
depolymerisation///nuclear 
microtubule 
Afu8g05770 -4.79 -3.91 -4.06 hypothetical protein  
Afu4g00180 -4.79 -3.96 -4.37 fatty acid oxygenase, putative  
Afu8g02290 -4.77 -3.78 -3.97 conserved hypothetical protein  
Afu3g10690 -4.73 -3.19 -4.59 calcium-translocating P-type 
ATPase(PMCA-type),putative 
calcium ion 
transport///cellular calcium 
ion homeostasis///calcium-
transporting ATPase activity 
Afu2g06290 -4.71 -4.55 -4.99 nuclear division rft1 protein protein amino acid N-linked 
glycosylation///oligosaccharid
e transmembrane transporter 
activity///oligosaccharide 
transport///endoplasmic 
reticulum membrane 
Afu1g00910 -4.67 -3.73 -3.92 conserved hypothetical protein  
165 
 
Afu5g04040 -4.66 -2.16 -3 conserved hypothetical protein  
Afu5g01930 -4.66 -3.51 -3.84 hypothetical protein  
Afu3g00500 -4.63 -4.41 -5 integral membrane protein  
Afu7g00400 -4.61 -3.35 -3.33 hypothetical protein  
Afu7g00410 -4.57 -3.16 -2.56 C6 transcription factor, putative DNA binding///zinc ion 
binding 
Afu4g00860 -4.56 -4.64 -5.36 conserved hypothetical protein  
Afu4g12490 -4.51 -2.92 -3.94 guanine nucleotide exchange 
factor VPS9, putative 
ubiquitin 
binding///cytosol///protein 
targeting to vacuole///guanyl-
nucleotide exchange factor 
activity 
Afu3g08920 -4.47 -4.65 -4.54 hypothetical protein  
Afu8g01570 -4.46 -3.41 -4.26 ADP-ribosylglycohydrolase 
family protein 
 
Afu2g15270 -4.41 -3.57 -3.79 conserved hypothetical protein  
Afu5g10270 -4.4 -3.02 -2.9 heat shock protein, HSP20 
family 
 
Afu3g14550 -4.37 -2.71 -3.21 DNA repair protein (Rex1), 
putative 
 
Afu8g05880 -4.37 -2.35 -2.23 10 kDa chaperonin 
(GroES/Cpn10), putative 
protein folding///chaperone 
regulator activity///chaperone 
binding 
Afu3g01410 -4.36 -3.01 -3.23 polyketide synthase, putative 3-oxoacyl-[acyl-carrier-
protein] synthase 
activity///polyketide synthase 
activity 
Afu4g14770 -4.35 -2.81 -2.17 squalene-hopene-cyclase, 
putative 
lipid particle///plasma 
membrane///endoplasmic 
reticulum///ergosterol 
biosynthetic 
process///lanosterol synthase 
activity 
Afu6g03140 -4.34 -3.78 -3.75 isp4 protein, putative oligopeptide transporter 
activity///integral to plasma 
membrane///oligopeptide 
transport 
Afu2g09510 -4.33 -3.84 -4.29 hypothetical protein  
Afu1g01180 -4.33 -2.72 -2.66 isoamyl alcohol oxidase FAD binding 
Afu4g00740 -4.29 -5.6 -6.02 hypothetical protein  
Afu1g14330 -4.28 -4.3 -5.29 ABC transporter, putative ATP-binding cassette (ABC) 
transporter 
activity///transport///integral 
to membrane 
Afu8g01330 -4.25 -4.21 -4.46 hypothetical protein  
Afu2g15680 -4.19 -2.34 -3.81 transcription initiation factor iia 
small chain 
transcription factor TFIIA 
complex///transcription 
initiation from RNA 
polymerase II 
promoter///general RNA 
polymerase II transcription 
factor activity 
Afu2g04880 -4.17 -3.45 -4.54 DUF77 domain protein cell wall 
organisation///cytoplasm///nuc
leus///molecular function 
unknown 
Afu5g00800 -4.17 -3.28 -4.73 conserved hypothetical protein  
Afu1g17290 -4.15 -3.48 -3.35 conserved hypothetical protein  
Afu6g03130 -4.14 -3.76 -4.22 hypothetical protein  
Afu3g14870 -4.14 -4.02 -4.18 hypothetical protein  
Afu6g04470 -4.13 -2.82 -3.11 hypothetical protein  
Afu2g15130 -4.12 -3.08 -2.61 ABC multidrug transporter, response to drug///drug 
166 
 
putative transport///xenobiotic-
transporting ATPase 
activity///plasma membrane 
Afu1g17370 -4.11 -2.26 -3.32 chaperone/heat shock protein 
Hsp9, putative 
response to 
desiccation///response to 
heat///response to oxidative 
stress///cytoplasm///nucleus///
cell adhesion///hyperosmotic 
response///heat shock protein 
activity 
Afu6g10790 -4.09 -3.78 -4.12 MFS amine transporter, putative  
Afu6g13220 -4.08 -3.45 -3.11 hypothetical protein  
Afu1g04860 -4.07 -2.47 -3.33 hypothetical protein  
Afu2g00160 -4.03 -3.12 -2.56 hypothetical protein  
Afu5g02300 -4.03 -3.43 -3.57 peroxidase, putative  
Afu3g14810 -4.02 -3.41 -2.61 pathogenicity associated protein 
PEP2, putative 
 
Afu5g05480 -4.02 -4.33 -5.24 Rheb GTPase RhbA detection of 
nutrient///extrinsic to plasma 
membrane///pathogenesis///nit
rogen utilisation///RHEB 
small monomeric GTPase 
activity 
Afu5g00160 -4.01 -3.92 -4.57 MFS polyamine transporter, 
putative 
drug transport///drug 
transporter activity///integral 
to membrane 
Afu7g08410 -4.01 -3.07 -3.87 Tc1-mariner transposase, 
putative 
 
Afu2g05060 -4.01 -2.35 -2.05 alternative oxidase  
Afu1g01500 -4 -3.36 -3.32 short-chain 
dehydrogenase/reductase family 
protein, putative 
 
Afu3g12270 -3.98 -2.2 -3.42 glutathione peroxidase family 
protein 
intracellular///response to 
oxidative stress///thiol 
peroxidase 
activity///glutathione 
peroxidase activity 
Afu1g11560 -3.97 -3.42 -3.99 4-hydroxyphenylpyruvate 
dioxygenase, putative 
 
Afu5g14350 -3.96 -4.67 -4.92 c-24(28) sterol reductase delta24(24-1) sterol reductase 
activity///endoplasmic 
reticulum///ergosterol 
biosynthetic process 
Afu2g00170 -3.92 -3.29 -3.55 glutathione-dependent 
formaldehyde dehydrogenase 
cellular component 
unknown///D-xylulose 
reductase 
activity///monosaccharide 
metabolic process 
Afu6g02580 -3.92 -3.55 -3.82 hypothetical protein  
Afu5g07940 -3.91 -3.79 -4.33 hypothetical protein  
Afu6g10840 -3.91 -2.92 -3.34 hypothetical protein  
Afu3g00820 -3.9 -3.36 -4.15 putative exported protein  
Afu6g03080 -3.86 -3.11 -3.54 ABC multidrug transporter, 
putative 
ATP-binding cassette (ABC) 
transporter activity///ATP 
binding///transport 
Afu6g09340 -3.81 -2.23 -3.15 hypothetical protein  
Afu5g09440 -3.81 -2.78 -2.12 amino acid permease, putative  
Afu4g13230 -3.81 -3.47 -3.65 regulatory protein weta  
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Total up-regulated genes in the ATCC46645 ΔpacC time course 
GO ACCESSION GO Term p-value corrected p-
value 
Count in 
Selection 
% Count in 
Selection 
Count in 
Total 
% Count in 
Total 
GO:0044281 small molecule metabolic process 6.63651E-15 1.2072986E-10 25 12.315271 483 10.742883 
GO:0016491 oxidoreductase activity 5.785961E-14 5.262843E-10 50 24.630543 472 10.49822 
GO:0022891 substrate-specific transmembrane transporter activity 1.1653739E-11 7.066737E-8 21 10.344828 317 7.0507116 
GO:0022857|GO:0005386
|GO:0015646 
transmembrane transporter activity 5.0577924E-11 2.3002548E-7 23 11.3300495 354 7.8736653 
GO:0022892 substrate-specific transporter activity 9.059585E-11 3.2961975E-7 21 10.344828 357 7.9403915 
GO:0003824 catalytic activity 2.9774658E-10 9.027562E-7 57 28.078817 2044 45.462635 
GO:0005215|GO:0005478 transporter activity 5.084814E-10 1.3214537E-6 53 26.108374 525 11.677046 
GO:0005886|GO:0005904 plasma membrane 1.4289192E-9 3.249321E-6 66 32.512314 315 7.006228 
GO:0051119 sugar transmembrane transporter activity 4.3564534E-9 8.805732E-6 20 9.852217 47 1.0453737 
GO:0006091 generation of precursor metabolites and energy 1.0009635E-8 1.8209295E-5 18 8.866995 98 2.1797154 
GO:0006066 alcohol metabolic process 4.602692E-8 7.611919E-5 15 7.3891625 176 3.9145908 
GO:0015144 carbohydrate transmembrane transporter activity 7.047467E-8 1.0683824E-4 21 10.344828 52 1.1565837 
GO:0006082 organic acid metabolic process 1.1781765E-7 1.4288742E-4 17 8.374384 309 6.872776 
GO:0019752 carboxylic acid metabolic process 1.1781765E-7 1.4288742E-4 17 8.374384 309 6.872776 
GO:0043436 oxoacid metabolic process 1.1781765E-7 1.4288742E-4 17 8.374384 309 6.872776 
GO:0042180 cellular ketone metabolic process 1.4006086E-7 1.5924718E-4 17 8.374384 319 7.095196 
GO:0005355|GO:0015579 glucose transmembrane transporter activity 2.3727443E-7 2.2718114E-4 19 9.359606 33 0.7339858 
GO:0015145 monosaccharide transmembrane transporter activity 2.3727443E-7 2.2718114E-4 19 9.359606 33 0.7339858 
GO:0015149 hexose transmembrane transporter activity 2.3727443E-7 2.2718114E-4 19 9.359606 33 0.7339858 
GO:0016052|GO:0006095 carbohydrate catabolic process 4.342581E-7 3.5908743E-4 9 4.4334974 66 1.4679716 
GO:0016614 oxidoreductase activity, acting on CH-OH group of 
donors 
4.1676213E-7 3.5908743E-4 13 6.4039407 129 2.8692172 
GO:0044283 small molecule biosynthetic process 4.1528762E-7 3.5908743E-4 8 3.9408867 157 3.491993 
GO:0016020 membrane 1.1899675E-6 9.412006E-4 85 41.87192 816 18.149466 
GO:0006096|GO:0019641
|GO:0019642 
glycolysis 1.2537006E-6 9.50293E-4 9 4.4334974 10 0.22241993 
GO:0016616 oxidoreductase activity, acting on the CH-OH group 
of donors, NAD or NADP as acceptor 
1.3907705E-6 0.0010120231 13 6.4039407 114 2.535587 
GO:0034641 cellular nitrogen compound metabolic process 1.4911448E-6 0.0010433292 8 3.9408867 298 6.6281137 
GO:0044275 cellular carbohydrate catabolic process 3.4398627E-6 0.0023176735 9 4.4334974 44 0.9786477 
GO:0016903 oxidoreductase activity, acting on the aldehyde or 
oxo group of donors 
4.231417E-6 0.0027491772 2 0.9852217 38 0.8451957 
GO:0006811 ion transport 5.975443E-6 0.0037484097 1 0.49261084 132 2.9359431 
GO:0006113 fermentation 8.235532E-6 0.0048328675 9 4.4334974 16 0.3558719 
GO:0006753 nucleoside phosphate metabolic process 1.4288173E-5 0.00787658 2 0.9852217 80 1.7793595 
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GO:0009117 nucleotide metabolic process 1.4288173E-5 0.00787658 2 0.9852217 80 1.7793595 
GO:0019318 hexose metabolic process 1.939019E-5 0.01037476 12 5.91133 66 1.4679716 
GO:0016620 oxidoreductase activity, acting on the aldehyde or 
oxo group of donors, NAD or NADP as acceptor 
2.2327078E-5 0.01160483 2 0.9852217 35 0.77846974 
GO:0009309 amine biosynthetic process 3.3054006E-5 0.016703079 8 3.9408867 111 2.468861 
GO:0006810|GO:0015457
|GO:0015460 
transport 3.8006103E-5 0.018686438 53 26.108374 774 17.215303 
GO:0006007 glucose catabolic process 4.258342E-5 0.019863276 9 4.4334974 18 0.40035588 
GO:0019320 hexose catabolic process 4.258342E-5 0.019863276 9 4.4334974 18 0.40035588 
GO:0006090 pyruvate metabolic process 4.9155457E-5 0.021810358 4 1.9704434 24 0.5338078 
GO:0008643|GO:0006861
|GO:0008644 
carbohydrate transport 4.84225E-5 0.021810358 15 7.3891625 47 1.0453737 
GO:0051234 establishment of localisation 5.569749E-5 0.024124663 53 26.108374 784 17.437723 
GO:0044271 cellular nitrogen compound biosynthetic process 6.461863E-5 0.027337842 8 3.9408867 161 3.5809608 
GO:0005353|GO:0015585
|GO:0019192 
fructose transmembrane transporter activity 8.018974E-5 0.02861234 14 6.8965516 28 0.6227758 
GO:0006519 cellular amino acid and derivative metabolic process 8.0213715E-5 0.02861234 8 3.9408867 225 5.0044484 
GO:0008645 hexose transport 8.018974E-5 0.02861234 14 6.8965516 28 0.6227758 
GO:0009308 amine metabolic process 7.6350596E-5 0.02861234 8 3.9408867 243 5.404804 
GO:0015578|GO:0015589 mannose transmembrane transporter activity 8.018974E-5 0.02861234 14 6.8965516 28 0.6227758 
GO:0015749 monosaccharide transport 8.018974E-5 0.02861234 14 6.8965516 28 0.6227758 
GO:0032787 monocarboxylic acid metabolic process 7.832624E-5 0.02861234 9 4.4334974 115 2.5578291 
GO:0006526 arginine biosynthetic process 8.551552E-5 0.02902297 8 3.9408867 11 0.24466193 
GO:0009062 fatty acid catabolic process 8.615107E-5 0.02902297 5 2.4630542 25 0.5560498 
GO:0051179 localisation 9.239746E-5 0.030561332 53 26.108374 801 17.815836 
GO:0005975 carbohydrate metabolic process 1.0310591E-4 0.033494264 20 9.852217 292 6.494662 
GO:0044242 cellular lipid catabolic process 1.1437101E-4 0.036501944 5 2.4630542 32 0.7117438 
GO:0044106 cellular amine metabolic process 1.1960411E-4 0.03751397 8 3.9408867 205 4.5596085 
GO:0004022 alcohol dehydrogenase (NAD) activity 1.2755851E-4 0.039330762 6 2.955665 9 0.20017794 
GO:0005529 sugar binding 1.6262209E-4 0.042875122 5 2.4630542 5 0.111209966 
GO:0005536 glucose binding 1.6262209E-4 0.042875122 5 2.4630542 5 0.111209966 
GO:0005996 monosaccharide metabolic process 1.473509E-4 0.042875122 12 5.91133 81 1.8016014 
GO:0009746 response to hexose stimulus 1.6262209E-4 0.042875122 5 2.4630542 5 0.111209966 
GO:0009749 response to glucose stimulus 1.6262209E-4 0.042875122 5 2.4630542 5 0.111209966 
GO:0015980 energy derivation by oxidation of organic compounds 1.4673773E-4 0.042875122 9 4.4334974 77 1.7126335 
GO:0034284 response to monosaccharide stimulus 1.6262209E-4 0.042875122 5 2.4630542 5 0.111209966 
GO:0048029 monosaccharide binding 1.6262209E-4 0.042875122 5 2.4630542 5 0.111209966 
GO:0016042|GO:0006724 lipid catabolic process 1.7621237E-4 0.0451495 5 2.4630542 33 0.7339858 
4 hrs up-regulated genes in the ATCC46645 ΔpacC time course 
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GO ACCESSION GO Term p-value corrected p-
value 
Count in 
Selection 
% Count in 
Selection 
Count in 
Total 
% Count in 
Total 
GO:0044281 small molecule metabolic process 3.7342728E-14 6.0288985E-10 11 6.111111 483 10.742883 
GO:0016491 oxidoreductase activity 7.343491E-11 5.9279495E-7 25 13.888889 472 10.49822 
GO:0006082 organic acid metabolic process 8.269015E-9 2.0108255E-5 4 2.2222223 309 6.872776 
GO:0019752 carboxylic acid metabolic process 8.269015E-9 2.0108255E-5 4 2.2222223 309 6.872776 
GO:0043436 oxoacid metabolic process 8.269015E-9 2.0108255E-5 4 2.2222223 309 6.872776 
GO:0042180 cellular ketone metabolic process 1.4123668E-8 2.8502925E-5 4 2.2222223 319 7.095196 
GO:0044275 cellular carbohydrate catabolic process 6.2424937E-7 8.398637E-4 7 3.8888888 44 0.9786477 
GO:0016614 oxidoreductase activity, acting on CH-OH group of 
donors 
7.302754E-7 8.4215216E-4 6 3.3333333 129 2.8692172 
GO:0003824 catalytic activity 8.9877665E-7 8.6225814E-4 29 16.11111 2044 45.462635 
GO:0006066 alcohol metabolic process 9.290171E-7 8.6225814E-4 11 6.111111 176 3.9145908 
GO:0006091 generation of precursor metabolites and energy 9.613419E-7 8.6225814E-4 7 3.8888888 98 2.1797154 
GO:0005737 cytoplasm 2.6871924E-6 0.0021692056 129 71.666664 2039 45.351425 
GO:0022891 substrate-specific transmembrane transporter activity 3.2259588E-6 0.0024801127 1 0.5555556 317 7.0507116 
GO:0022892 substrate-specific transporter activity 6.524553E-6 0.004579888 1 0.5555556 357 7.9403915 
GO:0005215|GO:0005478 transporter activity 7.013951E-6 0.0047182767 20 11.111111 525 11.677046 
GO:0016052|GO:0006095 carbohydrate catabolic process 8.912103E-6 0.005620392 7 3.8888888 66 1.4679716 
GO:0016616 oxidoreductase activity, acting on the CH-OH group 
of donors, NAD or NADP as acceptor 
9.051239E-6 0.005620392 6 3.3333333 114 2.535587 
GO:0022857|GO:0005386
|GO:0015646 
transmembrane transporter activity 9.568086E-6 0.005682468 2 1.1111112 354 7.8736653 
GO:0006096|GO:0019641
|GO:0019642 
glycolysis 2.3987086E-5 0.012908868 7 3.8888888 10 0.22241993 
GO:0006090 pyruvate metabolic process 2.816085E-5 0.014666145 4 2.2222223 24 0.5338078 
GO:0051119 sugar transmembrane transporter activity 4.1540137E-5 0.02032291 1 0.5555556 47 1.0453737 
GO:0006007 glucose catabolic process 6.62467E-5 0.030531187 7 3.8888888 18 0.40035588 
GO:0019320 hexose catabolic process 6.62467E-5 0.030531187 7 3.8888888 18 0.40035588 
GO:0044282 small molecule catabolic process 7.657155E-5 0.03341163 7 3.8888888 75 1.6681495 
GO:0019318 hexose metabolic process 1.1145624E-4 0.043967117 9 5.0 66 1.4679716 
8 hrs up-regulated genes in the ATCC46645 ΔpacC time course 
GO ACCESSION GO Term p-value corrected p-
value 
Count in 
Selection 
% Count in 
Selection 
Count in 
Total 
% Count in 
Total 
GO:0005886|GO:0005904 plasma membrane 7.637119E-12 1.03925835E-7 50 42.016808 315 7.006228 
GO:0022892 substrate-specific transporter activity 7.765989E-11 5.283975E-7 17 14.285714 357 7.9403915 
GO:0022891 substrate-specific transmembrane transporter activity 2.3831545E-10 1.080998E-6 17 14.285714 317 7.0507116 
GO:0016491 oxidoreductase activity 1.3308146E-9 4.5274273E-6 24 20.168068 472 10.49822 
GO:0005215|GO:0005478 transporter activity 7.1044024E-9 1.4498662E-5 35 29.411764 525 11.677046 
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GO:0022857|GO:0005386
|GO:0015646 
transmembrane transporter activity 5.818035E-9 1.4498662E-5 17 14.285714 354 7.8736653 
GO:0051119 sugar transmembrane transporter activity 7.458166E-9 1.4498662E-5 16 13.445378 47 1.0453737 
GO:0015144 carbohydrate transmembrane transporter activity 5.8931413E-8 1.0024225E-4 17 14.285714 52 1.1565837 
GO:0005355|GO:0015579 glucose transmembrane transporter activity 2.05277E-7 2.4286375E-4 15 12.605042 33 0.7339858 
GO:0015145 monosaccharide transmembrane transporter activity 2.05277E-7 2.4286375E-4 15 12.605042 33 0.7339858 
GO:0015149 hexose transmembrane transporter activity 2.05277E-7 2.4286375E-4 15 12.605042 33 0.7339858 
GO:0044281 small molecule metabolic process 2.1416574E-7 2.4286375E-4 5 4.2016807 483 10.742883 
GO:0016614 oxidoreductase activity, acting on CH-OH group of 
donors 
3.5052767E-7 3.6692127E-4 5 4.2016807 129 2.8692172 
GO:0006811 ion transport 6.232896E-7 5.727891E-4 1 0.84033614 132 2.9359431 
GO:0016616 oxidoreductase activity, acting on the CH-OH group 
of donors, NAD or NADP as acceptor 
6.3138185E-7 5.727891E-4 5 4.2016807 114 2.535587 
GO:0016020 membrane 1.6291028E-6 0.0013855508 62 52.10084 816 18.149466 
GO:0003824 catalytic activity 3.8398152E-6 0.0030736567 34 28.571428 2044 45.462635 
GO:0044242 cellular lipid catabolic process 6.369742E-6 0.0045620725 5 4.2016807 32 0.7117438 
GO:0005529 sugar binding 1.0993901E-5 0.004986829 5 4.2016807 5 0.111209966 
GO:0005536 glucose binding 1.0993901E-5 0.004986829 5 4.2016807 5 0.111209966 
GO:0006753 nucleoside phosphate metabolic process 9.483033E-6 0.004986829 2 1.6806723 80 1.7793595 
GO:0009117 nucleotide metabolic process 9.483033E-6 0.004986829 2 1.6806723 80 1.7793595 
GO:0009746 response to hexose stimulus 1.0993901E-5 0.004986829 5 4.2016807 5 0.111209966 
GO:0009749 response to glucose stimulus 1.0993901E-5 0.004986829 5 4.2016807 5 0.111209966 
GO:0016042|GO:0006724 lipid catabolic process 9.544039E-6 0.004986829 5 4.2016807 33 0.7339858 
GO:0034284 response to monosaccharide stimulus 1.0993901E-5 0.004986829 5 4.2016807 5 0.111209966 
GO:0048029 monosaccharide binding 1.0993901E-5 0.004986829 5 4.2016807 5 0.111209966 
GO:0009062 fatty acid catabolic process 1.343512E-5 0.0058975792 5 4.2016807 25 0.5560498 
GO:0005975 carbohydrate metabolic process 1.45814865E-5 0.006200772 6 5.042017 292 6.494662 
GO:0006810|GO:0015457
|GO:0015460 
transport 2.5284562E-5 0.010119766 25 21.008404 774 17.215303 
GO:0051234 establishment of localisation 4.579353E-5 0.01730994 25 21.008404 784 17.437723 
GO:0006066 alcohol metabolic process 6.80319E-5 0.025021007 3 2.5210085 176 3.9145908 
GO:0051179 localisation 7.401006E-5 0.025823796 25 21.008404 801 17.815836 
GO:0004553|GO:0016800 hydrolase activity, hydrolyzing O-glycosyl 
compounds 
8.374581E-5 0.0284903 4 3.3613446 91 2.0240214 
GO:0016798 hydrolase activity, acting on glycosyl bonds 1.13699854E-4 0.037737224 6 5.042017 112 2.4911032 
GO:0008643|GO:0006861
|GO:0008644 
carbohydrate transport 1.6033494E-4 0.049587183 1 0.84033614 47 1.0453737 
16 hrs up-regulated genes in the ATCC46645 ΔpacC time course 
GO ACCESSION GO Term p-value corrected p- Count in % Count in Count in % Count in 
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value Selection Selection Total Total 
GO:0005886|GO:0005904 plasma membrane 2.841722E-15 3.8772603E-11 85 50.898205 315 7.006228 
GO:0005215|GO:0005478 transporter activity 1.08944395E-14 6.138478E-11 48 28.742516 525 11.677046 
GO:0022891 substrate-specific transmembrane transporter activity 1.3497041E-14 6.138478E-11 20 11.9760475 317 7.0507116 
GO:0022892 substrate-specific transporter activity 4.870091E-14 1.6611944E-10 20 11.9760475 357 7.9403915 
GO:0022857|GO:0005386
|GO:0015646 
transmembrane transporter activity 8.0102334E-14 2.1858407E-10 21 12.57485 354 7.8736653 
GO:0016491 oxidoreductase activity 2.394451E-13 5.4450017E-10 37 22.15569 472 10.49822 
GO:0051119 sugar transmembrane transporter activity 9.279857E-12 1.8087833E-8 19 11.377246 47 1.0453737 
GO:0015144 carbohydrate transmembrane transporter activity 1.6450498E-10 2.8056428E-7 20 11.9760475 52 1.1565837 
GO:0016020 membrane 2.1066484E-9 3.1936909E-6 101 60.479042 816 18.149466 
GO:0005355|GO:0015579 glucose transmembrane transporter activity 4.8021573E-9 5.460073E-6 18 10.778443 33 0.7339858 
GO:0015145 monosaccharide transmembrane transporter activity 4.8021573E-9 5.460073E-6 18 10.778443 33 0.7339858 
GO:0015149 hexose transmembrane transporter activity 4.8021573E-9 5.460073E-6 18 10.778443 33 0.7339858 
GO:0006811 ion transport 1.5215225E-8 1.4828379E-5 1 0.5988024 132 2.9359431 
GO:0016614 oxidoreductase activity, acting on CH-OH group of 
donors 
8.2171574E-8 7.418002E-5 6 3.5928144 129 2.8692172 
GO:0016616 oxidoreductase activity, acting on the CH-OH group 
of donors, NAD or NADP as acceptor 
8.6988855E-8 7.418002E-5 6 3.5928144 114 2.535587 
GO:0003824 catalytic activity 1.3094343E-7 1.05094055E-4 42 25.1497 2044 45.462635 
GO:0006810|GO:0015457
|GO:0015460 
transport 1.620457E-7 1.228311E-4 47 28.143713 774 17.215303 
GO:0051234 establishment of localisation 2.0719052E-7 1.4878517E-4 47 28.143713 784 17.437723 
GO:0051179 localisation 4.617725E-7 3.1502236E-4 47 28.143713 801 17.815836 
GO:0008643|GO:0006861
|GO:0008644 
carbohydrate transport 8.1487195E-7 5.0537067E-4 14 8.383233 47 1.0453737 
GO:0016620 oxidoreductase activity, acting on the aldehyde or 
oxo group of donors, NAD or NADP as acceptor 
5.0529648E-6 0.0029975176 2 1.1976048 35 0.77846974 
GO:0005353|GO:0015585
|GO:0019192 
fructose transmembrane transporter activity 7.4749823E-6 0.0037773717 13 7.784431 28 0.6227758 
GO:0008645 hexose transport 7.4749823E-6 0.0037773717 13 7.784431 28 0.6227758 
GO:0015578|GO:0015589 mannose transmembrane transporter activity 7.4749823E-6 0.0037773717 13 7.784431 28 0.6227758 
GO:0015749 monosaccharide transport 7.4749823E-6 0.0037773717 13 7.784431 28 0.6227758 
GO:0031226 intrinsic to plasma membrane 1.3524271E-5 0.0065902085 24 14.371258 95 2.1129894 
GO:0016903 oxidoreductase activity, acting on the aldehyde or 
oxo group of donors 
1.693006E-5 0.007965332 2 1.1976048 38 0.8451957 
GO:0005529 sugar binding 2.647224E-5 0.009761853 5 2.9940119 5 0.111209966 
GO:0005536 glucose binding 2.647224E-5 0.009761853 5 2.9940119 5 0.111209966 
GO:0005887 integral to plasma membrane 2.294872E-5 0.009761853 24 14.371258 87 1.9350533 
172 
 
GO:0009746 response to hexose stimulus 2.647224E-5 0.009761853 5 2.9940119 5 0.111209966 
GO:0009749 response to glucose stimulus 2.647224E-5 0.009761853 5 2.9940119 5 0.111209966 
GO:0034284 response to monosaccharide stimulus 2.647224E-5 0.009761853 5 2.9940119 5 0.111209966 
GO:0048029 monosaccharide binding 2.647224E-5 0.009761853 5 2.9940119 5 0.111209966 
GO:0006113 fermentation 2.8851056E-5 0.010359086 8 4.790419 16 0.3558719 
GO:0044242 cellular lipid catabolic process 4.3537024E-5 0.015231317 5 2.9940119 32 0.7117438 
GO:0016042|GO:0006724 lipid catabolic process 6.395591E-5 0.021815442 5 2.9940119 33 0.7339858 
GO:0006091 generation of precursor metabolites and energy 7.1965354E-5 0.023378545 8 4.790419 98 2.1797154 
GO:0009062 fatty acid catabolic process 7.123115E-5 0.023378545 5 2.9940119 25 0.5560498 
 
Table 4.12: Significant GO terms among the up-regulated genes in the ATCC46645 ΔpacC time course. p-value represents the probability of obtaining the GO term 
from a list of random entities, corrected p-value derived from Bonferroni testing of multiple comparisons. Analysis performed using Genespring GX 11.02.  
 
Total down-regulated genes in the ATCC46645 ΔpacC time course 
GO ACCESSION GO Term p-value corrected p-
value 
Count in 
Selection 
% Count in 
Selection 
Count 
in 
Total 
% Count in 
Total 
GO:0005634 nucleus 4.52213E-6 0.02259516 126 99.2126 1124 25.0 
GO:0006350 transcription 3.4448162E-6 0.02259516 10 7.874016 120 2.6690392 
GO:0016591 DNA-directed RNA polymerase II, holoenzyme 1.1784711E-5 0.041981492 1 0.78740156 37 0.82295376 
GO:0030528 transcription regulator activity 4.75705E-6 0.02259516 2 1.5748031 280 6.227758 
 
Table 4.13: Significant GO terms among the down-regulated genes in the ATCC46645 ΔpacC time course. p-value represents the probability of obtaining the GO term 
from a list of random entities, corrected p-value derived from Bonferroni testing of multiple comparisons. Analysis performed using Genespring GX 11.02. 
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Genes differentially expressed in the ATCC46645 ΔpacC time course were clustered 
using the STEM software (Fig. 4.20) which allocated differentially expressed genes to twelve 
model profiles. Among these, five model profiles (12, 1, 9, 4 and 3) contain genes whose 
expression is down-regulated across the ATCC46645 ΔpacC time course and seven (48, 42, 
49, 45, 46, 29 and 47) contain genes whose expression is up-regulated across the ATCC46645 
ΔpacC time course.  
 
Fig. 4.20: STEM clustering analysis of differentially expressed genes in the ATCC46645 ΔpacC 
time course during initiation of murine infection. Statistically significant model profiles are coloured, 
similarly coloured profiles cluster according to the similar temporal nature of gene expression profiles assigned 
Profile 48, n = 351 (2e-132), Profile 42, n = 229 (1e-110), Profile 49, n = 159 (1e-11), Profile 12, n = 332 (2e-
98), Profile 9, n = 202 (5e-88), Profile 1, n = 194 (3e-64), Profile 45, n = 185 (3e-44), Profile 46, n = 95 (3e-10), 
Profile 4, n = 163 (1e-38), Profile 3, n = 76 (2e-8), Profile 29, n = 75 (4e-20), Profile 47, n = 70 (9e-4). Analysis 
performed using STEM. Red lines represent all analysed gene expression profiles in the dataset. 
 
GO analysis in STEM (Table 4.14) of the ATCC46645 ΔpacC time course experiment 
followed the protocol described earlier for ATCC46645, using the expanded A. fumigatus 
gene annotation created for this study. GO terms with corrected p-value <0.05 are included, 
where the p-value, initially based on an hypergeometric distribution, was corrected by the 
software using a Bonferonni correction for multiple GO categories being tested 
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simultaneously. This corrected p-value is the original p-value divided by the number of GO 
categories for which the number of genes on the array is above the GO analysis minimum 
number of genes parameter. Profile 48, containing upregulated genes across the ATCC46645 
ΔpacC time course, was significantly enriched in GO terms associated with the functional 
categories of transport and cell wall. Profile 12, containing OFRs whose expression was 
decreased across the ATCC46645 ΔpacC time course, was significantly enriched in GO terms 
associated with the functional category of transcription. 
 
Significant GO terms for Profile 48 (n = 351) 
Category ID Genes in 
Category 
Count  
Genes  
Genes 
Expected  
Genes 
Enriched 
p-value Corrected 
p-value 
IC 284 66.0 8.0 +58.0 3.5E-40 7.3E-38 
Subtelomeric 430 71.0 12.1 +58.9 6.8E-33 1.4E-30 
cytoplasm 276 43.0 7.7 +35.3 1.4E-19 2.9E-17 
In vitro pH response genes 254 37.0 7.1 +29.9 4.2E-16 8.7E-14 
oxidoreductase activity 68 20.0 1.9 +18.1 2.1E-15 4.3E-13 
transporter activity 42 16.0 1.2 +14.8 1.2E-14 2.6E-12 
transport 55 17.0 1.5 +15.5 1.0E-13 2.1E-11 
metabolic process 82 19.0 2.3 +16.7 1.2E-12 2.5E-10 
Semi-subT 403 41.0 11.3 +29.7 2.5E-12 5.2E-10 
plasma membrane 91 19.0 2.6 +16.4 8.5E-12 1.8E-9 
cellular component 
unknown 
75 17.0 2.1 +14.9 2.6E-11 5.4E-9 
membrane 23 9.0 0.6 +8.4 6.2E-9 1.3E-6 
SECMET 96 15.0 2.7 +12.3 8.0E-8 1.7E-5 
integral to plasma 
membrane 
39 10.0 1.1 +8.9 9.1E-8 1.9E-5 
biological process unknown 127 17.0 3.6 +13.4 1.2E-7 2.4E-5 
molecular function 
unknown 
143 18.0 4.0 +14.0 1.3E-7 2.7E-5 
nucleus 211 22.0 5.9 +16.1 1.7E-7 3.5E-5 
mitochondrion 74 12.0 2.1 +9.9 1.0E-6 2.2E-4 
cell wall organisation 30 7.0 0.8 +6.2 1.6E-5 0.003 
membrane fraction 21 6.0 0.6 +5.4 1.8E-5 0.004 
AFU-SPECIFIC 112 12.0 3.1 +8.9 7.8E-5 0.016 
Significant GO terms for Profile 42 (n = 229) 
Category ID Genes in 
Category 
Count  
Genes  
Genes 
Expected  
Genes 
Enriched 
p-value Corrected 
p-value 
Subtelomeric 430 71.0 5.8 +65.2 4.5E-53 9.3E-51 
IC 284 60.0 3.8 +56.2 9.2E-52 1.9E-49 
Semi-subT 403 45.0 5.5 +39.5 8.2E-27 1.7E-24 
In vitro pH response genes 254 37.0 3.4 +33.6 1.9E-26 3.9E-24 
plasma membrane 91 19.0 1.2 +17.8 2.3E-17 4.8E-15 
SECMET 96 17.0 1.3 +15.7 2.0E-14 4.1E-12 
AFFC specific 52 8.0 0.7 +7.3 5.0E-7 1.0E-4 
metabolic process 82 9.0 1.1 +7.9 1.8E-6 3.9E-4 
cellular component 
unknown 
75 8.0 1.0 +7.0 8.5E-6 0.002 
hydrolase activity 27 5.0 0.4 +4.6 2.9E-5 0.006 
nucleus 211 12.0 2.9 +9.1 3.8E-5 0.008 
integral to plasma 
membrane 
39 5.0 0.5 +4.5 1.8E-4 0.037 
Significant GO terms for Profile 49 (n =159) 
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Category ID Genes in 
Category 
Count  
Genes  
Genes 
Expected  
Genes 
Enriched 
p-value Corrected 
p-value 
In vitro pH response genes 254 23.0 9.1 +13.9 5.2E-5 0.011 
Significant GO terms for Profile 12 (n =332) 
Category ID Genes in 
Category 
Count  
Genes  
Genes 
Expected  
Genes 
Enriched 
p-value Corrected 
p-value 
nucleus 211 41.0 7.1 +33.9 1.1E-19 2.2E-17 
Semi-subT 403 54.0 13.5 +40.5 9.6E-18 2.0E-15 
AFU-SPECIFIC 112 28.0 3.7 +24.3 6.0E-17 1.3E-14 
Subtelomeric 430 46.0 14.4 +31.6 8.1E-12 1.7E-9 
regulation of transcription 46 15.0 1.5 +13.5 1.4E-11 2.9E-9 
zinc ion binding 61 16.0 2.0 +14.0 1.2E-10 2.5E-8 
molecular function 
unknown 
143 21.0 4.8 +16.2 1.5E-8 3.2E-6 
transcription factor activity 46 12.0 1.5 +10.5 2.6E-8 5.5E-6 
In vitro pH response genes 254 27.0 8.5 +18.5 1.7E-7 3.5E-5 
DNA-dependent 20 7.0 0.7 +6.3 2.5E-6 5.2E-4 
DNA binding 30 8.0 1.0 +7.0 4.7E-6 9.9E-4 
cellular component 
unknown 
75 12.0 2.5 +9.5 7.2E-6 0.002 
ATP-binding cassette 
(ABC) transporter activity 
13 5.0 0.4 +4.6 4.3E-5 0.009 
Significant GO terms for Profile 9 (n =202) 
Category ID Genes in 
Category 
Count  
Genes  
Genes 
Expected  
Genes 
Enriched 
p-value Corrected 
p-value 
cytoplasm 276 34.0 3.7 +30.3 4.9E-22 1.0E-19 
nucleus 211 27.0 2.9 +24.1 3.0E-18 6.2E-16 
molecular function 
unknown 
143 23.0 1.9 +21.1 5.0E-18 1.0E-15 
biological process unknown 127 20.0 1.7 +18.3 1.1E-15 2.3E-13 
Semi-subT 403 25.0 5.5 +19.5 5.8E-10 1.2E-7 
cellular component 
unknown 
75 9.0 1.0 +8.0 8.6E-7 1.8E-4 
transcription factor activity 46 7.0 0.6 +6.4 2.8E-6 5.9E-4 
endoplasmic reticulum 48 7.0 0.7 +6.3 3.8E-6 7.9E-4 
mitochondrion 74 7.0 1.0 +6.0 6.8E-5 0.014 
Significant GO terms for Profile 1 (n =194) 
Category ID Genes in 
Category 
Count  
Genes  
Genes 
Expected  
Genes 
Enriched 
p-value Corrected 
p-value 
Semi-subT 403 33.0 7.0 +26.0 5.0E-13 1.0E-10 
nucleus 211 24.0 3.7 +20.3 6.9E-13 1.4E-10 
In vitro pH response genes 254 21.0 4.4 +16.6 6.5E-9 1.4E-6 
cytoplasm 276 20.0 4.8 +15.2 1.3E-7 2.7E-5 
protein binding 26 7.0 0.5 +6.5 2.4E-7 5.1E-5 
transcription initiation from 
RNA polymerase II 
promoter 
10 5.0 0.2 +4.8 3.8E-7 7.9E-5 
Subtelomeric 430 24.0 7.5 +16.5 9.4E-7 2.0E-4 
molecular function 
unknown 
143 11.0 2.5 +8.5 4.8E-5 0.010 
DNA binding 30 5.0 0.5 +4.5 1.6E-4 0.034 
Significant GO terms for Profile 45 (n =185) 
Category ID Genes in 
Category 
Count  
Genes  
Genes 
Expected  
Genes 
Enriched 
p-value Corrected 
p-value 
cytoplasm 276 40.0 6.1 +33.9 8.8E-21 1.8E-18 
cytosol 45 13.0 1.0 +12.0 1.1E-11 2.3E-9 
mitochondrion 74 14.0 1.6 +12.4 8.5E-10 1.8E-7 
Semi-subT 403 30.0 8.9 +21.1 1.2E-8 2.5E-6 
In vitro pH response genes 254 22.0 5.6 +16.4 7.4E-8 1.5E-5 
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biological process unknown 127 14.0 2.8 +11.2 9.6E-7 2.0E-4 
translation 19 6.0 0.4 +5.6 2.4E-6 5.1E-4 
nucleus 211 17.0 4.7 +12.3 5.7E-6 0.001 
structural constituent of 
ribosome 
15 5.0 0.3 +4.7 1.3E-5 0.003 
Significant GO terms for Profile 46 (n =95) 
Category ID Genes in 
Category 
Count  
Genes  
Genes 
Expected  
Genes 
Enriched 
p-value Corrected 
p-value 
cytoplasm 276 17.0 5.1 +11.9 2.2E-5 0.005 
membrane fraction 21 5.0 0.4 +4.6 3.6E-5 0.007 
Significant GO terms for Profile 4 (n =163) 
Category ID Genes in 
Category 
Count  
Genes  
Genes 
Expected  
Genes 
Enriched 
p-value Corrected 
p-value 
AFU-SPECIFIC 112 20.0 2.2 +17.8 7.8E-14 1.6E-11 
Semi-subT 403 25.0 7.9 +17.1 6.3E-7 1.3E-4 
SECMET 96 11.0 1.9 +9.1 3.1E-6 6.4E-4 
structural constituent of 
ribosome 
15 5.0 0.3 +4.7 7.3E-6 0.002 
In vitro pH response genes 254 17.0 5.0 +12.0 1.4E-5 0.003 
AFFC specific 52 7.0 1.0 +6.0 6.8E-5 0.014 
Subtelomeric 430 21.0 8.4 +12.6 1.5E-4 0.032 
Significant GO terms for Profile 3 (n =76) 
Category ID Genes in 
Category 
Count  
Genes  
Genes 
Expected  
Genes 
Enriched 
p-value Corrected 
p-value 
Transposition 20 9.0 0.3 +8.7 5.3E-12 1.1E-9 
Significant GO terms for Profile 29 (n =75) 
Category ID Genes in 
Category 
Count  
Genes  
Genes 
Expected  
Genes 
Enriched 
p-value Corrected 
p-value 
Subtelomeric 430 29.0 3.6 +25.4 2.3E-17 4.7E-15 
IC 284 19.0 2.4 +16.6 7.6E-12 1.6E-9 
In vitro pH response genes 254 18.0 2.1 +15.9 1.0E-11 2.1E-9 
SECMET 96 8.0 0.8 +7.2 1.7E-6 3.5E-4 
Semi-subT 403 13.0 3.4 +9.6 4.8E-5 0.010 
Significant GO terms for Profile 47 (n =70) 
Category ID Genes in 
Category 
Count  
Genes  
Genes 
Expected  
Genes 
Enriched 
p-value Corrected 
p-value 
molecular function 
unknown 
143 12.0 2.7 +9.3 1.8E-5 0.004 
 
Table 4.14: Significant GO terms among profiles 0, 12, 1, 9, 49, 48, 42, 47, 29 in the ATCC46645 
ΔpacC time course experiment. For each significant profile identified by STEM, corrected p-values based on 
the expected number of genes assigned to the profile, and satisfying the cut-off of <0.05.  
 
The model profiles from the ATCC46645 STEM analysis were ordered according to 
the significance of IC enrichment, and other functional classifications (Section 4.3.2). 
Likewise (Fig. 4.21), a STEM clustering analysis was performed on the ATCC46645 ΔpacC 
dataset to interrogate the presence of Af293 infection cluster genes in the dataset (McDonagh 
et al., 2008a) (unabridged output is reported in Appendix D). Model profiles are coloured 
according to significance in the initial analysis, however, red profiles now indicate IC gene 
profiles. 
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Fig. 4.21: Selection of STEM clustering analysis of differentially expressed genes in the 
ATCC46645 ΔpacC time course during initiation of murine infection ordered on the basis of the Af293 
infection clusters (McDonagh et al., 2008a). The two values at the bottom of each profile indicate the number 
of specific genes (in this case genes previously identified in the Af293 infection clusters) are present in the 
profile and the significance of the intersect size, based upon the hypergeometric distribution of dataset genes in 
the respective model profiles. 
 
The whereabouts of subtelomeric genes within the ATCC46645 ΔpacC time course 
dataset  was also examined (Fig. 4.22) (unabridged output is reported in Appendix D).  
 
 
 
 
 
Fig. 4.22: Selection of STEM clustering analysis of the differentially expressed genes in the 
ATCC46645 ΔpacC time course during initiation of murine infection ordered on the basis of the 
subtelomeric gene inclusion. For each profile indicate are indicated the number of genes (in this case genes 
with subtelomeric location) and the significance of the intersect size, based upon the hypergeometric distribution 
of dataset genes in the respective model profiles. 
 
A. fumigatus annotation was also extended for genes involved in the production of 
secondary metabolites, using predictions made by(Perrin et al., 2007)and STEM model 
profiles were ordered by enrichment for this functional category to examine the effect of pacC 
deletion upon secondary metabolism genes (Fig. 4.23) (unabridged output is reported in 
Appendix D). In contrast to results obtained in the ATCC46645 analysis, where only model 
profiles containing up-regulated genes (42 and 29) were significantly enriched in genes 
predicted to be involved in secondary metabolism, profile 4, to which down-regulated genes 
are assigned, contains eleven ORFs identified by(Perrin et al., 2007)as involved in secondary 
metabolite production.  
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Fig. 4.23: Selection of STEM clustering analysis of the differentially expressed genes in the 
ATCC46645 ΔpacC time course during initiation of murine infection ordered on the basis of secondary 
metabolism gene inclusion. For each profile the number of assigned genes (in this case genes involved in 
secondary metabolite production) are indicated as well as the significance of the intersect size, based upon the 
hypergeometric distribution of dataset genes in the respective model profiles. 
 
Given the role of PacC in regulating pH-dependent gene expression, the inclusion of 
alkaline-responsive genes among those differentially expressed genes in the ATCC46645 
ΔpacC time course was intriguing. This was addressed by STEM analysis (Fig. 4.24 and Fig. 
4.25) (unabridged output is reported in Appendix D). As illustrated in Fig. 4.24, only model 
profiles containing up-regulated genes across the ATCC46645 ΔpacC time course (29, 48 and 
42) were significantly enriched in genes annotated as up-regulated in vitro at high pH and 
must correspond to alkaline-responsive genes regulated independently of PacC regulation. As 
illustrated in Fig. 4.25, comparison with the down-regulated in vitro pH response genes, 
revealed a differential behaviour in murine and in vitro experimentation for several genes in 
profiles 49 and 45, which are instead up-regulated in vivo in ATCC46645 ΔpacC during 
initiation of murine infection. Only three of these genes (Afu5g04230, Afu1g07380, and 
Afu5g03750) were found to behave in an opposite manner in vivo and in vitro when analysing 
the ATCC46645 transcriptional profile. The remainder may correspond to PacC-repressible 
functions. 
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Fig. 4.24: Selection of STEM clustering analysis of the differentially expressed genes in the 
ATCC46645 ΔpacC time course during initiation of murine infection ordered on the basis of in vitro 
alkaline-responsive gene inclusion. For each profile the number of assigned genes (in this case up-regulated 
genes in response to an alkaline pH shift) are indicated, as well as the significance of the intersect size, based 
upon the hypergeometric distribution of dataset genes in the respective model profiles. 
 
Fig. 4.25: Selection of STEM clustering analysis of the differentially expressed genes in the 
ATCC46645 ΔpacC time course during initiation of murine infection ordered on the basis of in vitro 
alkaline-down-regulated gene inclusion. For each profile the number of genes assigned (in this case down-
regulated genes in response to an alkaline pH shift) are indicated, as well as the significance of the intersect size, 
based upon the hypergeometric distribution of dataset genes in the respective model profiles. 
 
A. fumigatus STEM analysis was also selectively extended to genes putatively 
involved in transposition. (Fig. 4.26) (unabridged output is reported in Appendix D).  In this 
analysis only model profiles containing down-regulated genes across the ATCC46645 ΔpacC 
time course (3 and 4) were significantly enriched in genes involved in transposition, 
confirming the trend observed in the GO analysis (Table 4.11).   
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Fig. 4.26: Selection of STEM clustering analysis of the differentially expressed genes in the 
ATCC46645 ΔpacC time course during initiation of murine infection ordered on the basis of transposition 
gene inclusion. For each profile the number of assigned genes is indicated (in this case genes involved in 
transposition) as well as the significance of the intersect size, based upon the hypergeometric distribution of 
dataset genes in the respective model profiles. 
 
To identify general trends crucial for A. fumigatus infection and affected by PacC 
deletion, a genome-wide comparison between the two sets of differentially expressed genes in 
the ATCC46645 and ATCC46645 ΔpacC time courses during initiation of murine infection 
was performed utilising the genome browser function of Genespring GX 11.02. This 
comparison is graphically represented in Figure 4.27, which aligns the up-regulated (A) and 
down-regulated genes (B) genes (fold change cut off of ±2 on a log2 scale) for the wild type 
and ATCC46645 ΔpacC time course (4, 8 and 16 hours post-infection) experiments according 
to chromosomal locus.  
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Fig. 4.27: Genome-wide comparison of transcriptome in the A. fumigatus ATCC46645 ΔpacC and 
respective parental strain during initiation of murine infection. According to their location on the eight A. 
fumigatus chromosomes, green (A) and red (B) lines correspond respectively to down- and up-regulated genes 
for the three time points (4 hrs, 8 hrs and 16 hrs) studied. 
 
 As shown in Fig. 4.28, the overlap between the ATCC46645 and ATCC46645 ΔpacC 
datasets extends to 1573 genes (A), of which 816 are up-regulated (A.1) and 719 are down-
regulated (A.2).   
 
Fig. 4.28: Venn diagrams comparing datasets of differentially expressed genes during initiation of 
murine infection for the wild type ATCC46645 and the ATCC46645 ΔpacC mutant. Analysis performed 
using Genespring GX 11.02.  
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STEM permits the comparison of gene expression data sets from two different 
experimental conditions, allowing the identification of genes which are co-expressed under 
both experimental conditions. STEM pairs model profiles from two experiments identifying 
intersecting gene sets which are coexpressed in both experiments, implicating commonality of 
function. Using STEM gene expression time courses for the wild type ATCC46645 and the 
ATCC46645 ΔpacC mutant were compared to identify statistically significant sets of genes 
which were co-expressed in both experiments. The maximum uncorrected intersection p-
value set to 0.05 and the minimum number of genes in the intersection of the set of genes 
assigned to two profiles to 5 (Fig. 4.29). Output data are ordered according to correlation 
between matched profiles (test set and comparison set organised to the left and the right, 
respectively) of the yellow bar. For intersections in which temporal expression of co-
expressed genes differs between the two datasets (based upon an arbitrary cut-off of 
correlation coefficient equal to 0.7 or less) GO enrichment analysis was performed. The 
number of intersecting genes, and the significance of the intersection are indicated in bottom 
left hand corners of every model profile returned from the comparison.  
Profile 3 of the ATCC46645 ΔpacC dataset and profile 8 of the ATCC46645 dataset 
contain a set of 10 intersecting co-expressed genes having an altered temporal expression 
profile in the ΔpacC mutant, relative to the wild type (correlation coefficient=0.2). This 
revealed a specific trend of down-regulation for these 10 genes in the ATCC46645 ΔpacC 
mutant in the murine niche. GO enrichment analysis revealed 8 of these genes are putatively 
involved in transposition, thereby indicating similarity of function for these genes and 
suggesting the existence of a common regulatory mechanism for them. 
Profiles 48 and 46 of the ATCC46645 ΔpacC dataset have intersections containing co-
expressed genes (22 and 14 genes, and correlation co-efficients of 0.62 and 0.64 respectively) 
with profile 47 of the ATCC46645 dataset. Although the three profiles contain up-regulated 
genes, a deviation in temporal gene expression is observable at 16 hrs post-infection, whereby 
a decrease in gene expression in the wild type strain is not observed in the mutant. GO 
enrichment analysis revealed 5 of the 22 genes in the ATCC46645 ΔpacC profile 48 
intersection as belonging to infection clusters identified in Af293 (McDonagh et al., 2008a). 
Among 14 co-expressed genes in the ATCC46645 ΔpacC profile 46, six of them are located 
in subtelomeric regions of the genome.  
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Fig. 4.29: Comparison of the ATCC46645 and ATCC46645 ΔpacC time course datasets. The 
immediate left of the vertical yellow bar contains the “Original set profiles”, in this case from the ATCC46645 
time course, whereas to the right of the yellow bars are reported the “Comparison Set Profiles”, in this case from 
the ATCC46645 ΔpacC time course. A profile appears to the right of the yellow bar if the intersection satisfies 
the minimum size of 5 and p-value not greater than 0.05 (reported in bottom left of each profile intersection). 
Profiles which cluster with respect to similar temporal expression profiles are similarly coloured. Analysis 
performed using STEM.  
 
4.3.4 Directly comparative analysis of A. fumigatus ATCC46645 and ATCC46645 ΔpacC 
transcription during initiation of murine infection  
 
A directly comparative study of transcription was performed by hybridising doubly 
amplified fungal RNA, extracted from BALFs harvested, for each strain, at 3 time points (4, 8 
and 16 hrs) as shown in Fig. 4.30.  
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Fig. 4.30: Schematic representation of the hybridisations performed to directly compare A. 
fumigatus ATCC46645 and ATCC46645 ΔpacC host adapting transcriptional profiles.  
 
Fig. 4.31, 4.32 and 4.33 show microarray (MA) and box plots of the datasets for each 
of the three time points studied, both before and after normalisation. The MA plots for each 
time point (A) show the distribution of data before (UN-NORMALISED) and after 
(NORMALISED) LOWESS normalisation thereby depicting the dataset adjustments 
implemented by normalisation. In MA plots the log2 ratio between red and green channels (Y-
axis) is plotted against the sum of red and green channels (X-axis). Normalisation adjusts for 
the higher measured spot intensities associated with the green dye (Cy3). Box plots (B) also 
show dataset log2 ratio distributions for each time point before (UN-NORMALISED) and 
after LOWESS normalisation (NORMALISED) but on a slide specific basis. After 
normalisation the medians of the blocks are all equal to zero and the standard deviation is 
regularised.   
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Fig. 4.31: Data normalisation plot for the ATCC46645 ΔpacC/ATCC46645 4 hrs analysis. Pairwise 
MA (A) and box plots (B) for the 4 hour time point of ATCC46645 ΔpacC versus ATCC46645 RNA. Datasets 
plotted before (UN-NORMALISED) and after (NORMALISED) LOWESS normalisation are shown.  
 
Fig. 4.32: Data normalisation plot for theATCC46645 ΔpacC/ATCC46645 8 hrs analysis. Pairwise 
MA (A) and box plots (B) for the 8 hour time point of ATCC46645 ΔpacC versus ATCC46645 RNA. Datasets 
plotted before (UN-NORMALISED) and after (NORMALISED) LOWESS normalisation are shown. 
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Fig. 4.33: Data normalisation plot for the ATCC46645 ΔpacC/ATCC46645 16 hrs analysis. (A) 
Pairwise MA (A) and box plots (B) for the 16 hour time point of ATCC46645 ΔpacC versus ATCC46645 RNA. 
Datasets plotted before (UN-NORMALISED) and after (NORMALISED) LOWESS normalisation are shown.  
 
Among a total of 8243 genes represented on the slides, 8034, 7915 and 7442, returned 
detectable signals for the 4, 8 and 16 hrs time points, respectively (Table 4.15).  
 
 ATCC46645 ΔpacC vs 
ATCC46645 
4 hrs  
ATCC46645 ΔpacC vs 
ATCC46645 
8 hrs 
ATCC46645 ΔpacC vs 
ATCC46645 
16 hrs 
Observations 8034 7915 7442 
Missing observations 210 320 802 
Minimum value -5.70 -4.85 -7.37 
Maximum value 4.18 6.32 5.71 
Mean 0.0119 -0.0053 0.0079 
Median  0.06 -0.03 -0.02 
Standard deviation 0.8784 0.7167 0.9574 
Outliers  226 365 340 
 
Table 4.15: Summary statistics for the ATCC46645 ΔpacC/ATCC46645 comparison in vivo.  
 
Bioinformatic analysis of the dataset was conducted in Genespring GX 11.02 where 
normalised log2 expression ratios were filtered on expression level and differentially regulated 
transcripts were defined as having log2 (Cy5/Cy3) greater than the arbitrary threshold of ±1.5. 
The numbers of genes identified following these criteria as up-regulated, down-regulated or in 
general differentially regulated for each of the 3 time points in the ATCC46645 
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ΔpacC/ATCC466645 comparison are shown in Table 4.16. Among a total of 1491 (15.0% of 
A. fumigatus genome,(Nierman et al., 2005) differentially expressed genes across the entire 
comparison, 729 were up-regulated and 762 were down-regulated in at least one time point of 
the dataset. The complete lists of the differentially expressed genes are attached in the 
Supplementary Data CD, as listed in Appendix D.  
 
 Up-regulated Down-regulated Differentially expressed 
TOTAL 729 762 1491 
4 hrs  217 385 602 
8 hrs  161 134 295 
16 hrs  351 243 594 
 
Table 4.16: Number of differentially expressed genes in the ATCC46645 ΔpacC/ATCC46645 
comparison.  
 
The temporal basis of gene regulation in the ATCC46645 ΔpacC time course relative 
to the parental strain ATCC46645 is simply depicted in 3-way Venn diagrams in Fig 4.34. In 
addition, the entire dataset of differentially expressed genes is detailed in a heat map attached 
in the Supplementary Data CD, as listed in Appendix D.  
 
Fig. 4.34: Three-ways Venn diagrams depicting temporal aspects of differential gene expression in 
the ATCC46645 ΔpacC/ATCC466645 comparison during initiation of murine infection. Up-regulated (A) 
and down-regulated genes (B) have been identified using a fold change cut off of ±1.5 on a log2 scale. Analysis 
performed using Genespring GX 11.02.  
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Among a total of 729 up-regulated genes, 68 were similarly differentially expressed at 
all 3 time points, as listed in Table 4.17. Several of these genes are involved in the transport 
of various nutrients across the plasma membrane, such as sugars (Afu7g05550, Afu6g04270, 
Afu8g06870), amino acids (Afu2g17790), cytosine (Afu2g09860), zinc (Afu2g03860) and 
phosphate (Afu2g10690). Several transporters belong to the major facilitator superfamily 
(MFS), a group of multidrug resistance (MDR) transporter, whose substrates are still poorly 
characterised (Sa-Correia et al., 2009). Multiple ORFs are involved in cell wall biogenesis 
and organisation (Afu3g02040, Afu1g15440, Afu4g10150). Interestingly, the sexual 
development protein EsdC (Afu7g01930) is up-regulated in the ATCC46645 ΔpacC relative 
to the parental strain ATCC466645 during initiation of murine infection. To aid the evaluation 
of phase-specific up-regulated genes Tables AD.3.2-AD.3.4 in Appendix D list thirty ORFs 
having the greatest fold changes among up-regulated genes specific to each of the 4, 8 and 16 
hrs time points.  
Among a total of 762 down-regulated genes, 74 were similarly differentially expressed 
at all 3 time points, as listed in Table 4.18. These genes can be assigned to similar functional 
categories as those in the corresponding up-regulated geneset (Table 4.17) which likely 
reflects the role of PacC as both a repressor and activator of pH-responsive genes. Several of 
these genes are involved in the transport of various nutrients across the plasma membrane, 
such as sugars (Afu6g14500), zinc (Afu6g00470, Afu4g09560) and phosphate (Afu8g01850). 
However, transporters of elements such as iron (Afu6g13750), calcium (Afu7g01030 and 
Afu3g10690) and sodium (Afu2g01320, Afu4g09440 ) are uniquely found among the down-
regulated genes relative to the parental strain ATCC466645. Several ORFs involved in cell 
wall biogenesis and organisation (Afu7g05610, Afu2g14490, Afu6g11390, Afu2g14540) are 
also present. To aid the evaluation of phase-specific down-regulated genes in the ATCC46645 
ΔpacC/ATCC46645 comparison, Tables AD.3.6-AD.3.8 in Appendix D list the thirty ORFs 
having greatest fold changes at each of the three time points. Among genes specifically down-
regulated at 4 and 16 hrs post infection an enrichment for ORFs putatively involved in 
transposition (Afu6g14660, Afu4g00820, Afu4g14870, Afu2g18080, afu6g09470, 
Afu6g00780, Afu8g06290, Afu8g00310, Afu8g01040) is observable. At 8 hours these genes 
are moderately up-regulated (with the sole exception of Afu8g06290) with respect to the wild 
type.  
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Table 4.17: 68 up-regulated ORFs in common for the 3 time points (4 hrs, 8 hrs and 16 hrs) of the 
ATCC46645 ΔpacC/ATCC46645 comparison. 
ORFs  T4 T8 T16 Annotation  Functional classification 
Afu7g05550 4.175793 6.317348 5.587271 sugar transporter 
family protein 
lactate transmembrane transporter 
activity///lactate transport///plasma 
membrane 
Afu7g04950 3.926574 2.624316 2.603744 lipase, putative  
Afu7g04910 3.91836 6.050162 5.280204 phosphatidylglycerol 
specific 
phospholipase C, 
putative 
 
Afu2g17790 3.896936 5.420857 5.166142 amino acid 
transporter, putative 
 
Afu3g02040 3.746189 5.254534 4.7594 glycosyl hydrolase, 
putative 
membrane fraction///fungal-type 
cell wall biogenesis///anchored to 
plasma membrane///molecular 
function unknown 
Afu8g02060 3.723205 5.266514 5.04937 glycan biosynthesis 
protein (PigL), 
putative 
endoplasmic reticulum///hydrolase 
activity 
Afu1g03570 3.698552 5.100834 5.093108 acid phosphatase 
PHOa 
 
Afu4g14000 3.526856 4.978075 5.625625 tripeptidyl peptidase 
A 
protein catabolic process///serine-
type endopeptidase activity 
Afu8g01260 3.473357 4.504778 3.936613 hypothetical protein  
Afu6g03360 3.413945 2.829504 2.309741 oxidoreductase, zinc-
binding 
cytoplasm///nucleus///biological 
process unknown///alcohol 
dehydrogenase (NADP+) activity 
Afu2g09860 3.364603 4.368039 4.333609 purine-cytosine 
permease 
purine transport///cytosine 
transport///cytosine-purine 
permease activity///plasma 
membrane 
Afu8g02070 3.188502 4.379067 4.185896 glycosyl transferase, 
putative 
fungal-type vacuole///"transferase 
activity, transferring glycosyl 
groups"///biological process 
unknown 
Afu6g04270 3.104719 3.231792 4.351751 fructose symporter membrane///myo-inositol 
transport///myo-inositol 
transmembrane transporter activity 
Afu7g04930 3.081243 2.018681 3.62872 alkaline serine 
protease (PR1), 
putative 
protein catabolic process///cellular 
component unknown///peptidase 
activity 
Afu1g11250 3.064082 1.525513 2.960487 amidohydrolase, 
putative 
proteolysis///carboxypeptidase 
activity 
Afu2g03860 2.981831 3.334712 4.044913 plasma membrane 
low affinity zinc ion 
transporter, putative 
low-affinity zinc ion 
transmembrane transporter 
activity///low-affinity zinc ion 
transport///plasma membrane 
Afu8g02050 2.965567 4.341667 4.125514 hypothetical protein  
Afu8g01970 2.876005 4.263019 3.673103 extracellular endo-
polygalacturonase, 
putative 
pectin catabolic 
process///pseudohyphal 
growth///extracellular 
region///polygalacturonase activity 
Afu2g17800 2.68522 4.326293 3.936312 C6 transcription 
factor, putative 
 
Afu1g03490 2.614601 1.831615 1.826264 conserved 
hypothetical protein 
 
Afu5g13300 2.601901 4.370506 5.717124 aspartic 
endopeptidase Pep1 
protein catabolic process///aspartic-
type endopeptidase 
activity///extracellular 
region///pathogenesis 
Afu8g02090 2.597404 4.356246 4.31544 nucleotide-sugar integral to plasma membrane 
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transporter family 
protein 
Afu8g02040 2.543908 3.958048 4.145863 glycosyl transferase, 
putative 
N-linked glycoprotein 
maturation///"transferase activity, 
transferring glycosyl groups" 
Afu2g16860 2.542182 3.395212 3.139038 membrane transporter drug transport///drug transporter 
activity///integral to membrane 
Afu7g08540 2.507654 2.19692 2.047114 ankyrin repeat protein  
Afu5g03750 2.502965 2.641063 3.028794 WW domain protein  
Afu6g00230 2.489269 1.7238 1.918675 isoflavone reductase 
family protein 
 
Afu1g15440 2.430342 2.289956 1.816144 alpha-1,3-glucan 
synthase, putative 
cellular glucan metabolic 
process///fungal-type cell wall 
biogenesis///plasma 
membrane///pathogenesis///"alpha-
1,3-glucan synthase activity"///cell 
morphogenesis 
Afu1g01730 2.429553 2.12989 2.352826 glycosyl hydrolase, 
putative 
membrane fraction///fungal-type 
cell wall biogenesis///anchored to 
plasma membrane 
Afu1g12240 2.384094 4.672033 4.825639 MFS peptide 
transporter, putaitve 
peptide transporter 
activity///plasma 
membrane///peptide transport 
Afu2g17780 2.379672 1.973376 2.608322 hypothetical protein  
Afu7g01930 2.362303 2.264808 2.883049 sexual development 
protein EsdC, 
putative 
GTP binding 
Afu7g01490 2.343722 3.670149 4.50575 MFS peptide 
transporter, putative 
peptide transporter 
activity///plasma 
membrane///peptide transport 
Afu6g03230 2.301067 3.139545 1.81531 cell wall glucanase, 
putative 
hydrolase activity, hydrolyzing O-
glycosyl compounds///cellular 
glucan metabolic process///fungal-
type cell wall 
Afu5g06290 2.300585 1.57533 2.879125 MFS transporter, 
putative 
nicotinamide mononucleotide 
transport///nicotinamide 
mononucleotide permease 
activity///integral to plasma 
membrane///transporter 
activity///transport 
Afu6g00160 2.287963 1.612811 2.412885 Ser/Thr protein 
phosphatase family 
protein 
phosphate metabolic 
process///phosphoric ester 
hydrolase activity///fungal-type 
vacuole 
Afu6g14440 2.28792 3.410211 4.332058 MFS monosaccharide 
transporter, putative 
response to glucose 
stimulus///plasma 
membrane///glucose 
transmembrane transporter 
activity///signal 
transduction///glucose 
binding///receptor activity 
Afu8g02130 2.28665 3.44073 2.971659 1,3-beta-
glucanosyltransferase
, putative 
cell wall organisation///cellular 
glucan metabolic process///"1,3-
beta-glucanosyltransferase 
activity"///anchored to plasma 
membrane 
Afu6g00430 2.283747 2.252905 3.478899 IgE-binding protein  
Afu5g07250 2.237775 1.718106 1.650559 DUF300 domain 
protein, putative 
 
Afu6g13710 2.232682 2.269822 2.409657 hypothetical protein  
Afu1g15940 2.10417 1.667671 1.754036 Auxin Efflux Carrier 
superfamily 
endoplasmic reticulum///biological 
process unknown///molecular 
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function unknown 
Afu6g03260 2.095991 1.834628 2.978108 aspartic 
endopeptidase (AP1), 
putative 
aspartic-type endopeptidase 
activity///protein metabolic process 
Afu2g03510 2.095412 2.601344 3.272029 pheromone 
processing 
carboxypeptidase 
(Sxa2), putative 
trans-Golgi 
network///carboxypeptidase D 
activity///protein 
processing///pheromone-dependent 
signal transduction involved in 
conjugation with cellular fusion 
Afu1g11060 2.093834 1.898946 2.105986 ubiquitin domain 
protein, putative 
protein tagging activity 
Afu2g17480 2.075763 2.844162 1.691341 amino acid 
transporter, putative 
 
Afu5g10320 2.041693 2.750266 2.635519 toxin biosynthesis 
protein (GliH), 
putative 
 
Afu4g10150 2.007181 2.48935 3.190924 alpha-glucosidase alpha-glucosidase activity///fungal-
type cell wall 
biogenesis///endoplasmic reticulum 
Afu8g06560 1.984356 2.355302 3.511185 DUF895 domain 
membrane protein 
 
Afu6g07750 1.912118 1.993151 2.4586 MFS phospholipid 
transporter (Git1), 
putative 
phospholipid transporter 
activity///phospholipid 
transport///plasma membrane 
Afu5g10350 1.886612 3.16846 3.590186 conserved 
hypothetical protein 
 
Afu1g02730 1.885592 1.826359 1.82254 mitochondrial 
phosphate carrier 
protein (Ptp), putative 
mitochondrial envelope///inorganic 
phosphate transmembrane 
transporter 
activity///mitochondrion///phosphat
e transport 
Afu3g08990 1.872484 2.080799 2.092822 hypothetical protein  
Afu2g15240 1.823145 3.90622 5.275664 small oligopeptide 
transporter, OPT 
family 
sulfur metabolic 
process///oligopeptide transporter 
activity///integral to plasma 
membrane///endoplasmic reticulum 
Afu5g10340 1.819392 2.310857 2.194829 MFS transporter, 
putative 
membrane///transporter 
activity///transport 
Afu3g00470 1.781531 4.620455 5.052703 endo-1,4-beta-
xylanase, putative 
xylan metabolic process 
Afu8g06870 1.758739 2.950008 3.317154 MFS sugar 
transporter, putative 
mannose transmembrane 
transporter activity///hexose 
transport///fructose transmembrane 
transporter activity///plasma 
membrane///glucose 
transmembrane transporter activity 
Afu3g00560 1.748148 2.19679 1.513076 conserved 
hypothetical protein 
 
Afu6g14020 1.714603 2.277314 2.925721 conserved 
hypothetical protein 
 
Afu6g00220 1.694713 2.450534 2.411222 fungal specific 
transcription factor, 
putative 
transcription factor 
activity///nucleus///regulation of 
transcription 
Afu2g17730 1.668651 2.508534 3.165124 MFS multidrug 
transporter, putative 
integral to plasma 
membrane///multidrug transporter 
activity///response to toxin 
Afu2g00180 1.651918 2.351271 2.351043 neutral amino acid 
permease 
 
Afu3g02970 1.635816 4.987893 4.891337 aspergillopepsin, 
putative 
 
Afu5g06670 1.592823 2.238361 2.820534 related to L-fucose  
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permease, putative 
Afu2g10690 1.583959 2.539124 3.414005 MFS phosphate 
transporter, putative 
integral to plasma 
membrane///inorganic phosphate 
transmembrane transporter 
activity///phosphate transport 
Afu6g10160 1.57446 3.416952 2.119306 hypothetical protein  
Afu3g13640 1.560996 2.265358 2.088059 extracellular serine-
rich protein 
 
Afu2g17770 1.503121 3.490145 3.710501 conserved 
hypothetical protein 
 
 
 
Table 4.18: 74 down-regulated ORFs in common for the 3 time points (4 hrs, 8 hrs and 16 hrs) of the 
ATCC46645 ΔpacC/ATCC46645 comparison. 
ORFs  T4 T8 T16 Description  Annotation  
Afu4g09320 -5.70488 -3.6869 -6.06983 antigenic dipeptidyl-
peptidase Dpp4 
proteolysis///serine-type 
peptidase 
activity///aminopeptidase activity 
Afu8g02550 -5.63989 -3.67786 -2.73562 Ptr2-like MFS 
peptide transporter, 
putative 
peptide transporter 
activity///plasma 
membrane///peptide transport 
Afu8g01850 -5.48612 -2.47323 -3.55294 phosphate-repressible 
phosphate permease 
sodium:inorganic phosphate 
symporter activity///plasma 
membrane///phosphate transport 
Afu6g13750 -5.45038 -4.1642 -5.5474 ferric-chelate 
reductase, putative 
ferric-chelate reductase 
activity///transition metal ion 
transport///integral to membrane 
Afu3g03010 -5.35211 -2.98665 -2.88884 phosphate-repressible 
phosphate permease 
sodium:inorganic phosphate 
symporter activity///plasma 
membrane///phosphate transport 
Afu8g02450 -5.13943 -3.62022 -4.96588 hypothetical protein  
Afu6g12240 -4.95213 -4.27884 -5.18859 Glycerophosphoryl 
diester 
phosphodiesterase 
family family 
 
Afu5g01580 -4.89919 -1.80796 -3.66114 oxidoreductase, short 
chain 
dehydrogenase/reduct
ase family 
 
Afu3g14030 -4.81041 -3.75299 -3.91879 alkaline phosphatase  
Afu6g13840 -4.18974 -1.79254 -1.62686 conserved 
hypothetical protein 
 
Afu2g09450 -4.14543 -4.46141 -4.48151 carboxylic acid 
transport protein 
lactate transmembrane transporter 
activity///lactate 
transport///plasma membrane 
Afu6g14500 -4.11452 -3.69359 -2.59179 MFS sugar 
transporter, putative 
mannose transmembrane 
transporter activity///hexose 
transport///fructose 
transmembrane transporter 
activity///plasma 
membrane///glucose 
transmembrane transporter 
activity 
Afu1g16250 -3.98608 -1.86471 -1.9136 alpha-glucosidase B alpha-glucosidase 
activity///fungal-type cell wall 
biogenesis///endoplasmic 
reticulum 
Afu3g11970 -3.9454 -2.86591 -3.86937 C2H2 transcription 
factor PacC, putative 
negative regulation of 
transcription from RNA 
polymerase II promoter///specific 
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transcriptional repressor 
activity///cytoplasm///nucleus///re
sponse to pH 
Afu4g00930 -3.89543 -2.73872 -3.68476 CorA family metal 
ion transporter, 
putative 
di-, tri-valent inorganic cation 
transmembrane transporter 
activity///plasma membrane///"di-
, tri-valent inorganic cation 
transport"///magnesium ion 
transport 
Afu3g07910 -3.87473 -2.69264 -3.09276 UDP-glucose 4-
epimerase, putative 
cellular component 
unknown///UDP-glucose 4-
epimerase activity///galactose 
metabolic process 
Afu6g00470 -3.8478 -2.43813 -3.05478 plasma membrane 
zinc ion transporter, 
putative 
high-affinity zinc ion 
transport///integral to plasma 
membrane///high affinity zinc 
uptake transmembrane 
transporter activity 
Afu7g00580 -3.83554 -3.25568 -4.67765 conserved 
hypothetical protein 
 
Afu7g00450 -3.53704 -2.76433 -3.10848 GPI anchored 
protein, putative 
 
Afu8g07080 -3.50607 -4.1299 -7.06079 elastinolytic 
metalloproteinase 
Mep 
pathogenesis///endopeptidase 
activity 
Afu3g00490 -3.43907 -2.56088 -3.98654 C6 finger domain 
protein, putative 
 
Afu4g09990 -3.33982 -3.09717 -3.52317 Nucleoside 
transporter family 
nucleoside 
transport///intracellular///nucleosi
de transmembrane transporter 
activity///membrane 
Afu5g01570 -3.30705 -2.19541 -3.33579 hypothetical protein  
Afu3g07870 -3.2583 -2.58044 -3.08684 extracellular serine-
rich protein 
 
Afu4g09580 -3.21865 -2.25343 -2.20607 major allergen Asp 
F2 
biological process 
unknown///molecular function 
unknown 
Afu2g07840 -3.18255 -1.80366 -2.73814 competence/damage-
inducible protein 
CinA, putative 
 
Afu3g03000 -3.03972 -1.69699 -2.63717 phosphatidylethanola
mine-binding protein, 
putative 
 
Afu8g06880 -2.98178 -2.70623 -2.9835 pectin 
methylesterase, 
putative 
pectin catabolic 
process///pectinesterase activity 
Afu8g00980 -2.91964 -2.04418 -2.34145 hypothetical protein  
Afu4g09560 -2.88717 -2.23687 -2.91824 ZIP Zinc transporter, 
putative 
low-affinity zinc ion 
transmembrane transporter 
activity///low-affinity zinc ion 
transport///plasma membrane 
Afu2g01320 -2.85971 -2.44687 -2.62818 P-type ATPase, 
putative 
sodium ion transport///plasma 
membrane///"ATPase activity, 
coupled to transmembrane 
movement of ions, 
phosphorylative mechanism" 
Afu4g00750 -2.82259 -2.86946 -3.5066 hypothetical protein  
Afu2g00720 -2.8001 -2.92199 -2.97175 aldehyde 
dehydrogenase, 
putative 
aldehyde dehydrogenase (NAD) 
activity///fermentation///mitochon
drion 
Afu7g01030 -2.78931 -1.68384 -1.60965 Calcium-transporting 
ATPase 1 (PMC1), 
calcium ion transport///fungal-
type vacuole membrane///cellular 
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putative calcium ion 
homeostasis///calcium-
transporting ATPase activity 
Afu3g10690 -2.76171 -2.36651 -3.77666 calcium-translocating 
P-type 
ATPase(PMCA-
type),putative 
calcium ion transport///cellular 
calcium ion 
homeostasis///calcium-
transporting ATPase activity 
Afu5g10250 -2.74254 -1.60641 -3.38493 hypothetical protein  
Afu4g09440 -2.7356 -2.04896 -1.70613 sodium P-type 
ATPase, putative 
sodium ion transport///plasma 
membrane///"ATPase activity, 
coupled to transmembrane 
movement of ions, 
phosphorylative mechanism" 
Afu2g09030 -2.7325 -2.51411 -3.13085 secreted dipeptidyl 
peptidase 
proteolysis///serine-type 
peptidase activity 
Afu7g06160 -2.6903 -2.23403 -1.68728 hypothetical protein  
Afu7g05610 -2.65728 -2.40367 -2.88316 glucanase, putative  
Afu6g13760 -2.5832 -2.2536 -2.55726 alpha-1,2-
mannosidase, 
putative subfamily 
 
Afu4g01560 -2.56994 -3.05494 -4.91541 MFS myo-inositol 
transporter, putative 
membrane///myo-inositol 
transport///myo-inositol 
transmembrane transporter 
activity 
Afu5g00870 -2.53523 -1.90113 -3.24655 hypothetical protein  
Afu8g01030 -2.53032 -2.9141 -2.53425 hypothetical protein  
Afu4g09310 -2.5043 -2.76968 -3.89044 hypothetical protein  
Afu8g06960 -2.47942 -2.85947 -3.43666 hypothetical protein  
Afu4g06650 -2.44872 -2.23717 -2.72098 hypothetical protein  
Afu6g03350 -2.40852 -3.59946 -4.50725 acetyltransferase, 
GNAT family, 
putative 
N-acetyltransferase 
activity///metabolic process 
Afu1g10460 -2.40156 -1.50526 -2.15278 hypothetical protein  
Afu5g00790 -2.39026 -2.76225 -3.68673 ABC multidrug 
transporter, putative 
ATP-binding cassette (ABC) 
transporter activity///ATP 
binding///transport 
Afu8g01400 -2.37446 -1.96089 -1.59242 mitochondrial carrier 
protein (Pet8), 
putative 
S-adenosylmethionine 
transmembrane transporter 
activity///mitochondrial inner 
membrane///S-
adenosylmethionine 
transport///mitochondrion 
Afu3g07900 -2.35902 -1.77246 -2.56435 conserved 
hypothetical protein 
 
Afu4g08840 -2.25856 -2.9668 -2.17697 RING finger domain 
protein, putative 
zinc ion binding 
Afu6g03460 -2.24279 -1.65175 -3.10588 hypothetical protein  
Afu2g14490 -2.22677 -4.64428 -4.74212 endoglucanase, 
putative 
 
Afu3g08130 -2.19257 -1.96609 -2.49794 hypothetical protein  
Afu7g00440 -2.17307 -2.4214 -2.77414 GABA permease, 
putative 
plasma membrane///choline 
transport///choline 
transmembrane transporter 
activity 
Afu6g11390 -2.10708 -2.45351 -3.3174 1,3-beta-
glucanosyltransferase 
Gel2 
cell wall organisation///fungal-
type cell wall///"1,3-beta-
glucanosyltransferase activity" 
Afu3g13600 -2.07268 -1.86632 -2.05877 C6 transcription 
factor, putative 
transcription factor 
activity///nucleus///zinc ion 
binding///regulation of 
transcription 
Afu4g13760 -2.04993 -2.0473 -3.66204 hypothetical protein  
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Afu8g07340 -2.04659 -2.61429 -2.69408 HET domain protein  
Afu3g00770 -2.03269 -2.90049 -2.9231 hypothetical protein  
Afu4g08850 -1.95902 -1.88833 -1.92419 hypothetical protein  
Afu2g14540 -1.94557 -2.0974 -1.81869 endoglucanase, 
putative 
 
Afu8g02660 -1.93589 -2.39552 -2.72212 chromate ion 
transporter, putative 
chromate transport///chromate 
transmembrane transporter 
activity 
Afu6g00140 -1.89921 -2.3289 -2.24832 hypothetical protein  
Afu3g10500 -1.86875 -2.1834 -2.772 hypothetical protein  
Afu5g11190 -1.7936 -1.76659 -2.89347 hypothetical protein  
Afu8g02440 -1.7788 -2.02111 -2.56518 C-4 methyl sterol 
oxidase, putative 
plasma membrane///ergosterol 
biosynthetic 
process///endoplasmic reticulum 
membrane///C-4 methylsterol 
oxidase activity 
Afu5g02990 -1.73048 -2.01029 -2.89557 aromatic amino acid 
aminotransferase, 
putative 
aromatic amino acid family 
metabolic 
process///cytoplasm///aromatic-
amino-acid:2-oxoglutarate 
aminotransferase activity 
Afu8g02670 -1.67504 -1.7847 -2.06379 conserved 
hypothetical protein 
 
Afu2g07910 -1.67143 -1.62151 -1.65005 myo-inositol 
transporter 
membrane///myo-inositol 
transport///myo-inositol 
transmembrane transporter 
activity 
Afu2g12680 -1.58025 -3.39852 -4.33782 conserved 
hypothetical protein 
 
Afu1g17150 -1.51031 -2.19274 -2.08193 C6 transcription 
factor, putative 
carbohydrate metabolic 
process///"regulation of 
transcription, DNA-
dependent"///transcription factor 
activity///nucleus 
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According to the expanded functional classifications generated for this study, GO 
analysis of the differentially expressed genes (fold change cut off of ±1.5 on a log2 scale) was 
performed using Genespring GX 11.02. Table 4.19 and Table 4.20 show the GO terms, which 
satisfy an imposed p-value cut-off of 0.05 respectively among the up-regulated and down-
regulated genes, with respect to their occurrence in the A. fumigatus genome. Aiming to 
identify the phase-specific biological categories enriched among the differentially expressed 
genes, GO terms are reported for both the entire differentially expressed geneset and on the 
genesets for each of the single time points (4, 8 and 16 hrs). Transport across the plasma 
membrane is strikingly affected by pacC deletion and many transporters are therefore 
differentially expressed on the in the ATCC46645 ΔpacC relative to the parental strain 
ATCC466645 during initiation of murine infection. While sugar transporters predominate 
among genes upregulated in the ATCC46645 ΔpacC mutant relative to the parental strain, 
metal ion transporters predominate among down-regulated genes, such as those transporting 
iron, calcium and sodium.   
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Total up-regulated genes in the ATCC46645 ΔpacC /ATCC46645 analysis 
GO ACCESSION GO Term p-value corrected p-
value 
Count in 
Selection 
% Count in 
Selection 
Count in 
Total 
% Count in 
Total 
GO:0005215|GO:0005478 transporter activity 2.556894E-13 2.617588E-9 20 25.974026 525 11.677046 
GO:0005886|GO:0005904 plasma membrane 3.1958737E-12 1.6358676E-8 48 62.33766 315 7.006228 
GO:0022857|GO:0005386
|GO:0015646 
transmembrane transporter activity 8.949631E-9 3.054024E-5 1 1.2987013 354 7.8736653 
GO:0016020 membrane 1.1439736E-7 2.9278212E-4 60 77.92208 816 18.149466 
GO:0031226 intrinsic to plasma membrane 1.7446146E-7 3.5720543E-4 17 22.077923 95 2.1129894 
GO:0044459 plasma membrane part 1.081094E-6 0.0013834452 17 22.077923 114 2.535587 
GO:0004553|GO:0016800 hydrolase activity, hydrolyzing O-glycosyl 
compounds 
1.7424368E-6 0.0019819974 8 10.38961 91 2.0240214 
GO:0005975 carbohydrate metabolic process 1.3817783E-5 0.01414578 6 7.7922077 292 6.494662 
GO:0005887 integral to plasma membrane 1.5841506E-5 0.014743219 17 22.077923 87 1.9350533 
GO:0016798 hydrolase activity, acting on glycosyl bonds 4.1193092E-5 0.03514242 9 11.688312 112 2.4911032 
GO:0005529 sugar binding 6.715382E-5 0.038193263 4 5.194805 5 0.111209966 
GO:0005536 glucose binding 6.715382E-5 0.038193263 4 5.194805 5 0.111209966 
GO:0009746 response to hexose stimulus 6.715382E-5 0.038193263 4 5.194805 5 0.111209966 
GO:0009749 response to glucose stimulus 6.715382E-5 0.038193263 4 5.194805 5 0.111209966 
GO:0034284 response to monosaccharide stimulus 6.715382E-5 0.038193263 4 5.194805 5 0.111209966 
GO:0048029 monosaccharide binding 6.715382E-5 0.038193263 4 5.194805 5 0.111209966 
4 hrs up-regulated genes in the ATCC46645 ΔpacC /ATCC46645 analysis 
GO ACCESSION GO Term p-value corrected p-
value 
Count in 
Selection 
% Count in 
Selection 
Count in 
Total 
% Count in 
Total 
GO:0005886|GO:0005904 plasma membrane 3.2131474E-8 2.1500605E-4 15 100.0 315 7.006228 
8 hrs up-regulated genes in the ATCC46645 ΔpacC /ATCC46645 analysis 
GO ACCESSION GO Term p-value corrected p-
value 
Count in 
Selection 
% Count in 
Selection 
Count in 
Total 
% Count in 
Total 
GO:0005886|GO:0005904 plasma membrane 2.7505406E-11 1.0179134E-7 27 57.446808 315 7.006228 
GO:0005215|GO:0005478 transporter activity 9.147836E-11 1.6927045E-7 10 21.276596 525 11.677046 
GO:0022892 substrate-specific transporter activity 6.1910434E-8 7.637221E-5 3 6.382979 357 7.9403915 
GO:0022857|GO:0005386
|GO:0015646 
transmembrane transporter activity 2.3556998E-7 2.1794793E-4 3 6.382979 354 7.8736653 
GO:0022891 substrate-specific transmembrane transporter activity 6.477588E-7 4.79442E-4 3 6.382979 317 7.0507116 
GO:0031226 intrinsic to plasma membrane 2.1938467E-6 0.0013531558 11 23.404255 95 2.1129894 
GO:0016020 membrane 7.2993053E-6 0.003859013 29 61.70213 816 18.149466 
GO:0000322 storage vacuole 1.559729E-5 0.004123005 9 19.148935 95 2.1129894 
GO:0000323 lytic vacuole 1.559729E-5 0.004123005 9 19.148935 95 2.1129894 
GO:0000324 fungal-type vacuole 1.559729E-5 0.004123005 9 19.148935 95 2.1129894 
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GO:0005976 polysaccharide metabolic process 1.4402617E-5 0.004123005 2 4.255319 115 2.5578291 
GO:0006811 ion transport 9.650219E-6 0.004123005 4 8.510638 132 2.9359431 
GO:0015082 di-, tri-valent inorganic cation transmembrane 
transporter activity 
1.1094846E-5 0.004123005 3 6.382979 40 0.88967973 
GO:0044459 plasma membrane part 1.3240378E-5 0.004123005 11 23.404255 114 2.535587 
GO:0046873 metal ion transmembrane transporter activity 3.8471688E-5 0.009491673 2 4.255319 48 1.0676156 
GO:0006810|GO:0015457
|GO:0015460 
transport 5.109021E-5 0.011817088 12 25.531916 774 17.215303 
GO:0015085 calcium ion transmembrane transporter activity 6.576237E-5 0.01355278 2 4.255319 12 0.2669039 
GO:0051234 establishment of localisation 6.591862E-5 0.01355278 12 25.531916 784 17.437723 
GO:0004553|GO:0016800 hydrolase activity, hydrolyzing O-glycosyl 
compounds 
7.032721E-5 0.013698169 5 10.638298 91 2.0240214 
GO:0051179 localisation 1.0037675E-4 0.018573591 12 25.531916 801 17.815836 
GO:0005773 vacuole 1.1074471E-4 0.019516254 9 19.148935 119 2.6467972 
GO:0015674 di-, tri-valent inorganic cation transport 1.2081563E-4 0.020323252 4 8.510638 40 0.88967973 
GO:0006816 calcium ion transport 1.289598E-4 0.020750057 4 8.510638 14 0.3113879 
GO:0004180 carboxypeptidase activity 2.5621933E-4 0.03792841 1 2.1276596 7 0.15569395 
GO:0005887 integral to plasma membrane 3.023021E-4 0.043028932 8 17.021276 87 1.9350533 
GO:0016798 hydrolase activity, acting on glycosyl bonds 3.4942618E-4 0.04789437 5 10.638298 112 2.4911032 
GO:0004339 glucan 1,4-alpha-glucosidase activity 3.9634787E-4 0.049839173 2 4.255319 2 0.044483986 
GO:0031225 anchored to membrane 4.040167E-4 0.049839173 3 6.382979 8 0.17793594 
GO:0046658 anchored to plasma membrane 4.040167E-4 0.049839173 3 6.382979 8 0.17793594 
16 hrs up-regulated genes in the ATCC46645 ΔpacC /ATCC46645 analysis 
GO ACCESSION GO Term p-value corrected p-
value 
Count in 
Selection 
% Count in 
Selection 
Count in 
Total 
% Count in 
Total 
GO:0005215|GO:0005478 transporter activity 3.3751432E-15 2.6466893E-11 25 40.322582 525 11.677046 
GO:0005886|GO:0005904 plasma membrane 7.858818E-13 3.0813283E-9 40 64.51613 315 7.006228 
GO:0022857|GO:0005386
|GO:0015646 
transmembrane transporter activity 6.496924E-10 1.6982331E-6 9 14.5161295 354 7.8736653 
GO:0022892 substrate-specific transporter activity 2.9585399E-9 5.8000023E-6 9 14.5161295 357 7.9403915 
GO:0022891 substrate-specific transmembrane transporter activity 1.3164447E-8 2.0646354E-5 9 14.5161295 317 7.0507116 
GO:0031226 intrinsic to plasma membrane 7.909516E-8 1.0337354E-4 14 22.580645 95 2.1129894 
GO:0016020 membrane 1.4121808E-7 1.5819875E-4 49 79.03226 816 18.149466 
GO:0004553|GO:0016800 hydrolase activity, hydrolyzing O-glycosyl 
compounds 
2.2975897E-7 2.2521288E-4 6 9.67742 91 2.0240214 
GO:0044459 plasma membrane part 1.3735781E-6 0.0011968 14 22.580645 114 2.535587 
GO:0016798 hydrolase activity, acting on glycosyl bonds 4.790316E-6 0.0037564265 7 11.290322 112 2.4911032 
GO:0005887 integral to plasma membrane 1.7249293E-5 0.010404918 14 22.580645 87 1.9350533 
GO:0005975 carbohydrate metabolic process 1.6606062E-5 0.010404918 5 8.064516 292 6.494662 
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GO:0006810|GO:0015457
|GO:0015460 
transport 1.5189253E-5 0.010404918 16 25.806452 774 17.215303 
GO:0051179 localisation 2.0952391E-5 0.0117358975 16 25.806452 801 17.815836 
GO:0051234 establishment of localisation 2.255319E-5 0.011790371 16 25.806452 784 17.437723 
GO:0005355|GO:0015579 glucose transmembrane transporter activity 5.9088194E-5 0.025741803 8 12.903226 33 0.7339858 
GO:0015145 monosaccharide transmembrane transporter activity 5.9088194E-5 0.025741803 8 12.903226 33 0.7339858 
GO:0015149 hexose transmembrane transporter activity 5.9088194E-5 0.025741803 8 12.903226 33 0.7339858 
GO:0031224 intrinsic to membrane 6.44668E-5 0.02660684 14 22.580645 251 5.5827403 
GO:0005976 polysaccharide metabolic process 1.0928889E-4 0.040810082 2 3.2258065 115 2.5578291 
  
Table 4.19: Significant GO terms among the up-regulated genes of the ATCC46645 ΔpacC/ATCC466645 comparison. p-value represents the probability of obtaining 
the GO term from a list of random entities, corrected p-value derived from Bonferroni testing of multiple comparisons. Analysis performed using Genespring GX 11.02.  
 
Total down-regulated genes in the ATCC46645 ΔpacC /ATCC46645 analysis 
GO ACCESSION GO Term p-value corrected p-
value 
Count in 
Selection 
% Count in 
Selection 
Count in 
Total 
% Count in 
Total 
GO:0005215|GO:0005478 transporter activity 2.5311437E-9 1.9870076E-5 15 29.411764 525 11.677046 
GO:0005886|GO:0005904 plasma membrane 9.274286E-9 3.640267E-5 26 50.980392 315 7.006228 
GO:0006810|GO:0015457
|GO:0015460 
transport 8.783157E-8 1.1407305E-4 17 33.333332 774 17.215303 
GO:0051234 establishment of localisation 6.156969E-8 1.1407305E-4 17 33.333332 784 17.437723 
GO:0051179 localisation 1.4760494E-7 1.448417E-4 17 33.333332 801 17.815836 
GO:0016020 membrane 5.949372E-5 0.038919978 33 64.70588 816 18.149466 
GO:0019184 nonribosomal peptide biosynthetic process 7.958824E-5 0.048060495 5 9.803922 11 0.24466193 
4 hrs down-regulated genes in the ATCC46645 ΔpacC /ATCC46645 analysis 
GO ACCESSION GO Term p-value corrected p-
value 
Count in 
Selection 
% Count in 
Selection 
Count in 
Total 
% Count in 
Total 
GO:0005215|GO:0005478 transporter activity 2.7621502E-7 4.5917497E-4 7 26.923077 525 11.677046 
GO:0005886|GO:0005904 plasma membrane 2.9486916E-6 0.0031683843 19 73.07692 315 7.006228 
GO:0006810|GO:0015457
|GO:0015460 
transport 3.55948E-6 0.0031683843 8 30.76923 774 17.215303 
GO:0051179 localisation 3.8118599E-6 0.0031683843 8 30.76923 801 17.815836 
GO:0051234 establishment of localisation 2.0431485E-6 0.0027171953 8 30.76923 784 17.437723 
8 hrs down-regulated genes in the ATCC46645 ΔpacC /ATCC46645 analysis 
GO ACCESSION GO Term p-value corrected p-
value 
Count in 
Selection 
% Count in 
Selection 
Count in 
Total 
% Count in 
Total 
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GO:0000041 transition metal ion transport 1.18887285E-4 0.026356254 2 8.695652 51 1.1343416 
GO:0005215|GO:0005478 transporter activity 1.964337E-6 7.257934E-4 7 30.434782 525 11.677046 
GO:0005436 sodium:phosphate symporter activity 2.3899628E-4 0.04182896 2 8.695652 2 0.044483986 
GO:0005886|GO:0005904 plasma membrane 1.7641414E-5 0.0048886808 15 65.21739 315 7.006228 
GO:0006810|GO:0015457
|GO:0015460 
transport 1.348755E-6 6.4072927E-4 6 26.086956 774 17.215303 
GO:0006811 ion transport 7.912988E-11 2.631359E-7 2 8.695652 132 2.9359431 
GO:0006812|GO:0006819 cation transport 5.356705E-8 3.5626017E-5 2 8.695652 106 2.3576512 
GO:0015075 ion transmembrane transporter activity 1.4707778E-5 0.004446251 5 21.73913 149 3.3140569 
GO:0015082 di-, tri-valent inorganic cation transmembrane 
transporter activity 
2.8995273E-5 0.007416917 1 4.347826 40 0.88967973 
GO:0015296 anion:cation symporter activity 2.3899628E-4 0.04182896 2 8.695652 2 0.044483986 
GO:0015319 sodium:inorganic phosphate symporter activity 2.3899628E-4 0.04182896 2 8.695652 2 0.044483986 
GO:0015662 ATPase activity, coupled to transmembrane 
movement of ions, phosphorylative mechanism 
1.7512009E-4 0.036396157 2 8.695652 19 0.42259786 
GO:0016020 membrane 4.153547E-5 0.009865763 19 82.608696 816 18.149466 
GO:0022857|GO:0005386
|GO:0015646 
transmembrane transporter activity 2.0520172E-7 1.137285E-4 5 21.73913 354 7.8736653 
GO:0022891 substrate-specific transmembrane transporter activity 3.216616E-8 3.5626017E-5 5 21.73913 317 7.0507116 
GO:0022892 substrate-specific transporter activity 4.555204E-8 3.5626017E-5 5 21.73913 357 7.9403915 
GO:0030001 metal ion transport 7.107388E-9 1.1817336E-5 2 8.695652 71 1.5791816 
GO:0051179 localisation 2.7942067E-6 9.2917617E-4 6 26.086956 801 17.815836 
GO:0051234 establishment of localisation 1.7740875E-6 7.257934E-4 6 26.086956 784 17.437723 
16 hrs down-regulated genes in the ATCC46645 ΔpacC /ATCC46645 analysis 
GO ACCESSION GO Term p-value corrected p-
value 
Count in 
Selection 
% Count in 
Selection 
Count in 
Total 
% Count in 
Total 
GO:0005215|GO:0005478 transporter activity 1.056156E-7 2.630451E-4 9 31.034483 525 11.677046 
GO:0005886|GO:0005904 plasma membrane 4.2751494E-6 0.002366143 15 51.724136 315 7.006228 
GO:0006810|GO:0015457
|GO:0015460 
transport 1.4177001E-5 0.005432168 9 31.034483 774 17.215303 
GO:0015075 ion transmembrane transporter activity 5.1712872E-5 0.015152418 1 3.4482758 149 3.3140569 
GO:0015082 di-, tri-valent inorganic cation transmembrane 
transporter activity 
3.9102913E-5 0.012173665 1 3.4482758 40 0.88967973 
GO:0019184 nonribosomal peptide biosynthetic process 3.1439588E-6 0.001957578 5 17.241379 11 0.24466193 
GO:0022857|GO:0005386
|GO:0015646 
transmembrane transporter activity 2.428222E-6 0.0017279156 1 3.4482758 354 7.8736653 
GO:0022891 substrate-specific transmembrane transporter activity 1.268885E-6 0.001053424 1 3.4482758 317 7.0507116 
GO:0022892 substrate-specific transporter activity 7.7334255E-7 9.658953E-4 1 3.4482758 357 7.9403915 
GO:0043041 amino acid activation for nonribosomal peptide 2.1239788E-5 0.00705328 4 13.793103 8 0.17793594 
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biosynthetic process 
GO:0043042 amino acid adenylylation by nonribosomal peptide 
synthase 
2.1239788E-5 0.00705328 4 13.793103 8 0.17793594 
GO:0043043 peptide biosynthetic process 8.424223E-6 0.0038147788 5 17.241379 13 0.28914592 
GO:0051179 localisation 1.22373995E-5 0.005079724 9 31.034483 801 17.815836 
GO:0051234 establishment of localisation 7.2663747E-6 0.0036195116 9 31.034483 784 17.437723 
 
Table 4.20: Significant GO terms among the down-regulated genes of the ATCC46645 ΔpacC/ATCC466645 comparison. p-value represents the probability of 
obtaining the GO term from a list of random entities, corrected p-value derived from Bonferroni testing of multiple comparisons. Analysis performed using Genespring GX 11.02.  
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Functional classification of differentially expressed genes (fold change cut off of ±1.5 
on a log2 scale) was also annotated in a non-automated manner by reference to the literature to 
further identify functional trends within the up-regulated and down-regulated genes. The 
entire datasets of up-regulated (729 ORFs) and down-regulated (762 ORFs) genes in the 
ATCC46645 ΔpacC/ATCC46645 comparison were analysed and a summary is provided in 
Tables 4.21 and 4.22. Interestingly, the transcriptional profile of the A. fumigatus ΔpacC 
mutant aligns with the acidic-mimicking profile, according to which the prevention or the 
reduction of growth at alkaline pH corresponds to the increase of GABA transport and acid 
phosphatase levels and the decrease of alkaline phosphatase, molybdate hypersensitivity and 
neomycin resistance, is shown by the acidity-mimicking mutations.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
205 
 
Functional classification of selected up-regulated genes in the ATCC46645 ΔpacC/ATCC46645 comparison  
Transport  Metabolism 
Afu6g13190 
Afu3g14170 
Afu3g12170 
Afu4g01360 
Afu1g01800 
Afu1g03730 
Afu6g12900 
Afu6g03060 
Afu5g02700 
Afu7g00910 
Afu5g01320 
Afu1g05170 
Afu3g13670 
Afu3g03700 
Afu8g00720 
Afu1g17480 
Afu8g06580 
Afu3g11790 
Afu2g05320 
Afu6g02400 
Afu4g00150 
Afu6g14440 
Afu4g13660 
Afu2g17730 
Afu3g01940 
Afu1g12240 
Afu7g01490 
Afu2g10690 
Afu8g06870 
Afu4g01480 
Afu7g04570 
Afu8g07200 
Afu8g00770 
Afu4g09150 
Afu5g04260 
Afu8g06560 
Afu6g04270 
Afu8g06760 
Afu8g06410 
Afu6g07750 
Afu3g04010 
H+/nucleoside cotransporter 
high-affinity hexose transporter 
MFS sugar transporter 
MFS transporter of unkown specificity 
MFS transporter 
MFS transporter 
mitochondrial carrier protein 
monosaccharide transporter 
multidrug resistant protein 
peptide transporter MTD1 
phosphate permease 
related to monocarboxylate transporter 
siderochrome-iron transporter 
Sugar transporter subfamily  
amino acid transporter 
conserved hypothetical protein 
GABA permease 
galactose-proton symport 
ion transporter 
MFS drug efflux pump 
MFS maltose transporter 
MFS monosaccharide transporter 
MFS multidrug resistance transporter 
MFS multidrug transporter 
MFS multidrug transporter 
MFS peptide transporter 
MFS peptide transporter 
MFS phosphate transporter 
MFS sugar transporter 
MSF transporter, putative 
Na/K ATPase alpha 1 subunit 
neutral amino acid permease 
sugar transporter family protein 
ABC multidrug 
arginine transporter 
DUF895 domain membrane protein 
fructose symporter 
integral membrane protein 
MFS multidrug transporter 
MFS phospholipid transporter (Git1) 
MFS transporter 
Afu2g01410 
Afu5g14510 
Afu2g01230 
Afu2g00140 
Afu8g00640 
Afu2g04080 
Afu7g06380 
Afu3g02640 
Afu5g11240 
Afu2g14460 
Afu4g13780 
Afu7g00150 
Afu8g00680 
Afu5g14340 
Afu8g04120 
Afu4g10140 
Afu1g00480 
Afu8g04070 
Afu4g06620 
Afu4g13120 
Afu8g02040 
Afu1g01430 
Afu6g12930 
Afu1g11280 
Afu1g10630 
Afu4g14800 
Afu6g00230 
Afu3g14920 
Afu4g11720 
Afu4g10790 
Afu1g10130 
Afu5g13090 
Afu2g11620 
Afu1g11250 
Afu8g06970 
Afu7g06900 
Afu6g11670 
Afu5g07210 
Afu2g11920 
Afu6g00260 
Afu5g14810 
aldo-keto reductase 
beta-lactamase 
dihydrodipicolinate synthetase family protein 
FAD monooxygenase 
glycosyl transferase 
GPR/FUN34 family protein 
maltase 
nucleoside-diphosphate-sugar epimerase family protein 
oxidoreductase, short chain dehydrogenase/reductase family 
oxidoreductase, short-chain dehydrogenase/reductase family 
polyphenol monooxygenase 
FAD-dependent monooxygenase 
glycosyl transferase, group 2 family protein 
oxidoreductase, short-chain dehydrogenase/reductase family 
carboxypeptidase S1 
glucoamylase 
glucosamine-6-phosphate deaminase 
glucosamine-6-phosphate deaminase 
Glutamate/Leucine/Phenylalanine/Valine dehydrogenase 
glutamine synthetase 
glycosyl transferase 
hypothetical protein 
mitochondrial aconitate hydratase 
oxidoreductase 
S-adenosylmethionine synthetase 
short chain dehydrogenase 
isoflavone reductase family protein 
LaeA-like methyltransferase 
phosphatidyl synthase 
phosphoribosyl diphosphate synthase isoform 4 
adenosylhomocysteinase 
alpha-1,2-mannosyltransferase 
alpha-glucosidase 
amidohydrolase 
beta-glucosidase 
branched-chain amino acid aminotransferase 
conserved hypothetical protein 
homoserine O-acetyltransferase 
hypothetical protein 
phosphatidylserine decarboxylase family protein 
pyruvate decarboxylase 
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Afu2g03860 
Afu5g06670 
Afu7g06570 
Afu5g11840 
Afu7g01720 
Afu8g05710 
Afu6g00630 
Afu6g12550 
Afu1g10310 
Afu6g13070 
Afu2g13390 
Afu5g06290 
Afu7g04730 
plasma membrane low affinity zinc ion transporter 
related to L-fucose permease 
zinc/cadmium resistance protein 
protein kinase 
3-hydroxymethyl-3-methylglutaryl-Coenzyme A lyase 
autophagy protein Apg6, putative (MFS sugar transporter Stl1) 
MFS transporter 
mitochondrial carrier protein 
RNase L inhibitor of the ABC superfamily 
UDP-galactose transporter  
MFS transporter 
MFS transporter 
siderochrome-iron transporter 
Lipid metabolism 
Afu3g09960 
Afu4g14150 
Afu3g01950 
Afu1g00420 
Afu7g04950 
Afu1g11890 
Afu5g01340 
Afu6g03370 
Afu4g08440 
aureobasidin resistance protein Aur1 
Diacylglycerol acyltransferase family  
alcohol dehydrogenase, zinc-containing 
carboxypeptidase S1 
lipase 
serine palmitoyltransferase 2 lysophospholipase 
oxidoreductase, short-chain dehydrogenase/reductase family 
Patatin-like serine hydrolase 
Protein synthesis/degradation 
Afu6g13180 
Afu7g06840 
Afu6g06460 
Afu6g00310 
Afu6g03260 
Afu2g09820 
Afu2g03510 
Afu4g14000 
Afu1g11060 
Afu5g02400 
CECR1 family adenosine deaminase 
class III aminotransferase 
fumarylacetoacetate hydrolase family protein  
serine carboxypeptidase (CpdS)  
aspartic endopeptidase (AP1), putative 
conserved hypothetical protein 
pheromone processing carboxypeptidase (Sxa2), 
tripeptidyl peptidase A 
ubiquitin domain protein 
catabolite degradation protein 
Antigens/cell surface proteins 
Afu3g08990 
Afu6g00430 
Afu7g04930 
hypothetical protein 
IgE-binding protein 
alkaline serine protease (PR1) 
Pathogenesis 
Afu5g00980 
Afu5g00600 
multidrug resistant protein  
NPP1 domain protein 
Secondary metabolism 
Afu2g14470 
Afu6g12110 
Afu3g13240 
Afu5g13300 
Afu3g00470 
Afu3g03350 
Afu1g13660 
Afu3g12620 
oxidoreductase, FAD-binding 
salicylate synthetase  
aldose 1-epimerase 
aspartic endopeptidase Pep1 
endo-1,4-beta-xylanase 
nonribosomal peptide synthase SidE 
phenol 2-monooxygenase  
acyl-CoA:6-aminopenicillanic-acid-acyltransferase 
RNA processing 
Afu1g06980 
Afu3g04310 
Afu5g13040 
Afu1g15340 
Afu7g05430 
Afu3g06010 
Afu4g07580 
mitochondrial small ribosomal subunit protein S4 
snoRNA binding protein 
translation initiation factor eif-2b delta subunit 
polymerase  
nonsense-mediated mRNA decay factor (Upf2) 
Nucleolar essential protein 1 
translation initiation factor EF-2 gamma subunit 
Stress Transcription 
Afu3g14540 heat shock protein HSP30 Afu1g06900 
Afu4g12470 
Afu3g11330 
Afu3g05760 
Afu3g10120 
Afu3g10620 
Afu1g01850 
Afu5g03430 
Afu3g11250 
Afu4g10120 
Afu8g04810 
Afu3g08160 
C2H2 transcription factor (Crz1)  
bZIP transcription factor CpcA  
bZIP transcription factor (AtfA) 
C6 transcription factor (Fcr1) 
TATA-box binding protein 
transcription initiation protein 
hypothetical protein  
PHD transcription factor (Rum1) 
C2H2 transcription factor (Swi5)  
C6 finger domain protein 
casein kinase 
eukaryotic translation initiation factor eIF4A 
Cell wall 
Afu6g10580 
Afu7g05140 
Afu6g14480 
Afu8g00700 
Afu2g09350 
Afu2g00680 
Afu1g05790 
Afu6g10130 
Afu2g00430 
antigenic CFEM domain protein 
class III chitinase  
alpha-1,3-mannosyltransferase 
class III chitinase ChiA2 
endo-beta-1,6-glucanase 
glycosyl hydrolase 
GPI anchored serine-rich protein 
N,O-diacetyl muramidase  
exo-beta-1,3-glucanase 
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Afu1g01730 
Afu7g05370 
Afu4g10150 
Afu5g08580 
Afu5g02280 
Afu4g08960 
Afu1g12900 
glycosyl hydrolase 
septin AspB 
alpha-glucosidase 
alpha-1,6-mannosyltransferase subunit (Och1) 
endo-1,3(4)-beta-glucanase 
GPI anchored protein 
Leucine Rich Repeat domain protein 
Development and morphogenesis 
Afu7g01930 
Afu5g06190 
sexual development protein EsdC 
sexual development transcription factor SteA 
Endo/exocytosis 
Afu1g10950 
Afu3g09360 
Afu6g00640 
Afu5g09020 
vesicle-mediated transport protein Vid24 
vacuolar sorting ATPase  
Vps4 integral membrane protein 
WSC domain protein 
 
Table 4.21: Functional classification of selected genes having increased abundance in the ATCC46645 ΔpacC mutant relative to the parental isolate 
ATCC46645 during initiation of murine infection. Genes were included if showing a fold change of ±1.5 on a log2 scale in at least one of the time points. 
   
Functional classification of selected down-regulated genes in the ATCC46645 ΔpacC/ATCC46645 comparison  
Transport  Energy production 
Afu3g03670 
Afu3g12220 
Afu7g04970 
Afu8g01310 
Afu3g03640 
Afu7g06060 
Afu4g00930 
Afu6g00470 
Afu4g01570 
Afu7g01030  
Afu2g15150  
Afu7g00780  
ABC multidrug transporter, putative 
ABC transporter, putative 
metalloreductase, putative  
metalloreductase, putative  
siderochrome-iron transporter (MirB), putative 
siderochrome-iron transporter (Sit1), putative 
CorA family metal ion transporter 
plasma membrane zinc ion transporter 
neutral amino acid permease 
Calcium-transporting ATPase 1 (PMC1)  
choline transport protein  
MFS monocarboxylate transporter  
Afu5g09140 
Afu4g09980 
Afu8g00960  
Afu4g07150 
Afu2g13010  
Afu1g13480  
Afu7g02030 
amidase, putative 
cytochrome P450 monooxygenase 
cytochrome P450, putative  
cytochrome-c oxydase chain VIIc-like protein  
cytochrome c oxidase polypeptide  
vib ubiquinol-cytochrome C reductase complex subunit  
UcrQ cytochrome c oxidase assembly protein (Pet117) 
Ergosterol biosynthesis 
Afu8g02440 
Afu1g03150 
Afu1g05720 
C-4 methyl sterol oxidase  
c-14 sterol reductase  
c-14 sterol reductase 
Metabolism 
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Afu6g02220  
Afu3g01370  
Afu3g03010  
Afu8g01850  
Afu8g02550  
Afu4g09440  
Afu3g12740 
Afu3g07300 
Afu5g00790 
Afu8g02660 
Afu4g00750 
Afu6g03140 
Afu4g01560 
Afu7g00710 
Afu2g09450 
Afu7g00440 
Afu2g07910 
Afu4g09990 
Afu2g03000 
Afu2g01320 
Afu4g09560 
MFS toxin efflux pump  
MFS transporter  
phosphate-repressible phosphate permease  
phosphate-repressible phosphate permease  
Ptr2-like MFS peptide transporter 
sodium P-type ATPase  
copper resistance-associated P-type ATPase 
ABC multidrug transporter 
ABC multidrug transporter 
chromate ion transporter 
hypothetical protein 
isp4 protein 
MFS myo-inositol transporter 
oxalate/formate antiporter  
carboxylic acid transport protein 
GABA permease 
myo-inositol transporter 
Nucleoside transporter family 
nucleoside transporter 
P-type ATPase 
ZIP Zinc transporter 
Afu2g08500 
Afu2g05810 
Afu6g04700 
Afu1g02890 
Afu3g07560 
Afu6g02960 
Afu6g08560 
Afu5g01580 
Afu1g15280 
Afu5g09130 
Afu6g08830  
Afu4g10370  
Afu5g10090  
Afu7g05840 
Afu1g05820 
Afu6g12220  
Afu8g05690  
Afu7g05010 
Afu6g04620 
Afu3g13910  
Afu2g07940 
Afu5g02990 
Afu2g00540 
Afu3g07860 
Afu2g00720 
Afu5g00670 
Afu2g00570 
carboxylesterase 
dienelactone hydrolase 
imidazoleglycerol-phosphate dehydratase 
dUTPase (Dut) 
enoyl-CoA hydratase/isomerase family protein 
NADH-ubiquinone oxidoreductase 105 kDa subunit 
nonribosomal peptide synthase (NRPS) 
oxidoreductase, short chain dehydrogenase/reductase family 
polysaccharide deacetylase family protein 
polysaccharide deacetylase family protein 
2-oxoisovalerate dehydrogenase complex alpha subunit 
3-demethylubiquinone-9 3-methyltransferase 
3-demethylubiquinone-9 3-methyltransferase 
amidohydrolase family protein  
isochorismatase family  hydrolase,  
zinc binding dehydrogenase family protein 
acetyltransferase, GNAT family  
glyoxalase family protein  
NADH-ubiquinone oxidoreductase B14 subunit  
NADH-ubiquinone oxidoreductase B18 subunit  
NADPH-cytochrome P450 reductase (CprA) 
aromatic amino acid aminotransferase 
carboxyphosphonoenolpyruvate phosphonomutase 
glycosyl transferase  
aldehyde dehydrogenase 
glycosyl hydrolase family 35 
GNAT family acetyltransferase 
Antigens/cell surface proteins 
Afu4g09320  
Afu5g01440  
Afu4g09580 
Afu8g07080 
antigenic dipeptidyl-peptidase Dpp4  
allergen 
major allergen Asp F2  
elastinolytic metalloproteinase Mep 
Pathogenesis  Lipid metabolism 
Afu2g04570 
Afu2g12990 
Afu3g00350 
BNR/Asp-box repeat domain protein  
cyclophilin  
hypothetical protein 
Afu8g02270 
Afu2g14850  
Afu5g09150  
Afu3g01530 
Afu6g13280 
Afu6g12240 
dihydrodipicolinate synthetase family protein  
enoyl-CoA hydratase/isomerase family protein  
oxidoreductase, short-chain dehydrogenase/reductase family 
phosphatidylglycerol specific phospholipase 
Fox2 protein 
Glycerophosphoryl diester phosphodiesterase family  
Secondary metabolism 
Afu6g09640 
Afu6g09670 
Afu6g09730 
Afu6g09700 
Afu6g09650 
Afu6g09720 
Afu6g09710 
Afu6g09740 
Afu6g08700 
Afu6g14000 
aminotransferase GliI 
cytochrome P450 oxidoreductase GliC 
cytochrome P450 oxidoreductase GliF 
gliotoxin biosynthesis protein GliK 
membrane dipeptidase GliJ 
methyltransferase GliN 
MFS gliotoxin efflux pump GliA 
thioredoxin reductase GliT  
beta glucosidase,  
Tri7-like toxin biosynthesis protein 
Protein synthesis/degradation 
Afu2g08130 
Afu1g17120 
Afu1g01540 
Afu2g16880 
Afu2g02270 
ribosomal protein L41 
elongation factor-1 gamma 
Endonuclease/Exonuclease/phosphatase family  
ribosomal protein L37a  
ribosomal protein S14p/S29e 
RNA processing 
Afu6g04020 peptidyl-tRNA hydrolase domain protein  
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Afu2g09030 secreted dipeptidyl peptidase Afu7g04280  
Afu2g08320 
Afu3g11820 
Afu6g13310 
small nuclear ribonucleoprotein (LSM5)  
U3 small nucleolar ribonucleoprotein subunit (Imp3)  
mitochondrial oligoribonuclease 
26S proteasome non-ATPase regulatory subunit 9 
Calcium homeostasis 
Afu1g02930 
Afu3g10690 
Ca2+ binding protein (calmodulin) 
calcium-translocating P-type ATPase(PMCA-type) 
Stress   
Afu1g01370 
Afu4g10610 
Afu3g07930 
Afu3g01210 
Afu1g17370 
Afu3g14030 
Afu6g13750 
Afu6g11330 
glutathione S-transferase 
 hypothetical protein  
putative glutathione S-transferase  
ThiJ/PfpI family protein 
chaperone/heat shock protein Hsp9  
alkaline phosphatase 
ferric-chelate reductase 
histidine acid phosphatase 
Transcription 
Afu3g11970 
Afu2g05360 
Afu4g06600 
Afu3g14600 
Afu2g04260 
Afu1g05940 
Afu1g02860 
Afu4g06420 
Afu3g00490 
Afu1g17150 
Afu3g13600 
C2H2 transcription factor PacC 
C6 transcription factor 
hypothetical protein  
fungal specific transcription factor 
transcription factor  
conserved hypothetical protein  
C2H2 transcription factor  
fungal specific transcription factor  
C6 finger domain protein  
C6 transcription factor 
C6 transcription factor 
Development and morphogenesis 
Afu8g06130 FluG family protein 
 
DNA organisation 
Cell wall Afu2g16710 
Afu2g02090  
Afu3g05360  
Afu1g07430 
Afu2g04140 
Afu6g13290 
Afu2g05180 
hypothetical protein 
methylated-DNA-protein-cysteine methyltransferase  
histone H2A  
hypothetical protein  
conserved hypothetical protein 
SNF2 family helicase/ATPase  
NF-X1 finger and helicase domain protein 
Afu2g14630 
Afu4g06860  
Afu1g16250  
Afu3g03370  
Afu2g05150 
Afu6g11390 
Afu7g00970 
Afu8g07060 
Afu2g14540 
Afu7g05610 
Afu8g06880 
cell wall glycosyl hydrolase family 88 (YteR) 
conserved hypothetical protein  
alpha-glucosidase B  
cell surface protein  
cell wall galactomannoprotein Mp2 
1,3-beta-glucanosyltransferase Gel2 
GPI-anchored serine-threonine rich protein 
hydrophobin  
endoglucanase 
glucanase 
pectin methylesterase 
 
 
 
 
 
 
 
 
 
 
Endo/exocytosis 
Afu7g05950 
Afu2g01990 
Afu4g12490 
Afu2g09670 
EF-hand protein  
Signal recognition particle 14kD protein domain containing protein guanine 
nucleotide exchange factor VPS9 
SNARE protein (Ufe1), 
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Transposition 
Afu2g03570 
Afu3g03770 
Afu4g14370 
Afu2g18080 
Afu2g18080 
Afu3g09430 
Afu3g15370 
Afu4g14870 
Afu4g14870 
Afu6g00780 
Afu6g00780 
Afu8g00310 
Afu8g00310 
Afu8g06290 
Afu3g09410 
Afu7g08210 
Afu4g00820 
Afu4g00820 
Afu6g14660 
Afu6g14660 
Afu8g01040 
Afu8g01040 
Afu6g09470 
transposase  
transposase  
LINE-1 class reverse transcriptase, RNase H, putative 
LINE-1 class reverse transcriptase, RNase H, putative 
LINE-1 class reverse transcriptase, RNase H, putative 
LINE-1 class reverse transcriptase, RNase H, putative 
LINE-1 class reverse transcriptase, RNase H, putative 
LINE-1 class reverse transcriptase, RNase H, putative 
LINE-1 class reverse transcriptase, RNase H, putative 
LINE-1 class reverse transcriptase, RNase H, putative 
LINE-1 class reverse transcriptase, RNase H, putative 
LINE-1 class reverse transcriptase, RNase H, putative 
LINE-1 class reverse transcriptase, RNase H, putative 
revers LINE-1 class reverse transcriptase, RNase H, putative 
transcriptase  
reverse transcriptase, putative  
reverse transcriptase, RNaseH  
reverse transcriptase, RNaseH  
reverse transcriptase, RNaseH  
reverse transcriptase, RNaseH  
reverse transcriptase, RNaseH  
reverse transcriptase, RNaseH  
reverse transcriptase, RNaseH, putative 
 
Table 4.22: Functional classification of selected genes having decreased abundance in the ATCC46645 ΔpacC mutant relative to the parental isolate 
ATCC46645 during initiation of murine infection. Genes were included if showing a fold change of ±1.5 on a log2 scale in at least one of the time points.   
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4.4 Discussion  
 
In the past, microarray analyses of A. fumigatus transcriptional profiling during host 
infection have been strictly limited by the difficulty in obtaining RNA in sufficient quantity 
from the sites of infection. The transcriptional profiling of the A. fumigatus ATCC46645 
clinical isolate in a temporal window which analyses early, middle and late stages of A. 
fumigatus murine infection in a neutropenic model of IPA identifies genes preferentially 
expressed during adaptation to the murine niche and provides crucial information about the 
necessary requirements for establishment of a successful infection. The same experimental 
approach was used to study the transcriptome of a host-adapting ATCC46645 ΔpacC mutant, 
whose characterisation in terms of phenotype (Fig. 3.2, Chapter III), virulence (Fig. 3.3-3.5, 
Chapter III) and tissue invasion ability (Fig. 3.6, Chapter III) was presented in Chapter III. 
This provides significant insight into A. fumigatus PacC-mediated adaptation and the 
mechanisms through which PacC action is accomplished in the murine host.  
 
4.4.1 The A. fumigatus ATCC46645 transcriptional profile during initiation of murine 
infection highlighted crucial trends for the adaptation to the host niche and the 
establishment of infection   
 
Aiming to identify crucial biological functions for A. fumigatus adaptation to the 
murine host niche transcriptional profiling of the ATCC46645 strain was performed relative 
to in vitro–cultured dormant spores (Fig. 4.2). A total of 1364 and 1299 genes were identified 
respectively as up-regulated and down-regulated during adaptation to the mammalian host 
(13.7% and 13.1% of A. fumigatus genome,(Nierman et al., 2005); among them 617 and 556 
remained up- or down-regulated, respectively, across the entire time course of 
experimentation (Table 4.6). A milestone for DNA microarray analysis of A. fumigatus 
transcriptome analysis was reached when characterisation of the Af293 clinical isolate 
transcriptome during initiation of murine infection was achieved  (McDonagh et al., 2008a). 
In this previous study only one time point (i.e. 14 hours post-infection) was studied, the 
authors finding 2180 differentially expressed genes relative to an in vitro culture. This dataset 
is therefore roughly half the size of that reported here for ATCC46645, and though the 
relative percentages of induced and repressed genes between the two wild-type transcriptional 
profiles are similar, the overlap between the two datasets is limited to 890 genes. In the 
present study major transcriptional trends have been identified such as the up-regulation of 
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transport systems for the uptake and mobilisation of crucial elements, and cell wall functions 
to counteract the challenging host niche.  
Confirming the fundamental role of iron in A. fumigatus pathogenicity, at least five 
genes induced in the ATCC46645 strain during murine infection are involved in iron 
homeostasis (Afu3g03440, Afu3g03390, Afu7g04730, Afu2g07680, and Afu6g13750). The 
requirement for iron has been previously studied with respect to A. fumigatus virulence (Haas, 
2003; Haas et al., 2008; Schrettl et al., 2004; Schrettl et al., 2007). A. fumigatus lacks specific 
uptake systems for host iron sources (Schrettl et al., 2004), but possesses two high-affinity 
iron uptake mechanisms, namely siderophore-mediated uptake and reductive iron assimilation 
(RIA) (Schrettl et al., 2004). Both of these systems are induced, at the level of transcription, 
as a consequence of iron starvation (Schrettl et al., 2004), but whereas RIA is dispensable for 
A. fumigatus virulence, siderophore biosynthesis is essential (Schrettl et al., 2004). In fact, the 
elimination of both intra- and extracellular siderophores, by deletion of the SidA-encoded L-
ornithine N5-oxygenase (catalysing the first step of siderophore biosynthesis), completely 
attenuates A. fumigatus virulence in a murine model of invasive aspergillosis (Schrettl et al., 
2004). sidA (Afu2g07680) can be found among the top 100 up-regulated genes in the 
ATCC46645 timecourse (Table 4.3) thereby validating the physiological relevance of the 
dataset with respect to identifying virulence determinants.  
In addition to the genes involved in siderophore biosynthesis, other genes commonly 
associated with A. fumigatus pathogenicity are induced in the ATCC46645 strain during 
infection. Commonly classed as factors facilitating A. fumigatus virulence, secreted proteases 
(Latge, 1999) are proposed to release amino acid nutrients by degradation of murine lung 
parenchyma. A. fumigatus can synthesise a broad range of degradative enzymes, such as 
elastases and proteases, to assist with invasion of host tissue and nutrient acquisition. Elastin 
and collagen constitute major components of mammalian lung tissues, and a direct correlation 
has been demonstrated between elastase production in A. fumigatus strains and virulence. 
Strains not producing elastase showed fewer germinated spores and no destruction of alveoli 
in murine lungs (Kothary et al., 1984). A. fumigatus produces and secretes a series of 
catabolic enzymes, especially peptidases, to degrade macromolecular complexes and derive 
nutrients (Alp and Arikan, 2008), however A. fumigatus protease mutants have been described 
as fully virulent (Jaton-Ogay et al., 1994; Latge, 1999), probably because of the redundancy 
among the many enzymes produced and involved in the degradation of murine lung 
parenchyma. In this respect the global analysis of peptidase expression during colonisation of 
the host niche is intriguing and may identify the catalogue of enzymes required to establish 
infection. The ATCC46645 transcriptional profile does not reveal significant induction of 
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mechanisms directly involved in nitrogen acquisition, but several secreted peptidase 
(Afu4g09320, Afu4g11800, Afu6g08640 and Afu5g13300) were strongly upregulated from 
the earliest stages of infection, relative to dormant spores.  
The present study observes significant representation of enzymes and proteins known, 
and likely, to participate in the extensive cell wall remodelling required to direct  cellular 
morphologensis during developmental growth in the host and also to protect cells from 
external factors challenging cellular homeostasis (Afu7g05450, Afu1g16250, Afu4g10150 
and Afu2g00640 among the top 100 up-regulated genes in the ATCC46645 trascriptional 
analysis, Table 4.3). In S. cerevisiae, tolerance to cell wall stress is mediated by the cell wall 
integrity (CWI) pathway, a phosphorylative cascade initiated with the activation of protein 
kinase C (Pkc1p) and acting via various kinases including which Slt2p results in the 
phosphorylation of several cytosolic and nuclear targets including Rlm1p, Swi4p and Swi6p 
(Heinisch et al., 1999; Lagorce et al., 2003). A significant overlap has been observed in S. 
cerevisiae between the gene expression modulation as a consequence of the alkalinisation of 
the environment, and of exposure to cell wall damaging agents (Garcia et al., 2004; Lagorce 
et al., 2003). Cell wall damage induces genes involved in metabolism, energy production and 
stress response (such as chaperones), but decreases the expression of transcription factors and 
of genes involved in protein synthesis and cell growth; this pattern of transcriptional 
modulation is very similar to that observed as a consequence of other environmental stresses. 
According to its main function, i.e. to maintain cell morphology and to protect cells from the 
external factors challenging the cell internal homeostasis, the cell wall is a dynamic structure, 
which needs to adapt to support cell growth, but also to face environmental changes.  
During infection with the ATCC46645 strain, a general repression of transcription is 
noticeable (Table 4.4) and several ORFs involved in the regulation of transcription, ribosomal 
biogenesis and assembly, and protein biosynthesis and processing  (Afu5g02880, 
Afu7g02620, Afu5g06140, Afu3g11330, Afu3g10120, Afu1g17360, Afu4g12390, 
Afu1g14750, Afu2g10550) are down-regulated, relative to the parental strain. This may 
reflect the poor nutritional value of the host niche, resulting in the slowing of A. fumigatus 
growth. Metabolic repression is a trend which is commonly associated with microbial systems 
undergoing adaptation to stress, and was previously identified for host-adapting A. fumigatus 
(McDonagh et al., 2008a) where the trend manifested to a much broader extent, involving 
genes directing ribosomal biogenesis and assembly (rRNA synthesis, RNA polymerase 
activity) and protein biosynthesis and processing (translation initiation and elongation, tRNA 
processing and synthesis, intracellular trafficking, secretion and vesicular trafficking). An 
alternative explanation is that during developmental growth in the murine host niche the 
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organism experiences a lag phase in growth whereby transcription, relative to dormant spores, 
is down-regulated temporarily. In support of this hypothesis the trend appears to invert at later 
stages of infection, where on the contrary several genes encoding transcription regulators are 
induced (Afu6g12150, Afu1g02860, Afu5g13020 and Afu6g03800). However, of note is the 
fact that aerobic respiration and oxidative metabolism are concommittantly significantly up-
regulated (Tables 4.3) which implies that cell cycle-specific fluctuations in transcriptional 
activity might be contributing to the observed function profile.  
A previously reported finding that, during murine host adaptation, differentially 
expressed genes are located in contiguous gene clusters and preferentially in subtelomeric 
regions of the chromosomes was not disputed by this analysis of ATCC46645 transcription 
(Figs. 4.9 and Fig 4.10 respectively). Where temporal expression profiles were significantly 
enriched for these terms, temporal expression of such genes increased with time. This finding 
negates the hypothesis that previous findings were soley attributable to choice of reference 
sample and further assigns significance to activation of such loci duing murine infection.  
Subtelomeric genomic regions are predominantly hypoacetylated (Katan-Khaykovich and 
Struhl, 2005) and are also known to undergo ectopic recombination more often than the rate 
expected for homologous recombination (Farman, 2007), generating expansion and diversity 
of chromosome ends. Such gene arrangement has been thought to be advantageous for the 
fungus, especially in relation to secondary metabolite production (Shwab et al., 2007). The 
organisation of up-regulated A. fumigatus genes into infection clusters, predominantly 
residing in the telomeric regions of chromosomes suggests additional epigenetic mechanisms 
of regulation. Epigenetic regulation of gene expression is thought to be mediated by 
modification in chromatin properties, such as histone acetylation and methylation, which 
likely modify the interactions of histones with transcriptional regulators (Jenuwein and Allis, 
2001). Histone acetylation is probably the best investigated type of histone modification and 
is controlled by the opposite action of histone acetyltransferases and deacetylases (HDACs). 
Generally, hypoacetylation of histones is associated with gene silencing, whereas 
hyperacetylation is associated with gene activation (Robyr et al., 2002; Trojer et al., 2003). 
Regulation of gene expression has been linked to chromosomal architecture for subtelomeric 
gene clusters in A. nidulans which direct the biosynthesis of penicillin and sterigmatocystin, 
regulated in opposing fashions by the methyltransferase LeaA (Bok et al., 2005) and the 
HdaA histone deacteylase (Shwab et al., 2007). In A. nidulans, deletion of hdaA causes the 
transcriptional activation of these two gene clusters which are localised in proximity of the 
telomere. Interestingly, HdaA also regulates a cluster of un-related genes, comprising a 
variety of genes concomitantly activated as a consequence of challenging environmental 
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conditions and stresses (Robyr et al., 2002). With respect to the current investigation, it would 
not appear that subtelomeric regions of the genome are subject to silencing during infection 
(Fig. 4.10).  
Epigenetic regulatory mechanisms are involved in the pathogenicity of other microbes, 
such as Plasmodium falciparum (Freitas-Junior et al., 2005) and C. glabrata (De Las Penas et 
al., 2003). In P. falciparum, HDACs are involved in the regulation of the subtelomeric var 
gene cluster which allow the organism to develop antigenic variability, so as to elude the host 
immune response (Freitas-Junior et al., 2005). In C. glabrata, the NAD
+
-dependent HDAC 
Sir2p modulates the expression of the subtelomeric cluster EPA, which is crucial for biofilm 
formation and therefore pathogenicity (De Las Penas et al., 2003). Epigenetic mechanisms of 
gene regulation of proximal gene clusters have been identified also in yeast (Bernstein et al., 
2000; Hansen et al., 2005; Katan-Khaykovich and Struhl, 2005), where an ever broader and 
coordinated action for the HDACs has been demonstrated. The S. cerevisiae HDACs Hda1, 
Rpd3, and Sir2 suppress their own unique set of genes, but they also repress numerous shared 
genes (Bernstein et al., 2000). In Schizosaccharomyces pombe, the same scenario is present 
for the HDACs Clr3, Clr6, Sir2, and Hos2 (homologous to A. nidulans HdaA, RpdA, HstA, 
and HosA, respectively(Graessle et al., 2000), which modulate the expression of both unique 
and shared genes (Hansen et al., 2005; Wiren et al., 2005). An A. fumigatus Sir2 homologue 
is upregulated during ATCC46645 host adaptation (Table AD.1.3 in Appendix D). 
A. fumigatus relies upon the production of several toxic secondary metabolites, the 
biosynthetic pathways for which have evolved to counter hostility in ecological niches (Cui et 
al., 1996a; Cui et al., 1996b; Frisvad et al., 2009). In the present study the expression of a 
LaeA-like methyl transferase increased uniquely at 8 hrs post-infection with the ATCC46645 
strain. Secondary metabolite production is strongly affected by the disruption of LeaA (Bok et 
al., 2005), which regulates 10% of the A. fumigatus genome and whose deletion results in 
attenuated virulence in mice (Sugui et al., 2007a; Perrin et al., 2007). Transcriptional 
profiling of the ATCC46645 strain incorporated differentially expressed genes having 
predicted roles in secondary metabolite production (Perrin et al., 2007). Gliotoxin is the most 
extensively studied A. fumigatus secondary metabolite and is a metabolite of the 
epipolythiodioxopiperazine family (Mullbacher and Eichner, 1984; Mullbacher et al., 1985) 
which is acutely toxic and has immunosuppressive properties, blocking phagocytosis (Waring 
et al., 1988), release of inflammatory mediators by leukocytes (Pahl et al., 1996), and 
inducing the apoptosis of neutrophils and monocytes (Frame and Carlton, 1988; Waring et al., 
1988; Stanzani et al., 2005). Environmental A. fumigatus strains defective in the production of 
gliotoxin have been demonstrated to be less virulent than strains producing this secondary 
216 
 
metabolite efficiently (Sutton et al., 1996). Deletion of gliotoxin differentially affects A. 
fumigatus virulence depending upon the immunosuppressive regimen of the host; in particular 
the gliotoxin mutant is characterised by wild type virulence in a neutropenic model, but 
reduced virulence in a non-neutropenic model (Bok et al., 2006; Spikes et al., 2008; Sugui et 
al., 2007b). In this study of ATCC46645 temporal gene expression, transcription of genes in 
the gliotoxin cluster (Afu6g09580–Afu6g09770) (Perrin et al., 2007) strictly follows the 
expression pattern of the LaeA-like regulator, which is induced at a middle stage of infection.  
Pseurotin A is a secondary metabolite which competitively inhibits chitin synthase and 
acts as an inducer of nerve-cell proliferation (Maiya et al., 2007). The genes required to direct 
biosynthesis of this compound have been identified and are are localised in a cluster 
(Afu8g00100-Afu8g00720) on chromosome eight (Perrin et al., 2007). The best characterised 
of these is the hybrid polyketide synthase-non-ribosomal peptide synthetase (Afu8g00540) 
(Maiya et al., 2007). Contrary to previous findings differential expression at this secondary 
metabolite gene cluster is not observed during initiation of ATCC46645 infection, confirming 
the predictable variability between different A. fumigatus strains isolates. Notwithstanding the 
use of an alternative reference sample, both gliotoxin and pseurotin A are induced during 
murine infection (McDonagh et al., 2008a) in the Af293 clinical isolate. Of note for the 
subsequent discussion is the presence of ORFs flanking these gene clusters which are 
implicated in transposition.  
The ATCC46645 transcriptional profiling was also analysed in comparison to the 
results for A. fumigatus shift to alkaline pH in vitro. A microarray study performed by our 
research group to elucidate the transcriptional response to alkaline conditions has recently 
delineated the temporal response of A. fumigatus to an alkaline shift in vitro (Loss et al., 
unpublished). For the in vitro study the transcriptional profile of A. fumigatus mycelia grown 
for 14 hours in AMM pH 5.0 and subsequently shifted to pH 8.0 was analysed for a window 
of 60 minutes and samples were taken for RNA extraction after 5, 15, 30, 45 and 60 minutes 
following alkaline shift. Among a total of 1364 and 433 genes upregulated, respectively, in 
the in vivo time course and in the in vitro study, the overlap consists of 127 genes, 
representing more than 25% of the in vitro alkaline-responsive genes, and reinforcing the 
significance of this adaptation mechanism in host-adaptation. Interestingly, among a total of 
1299 and 141 genes downregulated, respectively, in the in vivo time course and in the in vitro 
study, the overlap consists of only 30 genes. A plausible explanation for this is the 
requirement of both alkaline- and acid-regulatable functions during colonisation of the murine 
host, in support of which hypothesis the induction of both alkaline and acid phosphatases is 
observable. With respect to temporal expression profiles, high concordance was notable 
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between up- and down-regulation trends in host and laboratory niches. Some interesting 
differences were found by STEM analysis, whereby ORFs which were repressed in vitro after 
a shift to alkaline pH, were instead upregulated during infection. Two of these ORFs are 
predicted to be involved in cell wall organisation (Afu3g08110 and Afu2g144900).  
 
4.4.2 The A. fumigatus ATCC46645 ΔpacC mutant transcriptional profile during 
initiation of murine infection reveals possible involvement of epigenetic mechanisms to 
effect PacC-mediated gene regulation  
 
Elucidating the transcriptional response during initiation of murine infection in the A. 
fumigatus ΔpacC mutant and in comparison with the respective parental isolate provided 
significant insight into A. fumigatus PacC-mediated adaptation and the mechanisms through 
PacC action is accomplished in the murine host. Aiming to analyse biological functions which 
are crucial for infection at early, middle and late stages transcriptional profiling of the 
ATCC46645 ΔpacC strain was performed relative to isogenic dormant spores (Fig. 4.15). A 
total of 1198 (12.1% of A. fumigatus genome, (Nierman et al., 2005) and 1317 (13.3%) were 
identified respectively as up-regulated and down-regulated during adaptation to the 
mammalian host (Table 4.9). Within these same categories, 423 and 376 genes were similarly 
up- or down-regulated, respectively across the entire time course (Fig. 4.19). A direct 
comparative analysis of ATCC46645 ΔpacC relative to the parental isolate ATCC46645 was 
also performed (Fig. 4.30). This identified a total of 729 (7.3% of A. fumigatus 
genome,(Nierman et al., 2005) and 762 (7.8%) genes as being up-regulated or down-regulated 
respectively, among these 68 and 74 genes were similarly up- or down-regulated, 
respectively, across the entire temporal comparison (Fig. 4.34 and Table 4.16). This dual 
approach therefore constituted one focused strategy to analyse differences between 
ATCC46645 ΔpacC and ATCC46645 gene expression in the host and an accompanying set of 
temporal transcription profiles for both strains which could be selectively probed to identify 
stage-specific modulation of gene expression. Particularly noteworthy in this respect is the 
block in developmental growth demonstrated by the mutant strain during infection (Fig. 3.6, 
Chapter III). Morphological differences were minimal between mutant and parental strain at 4 
and 8 hours post-infection, but by 16 hours the ATCC46645 ΔpacC mutant was unable to 
progress beyond primary hyphal morphotypes, whereas ATCC46645 wild type revealed 
extensively branched invasive growth. 
As determined from the ATCC46645 transcriptional profile, nutrient acquisition 
represents one of the primary fungal requirements, and may be largely attributable to the 
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alkaline nature of the mammalian lung environment. Proteins often have an optimal pH at 
which to act and the alkalinisation of the external pH might constitute a challenge for surface 
or secreted proteins, required for the uptake and mobilisation of crucial nutrients. In addition, 
most of the transport system across the biological membrane is energised by a proton 
gradient, which is inevitably affected by the environmental pH. Additionally the solubility 
itself, of crucial elements can be modified as a function of pH. A conspicuously aberrant 
regulation of transport was noticeable when comparing the ΔpacC mutant transcriptome to 
that of the parental isolate (Table 4.17-4.18). PacC is known to act as both an activator and a 
repressor of Aspergillus gene expression. Accordingly, there was no bias towards 
derepression or induction among differential gene expression and moreover, ORFs associated 
with transport functions are enriched among both up- and down-regulated genes (Table 4.21-
4.22). A notable distinction between transporter functionality can be drawn between up- and 
down-regulated genes whereby those which are down-regulated in the ΔpacC genetic 
background predominantly include those involved in the uptake and mobilisation of metal 
ions such as copper, zinc, sodium, and calcium, phosphate, amino acids and various nutrients, 
whereas the up-regulated gene functions are predominantly involved in sugar transport. Given 
the bifunctional activity of PacC gene regulatory activity this observation might be explained 
in various ways. An immediately obvious assumption is that genes which are up-regulated in 
the mutant background, would normally be subject to PacC-mediated repression. Why would 
a transcription factor mediating alkaline-responsive gene expression negatively regulate such 
a group of transporters? The answer might lay in the nature of the transport functions 
supported by these proteins. Often sugars are transported in symport with protons, thereby 
neutralising the cytoplasm of the cell as carbohydrates are taken up into the cell. Under 
alkaline conditions such activities would be counterproductive and likely to halt growth. If 
this hypothesis were correct their upregulated expression in the mutant genetic background 
might contribute to pH sensitivity of the mutant. On the other hand the range of transporters 
in which down-regulation is observed in this study might largely represent functions essential 
for supporting growth at high pH. Given their normally positive regulation by PacC, and their 
plasma membrane locations they represent an important class of genes for further study as 
putative virulence modulators and therapeutic targets and would be prime candidates for 
analysis by split-ubiquitin screening.  
 The fungal cell wall undergoes extensive remodelling during morphogenesis and in 
response to stress, including that imposed by alkaline environments. Significant concordance 
between genes expressed during alkalinisation of the environment and in response to cell wall 
modulating agents has already been demonstrated (Garcia et al., 2004; Lagorce et al., 2003). 
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The enrichment of cell wall-related ORFs within the differentially expressed genes in the A. 
fumigatus ATCC46645 ΔpacC mutant transcription profile during murine infection and 
relative to the parental isolate ATCC46645 strengthen the putative connection between 
maintenance of cell wall integrity and PacC, which has been recently demonstrated for other 
pathogenic fungi. Using an over-expression rescue screen, Rim101p-dependent functions 
effecting cell wall alterations, and demonstrated to affect C. albicans pathogenic interaction 
with oral epithelial cells have been identified. Four Rim101p targets, implicated in cell wall 
organisation, were able to partially restore the pathogenic interactions of a C. albicans 
rim101Δ/Δ mutant with oral epithelial cells (Nobile et al., 2008). Also, in C. neoformans, the 
rim101Δ mutant, which is slightly more virulent than the wild-type, suffers major defects in 
the polysaccharide capsule (O'Meara et al., 2010). Because few capsule biosynthetic genes 
were transcriptionally regulated by Rim101p, the phenotype observed was attributed to 
defects in the attachment of the capsule to the cell wall (O'Meara et al., 2010).  
Regarding A. fumigatus virulence factors which may be affected by pacC deletion the 
analysis of the ATCC46645 transcriptome confirmed the fundamental importance of iron in 
A. fumigatus pathogenicity, showing that at least five genes induced during murine infection 
are involved in iron homeostasis (Afu3g03440, Afu3g03390, Afu7g04730, Afu2g07680, and 
Afu6g13750). The elimination of both intra- and extracellular siderophores causes the 
attenuation of A. fumigatus virulence in a murine model of IPA (Schrettl et al., 2004), 
however, down-regulation of these genes in the ATCC46645 ΔpacC mutant was not 
observed, with the exception of the ferric-chelate reductase (Afu6g13750). Unexpectedly, this 
disagrees with previous findings which established the PacC-mediated regulation of 
siderophore biosynthetic genes in A. nidulans through the use of acidity- and alkaline-
mimicking mutants (Eisendle et al., 2004). Thus the avirulence of ΔpacC mutants is unlikely 
to be simply explained by defective siderophore biosynthesis, although direct physiological 
support for this hypothesis would require an assessment of siderophore production. In 
addition to a putative role in the regulation of cation transport, PacC appears to regulate the 
expression of various other transporters, most notably the MFS gliotoxin efflux pump GliA. 
Interestingly, PacC may also regulate the expression of putative virulence determinants during 
infection (e.g. Mep, Afu8g07080, Alp1, Afu4g11800 and Catalase 1, Afu3g02270).  
The A. fumigatus ATCC46645 ΔpacC mutant transcription profile relative to the 
parental isolate ATCC46645 during initiation of murine infection supports the hypothesis that 
ΔpacC mutant development is specifically deregulated at early stages of infection, given that 
at least two developmental regulators, the FluG family protein (Afu8g06130) and the sexual 
development protein EsdC (Afu7g01930) showed altered expression during the initiation of 
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infection as a consequence of pacC deletion. The FluG family protein (Afu8g06130) 
(D'Souza et al., 2001) and the sexual development protein EsdC (Afu7g01930) (Han et al., 
2008) have been only characterised in A. nidulans, which differs from A. fumigatus for having 
a well known and characterised sexual cycle. In A. nidulans, several factors are able to 
influence developmental activation through FluG, which has been demonstrated as necessary 
for the synthesis of a small diffusible factor, required for the induction of asexual sporulation 
in air-exposed colonies (Lee and Adams, 1994). These stresses include air exposure, carbon 
or nitrogen starvation, and increased osmolarity. fluG and flbA are respectively up- and down-
regulated during murine infection by a wild-type strain suggesting their potential role in A. 
fumigatus development in the host, which is further strengthened by the strong down-
regulation of fluG expression in the ΔpacC mutant. Given this developmental block, two non-
mutually exclusive hypothesis can be applied when interpreting the comparative transcription 
data. On the one hand, where gene expression (and possibly also function) is limited to a 
specific developmental phase, differences in gene expression between the wild type 
ATCC46645 and the ATCC46645 ΔpacC mutant would be expected regardless of whether 
that specific ORF is under PacC regulatory control. In the absence of further experimentation 
it would not be possible to separate this hypothesis from that of a direct regulatory role for 
PacC upon expression of the ORF. 
A gene cluster on chromosome six, involved in the production of the secondary 
metabolite gliotoxin, was induced in both the ATCC46645 and Af293 (McDonagh et al., 
2008a) datasets. Comparing the transcriptional profiles of A. fumigatus ATCC46645 and A. 
fumigatus ATCC46645 ΔpacC mutant during initiation of murine infection the impairment of 
gliotoxin biosynthetic gene expression in the ΔpacC mutant relative to the wild-type was 
revealed (Table 4. 22). At least 8 genes in the gliotoxin cluster are highly down-regulated in 
the mutant (Afu6g09640, Afu6g09670, Afu6g09730, Afu6g0700, Afu6g0720, Afu6g09650, 
Afu6g09710, Afu6g09740). In addition, expression of a LeaA-like (Bok et al., 2005) 
methyltransferase is also affected by pacC deletion, suggesting a PacC-dependent mode of 
LaeA-like regulation for the gliotoxin cluster. The most attractive hypothesis is that gliotoxin 
biosynthesis is regulated by PacC therefore explaining why, in absence of pacC, the gliotoxin 
cluster is repressed. In support of this hypothesis, the promoter of the MFS gliotoxin efflux 
transporter GliA (Afu6g09710) contains a recognition site for PacC binding. Alternatively, 
gliotoxin gene expression is linked to developmental growth blocked and its expression is 
therefore blocked in the ΔpacC mutant.   
In addition to the confirmation of the aberrant regulation of many biological functions 
commonly associated with pH regulation, such as transport, ion homeostasis and cell wall 
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organisation, the comparison of the transcriptional profiles of A. fumigatus ATCC46645 and 
A. fumigatus ATCC46645 ΔpacC during initiation of murine infection highlighted the 
correlation between pacC deletion and defects in DNA organisation, whereby at least seven 
genes involved in this specific function are down-regulated in the ATCC46645 ΔpacC 
transcriptome relative to that of the parental isolate (Afu2g16710, Afu2g02090, Afu3g05360, 
Afu1g07430, Afu2g04140, Afu6g13290, Afu2g05189). Epigenetic mechanisms act as 
modulators of gene expression per se. The first reports of chromatin-mediated specification of 
transcriptional factor targets have emerged only recently (Buck and Lieb, 2006). Buck and 
collaborators demonstrated that the target set of the regulator of yeast metabolism Rap1p is 
determined by the chromatin regulator Tup1p and associated partners, showing that in this 
instance, the genome architecture itself is remodelled altering the targeting and therefore the 
biological effect of the transcription factor.  
A striking feature of the mutant transcriptome was the apparent PacC-mediated 
repression of ORFs involved in transposition, whereby transcriptases and transposable 
elements (TEs) are down-regulated in vivo in the ATCC46645 ΔpacC mutant relative to the 
respective parental isolate (see Table 4.18 and 4.22). TEs are DNA sequences which are able 
to migrate across the genome, affecting genome size, structure and gene expression, 
discovered initially by McClintock in the 50s (and discussed in(McClintock, 1984). They 
represent a substantial part of most eukaryotic genomes, e.g. respectively 45% and 3-5% of 
human and yeast genomes, respectively (Biemont and Vieira, 2006) and can be grouped into 
two main classes: DNA transposons (class II), acting via a DNA intermediate and using the 
cell machinery to replicate, and retrotransposons (class I), acting via an RNA intermediate. 
Retrotransposons include long interspersed nuclear elements (LINEs), short interspersed 
nuclear elements (SINEs), LTR (long terminal repeats) and non-LTR retrotransposons. LTR 
retrotransposons encode all the proteins necessary for their migration across the genome. TEs 
belonging both to class I and class II have been found in the Aspergillus species; however, 
active transposition has been demonstrated only in A. niger for the class II elements Ant1 
(Glayzer et al., 1995), Tan1 (Nyyssonen et al., 1996) and Vader (Amutan et al., 1996), 
whereas for A. fumigatus only inactive TEs have currently been identified, i.e. Afut1 
(Neuveglise et al., 1996) and Afut2 (Paris and Latge, 2001) for class I and TafI (Monroy and 
Sheppard, 2005) for class II. Due to the abundance and distribution of TEs within the 
genomes of eukaryotes, and analogies with retrovirus genomes, TEs have been for decades at 
the centre of an ongoing debate to establish whether they are parasitic entities or they actually 
provide some benefits to the host cell. Supported by increasing experimental evidence, the 
prevailing common belief is that TEs act as gene regulatory elements (Jordan et al., 2003; 
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Kashkush et al., 2003; Sehgal et al., 2007)and reviewed in(Biemont and Vieira, 2006). 
Although their impact on gene expression is not well characterised yet, TEs elements have 
reported to be normally silent, but able to be activated by a variety of stresses (Wessler, 
1996). In the fission yeast Schizosaccharomyces pombe the Tf2 transposon family has been 
recently associated with Sre1p oxygen-dependent gene regulation (Sehgal et al., 2007). In S. 
pombe, Sre1p is a transcription factor involved in the response to anaerobic stress. The 
activation and nuclear entry of Sre1p is determined by proteolytic processing in low-oxygen 
conditions (Todd et al., 2006). Tf2 LTRs have been demonstrated to act as Sre1-regulated 
mediators of oxygen-dependent transcription of adjacent genes (Sehgal et al., 2007). A brief 
examination of the results presented in the current study would reveal that PacC consensus 
binding sites are not present in all of the differentially expressed genes in the dataset. For 
example, considering the set of PacC-regulated genes during infection, 87% of these genes 
lack a PacC consensus sequence in their promoter, suggesting that this transcription factor has 
a predominantly indirect (i.e. non cis-acting) mechanism of gene regulation during infection. 
Interestingly, the GO Term enrichment analysis of the non cis-regulated genes and the genes 
having at least one PacC consensus sequence in the promoter region (13% of the genes in the 
same set) highlighted similar processes such as transport, metal-ion transport, pathogenesis, 
peptide metabolic processes, nonribosomal peptide biosynthetic processes, establishment of 
localisation and peptide biosynthetic processes. It is likely therefore that differential gene 
expression in the mutant results from deficits in several distinct regulatory mechanisms, 
perhaps via the participation of TEs as intermediates. The lack of an evident change in 
expression of the same set of genes in the ATCC46645 transcriptional profile may exclude a 
general role for transposition in A. fumigatus virulence. The model proposed in S. pombe and 
relating anaerobic stress to Sre1-mediated gene regulation through the Tf2 transposon family 
(Sehgal et al., 2007) presents an attractive hypothesis against which to test our results. The 
parallels between the two systems extend to several variables including the action of a 
proteolytically activated transcription factor (Sre1p or PacC) in response to environmental 
stress (anaerobic or alkaline) and modulation of expression of several genes, localised in close 
proximity along the chromosomes. The activity of TEs is under the control of epigenetic 
regulation, which implies the regulatory instructions relative to the specific element do not 
depend on the DNA sequence of the element itself, but rather on modification of the DNA or 
its associated proteins (especially histones). Such modifications consist of methylation of 
DNA nucleotides and methylation or acetylation of the associated histones (Fedoroff, 1989). 
Misregulation of genes involved in DNA organisation would therefore corroborate the 
hypothesis of the involvement of PacC-TE-mediated gene regulation.  
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The A. fumigatus ATCC46645 ΔpacC mutant transcription profile relative to the 
parental isolate ATCC46645 during initiation of murine infection pointed to the indirect way 
in which PacC might act to regulate the expression of the identified broad set of targets. In 
particular the results confirmed the possible role of epigenetic mechanisms, which would 
imply chromatin remodelling and/or transposition, to regulate blocks of adjacent genes. As 
previously discussed, in a challenging host environment, epigenetic mechanisms might act in 
a PacC-mediated manner to modulate gene expression per se and/or to activate TEs 
mobilisation. The comparison of A. fumigatus ATCC46645 ΔpacC and ATCC46645 
transcriptional profiles showed ORFs acting in DNA organisation were affected by pacC 
deletion, retrieving the previously mentioned hypothesis that PacC might act through 
chromatin-mediated specification of its transcriptional targets, as described for the regulator 
of yeast metabolism Rap1p (Buck and Lieb, 2006). Interestingly, histone modification has 
been recently identified as crucial for the regulation of secondary metabolite biosynthesis in 
A. nidulans, with the demonstration of a role for COMPASS complex member (complex 
associated with Set1), Bre1 in the activation of the expression of an otherwise cryptic 
secondary metabolite cluster (Bok et al., 2009). The conserved eukaryotic COMPASS 
complex acts to both facilitate and repress chromatin-mediated processes by methylation of 
lysine 4 of histone 3 (H3K4) (Mueller et al., 2006; Sims and Reinberg, 2006). Independently 
obtained experimental data to further support the hypothesised role for DNA reorganisation in 
PacC functionality will also emerge in several subsequent sections of this study. 
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CHAPTER V 
 
CHARACTERISATION OF AN A. FUMIGATUS MEMBRANE 
PROTEIN COMPLEX INVOLVED IN PH PERCEPTION USING 
THE SPLIT-UBIQUITIN MEMBRANE YEAST TWO-HYBRID 
(MYTH) SYSTEM 
 
5.1 Overview 
 
Sensory deprivation could provide a means to inhibit infectious fungal growth, 
considering protein interactions at the plasma membrane are formative events in A. fumigatus 
environmental sensing. These protein-protein interactions, in particular those occurring in the 
plasma membrane, are attractive candidates for antimicrobial chemotherapy and are often 
required during initial adaptations to the host environment. In pathogenic fungi, they could 
provide a way to interfere with the first stages of infectious fungal growth. For example, in A. 
nidulans, the absence of either of the transmembrane proteins PalH or PalI blocks pH 
signalling, as PacC is not proteolytically processed (Denison et al., 1995; Negrete-Urtasun et 
al., 1999). However, it still remains unclear how signalling through the PacC/Rim101 
pathway is initiated, particularly regarding the protein-protein interactions required for its 
activation.     
Interactions among fungal proteins involved in pH sensing and adaptation have been 
described in various studies (Calcagno-Pizarelli et al., 2007; Galindo et al., 2007; Herranz et 
al., 2005), providing important information about the connections within and between the two 
complexes involved in the establishment of the ambient pH signal in the model hypothesised 
for A. nidulans. The first of these complexes comprises the two plasma membrane proteins 
PalH and PalI and an arrestin-like protein PalF (Calcagno-Pizarelli et al., 2007; Herranz et al., 
2005; Maccheroni et al., 1997; Negrete-Urtasun et al., 1999). PalH contains seven 
transmembrane domains and a long, hydrophilic C-terminus located in the cytosol, whose 
analogies with G-protein coupled receptors have raised the possible involvement in pH 
signalling of G-protein functionality (Herranz et al., 2005). G-proteins are a group of 
transmembrane receptors involved in transmitting chemical signals received outside of the 
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cell and/or causing changes inside the cell. In A. nidulans, the hydrophilic C-terminal region 
of PalH interacts strongly with the arrestin-like protein PalF (Herranz et al., 2005). palF and 
palH mutations preventing this interaction prevent pH signalling (Herranz et al., 2005). These 
findings strongly indicate PalH as one, perhaps the only, essential component of a pH plasma 
membrane receptor. In A. nidulans, PalI contains three putative membrane-spanning domains 
with an N-terminal signal peptide and the basic C-terminus facing the cytosol (Calcagno-
Pizarelli et al., 2007). Unlike the null mutants of other pal genes, null palI mutants grow, 
though poorly, at alkaline pH (Denison et al., 1995), suggesting an important, but not 
essential role for PalI in pH signalling. The function of PalI is suggested as assisting the 
plasma membrane localisation of PalH (Calcagno-Pizarelli et al., 2007) by three possible 
mechanisms, which are still under investigation, namely down-regulation of PalH 
endocytosis, up-regulation of PalH recycling or assistance of PalH exit from the Golgi. Each 
of the three possibilities could require an interaction between PalH and PalI, either direct or 
indirect, but this has not been investigated (Peñalva et al., 2008).  
Membrane protein-protein interactions are immensely important in the organisation of 
living cells but they have been among the most difficult aspects of biology to be investigated. 
In this study, the MYTH (Fig. 5.1), commercially known as the DUALMembrane system, 
was used to investigate the interactions between component proteins of the A. fumigatus pH 
sensing and signalling pathway. Considering the high similarity between A. nidulans and A. 
fumigatus PalH, PalI and PalF (respectively 84.2%, 75.6% and 86.5%), A. fumigatus might 
mimic the model hypothesised for A. nidulans. Therefore, establishing the MYTH system 
utilising the pH sensing proteins PalH, PalI and PalF, not only represents an innovative 
platform to investigate A. fumigatus membrane protein-protein interactions, but will provide 
novel information about the pH signalling events leading to PacC activation. 
  Overcoming several limitations of the previous techniques adopted, the split-ubiquitin 
Membrane Yeast Two-Hybrid (MYTH) system innovatively exploits the functional 
complementarity of independently co-expressed amino and carboxy terminal portions of yeast 
ubiquitin (Ub), for characterising membrane protein-protein interactions (Fetchko and 
Stagljar, 2004; Johnsson and Varshavsky, 1994; Stagljar et al., 1998). Ub is a conserved 
protein of 76 residues, primarily involved in protein degradation (Hershko and Ciechanover, 
1992), whereby it is usually attached to the N-terminus of proteins as a signal for their 
degradation by the 26S proteosome. While the target protein is degraded by the 26S 
proteosome, the ubiquitin motifs are saved from degradation by cellular ubiquitin-specific 
proteases (UBPs), which cleave ubiquitin from the target protein after the C-terminal residue 
(Gly76), hence recycling the ubiquitin back to the cytoplasm. The two portions of yeast 
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ubiquitin, called Nub (for N-terminal ubiquitin, amino acids 1-34) and Cub (for C-terminal 
ubiquitin, amino acids 35-76) have a strong propensity for spontaneous reconstitution. A 
single amino acid exchange in position 13 of Nub from Ile to Gly (mutated Nub is termed 
NubG) abolishes the reconstitution of the two domains. However, the reconstitution of the 
split-ubiquitin can occur also as a consequence of the interaction between two proteins fused 
to NubG and Cub, which are therefore brought into close proximity within the cell. The bait, a 
membrane protein of interest which is expressed as a translational fusion to Cub and the 
hybrid transcription factor LexA-VP16 (Fig. 5.1A), is coexpressed with a second protein of 
interest, the prey, which is fused to NubG (Fig. 5.1B). The reconstituted split-ubiquitin is 
immediately recognised by ubiquitin-specific proteases (UBPs) which cleave the polypeptide 
chain between Cub and LexA-VP16, the latter being translocated to the nucleus of the cell 
where it binds the LexA operators situated upstream of several reporter genes (Fig. 5.1). The 
reporter genes used in the system are the two auxotrophic growth markers (HIS3 and ADE2), 
on which activation depend the yeast to grow on defined minimal medium missing histidine 
or adenine, and lacZ, which encodes the enzyme b-galactosidase. 
 
Fig. 5.1: Principle of the split-ubiquitin Membrane Yeast Two-Hybrid (MYTH) system. (A) The 
bait protein is an integral membrane protein, fused with a C-terminal region (Cub) of ubiquitin and the hybrid 
transcription factor LexA-VP16. The bait is immobilised at the membrane and unable to reach the nucleus to 
activate the reporter genes. (B) The prey is constructed by fusing a second protein of interest to a mutated N-
terminal region (NubG) of ubiquitin. (C) Interaction between bait and prey places Cub and NubG in close 
proximity resulting in reconstitution of split-ubiquitin and release, by protease cleavage, of the hybrid 
transcription factor. LexA-VP16 enters the nucleus and activates the reporter genes. Thus, the interaction 
between bait and prey results in prototrophy for certain essential nutrients, which is detected on selective media. 
Modified from www.dualsystems.com. 
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5.2 Methods 
 
5.2.1 S. cerevisiae strains  
 
S. cerevisiae strain NMY51 [MATa his3delta200 trp1-901 leu2-3,112 ade2 
LYS2::(lexAop)4-HIS3 ura3::(lexAop)8-lacZ (lexAop)8-ADE2 GAL4] was grown in yeast 
extract peptone adenine dextrose (YPAD) media (1% (w/v) yeast extract, 2% (w/v) peptone, 
2% (w/v) glucose, 0.004% adenine sulphate) or in appropriate SD media, as described in 
Section 2.3.2. Solid YPAD or SD media was produced by addition of 2% (w/v) agar prior to 
autoclaving. Liquid cultures were agitated by orbital shaking at 180 rpm unless otherwise 
specified. S. cerevisiae strains were cultured for 2-3 days at 30°C. Strains were either stored at 
4°C for up to 4 weeks on solid agar plates or for long term storage in 25% (w/v) glycerol at -
80°C. 
 
5.2.2 Plasmids 
 
Bait plasmids: pPR3-STE (x-Cub), pPR3-SUC (x-Cub) and pBT3-N (Cub-X)  
Three bait plasmids were used in this study. The bait vector pBT3-SUC (Fig. 5.2A) is 
specifically designed for expression of integral membrane proteins, having a Nout/Cin 
topology, whereby the N terminus is extracellular and the C terminus intracellular. The vector 
supplies a yeast signal sequence derived from the SUC2 (invertase) gene of S. cerevisiae. The 
Cub-LexA-VP16 cassette is fused to the cytosolic C-terminus of the protein of interest. The 
vector pBT3-STE (Fig. 5.2B) containing the STE2 leader sequence derived from the S. 
cerevisiae Ste2 protein (a G protein coupled receptor) is recommended for expressing, as 
baits, integral membrane proteins having multiple transmembrane domains and a Nout/Cin 
topology. The Cub-LexA-VP16 cassette is fused to the C-terminus of the bait. Membrane 
proteins having luminal C-termini are expressed from vector pBT3-N (Fig. 5.2C), permitting 
fusion of the LexA-VP16-Cub module to the cytosolic N-terminus of the protein of interest. 
The properties of these 3 bait vectors in terms of bacterial and fungal origin of replication, 
auxotrophic and resistance markers are summarised in Table 5.1.  
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Fig. 5.2: Bait plasmids. (A) pBT3-SUC. This vector contains a yeast signal sequence derived from the 
SUC2 (invertase) gene of S. cerevisiae. The Cub-LexA-VP16 cassette is fused to the cytosolic C-terminus of the 
protein of interest. (B) pBT3-STE. The STE2 leader sequence contained in this plasmid derives from the S. 
cerevisiae STE2p, which does not have any targeting function but only serves as a short leader sequence to 
increase the expression of the protein of interest. The Cub-LexA-VP16 cassette is fused to the C-terminus of the 
bait. (C) pBT3-N. This vector fuses the LexA-VP16-Cub module to the cytosolic N-terminus of the protein of 
interest. Maps generated by DNADynamo, www.bluetractorsoftware.co.uk. 
  
Bait vectors  
Vector Auxotrophic 
Marker (yeast) 
Origin of 
replication (yeast) 
Resistance 
Marker (E. coli) 
Origin of 
replication (E. coli) 
pBT3-SUC LEU2 CEN/ARS (1-2 
copies/ cell) 
Kan (select with 
30 μg/ml 
kanamycin) 
High copy 
 
pBT3-STE LEU2 CEN/ARS (1-2 
copies/cell) 
Kan (select with 
30 μg/ml 
kanamycin) 
High copy 
 
pBT3-N LEU2 CEN/ARS (1-2 
copies/cell) 
Kan (select with 
30 μg/ml 
kanamycin) 
High copy 
 
 
Table 5.1: Summary of the bait vectors properties. For each vector is shown the auxotrophic marker 
in yeast, the origin of replication in yeast, the resistance marker in E. coli and the origin of replication in E. coli.    
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Prey plasmids: pPR3-N (x-NubG) and pPR3-STE (NubG-X)  
Preys and cDNA libraries can be developed in two orientations expressing fusion 
proteins with C-terminal NubG (pPR3-STE x-NubG, Fig. 5.3A) or with N-terminal NubG 
(pPR3-N NubG-X, Fig. 5.3B). The properties of these 2 prey vectors in terms of bacterial and 
fungal origin of replication, auxotrophic and resistance markers are summarised in Table 5.2.  
 
Fig. 5.3: Prey plasmids. (A) pPR3-STE. The NubG domain is fused to the C-terminus of the bait. (B) 
pPR3-N. This vector fuses the NubG domain to the cytosolic N-terminus of the protein of interest. Maps 
generated by DNADynamo, www.bluetractorsoftware.co.uk. 
 
Prey vectors  
Vector Auxotrophic 
Marker (yeast) 
Origin of 
replication (yeast) 
Resistance 
Marker (E. coli) 
Origin of 
replication (E. coli) 
pPR3-STE TRP1 2 micron (20-50 
copies/cell) 
 
Amp (select 
with 100 μg/ml 
ampicillin) 
High copy 
 
pPR3-N TRP1 2 micron (20-50 
copies/cell) 
 
Amp (select 
with 100 μg/ml 
ampicillin) 
High copy 
 
 
Table 5.2: Summary of the prey vectors properties. For each vector is shown the auxotrophic marker 
in yeast, the origin of replication in yeast, the resistance marker in E. coli and the origin of replication in E. coli.    
 
Control plasmids: pCCW-Alg5, pAL-Alg5 and pDL-Alg5 The plasmid pCCW-
Alg5 (Fig. 5.4A) which expresses a fusion of the yeast ER protein Alg5 to the Cub-LexA-
Vp16 cassette has been used as control bait, in virtue of the presence of a functional and 
intracellularly-located Cub-LexA domain. The plasmids pAL-Alg5 (Fig. 5.4B) and pDL-Alg5 
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(Fig. 5.4C) which express a fusion of the yeast ER protein Alg5 to the wild type Nub portion 
of the yeast ubiquitin, or to the mutated NubG portion of the yeast ubiquitin, respectively, 
have been used as control preys. The properties of these control vectors in terms of bacterial 
and fungal origin of replication, auxotrophic and resistance markers are summarised in Table 
5.3. 
 
Fig. 5.4: Control plasmids. (A) pCCW-Alg5 for expressing a control bait, a fusion of the yeast ER 
protein Alg5 to the Cub-LexA-Vp16 cassette. (B) pAL-Alg5 for expression of control prey, a fusion of the yeast 
ER protein Alg5 to the wild type Nub portion of the yeast ubiquitin.  (C) pDL-Alg5 for expressing a control 
prey, a fusion of the yeast ER protein Alg5 to the mutated NubG portion of the yeast ubiquitin. Maps generated 
by DNADynamo, www.bluetractorsoftware.co.uk. 
 
Control vectors  
Vector Auxotrophic 
Marker (yeast) 
Origin of 
replication (yeast) 
Resistance 
Marker (E. coli) 
Origin of 
replication (E. coli) 
pCCW-
Alg5 
LEU2 CEN/ARS (1-2 
copies/ cell) 
Kan (select with 
30 μg/ml 
kanamycin) 
High copy 
 
pAL-Alg5 TRP1 2micron (20-50 
copies/cell) 
 
Amp (select 
with 100 μg/ml 
ampicillin) 
High copy 
 
pDl-Alg5 TRP1 2micron (20-50 
copies/cell) 
 
Amp (select 
with 100 μg/ml 
ampicillin) 
High copy 
 
 
Table 5.3: Summary of the control vectors properties. For each vector is shown the auxotrophic 
marker in yeast, the origin of replication in yeast, the resistance marker in E. coli and the origin of replication in 
E. coli.    
 
Detailed maps of all plasmids can be found in Appendix C.  
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5.2.3 MYTH system  
 
A. fumigatus membrane protein-protein interactions were tested using the 
DUALsystems split-ubiquitin MYTH system  (DUALsystems Biotech), according to the 
manufacturer‟s instructions. All protocols, media and solutions used to perform the 
DUALmembrane screen are listed in the manufacturer‟s instructions, unless otherwise stated.  
 
5.3 Results 
 
5.3.1 Construction of a panel of A. fumigatus baits and preys to test pH-sensing protein 
interactions  
 
In A. nidulans, PalH contains seven transmembrane domains and a long, hydrophilic 
C-terminus located in the cytosol, which interacts strongly with the arrestin-like protein PalF 
(Herranz et al., 2005). PalI contains four highly hydrophobic domains, but in silico 
predictions had revealed the presence of an N-terminal signal peptide, therefore the 
hypothesised structure for A. nidulans PalI consists of three putative membrane-spanning 
domains and a basic C-terminus facing the cytosol (Calcagno-Pizarelli et al., 2007). Whereas 
the interaction between PalH and PalF has been demonstrated as crucial for the establishment 
of pH signalling (Herranz et al., 2005), no published information is available about interaction 
between PalH and PalI. The function of PalI has been suggested to be as in assisting the 
plasma membrane localisation of PalH (Calcagno-Pizarelli et al., 2007) by three possible 
mechanisms, which are still under investigation and could require an interaction between 
PalH and PalI, either direct or indirect. However, no such demonstration has been provided in 
the current literature. A. fumigatus PalH, PalI and PalF show high similarity with the 
heterologous ones in A. nidulans (respectively 84.2%, 75.6% and 86.5% as shown in 
Appendix F), therefore suggesting a similar behaviour to that hypothesised for A. nidulans. 
The interaction between PalH and PalF was therefore used as positive control for the correct 
functioning of the MYTH platform, which was subsequently utilised to test the hypothesis 
that PalH and PalI directly interact in the plasma membrane.   
A fundamental requirement of the MYTH screen is for the Cub-LexA-VP16 module 
of the bait protein, and for the NubG moiety of the prey protein to be cytosolically located. In 
order to satisfy these requirements, and to appropriately accommodate the topology of cloned 
membrane proteins (where it was known), and to overcome problems associated with 
expression of heterologous proteins (for example expression levels below the limits of 
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detection or above the limits of cells tolerance) a total of seventeen constructions were made. 
Fig. 5.5 shows the plasmids constructed to test every possible interaction between the three 
components of the plasma membrane signalling complex involved in A. fumigatus adaptation 
to environmental pH.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.5: Scheme representing the plasmids constructed to test every possible interaction between 
the three components of the plasma membrane pH signalling complex of A. fumigatus. A. fumigatus 
membrane proteins PalH and PalI were cloned both in bait and prey vectors. Various different vectors were 
employed for the bait (pBT3-SUC, pBT3-STE and pBT3-N) and prey (pPR3-STE and pPR3-N) expression to 
accommodate the topology of cloned membrane proteins and overcome problems with heterologous expression. 
 
 A. fumigatus membrane proteins PalH and PalI were cloned both in bait and prey 
vectors. Multiple vectors were employed for bait (pBT3-SUC, pBT3-STE and pBT3-N) and 
prey (pPR3-STE and pPR3-N) expressions. In particular for PalI, whose in silico predicted 
topology has not been validated by any experimental evidence, was cloned both as bait and 
prey in two topological orientations, expressing the fusion protein with N-terminal Cub 
(pBT3-N) or C-terminal Cub (pBT3-STE and pBT3-SUC) for the baits and with N-terminal 
NubG (pPR3-N) or with C-terminal NubG (pPR3-STE) for the preys. As demonstrated by the 
physical interaction of its C-terminus with the cytosolic protein PalF in A. nidulans (Herranz 
et al., 2005), A. fumigatus transmembrane protein PalH is likely to possess an intracellular C-
terminus and was cloned as bait in the vectors pBT3-SUC and pBT3-STE and as prey in the 
vectors pPR3-N and pPR3-STE. According to its cytosolic location, A. fumigatus PalF was 
cloned uniquely as prey in the vectors pPR3-N and pPR3-STE. In fact, cytosolic proteins can 
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be tested in the system only as preys to avoid the entrance of the hybrid transcription factor 
into the nucleus independently of a detected interaction.  
A. fumigatus PalH, PalI and PalF cDNAs were obtained by PCR using Platinum HiFi 
polymerase (Invitrogen) and DNA extracted from a full length A. fumigatus cDNA library 
(Invitrogen, see Chapter VI for details) as template. Inserts were cloned using SfiI sites 
provided in the multiple cloning sites of the vectors (see Fig. 5.2 and Fig 5.3 and Appendix C 
for details). The polycloning site of each DUALmembrane system vector is flanked on either 
side by SfiI sites: GGCCATTA‟CGGCC and GGCCGCCT‟CGGCC (where the cleavage site 
is indicated as  ), resulting in non-complementary overhangs to allow directional cloning of 
DNA into the vectors. The absence of SfiI sites in most eukaryotic cDNAs means that most 
full-length cDNAs could be directionally cloned; nonetheless, every cloned sequence was 
checked with the software NEBcutter http://tools.neb.com/NEBcutter2/index.php (Biolabs). 
The oligonucleotides for PCR amplification were carefully designed to remove the native stop 
codon from the gene of interest and to add appropriate flanking SfiI restriction sites, allowing 
directional cloning of the insert into the vectors. Oligonucleotides were designed on a case by 
case basis to maintain an open reading frame in fusions between proteins of interest, and 
vector-encoded features. In the case of the prey plasmid pPR3-STE, a single nucleotide at the 
5‟ of the sequence was added for each gene, thereby effecting the insertion of a single amino 
acid at the N-terminus of fusion proteins. To maximise expression levels, and functionality of 
preys expressed from this vector, three different pPR3-STE preys, for each relevant protein of 
interest and differing by inserted amino acids, were constructed. The 3 amino acids inserted 
Leucine (L), Glutamine (G) and Arginine (R) have completely different properties because of 
their side chain polarity and chain; Leu is non-polar and neutral, Gln is polar and neutral and 
Arg is polar and positive. According to the amino acid inserted, the plasmids were named 
with a suffix of L, G, or R for Leu, Gln and Arg respectively. All plasmids were sequence-
verified using oligonucleotides specific to the genes of interest, as listed in Appendix B.  
Fig 5.6 summarises the experimental procedure to test A. fumigatus membrane 
protein-protein interactions using the split-ubiquitin MYTH system. Once sequence-verified, 
the plasmids were transformed separately into the yeast reporter strain NMY51 using a 
modification of the lithium-acetate protocol described by Gietz and Woods (Gietz et al., 
1992). The expression of baits and preys was verified by western blotting (Towbin et al., 
1979), using proteins extracted from overnight SD cultures. Total protein quantification of the 
samples was performed using the Bicinchoninic Acid Protein Assay Kit (sigma) according to 
the manufacturer‟s instructions. 30 µg of protein samples were run on 8% SDS-PAGE gels as 
described in Section 2.3.2. In addition, a functional assay was performed to ensure the bait 
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was properly located within the membrane and was functional by co-transformation with two 
control preys (D). Finally, the interaction of interest was tested by co-transformation in yeast 
of the test bait and prey plasmids (E).  
 
Fig. 5.6: Experimental procedure for testing A. fumigatus membrane protein-protein interactions 
using the split-ubiquitin MYTH system. (A) The cDNAs encoding the proteins of interest were obtained by 
PCR from DNA extracted from a full length A. fumigatus cDNA library and sub-cloned into the appropriate bait 
and prey vectors. Once sequence-verified, the plasmids were transformed separately into the yeast reporter strain 
NMY51 (B) and the expression of baits and preys was verified by western blotting (C). For the baits a functional 
assay was performed to ensure the bait was properly located within the membrane and was functional by co-
transformation with control preys (D). Then, the interaction was tested by co-transformation in yeast of the test 
bait and prey plasmids (E).  
 
5.3.2 Expression of A. fumigatus pH-sensing bait and prey fusion proteins  
 
The expression of the proteins of interest was verified by western blotting analysis of 
total yeast extracts using an antibody directed against the LexA domain of the fusion protein 
for the baits and an antibody directed against the HA epitope of the fusion protein for the 
preys. The construct pCCW-Alg5 was used as positive control for the detection of the LexA 
epitope and expresses a fusion of the yeast ER protein Alg5 to the wild type Cub portion of 
yeast ubiquitin (expected size, 77.5 KDa). The plasmid pPR3-N was used as positive control 
for the detection of the HA epitope (expected size, 15 KDa). Due to the vast differences in 
sizes of controls and test baits and preys, the controls are not visualised in Fig. 5.7. 
Panel A in Fig. 5.7 shows the results for the baits. The expression of PalH bait was 
confirmed from both the pBT3-STE and pBT3-SUC bait vectors (Fig. 5.7.A), where in both 
cases a recombinant protein of approximately 123.7 KDa is detectable by western blot, this 
agrees with the size expected following fusion of the PalH protein (85.7 KDa) to the Cub-
LexA-VP16 (38 KDa). PalI bait could only be expressed as a C-terminal Cub fusion (pBT3-
STE and pBT3-SUC), not as an N-terminal fusion (pBT3-N) (Fig. 5.7A). However, given that 
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equal amounts of total protein extract were loaded for PalH and PalI baits, it is likely that PalI 
bait was expressed at comparatively low levels, as a weak signal was visible for the pBT3-
STE bait vector, whilst no signal was detectable for pBT3-SUC. Considering the predicted 
size of PalI protein, (71.6 KDa), and the size of the Cub-LexA-VP16 fusion, the size of the 
expected product is 109.6 KDa.  
Panel B in Fig. 5.7 illustrates the results for the preys. Concordant with the 
cytoplasmic location for the arrestin-encoding PalF protein, the expression of PalF prey was 
confirmed from both C and N-terminal fusions (pPR3-STE) and (pPR3-N), respectively, to 
NubG (Fig. 5.7B). PalH and PalI prey could only be expressed when fusing the NubG domain 
at the C-termini (pPR3-STE) (Fig. 5.7B). Considering the size of the A. fumigatus PalF, PalH 
and PalI proteins, (respectively 82.1 KDa, 85.8 KDa and 71.6 KDa), and the size of the 
NubG-HA fusion (7 KDa), the size of the expected products is 89.1 KDa for A. fumigatus 
PalF, 92.8 KDa for A. fumigatus PalH and 78.6 KDa for A. fumigatus PalI. These experiments 
confirmed the requirement, when preparing the preys, to construct multiple pPR3-STE preys, 
with different single amino acid insertions, to secure clones expressing and functioning in the 
pPR3-STE prey vector. In fact, in the case of PalF pPR3-STE prey, expression was verified 
when the introduced amino acid was either L or G, but not R.  
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Fig. 5.7: Western blotting analysis to verify the expression of bait and prey proteins. (A) Baits. 
PalH bait expression (expected size 123.7 KDa) detected from both the pBT3-STE and pBT3-SUC vectors. PalI 
expression weakly detectable from pBT3-STE (expected size 109.6 KDa), but not from pBT3-SUC or pBT3-N 
vectors. (B) Preys. In pPR3-N, only PalF (expected size 89.1 KDa), but not PalH (expected size 92.8 KDa) and 
PalI (expected size 78.6 KDa), was expressed, whereas in pPR3-STE the majority of tested preys were expressed 
in detectable quantities, the exception being PalF R. To ensure the same loading of 30 µg of protein samples in 
the 8% SDS-PAGE gels, total protein extracts were quantified using the Bicinchoninic Acid Protein Assay Kit.  
 
5.3.3 Testing of A. fumigatus bait functionality for split-ubiquitin reconstitution  
 
Independent verification of PalH and PalI bait was derived by co-transformation with 
vectors expressing control preys. This control assay is important for determining whether the 
bait is functional in the split-ubiquitin assay and whether it results in any non-specific 
background activity. In order to assay the expression of A. fumigatus baits in yeast, each of 
the bait plasmids was co-transformed with the control plasmids pAI-Alg5 and pDL2-Alg5. 
The construct pAI-Alg5 expresses a fusion of the yeast ER protein Alg5 to the wild type Nub 
portion of yeast ubiquitin. If the test bait is properly inserted into the membrane of yeast and 
the Cub-LexAVP16 part is located on the cytosolic side of the membrane, co-expression of 
the tested bait together with pAI-Alg5 should result in reconstitution of split-ubiquitin through 
the strong affinity of wild type Nub for Cub and the concurrent activation of reporter genes. 
pDL2-Alg5 expresses a fusion of the same protein to the mutated Nub portion (NubG); 
therefore co-expression of the bait of interest together with pDL2-Alg5 should not lead to 
split-ubiquitin formation, because the mutated NubG has no affinity for Cub, and the bait does 
not interact with Alg5.  
Fig. 5.8 shows the result of the co-transformation experiment for PalH bait in the 
pBT3-SUC (B) and pBT3-STE (C) vectors and for PalI bait in the pBT3-N (D), pBT3-SUC 
(E) and pBT3-STE (F) vectors. The functioning prey pCCW-Alg5 (A), expressing a fusion of 
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the yeast protein Alg5 to the wild type Cub portion of yeast ubiquitin, was used as positive 
control. For each bait, the total transformants (TT), indicative of the transformation 
efficiency, and the prototrophic transformants (PT), indicative of a positive interaction and 
obtained following co-transformation with the tested bait and prey fusion proteins were 
enumerated. Transformation efficiency was quantified by growth in non selective SD-trp-leu 
media, and growth of yeast expressing interacting baits and preys in the selective media SD-
trp-leu-his-ade. In the case of the latter media, no growth is observed following the co-
expression of baits with the negative control prey, as the mutated NubG has no affinity for 
Cub, and split-ubiquitin is not reconstituted.  
From these experiments it was deduced that PalH pBT3-STE and pBT3-SUC, and PalI 
pBT3-STE and pBT3-SUC baits are appropriately localised in the membrane of yeast with 
corresponding Cub-LexAVP16 moieties located in the cytoplasm. For PalI pBT3-STE and 
pBT3-SUC baits, the number of colonies in selective media following co-transformation with 
the positive prey plasmid pAI-Alg5 was ten times less than that obtained for PalH pBT3-STE 
and pBT3-SUC baits. This supports a direct link between the expression levels observed in 
the previous western blotting and the functionality of a specific bait in terms of prototrophic 
transformants. In addition, whereas no growth is expected in selective media following the 
co-expression of a test bait with the negative control, a low level of background was visible 
for all functional baits, likely because of the leaky nature of the HIS reporter gene. In light of 
these findings, and to optimise relative levels of transformation efficiency and of false 
positives, PalH pBT3-SUC bait was chosen for further analyses.  
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Fig. 5.8: Verification of the expression and functionality of pH-sensing baits constructed by co-
transformation with control preys in yeast. The baits tested are (A) the positive control bait pCCW-Alg5, (B) 
PalH pBT3-SUC, (C) PalH pBT3-STE, (D) PalI pBT3-N, (E) PalI pBT3-SUC and (F) PalI pBT3-STE. Each of 
these baits was co-transformed with the positive control prey pAI-Alg5 and the negative control prey pDL2-
Alg5. For each co-transformation, the total transformants (TT) in SD-leu-trp, indicative of the transformation 
efficiency, and the prototrophic transformants (PT) in SD-leu-trp-his-ade, indicative of interaction between bait 
and prey are shown. With lack of interaction, yeast colonies turn pink during the incubation.  
 
NMY51 permits the use of ADE2 as a reporter gene. In the absence of a protein-
protein interaction, this gene is not transcribed and therefore, a red-coloured intermediate 
accumulates from the adenine metabolic pathway. Activation of the ADE2 gene by a protein-
protein interaction leads to expression of the ADE2 gene product and unblocks the pathway. 
For this reason, NMY51 cells expressing an interacting protein pair display a very faint pink 
to white colour, depending on the strength of the interaction. In the absence of a protein-
protein interaction, NMY51 displays a pink colour. When grown in SD-leu, SD-trp or SD-ura, 
no visible growth occurs after 3 days at 30°C, whereas in SD-his and SD-ade, a background 
of very small colonies (the colonies are  smaller than 1 mm in diameter and do not turn red 
upon storage) is visible after 3 days at 30°C, because of the slight leakiness respectively of the 
HIS3 gene and of the ADE2 reporter gene. 
Due to the ADE2 reporter gene, the colonies displayed different shades of colour, 
ranging from dark red to white, depending on whether an interacting protein pair is expressed 
or not. When the ADE2 reporter gene is not transcribed (as in the case of the co-
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transformation with PalH pBT3-SUC and the negative control prey plasmid, Fig. 5.8B, 
bottom row), the adenine synthesis pathway is blocked and a red colored intermediate is 
accumulated, turning the cells red. If a bait and prey interact (as in the case of the co-
transformation with PalH pBT3-SUC and the positive control prey plasmid Fig. 5.8B, top 
row), the ADE2 reporter gene is activated and the adenine synthesis pathway is unblocked, 
leading to the disappearance of the red coloured intermediate. Thus, yeast harbouring a 
protein-protein interaction can exhibit a colour ranging from faintly pink (weak interaction, 
corresponds with slow growth on SD-trp-leu-his-ade medium) to white (strong interaction, 
corresponds with strong growth on SD-trp-leu-his-ade medium).  
Taken together the results of the western blot and the control assay permitted new 
conclusions upon the topology for the two plasma membrane proteins PalH and PalI, 
confirming the literature and the in silico predictions and suggesting that both PalH and PalI 
have their C-terminal domain located intracellularly and their N-terminal domain located 
extracellularly. 
 
5.3.4 Use of A. fumigatus PalH bait to investigate the interaction network between 
components of the plasma membrane signalling complex 
 
The direct interaction between components of the plasma membrane signalling 
complex was addressed by co-transformation with PalH pBT3-SUC bait and the A. fumigatus 
preys described above. Fig. 5.9 depicts only a partial subset of the interactions tested to offer 
an idea of the layout of the experiment and introduce a variety of issues raised at this point of 
our experimentation. Specifically, the results shown include those from the co-transformation 
with PalH pBT3-SUC bait and either of PalH, PalI or PalF preys, the latter being expressed as 
fusions in either of two orientations fusing the NubG at the N-terminus (pPR3-N) or at the C-
terminus (pPR3-STE) (B). The functioning prey pCCW-Alg5 (A), expressing a fusion of the 
yeast protein Alg5 to the wild type Cub portion of yeast ubiquitin, was used as positive 
control. As before, for every co-transformation the total transformants (TT), indicative of the 
transformation efficiency, and the prototrophic transformants (PT), indicative of an 
interaction between the two partners tested were enumerated. As a means for comparison, the 
results of co-transformation with the positive pAI-Alg5 and the negative pDL-Alg5 control 
preys, expressing respectively a fusion of the yeast protein Alg5 to the wild type Nub portion 
of yeast ubiquitin and the mutated Nub portion (NubG) are also shown. 
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Fig. 5.9: Test to detect interactions between PalH, expressed as bait in the pBT3-SUC vector in 
the MYTH system, and the members of the membrane signalling complex PalH, PalI and PalF. To define 
an interaction, growth in selective media is compared with the control co-transformations pCCW-Alg5/pAL-
Alg5 (positive control for interaction) and pCCW-Alg5/pDL-Alg5 (negative control for interaction) (A). pBT3-
STE PalH has been co-transformed with the positive control prey pAL-Alg5, the negative control prey pDL-
Alg5, pPR-STE PalF, pPR-STE PalH, pPR-STE PalI, pPR-N PalF, pPR3-N PalH and pPR3-N PalI (B). For each 
co-transformation the total transformants (TT) in SD-leu-trp, indicative of the transformation efficiency, and the 
prototrophic transformants (PT) in SD-leu-trp-his-ade, indicative of interaction between bait and prey are shown. 
In case of lack of or weak interaction, yeast colonies turn pink during the incubation.  
 
In only one instance (i.e. the co-transformation with PalH pBT3-SUC bait and PalF 
pPR3-N) did the data support the previous hypothesis (Herranz et al., 2005). For the other 
preys, a limited number of colonies were present in selective media suggesting a possible 
limitation of the system in distinguishing between weak and strong interactors, and more 
importantly between weak interactors and false positive interactions. This was enforced by 
the fact that no difference in the number of colonies in selective media were observed when 
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PalH pBT3-SUC bait was co-transformed with the preys PalH pPR3-STE L and PalI pPR3-
STE L or with PalH pPR3-N and PalI pPR3-N, whereas western blotting had confirmed the 
expression of PalH pPR3-STE L and PalI pPR3-STE L, but not of PalH pPR3-N and PalI 
pPR3-N. The prototrophic transformants observed from the co-transformation with PalH 
pBT3-SUC bait and PalH pPR3-N or PalI pPR3-N preys therefore surely represent false 
positives.  
Considering the visual examination as too labile a criterion upon which to judge the 
interaction between two tested partners, attention was therefore focused on further 
optimisation of the assay by next addressing reproducibility, and limitation of false positive 
results.   
To address the problem of false positivity consistently observed with this bait, 3-
aminotriazole (3-AT) was added in varying concentrations to the selective media SD-trp-leu-
his-ade. 3-AT is a competitive inhibitor of the HIS3 gene product. Therefore, the increase in 
the concentration of 3-AT enhances the stringency of HIS3 selection. To find an optimal 3-
AT concentration, the same volume from three different co-transformation reactions was 
grown on SD-trp-leu-his-ade plates supplemented with 0, 5, 10, 20, 30, 40 and 50 mM 3-AT. 
Fig. 5.10 shows the results of one of the three replicates for the three co-transformation 
reactions, involving PalH pBT3-SUC bait and the empty prey vectors pPR3-STE (A) and 
pPR3-N (B), and also PalF pPR3-N (C). The prey plasmids pPR3-STE and pPR3-N were 
chosen because they carry only the NubG domain and therefore no prototrophic transformants 
are expected in the media selective for the interaction. In addition, these two plasmids 
represent the vectors for the construction of every A. fumigatus prey developed in this study. 
The prey fusion protein palF pPR3-N was used to exploit its strong positive interaction with 
PalH pBT3-SUC bait. In the co-transformations with PalH pBT3-SUC bait and the prey 
vectors pPR3-STE (A) or pPR3-N (B) no colonies are expected, because NubG and Cub have 
no affinity for each other. However, in the absence of 3-AT a significant number of colonies 
are visible, so that it is not possible to discriminate between these false positive and the 
positive interactors obtained from the co-transformation with PalH pBT3-SUC bait and PalF 
pPR3-N prey (C). Increasing the level of 3-AT up to 20 mM leads to the progressive 
elimination of false positive results, with minimal impact upon results obtained with the 
strongly interacting PalF pPR3-N prey. At concentrations of 3-AT exceeding of 20 mM, 
growth is drastically affected for all the samples, indicating the toxicity threshold for this 
compound has been reached.    
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Fig. 5.10: Panel showing the optimisation of the 3-AT concentration used in SD-leu-trp-his-ade to 
discriminate between positive interactors and false positives. The bait plasmid pBT3-SUC PalH is co-
transformed in NMY51 together with empty prey vectors pPR3-STE (A) and pPR3-N (B) and the prey pPR3-N 
PalF (C). Co-transformant cells are plated in SD-leu-trp-his-ade containing increasing concentrations of 3-AT, as 
indicated at the top of each column.  
 
Based upon these results, a concentration of 20 mM 3-AT was established as optimal 
for the reduction of the background in co-transformation reactions involving the bait palH 
pPR3-SUC. The robustness of the system was next tested by repeating, in triplicate, the co-
transformations previously shown in Fig. 5.9. Using the new culturing conditions, the direct 
interaction between PalH, PalI and PalF was addressed by co-transformation with PalH 
pBT3-SUC bait and the A. fumigatus preys as previously described. For each replicate, Table 
5.4 shows the results for the co-transformations in terms of number of total transformants 
(TT) obtained in SD-leu-trp, indicative of the transformation efficiency, and of prototrophic 
(PT*) transformants in SD-leu-trp-his-ade 20 mM 3-AT (the asterisk signifies the addition of 
3-AT to the media), indicative of interaction between bait and prey. In addition, the table 
illustrates the normalisation process performed upon the data. For each replicate, the ratio 
between prototrophic and total transformants was calculated and averaged. As control for the 
experiment, the functioning prey pCCW-Alg5 (A), expressing a fusion of the yeast protein 
Alg5 to the wild type Cub portion of yeast ubiquitin, was co-transformed with the positive 
pAI-Alg5 and the negative pDL-Alg5 control preys, expressing respectively a fusion of the 
yeast protein Alg5 to the wild type Nub portion of yeast ubiquitin and the mutated Nub 
portion (NubG). To establish the threshold for positive and negative interactions, PalH pBT3-
SUC bait was transformed with the positive pAI-Alg5 and the negative pDL-Alg5 control 
preys.  
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 1st experiment 2nd experiment 3rd experiment Normalisation   
Prey TT PT* 
PT*/
TT 
TT PT* 
PT*/
TT 
TT PT* 
PT*/ 
TT 
1 2 3 AVG SD 
pAL-Alg5  2000 1000 50 2000 500 25 2000 250 12.5 100 100 100 100 0 
pDL-Alg5  1000 0 0 500 2 0.4 500 3 0.6 0 1.6 4.8 2.1 2.4 
pPR3-STE 
PalH L 
1000 100 10 1000 100 10 1000 20 2 20 40 16 25.3 12.9 
pPR3-STE 
PalH Q 
1000 200 20 1000 100 10 1000 20 2 40 40 16 32.0 13.9 
pPR3-STE 
PalH R 
1000 50 5 1000 100 10 1000 20 2 10 40 16 22.0 15.9 
pPR3-STE 
PalF L 
1000 100 10 1000 100 10 1000 20 2 20 40 16 25.3 12.9 
pPR3-STE 
PalF Q 
1000 100 10 1000 100 10 1000 25 2.5 20 40 20 26.7 11.5 
pPR3-STE 
PalF R 
1000 0 0 1000 0 0 1000 0 0 0 0 0 0.0 0.0 
pPR3-STE 
PalI L 
1000 20 2 1000 5 0.5 1000 20 2 4 2 16 7.3 7.6 
pPR3-STE 
PalI Q 
1000 20 2 2000 0 0 1000 3 0.3 4 0 2.4 2.1 2.0 
pPR3-STE 
PalI R 
1000 0 0 1000 0 0 1000 10 1 0 0 8 2.7 4.6 
pPR3-N 
PalH 
1000 5 0.5 1000 0 0 1000 0 0 1 0 0 0.3 0.6 
pPR3-N 
PalF 
1000 200 20 1000 100 10 1000 20 2 40 40 16 32.0 13.9 
pPR3-N 
PalI  
1000 2 0.2 1000 0 0 1000 0   0 0.4 0 0 0.1 0.2 
 
Table 5.4: Results for co-transformations testing the interaction between PalH, expressed as bait 
in the pBT3-SUC vector in the MYTH system, and the members of the membrane signalling complex 
PalH, PalI and PalF. Each co-transformation was repeated 3 times and for each replicate the number of total 
transformants (TT) in SD-leu-trp, indicative of the transformation efficiency, and the prototrophic transformants 
(PT*) in SD-leu-trp-his-ade 20 mM 3-AT, indicative of interaction between bait and prey, was estimated. The 
ratio PT*/TT was calculated and averaged (1, 2 and 3 correspond respectively to the first, second and third 
replicate) fixing the value of the positive control co-transformation PalH pBT3-SUC /pAL-Alg5 to 100. AVG = 
Average, SD = Standard deviation 
 
Fig. 5.11 shows a graphical representation of the results for the co-transformations to 
test the interaction between PalH, expressed as bait in the vector pBT3-SUC, and the 
members of the membrane signalling complex PalH, PalI and PalF, expressed as preys as 
previously described. For each co-transformation, the ratio between prototrophic and total 
transformants is plotted, obtained by averaging the three independent experiments and 
normalizing by fixing the value of the positive control co-transformation with the control prey 
pAL-Alg5 to 100, reflecting the strong affinity between the two separable domains of the 
ubiquitin. The standard deviation between replicates is indicated by error bars. As highlighted 
by the graph, the introduction of the competitive inhibitor of the HIS3 gene product 3-AT 
indeed reduced false positives. Following addition of 20 mM 3-AT a clear difference in the 
number of colonies is visible when PalH pBT3-SUC bait is co-transformed with the preys 
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PalH pPR3-STE L and PalI pPR3-STE L or with PalH pPR3-N and PalI pPR3-N. Concordant 
with western blotting results which revealed that the preys PalH pPR3-N, PalI pPR3-N and 
PalF pPR3-STE R are not expressed, the ratio between prototrophic and total transformants in 
every co-transformation involving one of these preys is close to a null value, as observed for 
the negative control co-transformation with PalH pBT3-SUC bait and pDL-Alg5. For a well-
expressed bait, such as PalH pPR3-SUC, and in experimental conditions giving at least 1000 
total transformants per reaction, the repetition of the co-transformation in triplicate supplied 
reproducible data from which to infer the interactions between the three components of the 
membrane signalling complex PalH, PalI and PalF. In particular, by the addition of 20 mM 3-
AT to the selective media SD-trp-leu-his-ade, it is also possible to speculate upon the affinity 
of the interactions. Concordant with its cytosolic location, PalF preys expressed as fusions in 
either of two possible orientations (pPR3-STE and pPR3-N) interacted with PalH pBT3-SUC 
bait. This was true with the single exception of PalF pPR3-STE R, whose expression could 
not be verified by western blotting. A clear interaction, though less detectable than that 
between PalH pBT3-SUC bait and PalF preys, was also reproducibly demonstrated between 
PalH pBT3-SUC bait and PalH pBT3-STE preys. No interaction was demonstrated between 
PalH pBT3-SUC bait and PalI pBT3-STE preys.  
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Fig. 5.11: Graphical representation of the results for the co-transformations to test the interaction 
between PalH, expressed as bait in the pBT3-SUC vector in the MYTH system, and the members of the 
membrane signalling complex PalH, PalI and PalF. For each co-transformation, the value PT*/TT is shown, 
obtained by averaging the three independent experiments, and normalised by fixing the value of the positive 
control co-transformation PalH pBT3-SUC /pAL-Alg5 to 100.  
 
5.4 Discussion  
 
The split-ubiquitin Membrane Yeast Two-Hybrid (MYTH) system is a powerful 
methodology, for the analysis of heterologous protein-protein interactions in yeast, which 
overcomes the limitation of the yeast classical two-hybrid assay because it circumvents the 
requirement for nuclear localisation of interacting proteins. In this study, the split-ubiquitin 
MYTH system was optimised for A. fumigatus protein expression and interaction analysis and 
used to investigate the interactions between three components (PalH, PalI and PalF) of a 
plasma membrane signalling complex involved in A. fumigatus adaptation to environmental 
pH.  
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5.4.1 Split-ubiquitin MYTH analysis confirms in silico topological predictions for A. 
fumigatus PalH and PalI  
 
In the model hypothesised for A. nidulans, the first complex involved in the activation 
of the PacC/Rim101p pathway comprises the two plasma membrane proteins PalH and PalI 
and an arrestin-like protein PalF (Calcagno-Pizarelli et al., 2007; Herranz et al., 2005; 
Maccheroni et al., 1997; Negrete-Urtasun et al., 1999). PalH contains seven transmembrane 
domains and a long, hydrophilic C-terminus located in the cytosol (Negrete-Urtasun et al., 
1999), whose analogies with G-protein coupled receptors have raised the possible 
involvement in pH signalling of a G-protein (Herranz et al., 2005). PalI contains four highly 
hydrophobic domains (Arst et al., 1994), but in silico predictions had revealed the presence of 
an N-terminal signal peptide (Calcagno-Pizarelli et al., 2007) therefore the hypothesised 
structure for A. nidulans PalI consists of three putative membrane-spanning domains and a 
basic C-terminus facing the cytosol (Calcagno-Pizarelli et al., 2007). A. fumigatus PalH, PalI 
and PalF show high similarity with their homologous in A. nidulans (respectively 84.2%, 
75.6% and 86.5% as shown in Appendix F), therefore suggesting a similar behaviour to the 
model hypothesised for A. nidulans might be expected in A. fumigatus. In silico analysis of A. 
fumigatus PalH and PalI proteins by SignalP 3.0 (Bendtsen et al., 2004; Emanuelsson et al., 
2007) and TMpred (http://www.ch.embnet.org/software/TMPRED_form.html), which are 
reported in Appendix F, suggest the two proteins strictly resemble the topology of their 
homologues in A. nidulans.  
Taken together, the results of the western blotting and interaction assays permitted 
some new deductions about the topology (as shown in Fig. 5.12) of the two A. fumigatus 
plasma membrane proteins PalH and PalI. Protein interaction data agreed with reports in the 
A. nidulans literature and also with in silico predictions, reported in Appendix F. As 
suggested by the in silico predictions, the hypothesised model of topology for A. fumigatus 
PalH consists of a 7-TMD protein with an extracellular N-terminus and intracellular C-
terminus. This prediction is supported by the results presented here (Fig. 5.7 and Fig. 5.8). 
The expression of PalH as a bait was confirmed by western blotting for fusion proteins 
expressed from both the pBTR3-STE and pBT3-SUC bait vectors (Fig. 5.7A). In addition, 
interaction assays demonstrated that PalH baits expressed from pBT3-STE and pBT3-SUC 
are appropriately localised in the membrane of yeast, and are functional with respect to 
supporting reconstitution of split-ubiquitin. pBT3-STE PalH and pBT3-SUC PalH baits fuse 
the Cub domain to the C-terminus of PalH, and their functionality with respect to Alg5 
interaction (Fig. 5.8B and C) therefore reflects that the Cub-LexAVP16 reporter is 
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cytosolically located. If the 7-TMD topology prediction is correct it therefore follows that the 
PalH N-terminus is extracellular and PalH C-terminus is cytosolic. Accordingly, PalH prey 
could only be expressed as a C-terminal (pPR3-STE) NubG fusion. As suggested by the in 
silico predictions, the hypothesised model of topology for A. fumigatus Pal I (Appendix F) 
consists of three putative membrane-spanning domains and a basic C-terminus facing the 
cytosol since SignalP 3.0 (Bendtsen et al., 2004; Emanuelsson et al., 2007) had revealed the 
presence of an N-terminal signal peptide. In A. fumigatus, the predictions by SignalP 3.0 
indicate with a probability of 0.99, that the N-terminal hydrophobic domain of PalI is a signal 
peptide cleaved, with a probability of 0.84, between the residues Ser26 and Thr27. Likewise, 
in A. nidulans, in silico analysis with SignalP 3.0 predicted, with a probability of 0.96, that the 
N-terminal hydrophobic domain is a signal peptide cleaved, with a probability of 0.84, 
between the residues Ser26 and Thr27 (Calcagno-Pizarelli et al., 2007). Besides, studies in 
the S. cerevisiae homologue Rim9p suggest that the most terminal of the corresponding 
hydrophobic domains represents a signal peptide (Li and Mitchell, 1997). For A. nidulans, the 
predictions presented in(Calcagno-Pizarelli et al., 2007)were indeed confirmed by the results 
of the present study (see Appendix E “Use of A. nidulans PalH for optimisation of MYTH”). 
A. fumigatus PalI bait (Fig. 5.7A) was detectable only when C-terminally fused to the Cub 
domain (pPR3-STE or pPR3-SUC). In addition, PalI prey (Fig. 5.7B) was only detectably 
expressed as a C-terminal fusion to NubG (pPR3-STE). In interaction assays, PalI pBT3-STE 
and pBT3-SUC baits could be demonstrated as appropriately localised in the membrane of 
yeast, presumably harbouring the Cub-LexAVP16 reporter on the cytosolic side of the 
membrane (Fig. 5.8D and E), whereas PalI pBT3-N bait was not functional (Fig. 5.8F). Since 
pBT3-STE PalI and pBT3-SUC PalI baits and pPR3-STE PalI prey fuse ubiquitin domains at 
the C-termini of the proteins of interest, our data suggest that A. fumigatus PalI has an 
extracellular N-terminus and cytosolic C-terminus (Fig. 5.12).  
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Fig. 5.12: PalH and PalI topology in the A. fumigatus plasma membrane, as demonstrated by 
western blot and interaction  assays. The Cub-LexA-VP16 domain is expressed and functional only if fused to 
the C-termini of PalH and PalI, suggesting that both have intracellular C-termini and extracellular N-terminal 
domains.  
 
5.4.2 A. fumigatus PalH baits are expressed and functional in the MYTH system  
 
As discussed in the previous section, the expression of PalH and PalI as bait was 
confirmed in both the pBT3-STE and pBT3-SUC bait vectors. The two plasmids pBT3-STE 
and pBT3-SUC are specifically designed for cloning bait proteins, whose topology includes 
an extracellular N-terminal domain and an intracellular C-terminal domain. In addition, the 
bait plasmid pBT3-STE contains the STE2 leader sequence derived from the S. cerevisiae 
Ste2 protein (a G-protein coupled receptor). The short leader sequence has no targeting 
function but it is intended to optimise the expression of the desired bait, providing a strong 
ATG sequence for the initiation of the transcription machinery (Romanos et al., 1992). Since 
its development, the MYTH system has been successfully applied to the study of a variety of 
membrane proteins from different organisms, as extensively reviewed in(Suter et al., 2006). 
This methodology has permitted the understanding of quaternary structures for sucrose 
transporters (Reinders et al., 2002), a yeast protein translocation machinery (Scheper et al., 
2003a; Stagljar et al., 1998), ErbB3 (a receptor tyrosine kinase) (Thaminy et al., 2003), plant 
K+ channels (Obrdlik et al., 2004) and the yeast Ycf1p (an ATP-binding cassette transporter) 
(Paumi et al., 2007). Several of these findings underline, however, that in its current form the 
system is extremely sensitive to perturbations in the expression levels of baits. The earliest 
large scale split-ubiquitin screen reported showed that, of a total of 705 integral membrane 
proteins analysed, 365 were competent for utilisation as baits in the system, whereas many of 
the remaining 340 were over-expressed from the plasmid chosen and therefore mislocalised 
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within the cell (Miller et al., 2005). In some instances, ubiquitin fusion can alter irremediably 
the topology of the membrane protein, which is not directed to the native localisation with 
unpredictable effects on its functioning and interactions with other proteins. The expression 
levels for a specific bait in use are therefore crucial for the correct functioning of the MYTH 
system and several issues had to be considered at this stage of the experimentation. A. 
fumigatus proteins might be detected as heterologous in yeast, and therefore become 
proteolytically degraded. Also, in an opposing scenario, over-expression could lead to toxicity 
for the yeast cells. Finally, post-translational modifications in yeast may not reflect the actual 
post-translational modifications occurring in A. fumigatus and affect the localisation of the 
expressed protein. To overcome these limitations, the system has recently been revised as 
integrated MYTH (iMYTH) system, where the full-length bait under investigation is 
expressed under the control of the endogenous promoter (Paumi et al., 2007). Therefore the 
bait protein is properly expressed within a cell and the stoichiometry is maintained among 
members of a protein complex, so to drastically reduce inappropriate interactions due to the 
over-expression via exogenous promoters. In addition bait proteins are expressed in their 
native context, contributing to their appropriate posttranslational modifications and 
localisation. Interestingly, another advantage of the revised system is the incorporation of a 
bait tag, permitting localisation by fluorescence microscopy.  
In light of these considerations, in the present study, multiple bait plasmids have been 
used in parallel to ensure the adequate expression of the proteins of interest. In the western 
blotting analysis, for both PalH and PalI a difference was visible in expression, depending on 
the bait vector used for the cloning whereby higher expression levels were always associated 
with the use of the plasmid pBT3-STE (Fig.5.7A). However, in comparison with the same 
amount of total protein extract loadings for PalH baits, PalI produced only low protein yields, 
whereby a weak signal is visible for the pBT3-STE bait vector, and almost no signal is 
detectable for pBT3-SUC. Interestingly, the interaction assays reflect these results, suggesting 
a direct link between the expression levels observed in western blotting and the functionality 
of a specific bait in terms of prototrophic transformants. The baits tested (PalH pBT3-STE 
and pBT3-SUC and PalI pBT3-STE and pBT3-SUC) were appropriately localised in the 
membrane of yeast and the Cub-LexAVP16 reporter is located on the cytosolic side of the 
membrane. However, for PalI pBT3-STE and pBT3-SUC, which were less expressed by 
western blotting (Fig. 5.7), the number of colonies in selective media after co-transformation 
with the positive prey plasmid pAI-Alg5 was ten times less than that obtained with PalH 
pBT3-STE and pBT3-SUC baits. In virtue of all these considerations, to balance between the 
levels of transformation efficiency and of false positives, PalH pBT3-SUC bait was chosen 
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for further analysis. Further indications about the choice of this bait and the balance between 
false positivity and self activation in the MYTH system will be discussed in the Chapter VI. 
 
5.4.3 MYTH analysis identifies A. fumigatus PalH and PalF interaction, and PalH 
homodimerisation  
 
Direct interactions between components of the predicted plasma membrane signalling 
complex were addressed by yeast co-transformation with pBT3-SUC PalH bait and PalH, PalI 
and PalF preys expressed as both C- and N-terminal NubG fusions. During this 
experimentation, a number of technical shortcomings in the manufacturer‟s protocols became 
apparent, including extreme subjectivity in using colony counts for identifying interacting 
partners and a confounding lack of reproducibility, and false positive results. In fact, the 
initial experiment (Fig. 5.9) identified a single interacting prey for the tested pBT3-SUC PalH 
bait, resulting from co-transformation with PalF pPR3-N, but nonetheless confirming 
previous findings (Herranz et al., 2005). For all other preys a paucity of colonies on selective 
media likely prevented identification of lower affinity, or possibly less frequent interactions, 
and moreover could not distinguish between weak interactors and false positive results. 
Titration of 3-aminotriazole (3-AT) in selective media overcame the problem of false 
positivity (Fig. 5.10) for the PalH pBT3-SUC bait. A detailed discussion on the possible 
causes of false positive results in MYTH analyses will follow in Chapter VI. The robustness 
of data acquired with heightened (20 mM 3-AT) selectivity was tested by triplicating the co-
transformations with pBT3-SUC PalH bait and all PalH, PalI and PalF preys and counting the 
number of total and prototrophic transformants (Table. 5.4). For each replicate, the ratio 
between prototrophic and total transformants was counted and averaged, and the standard 
deviation was calculated. To establish a lower threshold for positive interactions, PalH pBT3-
SUC bait was also transformed with the positive pAI-Alg5 and the negative pDL-Alg5 
control preys. For the analysis, the value of the positive control co-transformation with the 
prey pAL-Alg5 was set to 100, reflecting the strong affinity between the two separable 
domains of the ubiquitin. These adjustments to the manufacturer‟s screening protocol 
permitted the observation of a previously unachievable distinction between positive and 
negative interaction data for the PalH pBT3-SUC bait with the PalH pPR3-STE and PalI 
pPR3-STE or PalH pPR3-N and PalI pPR3-N preys (Fig. 5.11). In addition, for well-
expressed baits, such as PalH pPR3-SUC, in experiments achieving a minimum of 1000 total 
transformants, triplicated analyses supplied reproducible data. These experiments inferred 
interactions between two of the three membrane signalling components, PalH and PalF. It was 
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also possible to discriminate between the different affinity of these interactors.  
Concordant with a predicted cytosolic location for PalF, both C-terminal (pPR3-STE) 
and N-terminal (pPR3-N) NubG-fused PalF preys interacted with PalH pBT3-SUC bait, with 
the sole exception of PalF pPR3-STE R, whose expression was not verified by western 
blotting. The fusion of the NubG domain at the C-terminus (pPR3-STE) or at the N-terminus 
(pPR3-N) of PalF, does not affect the interaction between A. fumigatus PalF and PalH in 
MYTH analysis. This finding corroborated the importance of constructing three different 
amino acid insertions for preys of interest. Moreover, an interaction between PalH and PalF 
was detected, as previously demonstrated for A. nidulans (Herranz et al., 2005). In A. 
nidulans, the interaction between PalF and PalH was identified by two-hybrid analysis, using 
a LexA-PalF fusion protein bait to screen an A. nidulans two-hybrid cDNA library. The 
affinity between the detected interactors was revealed by β-galactosidase assessment, 
revealing a strong interaction between the hydrophilic PalH C-terminus (amino acids 506-
760) and the arrestin-like protein PalF. Besides, two-hybrid mapping demonstrated that two 
regions in the C-terminus of PalH (residues 349-385 and 657-760) and the arrestin N-terminal 
domain of PalF plus 63 additional N-terminal residues are crucial for the interaction. In fact, 
PFAM database searches identify two arrestin-like domains in A. nidulans PalF and the yeast 
homologue Rim8 (Herranz et al., 2005). In mammalian arrestins, through the analysis of 
truncated and chimeric proteins, it has been established that the N-domain is involved in 7- 
TMD protein binding, although additional elements in the C-terminus may participate in 
receptor recognition (Granzin et al., 1998; Gurevich et al., 1995). Mutant phenotype analysis 
confirmed the importance of this interaction, because palF and palH mutations, affecting any 
of the domains involved in the interaction, also prevent pH signalling (Herranz et al., 2005). 
Among these mutations, PalH truncation of the C-terminal PalF-binding site and PalF 
substitution of the highly conserved residue Ser86 by Pro, completely prevent fungal growth 
at pH 8, and the interaction of the respective proteins in vitro. On the contrary, PalF 
substitution of the highly conserved residue Ile133 in the arrestin C-domain, does not affect 
the interaction in vitro, suggesting the associated inability to grow at alkaline pH is due to 
causes unrelated to the interaction itself (Herranz et al., 2005). This interaction is also 
required for PalF ubiquitination and phosphorylation, as pH-mediated phosphorylation of 
PalF was abolished by a palH
-
 mutation (Herranz et al., 2005).  
An attractive hypothesis places the interaction between the putative pH sensor and the 
arrestin-like protein as initial step for the internalisation of the 7-TMD protein receptor PalH. 
S. cerevisiae Rim21p and Dfg16p and A. nidulans PalH are predicted to be 7-TMD proteins 
with hydrophilic C-termini and are therefore hypothesised to be G-protein coupled receptors 
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(Barwell et al., 2005; Herranz et al., 2005). This prediction has been demonstrated in the 
present study for A. fumigatus PalH, whose structure indeed resembles that of G-protein 
coupled receptors (GPCRs). In association with their classical role in desensitising 7-TMD 
protein receptor, arrestins are now known to participate in signalling from 7-TMD receptors 
to downstream regulatory proteins (Lefkowitz and Shenoy, 2005). GPCRs are 7-TMD protein 
receptors and represent the largest and widespread family of membrane receptors (Fredriksson 
et al., 2003), also well studied as common targets of therapeutic drugs in mammalians 
(Gudermann et al., 1995). To participate in signal transduction from a 7-TMD receptor, 
transducer should be able to interact with the receptor in an activation-dependent way and 
then undergo conformational changes (Lefkowitz and Shenoy, 2005). Three groups of 
proteins have this ability: heterotrimeric G proteins, β-arrestin and GRKs. G protein-coupled 
receptors (GPCRs) are transmembrane receptors, which bind with signal molecules through 
their extracellular domains and activate a heterotrimetric G protein through their intracellular 
domain, generating a cascade involving further proteins to ultimately cause a change 
downstream in the cell. Heterotrimeric G-proteins (guanine nucleotide-binding proteins) are a 
group of proteins involved in transmitting a remarkable range of stimuli inside the cell 
regulating various aspects of cell biology, such as metabolism, secretory protein, electrical 
activity, shape and motility. Receptor-mediated exchange of GTP on the α-subunit of the 
heterotrimer determines the dissociation of the activated α-subunit from the β-γ subcomplex 
(Neer, 1995). This subcomplex is able to modulate an array of downstream effectors, whereas 
the α-subunit contains an intrinsic GTPase activity, to terminate signalling converting the 
GTP-bound α-subunit into the corresponding GDP-bound form, therefore promoting the 
reassembly of the heterotrimer. Pioneering studies on the rhodopsin and the β2AR (adenylyl 
cyclase-coupled β2-adrenergic receptor for chatecholamines) indicated G protein-mediated 
signaling is attenuated by highly conserved mechanisms (Kohout and Lefkowitz, 2003); the 
active form of the receptors stimulates heterotrimeric G proteins and is phosphorylated by G 
protein–coupled receptor kinases (GRKs), which leads to β-arrestin recruitment. Arrestins 
were originally described as proteins that regulate signal transduction by binding activated 
phosphorylated G-protein-coupled receptors (GPCR). The receptor is thereby desensitised, 
and the signalling is stalled. However, more recent studies have demonstrated that arrestins 
also bind a growing list of endocytic and signaling proteins (Shenoy and Lefkowitz, 2003) 
and act as signal transducers themselves playing an important role in scaffolding receptors to 
membrane-trafficking machinery, helping receptor internalisation, Mitogen-activated protein 
kinase (MAPK) activation and regulating gene expression (as reviewed in(Jean-Alphonse and 
Hanyaloglu, 2010)and(Lefkowitz and Shenoy, 2005). Endocytosis of the receptors is crucial 
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for the resensitisation of the receptors by dephosphorylation and for their recycling (Claing et 
al., 2002) and studies performed in mammalian cells finds that β-arrestins link activated 
receptors to clathrin-coated pits for endocytosis (Goodman et al., 1996; Moore et al., 2007). 
Currently, arrestins have been found to regulate inactivation, internalisation, trafficking and 
signalling of several 7-TMRs (Laporte et al., 1999; McDonald et al., 2000; Shenoy et al., 
2001). Upon activation of 7-TMRs, β-arrestins undergo ubiquitination, a process which is 
now thought to help protein trafficking and signal transduction, other than the classical role of 
tagging proteins for degradation by the proteasome (Shenoy et al., 2001).  
The structural and functional analogies with mammalian arrestins for PalF and with G-
protein coupled receptors for PalH raise the possibility of G-protein involvement in fungal pH 
signalling, particularly given the demonstrated role for arrestins in the stimulation of G-
proteins (Lefkowitz and Shenoy, 2005; Shenoy and Lefkowitz, 2005b; Shenoy and Lefkowitz, 
2005a). In A. nidulans, genetic screens, expressed sequence tags (ESTs), or partial 
examination of the genome revealed the presence of nine GPCRs (GprA-I) (Han et al., 2004). 
In addition, heterotrimeric G-protein components have been identified, such as the α-subunits 
FadA, GanA, and GanB (Chang et al., 2004; Yu et al., 1996), the β subunit SfaD (Rosen et 
al., 1999), and the γ-subunit GpgA (Seo et al., 2005). FadA/SfaD/GpgA and 
GanB/SfaD/GpgA are involved in regulation of germination, hyphal growth, and 
conidiogenesis (Lafon et al., 2005; Rosen et al., 1999; Seo et al., 2005; Yu et al., 1996), but 
no function has yet been attributed to GanA (Chang et al., 2004; Han et al., 2004). 
Unfortunately, the components and the roles of G-proteins in A. fumigatus are not well 
investigated, but the publication of the genome (Nierman et al., 2005) permitted analysis in 
comparison with the genomes of other better studied species, such as A. nidulans and A. 
oryzae (Lafon et al., 2006), revealing overlap for most of the GPCRs and G-proteins across 
the Aspergillus species investigated.  
An alternative hypothesis raised by this work is that PalH is a G-protein coupled 
receptor, whose dimerisation is likely involved in pH signalling. This hypothesis was 
originally suggested for S. cerevisiae Rim21p/Dfg16p, which is thought to function as an 
heterodimeric receptor (Barwell et al., 2005). In the present study, an interaction was also 
demonstrated between PalH pBT3-SUC bait and PalH pPR3-STE preys (Fig. 5.11). G-protein 
mutants might present a very pleiotropic phenotype, precluding selection or recognition in pH 
mutant screens (Herranz et al., 2005). However, mammalian GPCRs have been shown also to 
activate non-G-protein signaling pathways from endosomes, mostly by interaction with β-
arrestins, which create a bridge with MAPK signaling molecules, to establish spatial and 
temporal control for signalling (Reiter and Lefkowitz, 2006). A range of different approaches 
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has revealed recently that rather than acting as monomers, GPCRs forms dimers and/or 
higher-order oligomeric complexes (as reviewed in(Milligan et al., 2003; Milligan et al., 
2006; Milligan, 2007; Milligan, 2010). The first evidence was provided by the functional 
GABAb receptor, which is a dimer composed of two distinct GPCR products (Marshall et al., 
1999; Mohler and Fritschy, 1999). GABAbR1 does not function on addition of agonist and is 
trapped intracellularly if expressed in heterologous systems. Its C-terminal domain has been 
demonstrated by two-hybrid screenings to interact with the C-terminal domain of GABAbR2 
(White et al., 2002) and the coexpression of both GABAbR1 and GABAbR2b results in 
functional GABA activity. Because GABAbR1, when expressed in a heterologous system, is 
retained in the ER/Golgi, dimerisation is thought to occur, at least for the GABAb receptor in 
that site, coincidently with protein production. The interaction of the GABAb receptors would 
provide a mechanism to control delivery of the active GPCRs to the plasma membrane 
(Milligan, 2001). However, increasing evidence suggests other roles for GPCRs dimerisation 
beyond that of quality control of protein folding for the plasma membrane delivery, however 
this topic is just starting to be described in the current literature (as reviewed in(Milligan, 
2007). Interestingly, however, for Chapter VI, which will describe the use of the MYTH 
system to identify novel interactors of A. fumigatus PalH, the notion has arisen that the early 
phases of quality control in the ER involve interaction with resident chaperones and possible 
N-glycosylation, as GPCRs undergo the same processing as proteins trafficked through the 
secretory pathway (Milligan, 2010).  
In A. nidulans, null palI mutants grow, though poorly, at alkaline pH, unlike the null 
mutants of other pal genes (Denison et al., 1995), suggesting for PalI an important, but not 
essential role in pH signalling, perhaps in assisting the plasma membrane localisation of PalH 
(Calcagno-Pizarelli et al., 2007). This suggestion is based upon the observation that co-
overexpression of PalI redirects GFP-tagged PalH (PalH-GFP) to the plasma membrane in A. 
nidulans, that otherwise, when over-expressed, is predominantly located in cytosolic punctate 
structures (Calcagno-Pizarelli et al., 2007). In addition, over-expression of PalH also allows 
almost wild type growth of palI mutants at alkaline pH, as expected if in these mutants the 
physiological quantity of PalH is unable to sufficiently populate the plasma membrane 
without the assistance of PalI (Calcagno-Pizarelli et al., 2007). PalI could assist plasma 
membrane localisation of palH according to three possible mechanisms still under 
investigation and each of these three possibilities could require an interaction between PalH 
and PalI, either direct or indirect, but this is still not demonstrated (Peñalva et al., 2008). The 
first of the hypothesised mechanisms, based on localisation experiments of the GFP-tagged 
proteins, implies that PalI could assist PalH along the secretory pathway or in its exit from the 
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Golgi. The abundance of PalI on the plasma membrane suggests PalI exits the Golgi 
efficiently, so it could mediate or facilitate the sorting of PalH at the Golgi into secretory 
vesicles destined for the plasma membrane rather than into vesicles destined for endosomes. 
However, this hypothesis may be ruled out by the demonstration that PalH homodimerises 
and that this event, as for the GABAb receptors mediates the maturation of the protein.  
Alternatively, PalI could be involved in the down-regulation of PalH endocytosis, or in the 
up-regulation of its recycling after PalF-mediated endocytosis. However, in the present study, 
no interaction was demonstrated between PalH pBT3-SUC bait and any of several PalI pBT3-
STE preys.  
In this context however, it is important to notice that the MYTH system is developed 
in the way that the reconstitution of the split-ubiquitin is due to the close proximity of the two 
proteins tested for the interaction. Hypothesising the participation of PalF in joining the two 
plasma membrane proteins PalH and PalI, the results of the MYTH test for direct interaction 
do not completely rule out the participation of PalI in the plasma membrane pH signalling 
complex.     
 
5.4.5 The MYTH is a versatile and powerful approach to test in yeast A. fumigatus 
protein-protein interactions  
 
The split-ubiquitin Membrane Yeast Two-Hybrid (MYTH) system was here 
demonstrated to be a versatile and powerful methodology for the analysis of A. fumigatus 
protein-protein interaction in yeast. The current literature reports its broad utilisation, but 
never regarding its use for A. fumigatus proteins. This system has been applied successfully in 
various studies, for example investigation of mutations affecting the assembly of fragments of 
presenilin in the development of Alzheimers disease (Cervantes et al., 2001), or the 
interaction between the two yeast α1,2-mannosidase proteins Mns1p and Rer1p in the 
endoplasmic reticulum (Massaad and Herscovics, 2001), or the intra- and intermolecular 
interactions between plant sucrose transporters (Reinders et al., 2002). Of particular 
importance for the present study is its application to investigate the protein-protein 
interactions involved in yeast ergosterol biosynthesis (Alcazar-Fuoli et al., 2008; Ferreira et 
al., 2005); several studies  have provided insight on experimental design and optimisation 
(Mo et al., 2004; Mo and Bard, 2005b; Mo and Bard, 2005a), which will be discussed in 
Chapter VII.   
Summarising the advantages of the system, it does not require the localisation of tested 
proteins in the nucleus, because the detection of interaction is due to cleavage by UBPs and 
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not directly to transcriptional activation, therefore, it particularly suits studies involving 
membrane proteins, such as PalH, PalI and PalF, whose role in pH sensing and virulence has 
been extensively studied in the Aspergillus species. In addition, the fusion of small modules 
(Cub and NubG) to the proteins of interest generally reduces potential steric influences, as 
demonstrated when testing the interaction between PalH and PalF in the present study. The 
fusion of the NubG domain at the C-terminus (pPR3-STE) or at the N-terminus (pPR3-N) of 
PalF, did not affect the interaction between A. fumigatus PalF and PalH in the MYTH system.  
However, the system requires at least one of the proteins tested to be integral to, or attached to 
the membrane, because the translocation of a soluble bait to the nucleus would activate the 
reporter genes independently of a protein interaction. The suitability of a protein of interest 
for the use as a MYTH bait depends on many variables and therefore has to be tested on a 
case-by-case basis. This is indeed shown by the results observed for PalH and PalI, whose 
expression strictly depend upon the vector baits used for the cloning, but also on intrinsic 
characteristics of the proteins themselves. The orientation in which the domains of the 
ubiquitin are fused and the expression levels of the bait profoundly affect the types of 
interactions detected and the level of false positive detection, representing an issue to address 
in the initial step of the experimentation. Finally, as observed in the case of PalH and PalI, the 
MYTH system is more appropriate for testing direct binary interactions, because the detection 
of an interaction between a bait and a prey, which only interact indirectly via a third member, 
is likely not to be reproduced or detectable in yeast (Snider et al., 2010a; Snider et al., 2010b).      
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CHAPTER VI 
 
IDENTIFICATION OF NOVEL PROTEIN INTERACTORS FOR A. 
FUMIGATUS PALH  
6.1 Overview 
 
The most interesting application of the split-ubiquitin MYTH system is that, by using 
a membrane-associated protein bait for the screening, it allows the isolation of novel protein 
interactors from a library of expressed prey proteins. As reported in the current literature, the 
system has been adapted for large-scale screens using cDNA or gDNA (genomic DNA) 
libraries for a variety of membrane proteins from various organisms (Snider et al., 2010b; 
Thaminy et al., 2003; Wang et al., 2004), but never before for A. fumigatus. Interestingly, this 
possibility extends the future use of the system to the screening for potential drugs or 
inhibitors for a specific membrane-associated protein. In the present study, the MYTH 
screening system has been optimised and adapted to a high-throughput platform to discover 
novel protein interactors for A. fumigatus PalH from a full-length A. fumigatus cDNA prey 
library.  
 
6.2 Methods 
 
For methods regarding the split-ubiquitin MYTH system and the construction and 
testing of the pBT3-SUC PalH and the pBT3-STE PalH baits utilised for the screening please 
refer to Chapter V.  
 
6.2.1 The full length A. fumigatus cDNA prey library 
 
The full length A. fumigatus cDNA library was constructed by Invitrogen using 
Invitrogen‟ proprietary full length technology and a DUALmembrane prey Gateway adapted 
vector (pPR3N-GW).  
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The pPR3-N vector (Fig. 6.1.A) was Gateway adapted and used for LR recombination 
with the cDNA library (pENTR). This allows for a fraction of the cDNAs to be fused and 
expressed in frame with the N-terminal NubG domain; whereas the presence of native stop 
codons in the oligodT primed cDNAs precluded the possibility of generating in frame fusion 
proteins with the C-terminal NubG domain containing vector (pPR3-STE). The pPR3-N 
vector was adapted at the EcoRI site by insertion of a Gateway cassette for in-frame fusion of 
the gene of interest, at its N-terminus, with NubG-HA (Fig. 6.1 B). The process typically 
involves the substitution of the multiple cloning site with a conversion cassette containing 
attR recombination sites, the ccdB selection gene and the chloramphenicol resistance gene 
(CAT). The attR1 and attR2 sites allow recombinational cloning of the gene of interest from 
an entry clone, whereas the ccdB and CAT genes are used, respectively, for the negative 
selection and counter-selection of plasmids. The modified vector was validated by restriction 
analysis using SmaI and DNA sequencing.  
 
Fig. 6.1: Invitrogen Gateway adaptation of the DUALmembrane vector pPR3-N to generate 
pPR3-N GW. (A) pPR3-N. The prey vector pPR3-N was adapted by inserting Gateway cassette in frame with 
NubG-HA via EcoRI digestion. (B) pPR3-N GW. The Gateway adapted prey vector pPR3-N GW carries the 
cassette containing attR recombination sites, the ccdB selection gene and the chloramphenicol resistance gene 
(CAT). The attR1 and attR2 sites allow recombinational cloning of cDNAs of interest directly from entry clones. 
The ccdB  and CAT genes are used for the negative selection and counterselection of plasmids, respectively. The 
modified vector is validated by restriction analysis using the enzyme SmaI. 
 
RNA was isolated from the A. fumigatus clinical isolate 237 under a range of different 
A. fumigatus culture conditions (e.g. minimal and complete media, alkaline and acid 
conditions, nitrogen starvation, different growth stages from spores to hyphae, oxidative 
stress) to provide Invitrogen with at least 1 mg of total DNA for library construction. mRNA 
was isolated by Invitrogen from the total RNA and the library was firstly constructed in the 
Gateway compatible entry vector pDONR
TM
222, which can be directionally swapped into any 
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expression vector, in this study pPR3N-GW, using Invitrogen‟s SUPERSCRIPTTM III RNase 
H-RT and ELECTROMAX
TM 
DH10B ton A cells (T1 phage resistant). The proportion of 
full-length clones was tested by sequencing 24 random clones, representing a minimum of 20 
different genes. The clones were defined as full-length if containing the predicted initiating 
ATG at the 5‟ end of the gene and a polyA tail in the expected position at the 3‟ end. As 
stated by Invitrogen, for unknown clones or clones showing no matches to databases, if the 
clone contains an ATG with a potential open reading frame downstream, it should be counted 
as a potential full-length clone. In Table 6.1 the characteristics of the full-length A. fumigatus 
cDNA library are summarised.  
 
Full-length A. fumigatus cDNA library  
Number of primary clones (cfu) 
 1.932 x 10
7
 
Average of the insert size (kb)  1.309 
Percent of clones containing inserts  > 99 
Titre of the full length cDNA library (cfu/ml) 1.61 x 10
6 
 
Complexity of the full length cDNA library 1.9 x 10
7
 
 
Table 6.1: Summary of the characteristics of the full-length A. fumigatus cDNA library. The 
library was constructed in collaboration with Invitrogen using Invitrogen‟s proprietary full length technology, 
the appropriate DUALmembrane prey Gateway adapted vector (pPR3N-GW) and the RNA isolated by our 
research-group from the A. fumigatus clinical isolate 237.  
 
 Because the frame of NubG fusions with cDNAs of interest is uncontrolled, only 1/3 
of the clones in the library maintain an in-frame translational fusion. It was therefore 
important to ensure the complexity of the library was high enough to cover the entire genome 
multiple times (ideally a complexity higher than 2x10
6
 is required). Good quality NubG-x 
libraries should contain cDNA with an average length of 1.5 kb and complexity ranging from 
1x10
6
 to 5x10
6
 (Iyer et al., 2005).     
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6.2.2 Large scale and high-efficiency lithium acetate transformation protocol for library 
screenings  
 
The protocol suggested by the manufactures is a variation of the classical lithium 
acetate protocol for yeast transformation (Gietz et al., 1992), which ensures high efficiency 
for large scale experiments such library screenings.  
NMY51 cells expressing pBT3-SUC PalH bait were initially inoculated into 10 ml of 
SD-leu and grown for 8 hours at 30°C with shaking. The 10 ml culture was then used to 
inoculate 100 ml SD-leu and the culture was grown overnight at 30°C with shaking. After 
measuring the OD546 of the sample against a H2O blank and calculating the amount of culture 
needed for 30 OD units (30 OD units in 200 ml=OD 0.15), this amount of the overnight 
culture was centrifuged at 700 g for 5 minutes and the pellet was resuspended in 200 ml 2X 
YPAD, which was pre-warmed to 30°C, in a 1 litre flask to ensure appropriate aeration of the 
culture. Cells were grown at 30°C with vigorous shaking to an OD546 of 0.6. Single-stranded 
carrier DNA was prepared by two cycles of boiling and incubation on ice. The LiOAc/TE 
master mix for 10 ml was prepared with 1.1 ml 1 M LiOAc, 1.1 ml 10 x TE pH 7.5 and 7.8 ml 
H2O. The PEG/LiOAc master mix for 12 ml was prepared with 1.2 ml 1 M LiOAc, 1.2 ml 10 
x TE pH 7.5 and 9.6 ml 50 % PEG. When the culture was ready, it was divided into four 50 
ml Falcon tubes and centrifuged at 700 g for 5 minutes. Each pellet was resuspended in 30 ml 
of sterile H2O by vortexing and centrifuged at 700 g for 5 minutes. The supernatant was 
removed and the pellet was resuspended in 1 ml LiOAc/TE master mix, transferred to an 
eppendorf tube and centrifuged at 700 g for 5 minutes. The supernatant was removed and 
each pellet was resuspended in 600 µl of LiOAc/TE master mix. Four 50 ml Falcon tubes 
were prepared adding 7 µg of the library plasmid, 100 µl of single stranded carrier DNA, 600 
µl of cells and 2.5 ml of the PEG/LiOAc mix. The mix was vortexed for 1 minute to 
thoroughly mix all components and then incubated at 30°C for 45 minutes with mixing briefly 
every 15 minutes. 160 µl of DMSO were added to each tube, which were mixed immediately 
by shaking and incubated at 42°C for 20 minutes. Cells were centrifuged at 700 g for 5 
minutes and the pellets were resuspend in 3 ml 2X YPAD. The 4 cell suspensions were 
pooled together and cells were allowed to recover at 30°C for 90 minutes with shaking. Cells 
were centrifuged at 700 g for 5 minutes and resuspended in 4.8 ml 0.9 % NaCl. The 
transformation was plated onto sixteen 150 mm SD –leu –trp –his –ade plates, using 300 µl of 
resuspended cells per 150 mm plate. The remaining resuspended cells were used to prepare 
1:100, 1:1000 and 1:10000 dilutions in 0.9% NaCl, 100 µl of which were plated onto a 90 
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mm SD-trp-leu plate, to calculate the transformation efficiency. Plates were incubated at 30°C 
for 3-4 days. 
The total number of transformants and the transformation efficiency was calculated 
from the number of colonies on SD-trp-leu plates as follows: Total number of transformants = 
number of colonies on SD-trp-leu plate x dilution factor x 10 x 4.8. The total number of 
transformants should be greater than 2x10
6
. Transformation efficiency is calculated as 
follows: Transformation efficiency (clones/µg DNA) = total number of transformants/28 µg. 
Transformation efficiency should be greater than 7x10
4
.  
 
6.2.3 Optimisation of A. fumigatus cDNA prey library screening  
 
Fig. 6.2 shows the experimental procedure for the screening of the A. fumigatus cDNA 
prey library using the MYTH system. The first step of the library screen involved a pilot 
screen with the empty library vector pPR3-N, to determine whether the baits PalH pPBT3-
SUC and PalH pPBT3-STE display any self-activation and to optimise the screening 
conditions to minimise false positive results (Fig. 6.2A). The cDNA library was then 
transformed into PalH bait-expressing S. cerevisiae NMY51 and interactors were selected 
using the stringency conditions determined in the pilot screen (Fig. 6.2B). From this stage, 
two different approaches can be used to analyse putative interactors, the first of which is 
suggested by DUALsystems and the second having been developed in this study. In the case 
of the former strategy, colonies were screened one by one whereby the library plasmids 
encoding putative positive interactors were isolated from individual positive clones and 
retransformed into E. coli (Fig. 6.2C) for plasmid DNA rescue and sequencing (Fig. 6.2D). 
However, due to the high numbers of colonies obtained from these primary screens a new 
method was implemented to facilitate screening in a more high throughput manner. Thus, 
clones obtained from primary screens were pooled together for a subsequent confirmation 
assay to collectively identify the putative interactor plasmids of interest. Plasmids encoding 
putative interactors were passaged in E.coli (Fig. 6.2E) and used to transform S. cerevisiae a 
second time with increased stringency of 3-AT titration (Fig. 6.2F). This experimental scheme 
permitted confirmation of putative interactors before proceeding with sequence analysis, 
thereby reducing the number of clones to analyse and therefore demanding less resources and 
manpower.  
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Fig. 6.2: Experimental procedure for the screening of the full length A. fumigatus cDNA prey 
library using the MYTH system. Steps A-D represent the recommended protocol (DUALsystems) and Steps 
A, E, and F represent a modified high-throughput screening protocol optimised in this study. (A) Pilot screen 
with the empty library vector pPR3-N, to determine whether the baits (pPBT3-SUC PalH and pPBT3-STE PalH) 
self-activate and to optimise the screening conditions. (B) Transformation of cDNA library into NMY51 
expressing A. fumigatus PalH bait, and selection of interactors using stringency conditions determined in the 
pilot screen. (C) Isolation of library plasmids from single positive clones. (D). Sequencing to identify putative 
interactors. (E) In a modified high-throughput protocol, primary clones obtained from the screening of the library 
were pooled prior to performing confirmation assay. Following passage in E. coli pooled plasmid DNA was 
transformed into bait-expressing yeast and an increased stringency used for screening. (F) Confirmation of 
putative interactors before proceeding with sequence analysis.  
 
6.3 Results 
 
6.3.1 Optimisation of library screening conditions for A. fumigatus PalH baits 
 
To optimise library screening with A. fumigatus PalH bait, a pilot screen was 
performed to determine whether the baits of interest displayed self-activation when 
cotransformed, with empty library vector, into NMY51. In split-ubiquitin screens, activation 
of reporter genes in the absence of a protein-protein interaction may result from over-
expression or instability of the bait. Alternatively, some baits contain sequences that are 
targets for endogenous proteases. In preparation for library screening, the PalH pBT3-STE 
and PalH pBT3-SUC baits were tested for self-activation. 
As explained in Chapter V, sequence-verified constructs were transformed into S. 
cerevisiae NMY51 for expression tests and control assays. The expression of PalH bait in 
both the pBT3-STE and pBT3-SUC bait vectors was verified by western blotting analysis of 
total yeast extracts using an antibody directed against the LexA domain of the fusion proteins. 
The two plasmids differ by presence of a STE2 leader sequence in the pBT3-STE vector, 
which enhances the expression of encoded bait fusion protein. The level of bait expression 
was found (Chapter V) to be crucial for optimal functionality of MYTH interaction studies 
and this must be independently assessed for small- and large-scale experiments since 
transformation protocols differ between the two. PalH bait expression was found to be 
consistently higher for plasmid pBT3-STE (Fig. 5.7, Chapter V). Expression and functionality 
of the two A. fumigatus palH baits was validated (Fig. 5.8, Chapter V) by co-transformation 
with pAI-Alg5 and pDL2-Alg5, respectively expressing a fusion of the yeast ER protein Alg5 
to the wild type Nub and to the mutated Nub portion (NubG).  
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A pilot screen was performed to determine whether PalH pBT3-STE or PalH pBT3-
SUC baits self-activate when cotransformed with an empty library vector into NMY51.  
Following the recommended large-scale lithium-acetate transformation protocol, self-
activation was assayed on selective SD-trp-leu-his-ade plates of increasing 3-AT stringency 
(0-50 mM). Since the bait is co-transformed with un-fused mutated NubG (expressed from the 
empty library vector pPR3-N), any colonies obtained on these screening plates must be 
physiologically insignificant, thus the pilot screen aids adjustment of the screening conditions 
to minimise false positive results.  Transformation efficiency was verified by enumeration of 
the total number of transformants on SD-trp-leu media. For both PalH pBT3-STE and PalH 
pBT3-SUC baits, transformation efficiency was greater than 7x10
4 
clones/µg of DNA, 
ensuring meaningful results for the assay. SD-trp-leu-his-ade selective plates were 
supplemented with 0, 5, 10, 20, 30, 40 and 50 mM 3-AT to fine-tune the selection of positive 
interactors and reduce the frequency of false positive results. The results of the co-
transformation are shown in Fig. 6.3. Growth is expected to be progressively inhibited with 
increasing 3-AT concentration, as observed for PalH pBT3-SUC where a concentration of 10 
mM 3-AT leads to the complete elimination of background. To the contrary, the number of 
colonies obtained for PalH pBT3-STE was not lessened by the addition of 3-AT, indicating 
self-activation with this bait. The PalH pBT3-SUC bait was therefore chosen for the screening 
of the full length A. fumigatus cDNA prey library. 
  Fig. 6.3: Panel showing the results of the pilot screen for the baits PalH pBT3-STE and PalH 
pBT3-SUC. Test baits were co-transformed into NMY51 with the empty library vector pPR3-N, to determine 
whether proteins expressed from PalH pBT3-STE (A) or PalH pBT3-SUC (B) self-activate and to optimise the 
screening conditions to reduce false positivity. Co-transformant cells were plated in SD-leu-trp-his-ade 
containing increasing concentrations of 3-AT.   
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6.3.2 A. fumigatus cDNA prey library transformation to select for putative interactors of 
A. fumigatus PalH  
 
The A. fumigatus cDNA library was transformed into NMY51 expressing PalH pBT3-
SUC bait and prototrophic transformants were selected on SD-trp-leu-his-ade supplemented 
with 10 mM 3-AT. The recommended high-efficiency transformation protocol yielded 
transformation efficiencies in the range of 5x10
5
 to 2x10
6
 clones/μg DNA. Table 6.2 
summarises two independent screenings of the full-length A. fumigatus cDNA prey library 
with the A. fumigatus PalH pBT3-SUC bait. For each screening, the total number of 
transformants, the transformation efficiency obtained (clones/µg DNA) and the number of 
colonies are indicated. In order to screen the library comprehensively, it is recommended that 
one screens 2-3 times the number of independent clones represented in the library (1.9x10
7
).  
 
Screening of the full-cDNA library with pBT3-SUC PalH 
Complexity of the library (cfu) 1.9 x 10
7
  
Recent titre of the library (cfu/ml) 9 x 10
8
  
 1
st
 screening 2
nd
 screening 
Total number of transformants 3.7 x 10
6
 5.8 x 10
6
 
Transformation efficiency (clones/µg DNA)    1.3 x 10
5
  2.1 x 10
5
  
Number of colonies 250 750 
 
 Table 6.2: Summary statistics of the two screenings of the full-length A. fumigatus cDNA prey 
library with the A. fumigatus PalH pBT3-SUC bait.  
 
Despite performing the screens under identical conditions, transformation efficiency 
differed significantly between the two screens, which resulted in 250 and 750 transformants 
for the first and the second screening, respectively.  
Initially following the manufacturers‟ protocol, plasmid DNA was isolated from 
individual yeast clones obtained from the screening. Plasmid DNA was then transformed into 
E. coli, where it is possible to separate clones expressing bait and prey library vectors by 
virtue of the differing selective markers contained in prey and bait vectors, ampR and kanR, 
respectively. The identity of each cloned prey cDNA is then verified by sequencing. 
Confirmation of interaction requires reintroduction of each bait and prey partner into NMY51. 
Prey clones which retain positivity in the second screen are retained for further analysis.  
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Given the high number of transformants obtained from the primary screens (Table 
6.2), a new method was developed to perform the analysis in a high-throughput manner, 
thereby reducing the number of clones to analyse. Yeast clones obtained from the second 
screening experiment (Table 6.2) were pooled together prior to performing the confirmation 
assay. Plasmid DNA isolated from the pool of yeast clones was transformed into E. coli to 
isolate the prey clones by ampicillin selection. Pooled prey clones were retransformed into 
yeast carrying PalH pBT3-SUC bait. Increasing the selection stringency, prototrophic 
transformants were selected in SD-trp-leu-his-ade selective plates supplemented with 20 mM 
3-AT. This permitted confirmation of positive prey clones prior to sequence analysis. After 
the confirmation assay, a set of 40 yeast colonies were selected for the extraction of plasmid 
DNA and sequencing. Table 6.3 shows the identity of the selected putative interactors 
obtained with this high-throughput screening approach. Validating the robustness of the 
system, some of the putative interactors were identified multiple times in the set of 40 clones 
selected, including the phosphate transporter Pho88 (Afu5g01960), the acyl-CoA binding 
protein (Afu2g11060), the UPF0136 domain protein (Afu1g03720), the MFS glucose 
transporter (Afu3g13980) and two conserved hypothetical proteins (Afu4g11100 and 
Afu5g07090). In three instances, however, it was not possible to accurately determine the 
identity of the putative interactors, because of the poor quality of the sequences obtained.    
 
A.fumigatus ORF Description  Multiple Id 
Afu5g01960 phosphate transporter (Pho88) 4 
Afu7g05270 COMPASS complex subunit Sdc1 1 
Afu2g12180 lectin family integral membrane protein 1 
Afu4g11330 Aha1 domain family   1 
Afu3g08380 inorganic diphosphatase 1 
Afu2g11060 acyl-CoA binding protein  9 
Afu1g02290 conserved hypothetical protein   1 
Afu1g03720 UPF0136 domain protein 3 
Afu1g04315 integral membrane protein 1 
Afu3g13980 MFS glucose transporter 2 
Afu5g13040 translation initiation factor eif-2b delta subunit   1 
Afu4g09550 conserved hypothetical protein 1 
Afu1g06580 high expression lethality protein Hel10 1 
Afu8g03905 conserved hypothetical protein   1 
Afu4g10350 polyubiquitin UbiD/Ubi4 1 
Afu4g11100 conserved hypothetical protein   2 
Afu5g07090 conserved hypothetical protein   4 
Afu4g09450 hypothetical protein   1 
Afu6g02280 allergen Asp F3, identical to peroxisomal-like protein PMP20 1 
Afu6g03690 sodium P-type ATPase maybe 1 
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Afu6g10300 Thioredoxin maybe 1 
Afu3g03470 conserved hypothetical protein maybe 1 
 
Table 6.3: Summary of the putative interactors identified from the analysis of 40 random 
candidates obtained in the high throughput screening of the full-length A. fumigatus cDNA prey library 
with the A. fumigatus PalH pBR3-SUC bait.  
 
Methods for testing the relative affinity of the identified interactors were also 
explored. In addition to the growth reporters HIS3 and ADE2, the strain NMY51 carries a 
reporter gene lacZ, encoding the bacterial enzyme β-galactosidase, which converts the 
substrate X-gal into a blue compound. In the MYTH system, development of blue colour in 
yeast cells incubated with X-gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside) is an 
indication of interaction between the bait and the prey tested. According to Kittanakom and 
collaborators (Kittanakom et al., 2009), the addition of 0.8 µl/ml X-gal (100 mg/ml in N,N-
dimethylformamide) and 0.1X sodium phosphate solution (0.07 g/ml sodium phosphate 
dibasic and 0.03 g/ml sodium phosphate monobasic) to the SD-trp-leu-his-ade media 
supplemented with 20 mM 3-AT can eliminate approximately one tenth of the colonies 
obtained from the screenings. In addition, use of the lacZ reporter is recommended by the 
DUALsystems manufacturer as a means to assess the affinity of the interactors identified 
from library screens. To date there are no published attempts at using the lacZ reporter to 
quantify the strength of interactions and in our experimentation, the β-galactosidase assay did 
not provide any reproducible data on the interactions validated by the confirmation assay 
(data not shown). 
Further validation of the detected interactions can be pursued using various 
techniques, including a bait-dependency test (see below), co-immunoprecipitation, 
fluorescence microscopy or in vitro transport of radiolabeled substrates for transported 
proteins.  
 
6.3.3 Bait-dependency assay for positive interactors of A. fumigatus PalH  
 
As previously described, confirmation of a suspected positive interaction requires that 
the bait and prey combination retain interaction capability when reintroduced into NMY51. 
The confirmation assay demonstrates that the activation of the reporter genes is attributable to 
the actual interaction between two coexpressed protein partners and not to an artefact, as 
might be expected from, for example, genomic mutations in yeast resulting in the constitutive 
activation of the reporter genes. A further crucial requirement is establishment of bait-specific 
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(as opposed to promiscuous) interaction of the prey. This can be tested by co-transformation 
with an irrelevant bait (in this case pCCW-Alg5) in parallel with a transformation with PalH 
pBR3-SUC bait. Hence, the plasmid DNA isolated from the 40 putative positive yeast clones 
was transformed into E. coli to amplify the prey protein-encoding plasmids. The prey vectors 
from the library were co-transformed into the two bait protein-bearing strains. For true 
interactors, growth on selective media SD-trp-leu-his-ade supplemented with 20 mM 3-AT 
should be observed only when co-transforming with PalH pBR3-SUC bait, but not with the 
control pCCW-Alg5 bait. Prey proteins interacting strongly with the PalH pBR3-SUC bait 
and weakly with the control pCCW-Alg5 bait were chosen for further analysis. The co-
transformations were repeated in triplicate, obtaining at least 1000 total transformants per 
reaction. The results for six putative interactors positive in all three bait dependency replicates 
is reported in Table 6.4 and summurised in Fig. 6.4. Clones were analyzed by sequencing to 
determine the identity of the encoding cDNA and to verify if the A. fumigatus cDNA was 
fused in frame with the NubG moiety. Six prey proteins reproducibly interact with PalH bait, 
these are the phosphate transporter Pho88 (Afu5g01960), the COMPASS complex subunit 
Sdc1 (Afu7g05270), the lectin family integral membrane protein (Afu2g12180), the MFS 
glucose transporter (Afu3g13980), the polyubiquitin UbiD/Ubi4 (Afu4g10350) and the acyl-
CoA binding protein (Afu2g11060). The A. fumigatus cDNA was verified to be in frame with 
the NubG moiety for all six prey vectors and among them three candidates, the phosphate 
transporter Pho88, the COMPASS complex subunit Sdc1 and the acyl-CoA binding protein 
contained full-length cDNA inserts.   
 
  PT*/TT 
  1st experiment 2nd experiment 3rd experiment 
  p-BT3-SUC palH pCCW-ALg5 p-BT3-SUC palH pCCW-ALg5 p-BT3-SUC palH pCCW-ALg5 
pAl-Alg5 70.0 83.3 40.0 50.0 89.24 56.49 
pDL-Alg5 5.0 9.5 5.0 3.3 7.18 9.19 
COMPASS complex 
subunit Sdc1 
50.0 2.5 50.0 25.0 11.30 0.97 
lectin family 
integral membrane 
protein 
66.7 3.3 50.0 25.0 17.94 0.90 
phosphate 
transporter (Pho88) 
75.0 6.7 66.7 25.0 4.90 2.89 
polyubiquitin 
UbiD/Ubi4 
50.0 5.0 50.0 20.0 40.12 2.50 
acyl-CoA binding 
protein  
10.0 2.0 50.0 2.0 14.86 0.00 
MFS glucose 
transporter 
66.7 7.5 23.3 3.3 32.14 3.23 
  Normalisation  
  1st experiment 2nd experiment 3rd experiment 
  p-BT3-SUC palH pCCW-ALg5 p-BT3-SUC palH pCCW-ALg5 p-BT3-SUC palH pCCW-ALg5 
pAl-Alg5 100 100 100 100 100 100 
pDL-Alg5 13 11 6 20 9 16 
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COMPASS complex 
subunit Sdc1 
125 3 56 17 13 2 
lectin family 
integral membrane 
protein 
167 4 56 17 21 2 
phosphate 
transporter (Pho88) 
188 8 75 17 6 15 
polyubiquitin 
UbiD/Ubi4 
125 6 56 20 48 4 
acyl-CoA binding 
protein  
25 2 56 4 18 0 
MFS glucose 
transporter 
167 9 26 3 38 6 
  Average  Standard deviation     
  p-BT3-SUC palH pCCW-ALg5 p-BT3-SUC palH pCCW-ALg5    
pAl-Alg5 100.0 100.0 0.0 0.0    
pDL-Alg5 8.9 15.9 3.5 4.3    
COMPASS complex 
subunit Sdc1 
64.8 7.1 56.3 8.3    
lectin family 
integral membrane 
protein 
81.4 7.4 75.9 8.1    
phosphate 
transporter (Pho88) 
89.3 13.3 91.7 4.7    
polyubiquitin 
UbiD/Ubi4 
76.3 10.1 42.4 8.6    
acyl-CoA binding 
protein  
32.9 2.1 20.4 2.0    
MFS glucose 
transporter 
77.0 6.0 77.9 2.8     
 
Table 6.4: Results for co-transformations testing the interaction between PalH, expressed as bait 
in the pBT3-SUC vector in the MYTH system, and the 6 putative interactors from the screening of the 
preys A. fumigatus library. Each co-transformation was repeated 3 times and for each replicate the number of 
total transformants (TT) in SD-leu-trp, indicative of the transformation efficiency, and the prototrophic 
transformants (PT*) in SD-leu-trp-his-ade 20 mM 3-AT, indicative of interaction between bait and prey, was 
estimated (not shown). The same set of interactors was also tested at the same time by co-trasformation with the 
unspecific bait pCCW-Alg5. The ratio PT*/TT was calculated and averaged (1, 2 and 3 correspond respectively 
to the first, second and third replicate) fixing the value of the positive control co-transformation bait /pAL-Alg5 
to 100.  
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Fig. 6.4: Graphical representation of the results for the co-transformations to test the interaction 
between PalH, expressed as bait in the pBT3-SUC vector in the MYTH system, and the 6 putative 
interactors from the screening of the preys A. fumigatus library. For each co-transformation with the specific 
bait pBT3-SUC PalH and the unspecific bait pCCW-Alg5, the value PT*/TT is shown, obtained by averaging 
the three independent experiments, and normalised by fixing the value of the positive control co-transformation 
bait/pAL-Alg5 to 100.  
 
6.4 Discussion  
 
In this study the split-ubiquitin MYTH system was used to isolate novel protein 
interactors of the membrane-associated protein PalH from an A. fumigatus prey library, and 
the MYTH screening methodology was adapted for higher throughput isolation of interactors.  
 
6.4.1 The MYTH system was adapted for the high-throughput screening of the full-
length A. fumigatus cDNA prey library  
 
Novel protein interactors for A. fumigatus PalH were isolated from a full-length A. 
fumigatus cDNA prey library, which was constructed by Invitrogen using their proprietary 
full length technology (Invitrogen) and a Gateway adapted prey vector (pPR3N-GW). 
-50.0 0.0 50.0 100.0 150.0 200.0
pAl-Alg5
pDL-Alg5
COMPASS complex subunit Sdc1
lectin family integral membrane protein
phosphate transporter (Pho88)
polyubiquitin UbiD/Ubi4
acyl-CoA binding protein 
MFS glucose transporter
pCCW-ALg5
p-BT3-SUC palH
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DUALmembrane prey cDNA was prepared using RNA isolated by our research-group from 
the A. fumigatus clinical isolate 237 under a range of different A. fumigatus culture 
conditions. Notwithstanding a one in three chance of in-frame fusion with N-terminal NubG 
moieties, the complexity of the library was high enough to cover the entire genome multiple 
times (ideally a complexity higher than 2x10
6
 is required). Good quality NubG-x libraries 
should show a complexity ranging from 1x10
6
 to 5x10
6
 (Iyer et al., 2005). Initially, two baits 
(PalH pBT3-STE and PalH pBT3-SUC) were tested in a pilot screen to determine the extent 
of associated self-activation when cotransformed into yeast with empty library vector, and 
thereby optimising the conditions for subsequent library screening. Stringency was titrated 
with increasing concentrations of 3-AT to fine-tune the selection of positive interactors (Fig 
6.3). For PalH pBT3-SUC, 10 mM3-AT led to the complete elimination of false positives. To 
the contrary, 3-AT titration did not reduce false positive background for PalH pBT3-STE bait, 
indicating self-activation of this bait. PalH pBT3-SUC bait was therefore chosen for library 
screening. The full-length A. fumigatus cDNA library was subsequently transformed into 
yeast expressing PalH pBT3-SUC bait and prototrophic transformants were selected in SD-
trp-leu-his-ade selective plates supplemented with 10 mM 3-AT. The strategy suggested by 
the DUALsystems manufacturers was moderated to accommodate the high numbers of 
colonies obtained from primary screenings (Fig 6.2). Yeast clones expressing putative 
interactors were pooled together prior to performing the confirmation assay and rescreened in 
yeast with heightened 3-AT stringency. This permitted confirmation of interacting prey 
plasmids prior to sequence analysis. A set of 40 yeast colonies were analysed by sequencing 
to determine the identity of the putative interactors, some of which were identified multiple 
times (Table 6.3). A bait-dependency test was performed to test promiscuity of prey 
interactions in the NMY51 reporter strain. Six putative interactors were found to act 
favourably in three bait dependency replicates and the sequence determined the identity of the 
encoding cDNA and verified if A. fumigatus cDNA is in frame with the NubG moiety. These 
six proteins, which if expressed as prey interact with PalH bait, are the phosphate transporter 
Pho88 (Afu5g01960), the COMPASS complex subunit Sdc1 (Afu7g05270), the lectin family 
integral membrane protein (Afu2g12180), the MFS glucose transporter (Afu3g13980), the 
polyubiquitin UbiD/Ubi4 (Afu4g10350) and the acyl-CoA binding protein (Afu2g11060) 
(Table 6.4).  
As previously explained in Chapter V, this methodology has permitted the 
understanding of quaternary structures for various plasma membranes, including sucrose 
transporters (Reinders et al., 2002), a yeast protein translocation machinery (Scheper et al., 
2003a; Stagljar et al., 1998), ErbB3 (a receptor tyrosine kinase) (Thaminy et al., 2003), plant 
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K+ channels (Obrdlik et al., 2004) and the yeast Ycf1p (an ATP-binding cassette transporter) 
(Paumi et al., 2007). However, several of these findings underlined a limitation in the MYTH 
system which is sensitive to perturbations in the expression levels of baits. In one of the 
earliest large scale split-ubiquitin screens reported,(Miller et al., 2005)found that around 340 
of the 705 proteins analysed were not suitable for studies in the MYTH system, due to over-
expression from the plasmid chosen and consequent mislocalisation. Unpredictably, the 
ubiquitin fusion can in some instances alter irremediably the topology of the membrane 
protein, which is not directed to its native localisation and whose functioning and interaction 
with other proteins is therefore impaired. Adequate bait expression is crucial for the correct 
functioning of the MYTH system and this must be carefully, and independently, verified for 
small-scale experiments (to test direct interactions) and in large-scale screening (of cDNA or 
gDNA libraries) because the transformation protocol differs between the two. 
DUALmembrane plasmids pBT3-STE and pBT3-SUC are specifically designed for 
expression of bait proteins like PalH, whose topology involves an extracellular N-terminal 
domain and an intracellular C-terminal domain. However, the STE2 leader sequence in pBT3-
STE was shown to enhance the expression of PalH, as demonstrated by the results of the 
western blotting analysis of total yeast extracts using an antibody directed against the LexA 
domain of the fusion protein (Fig. 5.7, Chapter V). For the optimisation of library screening 
conditions a pilot screen was performed with both PalH pBT3-STE and PalH pBT3-SUC 
baits to ascertain propensity for self-activation. Self-activation may be the result of several 
causes, for example, over-expression of the bait protein. Mistargeting of the bait protein can 
lead to bait instability and degradation and could therefore result in a bait protein that self-
activates the transcriptional reporter genes. The straightforward way to address the self-
activation issue is to supplement the media with 3-AT. This chemical compound is a 
competitive inhibitor of the HIS3 gene product and enhances the stringency of HIS3 selection 
when added to the selective media SD-trp-leu-his-ade. As suggested by several studies, which 
adressed protein-protein interactions involved in yeast ergosterol biosynthesis (Mo et al., 
2004; Mo and Bard, 2005b; Mo and Bard, 2005a), to titrate a bait protein under investigation, 
3-AT is added in increasing concentrations to the selective media. Whereas for PalH pBT3-
SUC growth is progressively inhibited in presence of increasing concentration of 3-AT, the 
number of colonies obtained for PalH pBT3-SUC is not affected by the progressive addition 
of 3-AT, indicating self-activation of this bait. 
Bait-specific background depends upon multiple variables and false positive clones 
probably arise from various distinct mechanisms. False positive interactors are proteins that 
behave as spurious interactors in the MYTH screening and do not interact with the bait 
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protein in a physiologically meaningful way. Non-specific activation of the NMY51-encoded 
reporter genes might occur as a result of mutations in their promoter regions or from over-
expression of the fusion protein in yeast (Serebriiskii et al., 2000; Thaminy et al., 2003). A 
list of common false positive interactors is publicly available (Kittanakom et al., 2009). Due 
to the mechanistic principles of the methodology, ubiquitin is often found as a false positive 
interactor, especially when using x-NubG prey libraries. In addition, H
+
-ATPase is a frequent 
false positive, likely because most vacuolar ATPases are involved in the sorting of bait 
proteins to their appropriate intracellular location. Rarely, histone deacetylases (HDAC) are 
identified as false positive interactors in MYTH screenings, because they are thought to bind 
to hydrophobic residues on the surface of the Cub domain of the bait. To address the issue of 
false-positivity, the bait-dependency test investigates if the prey protein under investigation 
interacts specifically with the bait of interest, or if non-specific interactions occur with other, 
using irrelevant baits expressed in the NMY51 reporter strain. Putative interactors, positive 
for interaction with the original bait, but not with the unrelated bait, were considered for 
further studies. Because MYTH screening is intrinsically prone to a significant level of false 
positive results, independent approaches are necessary to validate the interactions identified in 
the screening, such as co-immunoprecipitation or pull-down assay.  
 
6.4.2 Bioinformatic validation of PalH putative interactors  
 
As well as independent experimental verification of interactors there are several in 
silico investigations, addressing functionality of suspected interactors, which can aid 
deductions. Local (Bignell laboratory) and publicly available bioinformatics resources can be 
mined to determine, for example, whether bait and interactors follow a common 
transcriptional expression pattern and whether the associated GO terms support the relevance 
of the putative interaction in terms of function, process, and/or localisation (Ashburner et al., 
2000). For example, if two proteins share the same expression pattern the interaction 
identified might indeed be physiologically relevant (Ge et al., 2001; Lee et al., 2004). 
Proteins with different transcription profiles might also interact, but only transiently, so it is 
necessary to consider carefully the interactions identified case by case. Also, an identified 
interaction between a plasma membrane and a nuclear protein is likely to be a false positive.  
Further validation of the detected interactors of A. fumigatus PalH is ideally required 
and could be pursued using various techniques, such as co-immunoprecipitation, fluorescence 
microscopy or in vitro transport of radiolabeled substrates for transported proteins. The 
analysis of the results of the screening of the full-length A. fumigatus cDNA prey library with 
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PalH bait using the split-ubiquitin MYTH system support the current theory that in A. 
fumigatus, like in S. cerevisiae, adaptation to alkaline stress depends on the integration of 
simultaneous stress-related signalling pathways other than just PacC/Rim101p (Arino, 2010) 
and also that the PacC/Rim101p pathway functions in roles other than pH adaptation. Several 
biological functions are commonly associated with the PacC/Rim101p pathway and with the 
immediate implications for cells of a sudden alkalinisation of the environment. In the current 
literature, several pathways are often coupled with PacC/Rim101p to overcome alterations in 
nutrient homeostasis in alkaline environments. The associated pathways are usually involved 
in the uptake and mobilisation of essential ions and/or nutrients such as iron/copper, 
phosphate, zinc, and glucose and in the screening presented in this study, candidates such as 
the phosphate transporter Pho88 (Afu5g01960) and the MFS glucose transporter 
(Afu3g13980) fit into these categories. The available understanding for these two candidates 
comes especially from studies in S. cerevisiae, where the PHO pathway (for reviews, 
see(Huang et al., 2002; Lenburg and O'Shea, 1996; Mouillon and Persson, 2005) and the 
major facilitator superfamily (MFS) (for reviews, see(Sa-Correia et al., 2009) have been 
extensively studied.  
 The recent characterisation of the A. fumigatus PHO80 homologue has highlighted 
the importance of the PHO pathway for Aspergillus species, yielding important insight into 
the contribution of phosphate regulation in other stress-related pathways (de Gouvêa PF, 
2008). In S. cerevisiae, the PHO pathway regulates genes involved in the uptake and 
mobilisation of phosphate, whose presence is crucial for the synthesis of nucleic acids, 
proteins, lipids and sugars (for reviews, see(Huang et al., 2002; Lenburg and O'Shea, 1996; 
Mouillon and Persson, 2005). The PHO pathway is composed of various members, including 
the transcriptional activators Pho2p and Pho4p, the Pho80p-Pho85p cyclin dependent protein 
kinase (CDK) complex, the Pho81p CDK inhibitor and the high affinity phosphate transporter 
Pho84p. The expression of the plasma membrane transporter Pho84p is activated by the PHO 
pathway itself in phosphate-replete conditions, via Pho81p-mediated inhibition of the 
Pho80p-Pho85p CDK complex, which is therefore unable to hyperphosphorylate Pho4p 
(Ogawa et al., 1995a). Hypophosphorylated Pho4p is retained in the nucleus, where in 
concomitance with Pho2p, it activates gene expression (Kaffman et al., 1998). The S. 
cerevisiae homologue of the phosphate transporter Pho88 is a membrane protein involved in 
phosphate transport, modulating the function of Pho81p in association with Pho86p, via a 
mechanism still not characterised (Yompakdee et al., 1996).(Yompakdee et al., 1996)used a 
Gal4 promoter to drive high level constitutive expression of Pho81 and demonstrated that 
high level expression of Pho81p is not sufficient to promote expression of the acid 
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phosphatase Pho5p in high phosphate media. This implies that Pho81p activity is limited in 
high Pi conditions and that over-expression of Pho88p could force Pho81p activity in high 
phosphate conditions. Phosphate uptake was shown to be deficient in a Δpho88 mutant; 
however, PHO88 gene expression is not subject to phosphate regulation, as demonstrated by 
Northern analysis.(Hurto et al., 2007)demonstrated using an N-terminal GST-Pho88p fusion 
protein that the protein localised to the ER. Prediction with TMpred reveals that the protein 
has an extra luminal N terminus, and since the A. fumigatus prey was selected from a library 
of N-terminal NubG fusions, it follows that the Pho88p protein is likely to be located on an 
intracellular membrane.(Copic et al., 2009)performed a screen for S. cerevisiae mutants 
defective in intracellular retention of the ER chaperone Kar2p, identifying 87 Kar2p secreting 
strains including the Δpho88 mutant. Further analysis of the Δpho88 mutant identified 
synthetic lethality with a HAC1 deletion, suggesting a role in protein folding through post-
translational modification of secretory cargoes. Moreover the study found that the Δpho88 
mutant was defective for CPY glycosylation indicating that it is defective for processing of 
secretory proteins.(Copic et al., 2009)suggested therefore Pho88p as a prime candidate for 
participating directly in N-linked glycosylation. Thus, in light of the considerations in Chapter 
V which suggested PalH is a GPCR homodimer, a plausible hypothesis is that Pho88p 
facilitates N-glycosylation of the PalH extracellular domain to mediate protein folding and 
delivery to the cell surface. As previously described in Chapter V, GPCRs activity is 
modulated by a variety of post-translational modifications, such as phosphorylation, fatty acid 
acylation and glycosylation. The latter modification is crucial for GPCRs, their intracellular 
folding, their delivery to the plasma membrane and the protein-protein interactions they are 
involved in for activation of the specific signal pathways (Lanctot et al., 1999; Ray et al., 
1998; Wheatley and Hawtin, 1999). Hence, several GPCRs have been shown to be N-linked 
glycoproteins, whose activity is mediated by the Asn-X-Ser/Thr domain localised in the 
extracellular domain. In addition, N-glycosylation has been demonstrated to be involved in 
the high-affinity binding and signal transduction of several GPCRs (Breitfeld et al., 1984; 
Rademacher et al., 1988). N-glycosylation has been extensively studied for the family B 
glucagon-like peptide 1 (GLP-1) receptor, because of the multiple antidiabetic actions of its 
natural agonist GLP-1 (Chen et al., 2010).(Chen et al., 2010)demonstrated that tunicamycin 
inhibition, which specifically affects N-glycosylation of the GLP-1 receptor, abolishes its 
binding ability and therefore biological activity. Mutation of all the potential N-linked 
glycosylation sites, is required to impair binding and biological activity of the GPL-1 
receptor, which appears to be expressed at a lower rate on the cell surface, when not properly 
folded and/or retained in intracellular biosynthetic compartments. The presence of PalH N-
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glycosylation sites is predicted in silico using NetNGlyc 1.0 
(http://www.cbs.dtu.dk/services/NetNGlyc), which reveals with high probability (0.7432) an 
N-glycosylation site starting from residue 15 of A. fumigatus PalH. However, no signal 
peptide is present in the N-terminal luminal domain of PalH (residues 1-88), therefore 
indicating this prediction has to be carefully considered, because proteins without signal 
peptides are unlikely to be exposed to the N-glycosylation machinery. Signal peptides have 
been thought to be required for the posttranslational translocation of GPCRs across the 
endoplasmic reticulum membranes, otherwise not possible when stably folded domains are 
present in the N-terminus. However,(Huang et al., 2010)demonstrated for the GLP-1 receptor 
the cleavage of the signal peptide is not essential for receptor synthesis, but it facilitates 
processing and trafficking to the cell surface (Huang et al., 2010). Although critical to some 
extent, the role and indispensability of signal peptides in N-glycosylation of GPCRs remains 
unclear. The human Na
+
-Ca
2+
-exchanger possesses a signal peptide, which is not necessary 
for plasma membrane localisation or functioning of the receptor itself (Loo et al., 1995). The 
human family A endothelin ETb GPCR signal peptide is dispensable for synthesis but 
essential for delivery to the plasma membrane being otherwise accumulated in the ER (Kochl 
et al., 2002). The same scenario is observed for the Family B VPAC1 receptors (Couvineau et 
al., 2004), whereas for the Family B CRF1 signal peptides enhance the expression of the 
respective receptors (Alken et al., 2005). A large proportion of GPCRs (around 85%) show no 
signal peptide in their sequence (Kochl et al., 2002).  
 Studies in A. nidulans have highlighted the significant differences with the PHO 
pathway as compared to S. cerevisiae, suggesting the presence of another component in the 
Pho80p-Pho85p CDK complex, at least in some Aspergillus species, to support the function 
of A. nidulans Pho80p (Wu et al., 2004). A. nidulans possesses two PHO85 homologues, 
named phoA (Bussink and Osmani, 1998) and phoB (Dou et al., 2003), but the Pho85-like 
kinase pair has been demonstrated to likely have an essential function in cell cycle control and 
morphogenesis, rather than in the PHO pathway (Dou et al., 2003). Within the Aspergillus 
genus, only some species possess two PHO85 homologues, e.g. A. fumigatus only has a single 
homologue showing 96% homology with the S. cerevisiae one. The studies to investigate the 
role of the PHO pathway in A. fumigatus have started only relatively recently with the 
characterisation of the PHO80 homologue and the respective null mutant (de Gouvêa PF, 
2008). The Δpho80 mutant showed over-expression of the PHO genes and reduced polar 
growth, but was not attenuated in a murine low dose model of invasive aspergillosis.  
The MFS glucose transporter (Afu3g13980) identified as a PalH putative interactor 
belongs to the major facilitator superfamily (MFS), a group of multidrug resistance (MDR) 
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transporters, still poorly characterised in eukaryotes (for reviews, see(Sa-Correia et al., 2009) 
and whose importance has been described in Chapter V. In S. cerevisiae, the MFS 
transporters usually show a 12 or 14 TMD topology and transport physiological substrates, in 
this case glucose, one of the nutrients whose bioavailability is likely to be modified as a 
consequence of alkalinisation of the pH and/or during the infection.  
As comprehensively described in Chapter VII, the association between the yeast 
MultiVesicular Bodies (MVB) pathway and Rim101p-mediated regulation has been 
extensively studied and evidence in the literature links the two pathways. Though the lectin 
family integral membrane protein (Afu2g12180) and the acyl-CoA binding 
protein (Afu2g11060) do not belong to the MVB pathway, they may be crucial for the 
organisation and homeostasis of the biosynthetic and endocytic pathway, whose major 
coordinator site is the endoplasmic reticulum (ER) (Gruenberg and Maxfield, 1995). The ER 
has multiple functions within the cell for example participation in the biogenesis of secretory 
and membrane proteins and lipids. Linear polypeptide chains enter the ER to undergo proper 
folding, glycosylation and disulphide bond formation, whereas lipids are modified in the ER 
by several enzymes involved in fatty acid elongation and desaturation, ergosterol synthesis, 
and glycosylphosphoinositol (GPI) addition. Once modified, proteins and lipids leave the ER 
via transport vesicles and, as relevant to the present study, intracellular lectins have been 
extensively associated with N-linked glycoprotein traffic (as reviewed in(Hauri et al., 2000; 
Yamashita et al., 1999). One of the candidates identified by this screen is a lectin family 
integral membrane protein (Afu2g12180), whose human homologue, vesicular integral-
membrane protein VIP36, functions as a sorting receptor by recognising high-mannose type 
glycans for transport from the Golgi to the cell surface in polarised epithelial cells (Fiedler et 
al., 1994). The expression of two other animal lectin proteins, ERGIC-53 and VIP36, is up-
regulated by ER stress, which causes the accumulation of unfolded proteins in the ER and 
triggers the signalling response mechanism known as the unfolded protein response (UPR). 
Interestingly the increase of unfolded proteins in the ER in yeast has been attributed to 
various type of stresses (Nyfeler et al., 2003), among which the perturbation of calcium 
homeostasis or redox status, and nutrient deprivation are included. These stresses represent 
evident links with the PacC/Rim101p pathway as common consequences of the alkalinisation 
of the media/environment. 
The acyl-CoA binding protein (Afu2g11060) belongs to a widely distributed family 
(as reviewed in(Faergeman et al., 2007; Kragelund et al., 1999), whose functions have been 
extensively characterised in S. cerevisiae. Acyl-CoA binding proteins bind to medium and 
long chain saturated and unsaturated fatty acid acyl-CoA esters and are involved in their 
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intracellular transport and metabolism (Knudsen et al., 1994; Schjerling et al., 1996). 
Interestingly, long chain acyl-CoA esters are crucial intermediates in lipid biosynthesis and 
fatty acid degradation, and have been demonstrated to affect a large number of systems and 
functions, including ion channels, pumps and transporters (Faergeman and Knudsen, 1997; 
Knudsen et al., 2000). Besides, as relevant for the purposes of this study, deletion of ACP1 
decreases the levels of very-long-chain fatty acids and of sphingolipid synthesis, and impairs 
membrane assembly, and organelle organisation and structure, suggesting involvement in 
vesicular trafficking and cellular integrity maintenance (Gaigg et al., 2001). Accordingly, 
Δacp1 mutants show severe morphological alterations of the vacuole, whose functionality is 
dramatically impaired, and reduction of ceramide cellular content (Faergeman et al., 2004). 
Although it is not possible to clearly explain the mechanisms linking the acyl-CoA binding 
protein and the PacC/Rim101p pathway, at least two non-mutually exclusive hypotheses 
could be formulated. Regarding the importance of the endocytic system for pH adaptation, the 
first hypothesis is based on the demonstrated role of this highly-conserved protein family to 
influence the regulation and coordination of membrane fusion events necessary for endosomal 
vesicle transport, as demonstrated in yeast (Faergeman et al., 2004; Faergeman and Knudsen, 
1997) and recently in Caenorhabditis elegans (Larsen et al., 2006). Alternatively, the link 
between the acyl-CoA binding proteins and the PacC/Rim101p pathway could be attributed to 
the Acp1p-dependent connection of fatty acid metabolism and transcriptional regulation of 
phospholipid biosynthesis, as highlighted by the recent DNA microarray study of the Δacp1 
mutant (Feddersen et al., 2007). Deletion of ACP1 affects the expression of genes involved in 
fatty acid and phospholipid synthesis, glycolysis, glycerol metabolism, ion uptake and 
mobilisation and stress response. Validating the importance of lipid membrane composition, 
recent experimental evidence in yeast have shown the Rim101p pathway is activated in 
response to a change in lipid symmetry (Ikeda et al., 2008), composition and shape (Mattiazzi 
et al., 2010).       
A common feature of some of the studies in the current literature trying to explore the 
links between the PacC/Rim101p pathway and other functionally related pathways is the 
recurrent and unexplainable presence of members of the functional category chromatin 
assembly and modification (Copic et al., 2009; Mattiazzi et al., 2010), including components 
of the SWR1-complex (Korber and Horz, 2004). The functional relationship between the two 
pathways is still unexplored: however, evidence of the involvement of the SWI1/SNF2 group 
in pH sensing and regulation are demonstrated in the present study in various instances, as 
described also in Chapter IV and Chapter VII. Among the candidates of the screening of the 
full-length A. fumigatus cDNA prey library with PalH bait using the split-ubiquitin MYTH 
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system, SDC1 encodes the COMPASS complex subunit Sdc1 (Afu7g05270), which 
methylates lysine 4 of histone H3 and is required in chromatin silencing at telomeres (South 
et al., 2010). As extensively described in Chapter IV and VII, histone and chromatin 
remodelling have gained credit as regulators of transcription in the past few years (Buck and 
Lieb, 2006), with the discovery that these complexes alter nucleosome structure in different 
ways, such as by covalent modification of the N-terminal histone tails or by ATP-dependent 
perturbation of histone-DNA interactions (Fyodorov and Kadonaga, 2001).  
The remaining putative interactor is the polyubiquitin UbiD/Ubi4 (Afu4g10350).  This 
candidate requires particular attention in the downstream confirmation assay, because it is 
indicated as a common false positive in screenings, due to the principle of the methodology. 
However the possibility of an interaction between the polyubiquitin UbiD/Ubi4 and PalH is 
not to be excluded, considering such an interaction would validate the current model for pH 
adaptation in A. nidulans. Ubiquitination is considered as a signal to sort endosomal cargoes 
to the MVB pathway (Katzmann et al., 2001) and the current model for pH adaptation in A. 
nidulans hypothesises the involvement of endocytosis for pH-signal transduction; however, it 
suggests the arrestin-like PalF to be phosphorylated and multi-ubiquitinated depending on 
alkaline ambient pH in a PalH- and partially PalI- but not PalA-, PalB-, PalC-dependent 
manner (Herranz et al., 2005). 
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CHAPTER VII 
 
IDENTIFICATION OF NOVEL RIM101 REGULATORS BY 
GENETIC SCREENING IN S. CEREVISIAE  
 
7.1 Overview 
 
Previous studies have demonstrated that Rim101p (the yeast homologue of PacC)  
functionality extends beyond mere pH adaptation to the positive regulation of sporulation, 
invasive growth, ion tolerance and acquisition, and certain cell wall characteristics (Denison, 
2000; Hayashi et al., 1998; Lamb et al., 2001; Lamb and Mitchell, 2003; Li and Mitchell, 
1997). In yeast these processes are therefore inextricably linked to environmental pH, which 
not only influences S. cerevisiae growth, but also its differentiation, invasive growth and 
meiotic sporulation. The main effect of external alkalinity upon cellular physiology is the 
disruption of the membrane proton gradient, which supplies energy for the transmembrane 
transport necessary to face consequent nutrient and ion limitation. Rim101p appears to be 
principally required for ion homeostasis (Lamb et al., 2001; Lamb and Mitchell, 2003) and in 
alkaline conditions the maintenance of ion and pH homeostasis is ensured by the expression 
of  several pumps including the plasma membrane H
+
-ATPase Pma1p, the Na
+
-ATPase 
Ena1p and the vacuolar H
+
-ATPase Vma4p (Stevens and Forgac, 1997; Rodriguez-Navarro et 
al., 1994; van der Rest et al., 1995). The essential role of these transporters at alkaline pH is 
evidenced by phenotypes of null mutants lacking these pumps, which are unable to grow in 
alkaline conditions and/or display cation sensitivity (Lamb and Mitchell, 2003). Gene 
expression is dramatically modified as a consequence of a shift to alkaline pH. Among 
differentially regulated genes (Lamb et al., 2001), several are involved in zinc, phosphate, 
iron or copper uptake and utilisation (CTR3, FRE1, PHO11/12, PHO84, ARN4/ENB1, 
YOR154W). CTR3 and FRE1 are targets of the copper-responsive transcription factor Mac1p 
(Jungmann et al., 1993; Pena et al., 1998); YOR154W is a target of zinc-responsive 
transcription factor Zap1p (Lyons et al., 2000); PHO11/PHO12 and PHO84 are targets of the 
phosphate-responsive transcription factor Pho4p (Ogawa et al., 1995a; Ogawa et al., 1995b). 
Arn4p is involved in iron uptake and in particular imports a bacterial siderophore-iron 
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complex, facilitating competition with bacteria in alkaline conditions (Heymann et al., 2000; 
Lamb et al., 2001).  
In this study two screening strategies were used to identify novel regulators of S. 
cerevisae Rim101p functionality. Both screens focused upon the 80 mutants identified in the 
Euroscarf S. cerevisiae ORF deletion library as having Δrim101-like cation sensitivity 
profiles (Bignell, unpublished data). The characteristic cation sensitivity profile associated 
with Δrim101 mutants (which were confirmed in this study also, Fig. 7.3- Fig. 7.9) proved a 
useful tool to identify mutants having identical phenotypes to a Δrim101 strain, which may 
represent (for example) regulators of Rim101p signalling, processing, nuclear translocation. 
In this respect, pH sensitivity did not prove a useful phenotypic determinant given a) the poor 
capacity of S. cerevisiae for growth at high pH, and b) the high prevalence of gene deletions 
which predispose to alkaline sensitivity in a Rim101p-independent manner, such as those 
impacting de novo biosynthesis of nutrients whose uptake from the external medium is pH-
dependent. The first of the two screens, (Fig. 7.1) utilised a truncated Rim101p ORF, 
previously constructed by(Castrejon et al., 2006), and used to address how Rim101p 
contributes to yeast cell wall assembly through the Sltp2 kinase (Castrejon et al., 2006). 
Where Δrim101-like mutants lack specific regulators of Rim101p processing, introduction of 
a constitutively processed form of Rim101p would be expected to rescue cation sensitivity. 
Thus, to identify which of the 80 ∆rim101-like mutants lack proteins acting upstream of 
Rim101p, the mutants were transformed with an activated allele of RIM101 to attempt to 
rescue the phenotype. This epistacy screen relied upon the reversal of lithium and sodium 
toxicity in the presence of activated RIM101, thereby identifying PacC regulatory roles for the 
deleted genes.  
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Fig. 7.1: Epistacy screen of 80 S. cerevisiae ∆rim101-like mutants to identify novel regulators of 
Rim101p. A global phenotypic screen of the Euroscarf S. cerevisiae ORF deletion library had previously 
revealed that a Δrim101 shows cation hypersensitivity compared to the parental strain BY4741 (Bignell, 
unpublished) (A). This cation hypersensitivity was also observed for 80 other ORF deletions (B). To identify 
novel regulators of Rim101p, the epistacy screen selected for reversal of lithium and sodium toxicity following 
transformation with a constitutively active form of Rim101p (C). 
 
The second genetic screen utilised a synthetic Rim101p promoter constructed by 
(Lamb and Mitchell, 2003)and used to study Rim101p-mediated repression of the genes 
NRG1 and SMP1 to direct ion tolerance and cell differentiation (Lamb and Mitchell, 2003). 
The reporter, consisting of the lacZ reporter gene under the control of four Rim101p 
consensus binding sites, provides a read out of activated Rim101p binding to the synthetic 
promoter, and consequent transcriptional repression, as measured by β-galactosidase assay 
(Fig. 7.2). If proteins encoded by deleted ORFs participate in Rim101p processing, DNA 
binding or nuclear localisation, β-galactosidase activity would become derepressed.  
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Fig. 7.2: Use of a synthetic Rim101p promoter to identify mutants in Rim101p processing and/or 
transcriptional activity. Relative to wild type (A) lacZ expression is expected to become derepressed in 
mutants lacking regulators of Rim101p (B).  
 
7.2 Methods 
 
7.2.1 The Euroscarf S. cerevisiae ORF deletion library 
 
Yeast strains used in this study come from the YKO library, background BY4741 
(MATa his3_1 leu2_0 met15_0 ura3_0), which has been developed by the Saccharomyces 
Genome Deletion Project (Open Biosystems, http://www.openbiosystems.com/YKO) 
(Winzeler et al., 1999; Winzeler et al., 2000). It is a unique collection of non-essential S. 
cerevisiae knockout strains covering 95% of the yeast genome. This collection, which is 
composed of 4811 gene-disruption mutants for most of the non-essential S. cerevisiae genes, 
was created using a PCR-based gene deletion strategy. This strategy resulted in replacement 
of each yeast open reading frame (ORF) with a KanMX cassette and a tag.  
 
7.2.2 Plasmids  
 
pWL86URA. pWL86URA was derived from pWL86 (Li and Mitchell, 1997) which 
was kindly provided by A. P. Mitchell. The plasmid pWL86 was derived from the vector 
pRS314 and additionally contains the RIM101 gene truncated at codon 531 (Rim101-531p). 
pWL86 was constructed by inserting a 2.1-kb PstI-XhoI fragment from plasmid pSS239-CRX 
(Su and Mitchell, 1993b) between the PstI and XhoI sites of pRS314 (Sikorski and Hieter, 
1989). The resulting plasmid includes RIM101 5' sequences and coding region through codon 
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531, whereby the fusion to vector sequences adds C-terminal amino acids 
RILLEGGPGTSFCSL. For the purposes of this study, the URA auxotrophic marker was 
amplified by PCR from the plasmid Yep24 (New England Biolabs) using the BD advantage 
polymerase, and the oligonucleotides UraNot2F and UraNot2R (Appendix B) which added 
restriction sites for the enzyme NotI to promote cloning in pWL86. The URA auxotrophic 
marker was subsequently cloned into the single NotI site of pWL86. To facilitate cloning, the 
vector pWL86 and the NotI-digested URA auxotrophic marker were treated with the enzymes 
CIP and PNK respectively. After ligation clones were screened by colony-PCR for the 
presence of the URA auxotrophic marker. Positive clones were verified for the directional 
cloning of inserts by sequencing (see Appendix B) and for functionality of the URA 
auxotrophic cassette by transformation into BY4741 (for genotype, please consult Appendix 
A). The functionally verified plasmid pWL86URA was used to transform BY4741 (the 
parental strain of the Euroscarf S. cerevisiae ORF deletion library), Δrim101 and the 80 
∆rim101-like mutants. Transformant clones were selected on SD-ura media. For each 
transformation three independent transformants were isolated for further analysis.  
 
pAED39. The Rim101p repression reporter plasmid pAED39 was kindly provided by 
A. P. Mitchell (Lamb and Mitchell, 2003). The reporter plasmid pAED39 was constructed by 
inserting the sequence TCGAGTGCCAAGATGCCAAGACTCGAGTCTTGGCATCTTGG 
CAC into the XhoI site of LGΔ312S.  
 
7.2.3 S. cerevisiae phenotypic testing  
 
Δrim101-like mutant phenotypes were confirmed using the test conditions listed in 
Table 7.1.  
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Media Test Condition Comments 
YPD Control conditions  No buffer  
YPD pH 4 Acidic stress  Buffered with 100 mM glycolic acid 
YPD pH 8 Alkaline stress Buffered with 100 mM Tris-HCl 
YPD 100 mM LiCl Cationic stress Buffered with 100 mM LiCl 
YPD 200 mM LiCl Cationic stress Buffered with 200 mM LiCl 
YPD pH 4  
200 mM LiCl 
Acidic and cationic stress Buffered with 100 mM glycolic acid 
and 200 mM LiCl  
YPD pH 4.5  
800 mM NaCl 
Acidic and cationic stress Buffered with 100 mM glycolic acid 
and 800 mM NaCl  
YPD pH 7.4  
200 mM LiCl 
Alkaline and cationic stress  Buffered with 100 mM Tris-HCl 
and 200 mM LiCl 
 
 Table 7.1: Buffers used for pH-buffered media in the S. cerevisiae phenotypic screening. The 
composition of the media is indicated in Section 2.3.2.  
 
7.2.4 Assessment of yeast growth in liquid media 
 
 Yeast growth profiling was adapted to 96-well format in liquid media. Mutants and 
transformants, the latter gridded in triplicate, in 96-well plates were grown overnight in YPD 
and each was subsequently used to inoculate two further (one with YPD and one with YPD 
pH 7.4 200 mM LiCl) 96-well plates. OD600 was measured using Multiskan EX (Thermo 
Electron Corporation) at the initiation of 30°C incubation and at subsequent 2, 4, 6, 8, 10, 12 
and 24 hour time points.   
 
7.2.5 ß-galactosidase assay 
 
The β-galactosidase activity of S. cerevisiae strains was measured using the non-stop 
protocol recommended by the yeast β-galactosidase assay kit (Pierce) manufacturers, as 
previously described. The β-galactosidase assay was adapted to the 96-well plate format. 
Mutants and transformants, the latter gridded in triplicate, in 96-well plates were grown 
overnight in YPD and each was subsequently used to inoculate three further (YPD pH 6.5, 
YPD pH 4.5 and YPD pH 8.0) 96-well plates. Overnight YPD broth cultures were diluted 
(1/10) and grown to OD660 approximately of 0.6. The OD660 was then recorded and 100 μl of 
working solution (50 μl 2X ONPG and 50 μl Y-PER Reagent) was added to each well. After 
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20 minutes, the absorbance at 420 nm was measured and the β-galactosidase activity was 
calculated applying the following formula: (1000xA420)/(TxVxOD660)=β-galactosidase 
activity, where T is the reaction time (minutes), V corresponds to the reaction volume (ml) 
and A420 is the absorbance at 420 nm. The experiment was performed in culture conditions of 
varying pH, as summarised in Table 7.2.  
 
 
Media Test Condition Comments 
YPD pH 6.5 Control conditions  No buffer  
YPD pH 4.5 Acidic stress  Buffered with 100 mM glycolic acid 
YPD pH 8 Alkaline stress Buffered with 100 mM Tris-HCl 
 
 Table 7.2: Buffers used for pH-buffered media. The composition of the media is indicated in Section 
2.3.2. 
 
7.3 Results 
 
7.3.1 Confirmation of ∆rim101-like phenotypes for 80 mutants from the Euroscarf S. 
cerevisiae ORF deletion library 
 
A global phenotypic screen of the Euroscarf S. cerevisiae ORF deletion library 
performed in our laboratory (Bignell, unpublished) had previously revealed that Δrim101 
shows cation hypersensitivity compared to the parental strain BY4741. The cation sensitivity 
profile, termed by us as a Δrim101-like phenotype, was observed for deletions of 80 other 
ORFs, among which all of the yeast Rim101p signalling components (Rim8p, Rim9p, 
Rim13p, Rim16p, Rim20p, Rim21p, Dfg16p, Ygr122wp) were included. Phenotypic results 
are tabulated in Table 7.3. Prior to genetic screening of these mutants cation hypersensitivity 
was retested to confirm previous observations and also to optimize culture conditions for 
subsequent epistacy screening. The results of the phenotypic screening are summarised in 
Figs. 7.3 – 7.9. The media used for phenotype testing were: YPD, YPD pH 8 (100 mM Tris-
HCl) (Fig. 7.3), YPD pH 4 (100 mM glycolic acid) (Fig. 7.4), YPD pH 4 (100 mM glycolic 
acid) 200 mM LiCl (Fig. 7.5), YPD 100 mM LiCl (Fig. 7.6), YPD 200 mM LiCl (Fig. 7.7), 
YPD pH 4.5 (100 mM glycolic acid) 800 mM NaCl (Fig. 7.8), YPD pH 7.4 (100 mM Tris-
HCl) 200 mM LiCl (Fig. 7.9). For each strain, 6.6x10
7
, 3.3x10
7
, 1.65x10
7
 and 8.25x10
6
 cells 
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were plated and the plates were incubated for 3-5 days. No differences in growth between the 
wild type and mutant isolates were observed on YPD media (data not shown). Marked growth 
reduction was observed for all strains at pH 8 (Fig. 7.3), whereas no growth defects were 
observed at pH 4 (Fig. 7.4). In contrast with the wild type BY4741, reduction or prevention of 
growth for the mutant yeast strains analysed was observed following the addition of LiCl 
(Fig. 7.6). In particular, the effect is more pronounced as the concentration of LiCl (Fig. 7.7) 
and/or pH increased (Fig. 7.9). Coherently with this observation, growth for the yeast null 
mutants was almost completely prevented in YPD pH 7.4 200 mM LiCl (Fig. 7.9).  
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Fig. 7.3: Phenotypes of Δrim101 and Δrim101-like mutants on YPD pH 8 (100 mM Tris-HCl). For each null mutant 6.6x107, 3.3x107, 1.65x107 and 8.25x106 c.f.u.s 
were plated prior to incubation at 30°C for 3-5 days.  
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Fig. 7.4: Phenotypes of Δrim101 and Δrim101-like mutants on YPD pH 4 (100 mM glycolic acid). For each null mutant 6.6x107, 3.3x107, 1.65x107 and 8.25x106 c.f.u.s 
were plated prior to incubation at 30°C for 3-5 days.  
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Fig. 7.5: Phenotypes of Δrim101 and Δrim101-like mutants on YPD pH 4 (100 mM glycolic acid) 200 mM LiCl. For each null mutant 6.6x107, 3.3x107, 1.65x107 and 
8.25x10
6
 c.f.u.s were plated prior to incubation at 30°C for 3-5 days.  
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Fig. 7.6: Phenotypes of Δrim101 and Δrim101-like mutants on YPD 100 mM LiCl. For each null mutant 6.6x107, 3.3x107, 1.65x107 and 8.25x106 c.f.u.s were plated 
prior to incubation at 30°C for 3-5 days.  
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Fig. 7.7: Phenotypes of Δrim101 and Δrim101-like mutants on YPD 200 mM LiCl. For each null mutant 6.6x107, 3.3x107, 1.65x107 and 8.25x106 c.f.u.s were plated 
prior to incubation at 30°C for 3-5 days.  
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Fig. 7.8: Phenotypes of Δrim101 and Δrim101-like mutants on YPD pH 4.5 (100 mM glycolic acid) 800 mM NaCl. For each null mutant 6.6x107, 3.3x107, 1.65x107 and 
8.25x10
6
 c.f.u.s were plated prior to incubation at 30°C for 3-5 days.  
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Fig. 7.9: Phenotypes of Δrim101 and Δrim101-like mutants on YPD pH 7.4 (100 mM Tris-HCl) 200 mM LiCl. For each null mutant 6.6x107, 3.3x107, 1.65x107 and 
8.25x10
6
 c.f.u.s were plated prior to incubation at 30°C for 3-5 days.  
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Gene name Biological process pH 
8 
pH 
4 
pH 4  
200 mM 
LiCl 
100 
mM 
LiCl 
200 
mM 
LiCl 
pH 4.5  
800 mM 
NaCl 
pH 7.4 
200 mM 
LiCl 
BY4741  S G G G G S S 
RIM101 sporulation (sensu Fungi) SS G S S S SS SS 
ADH1 fermentation SS G NG S SS SS NG 
ALF1 post-chaperonin tubulin folding 
pathway 
SS G SS S SS SS NG 
ARP5 protein-vacuolar targeting NG G NG S S S NG 
ASF1 DNA damage response, signal 
transduction resulting in 
induction of apoptosis 
NG G S S S S NG 
ATG15 autophagy NG G NG S S SS NG 
BCK1 protein kinase C signaling 
pathway 
SS G NG S SS SS NG 
CDC10 cell wall organisation and 
biogenesis 
NG G S S S S NG 
CKB1 protein amino acid 
phosphorylation 
S G S S SS SS NG 
CRZ1 regulation of transcription, 
DNA-dependent 
NG G NG S S SS NG 
CTP1 mitochondrial citrate transport NG G NG S SS SS NG 
DCC1 mitotic sister chromatid 
cohesion 
NG G SS S SS SS NG 
DFG16 pseudohyphal growth SS G NG S SS SS NG 
DLS1 chromatin silencing at telomere SS G S S S G SS 
DOA4 endocytosis SS G S S SS SS NG 
DPB3 chromatin silencing at telomere NG G S S S S SS 
EAF7 biological process NK NG G S S S S SS 
FMP21 biological process NK NG G NG S S S NG 
GIS4 intracellular signaling cascade NG G SS S NG SS NG 
HEX3 sporulation (sensu Fungi) SS G NG S S SS NG 
IRA2 Ras protein signal transduction SS G NG S S SS NG 
KAP123 Protein-nucleus import NG G NG S S S NG 
LSM1 rRNA processing SS G NG S S SS NG 
MAL31 alpha-glucoside transport SS G NG S S SS NG 
MAL33 regulation of transcription, 
DNA-dependent 
S G NG S S SS NG 
MEH1 biological process NK NG G S S S S SS 
MET22 sulphate assimilation SS G NG S S SS NG 
MGA2 positive regulation of 
transcription from Pol II 
promoter 
NG G SS S SS SS NG 
MRP17 protein biosynthesis S G SS S SS SS NG 
MRPL27 protein biosynthesis S G SS S SS SS NG 
MRPL37 protein biosynthesis SS G SS S SS SS NG 
MSC7 meiotic recombination NG G S S SS SS NG 
NCL1 tRNA methylation SS G NG S SS SS NG 
PCA1 iron ion homeostasis NG G SS S SS SS NG 
PET117 cytochrome c oxidase 
biogenesis 
NG G S S S S NG 
PHO80 regulation of phosphate 
metabolism 
NG G SS S S SS NG 
PMP1 cation transport NG G S S S S SS 
RBK1 D-ribose metabolism NG G S S S S NG 
RHB1 L-arginine transport NG G NG S SS SS NG 
RIM13 protein processing SS G SS S S SS SS 
RIM20 proteolysis and peptidolysis SS G S S S SS NG 
RIM21 sporulation (sensu Fungi) SS G SS S S G SS 
RIM8 meiosis NG G SS S S SS SS 
RIM9 sporulation (sensu Fungi) SS G SS S S SS SS 
RMD8 biological process NK NG G NG S S SS NG 
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RPH1 DNA repair NG G S S S S NG 
RPL20B protein biosynthesis NG G SS S SS NG NG 
RPL43A protein biosynthesis SS G SS S SS SS NG 
SCP160 chromosome segregation NG G SS S S S NG 
SDC1 chromatin silencing at telomere NG G S S S S SS 
SIS2 G1/S transition of mitotic cell 
cycle 
NG G SS S NG SS NG 
SLT2 cell wall organisation and 
biogenesis 
SS G NG S SS SS NG 
SNF2 chromatin remodelling NG G S S S S NG 
SRO7 exocytosis S G S S SS NG SS 
SSQ1 DNA-dependent DNA 
replication 
NG G SS S S S NG 
SWR1 chromatin remodelling NG G S S S S SS 
TUF1 translational elongation SS G NG S S S NG 
VPS20 late endosome to vacuole 
transport 
NG G NG S NG NG NG 
VPS4 late endosome to vacuole 
transport 
NG G SS S SS SS NG 
VPS71 protein-vacuolar targeting NG G NG S S NG NG 
VRP1 actin filament organisation NG G NG S S SS NG 
YBR277C dubious ORF NG G S S S S SS 
YBR281C biological process NK NG G S S S S NG 
YBR284W biological process NK NG G NG S S S NG 
YCL001W-A biological process NK NG G NG S S S NG 
YCR025C dubious ORF NG G S S S S SS 
YCR026C biological process NK NG S NG S S S NG 
YCR045C biological process NK NG G S S S S SS 
YCR050C dubious ORF NG G S S S S NG 
YCR061W biological process NK NG G S S S S SS 
YCR085W dubious ORF NG G S S S S SS 
YCR087C-A biological process NK NG G S S S S NG 
YCR087W dubious ORF SS G S S S S NG 
YDR042C biological process NK NG G S S S S SS 
YGR122W biological process NK NG G S S S G SS 
YJL120W dubious ORF SS G SS S SS SS NG 
YKR073C dubious ORF NG G S S S S SS 
YLR334C dubious ORF SS G SS S SS SS NG 
YMR031W-A dubious ORF NG G SS S SS NG NG 
YPR044C dubious ORF NG G S S SS SS NG 
YPR045C biological process NK NG G S S S S NG 
 
Table 7.3: Phenotypes of Δrim101 and Δrim101-like mutants. For each null mutant 6.6x107, 
3.3x10
7
, 1.65x10
7
 and 8.25x10
6
 c.f.u.s were plated prior to incubation at 30°C for 3-5 days. G=growth, 
S=sensitive, SS=super sensitive, and NG=not growing, based on two independent observations.  
 
7.3.2 Epistacy screen of the S. cerevisiae ∆rim101-like mutants  
 
The parental strain BY4741 of the Euroscarf S. cerevisiae ORF deletion library, 
Δrim101 and the other 80 ∆rim101-like mutants were transformed with the plasmid 
pWL86URA. Three independent transformants were selected from each transformation for 
further analysis. In the first instance phenotypes were screened on solid YPD pH 7.4 mM 200 
LiCl medium. For each of the strains analysed, serial dilutions of 10
6
, 10
5
, 10
4
 and 10
3
 cells 
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were plated in parallel on YPD and on YPD pH 7.4 200 mM LiCl and plates were incubated 
for 3 and 5 days respectively. Phenotypes were scored by two independent observers. Despite 
the ease with which cation-sensitive ∆rim101-like mutants were initially identified among 
Euroscarf S. cerevisiae ORF deletants (Fig. 7.3-7.9 and Table 7.3) transformation with 
pWL86 expressing constitutively active Rim101p could not reproducibly rescue cation 
sensitivity in plate tests (Fig. 7.10). Attempts to resolve the problem included serial dilutions 
as well as technical and biological triplication but without success. An alternative, 
quantitative approach was therefore developed.   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7.10: Lithium sensitivity phenotype on solid media for BY4741, (A) Δrim101 (B), Δrim8 (C), 
Δrim9 (D) and Δrim13 (E) and resulting pWL86URA transformants. All strains are plated in serial dilutions 
representing inocula of 10
6
, 10
5
, 10
4
 and 10
3
 c.f.u.s.  
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 Quantitative assessments of yeast growth were subsequently performed in liquid 
media. BY4741, Δrim101, 80 ∆rim101-like mutants and three independent pWL86URA 
transformants (resulting from transformation of ∆rim101-like mutants with the plasmid 
pWL86URA: 1 rep, 2 rep and 3 rep) were arrayed in 96-well plates and yeast growth 
profiling was adapted to 96-well format in liquid media (Fig. 7.11). Mutants and 
transformants, the latter gridded in triplicate, in 96-well plates were grown overnight in YPD 
and each was subsequently used to inoculate two further (one with YPD and one with YPD 
pH 7.4 200 mM LiCl) 96-well plates. OD600 was measured at the initiation of 30°C 
incubation and at subsequent 2, 4, 6, 8, 10, 12 and 24 hour time points.   
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Fig. 7.11: Experimental scheme for assessment of cation sensitivity in liquid media. BY4741, 
Δrim101, 80 ∆rim101-like mutants (Grid KOs) and three independent pWL86URA transformants (resulting 
from transformation of ∆rim101-like mutants with the plasmid pWL86URA: 1 rep, 2 rep and 3 rep), were 
arrayed in 96-well plates. Following overnight culture in YPD these were each used to inoculate two further 
plates, one containing YPD and one containing YPD pH 7.4 200 mM LiCl. OD600 was measured at the initiation 
of 30°C incubation and at subsequent 2, 4, 6, 8, 10, 12 and 24 hour time points.   
 
 The assay was calibrated using BY4741 and Δrim101, comparing growth of the two 
strains in YPD and YPD pH 7.4 200 mM LiCl. To facilitate direct comparisons of media- and 
strain-specific growth profiles, sequential normalisations to OD600 of BY4741 at time-zero 
[BY4741(T0)] and time-zero OD600 on a strain-specific basis [∆(T0)] were performed (Fig. 
7.12A and B). To adjust for strain-specific differences in growth rates a further correction 
was made, using a growth coefficient [g] defined as the fractional OD600 in YPD relative to 
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the wild type, for each strain and time point of the analysis (Fig. 7.12C). Following this 
protocol, clear cation hypersensitivity was discernable for Δrim101 in YPD pH 7.4 200 mM 
LiCl relative to the parental strain BY4741.  
 
 Fig. 7.12: OD600 adjustments for comparative cation sensitivity analysis of BY4741 and Δrim101 
in liquid culture. To facilitate direct comparisons of media- and strain-specific growth profiles sequential 
normalisations to OD600 of BY4741 at time-zero [BY4741(T0)] and OD600, at time-zero, on a strain-specific basis 
[∆(T0)] were performed (A and B). To adjust for strain-specific differences in growth rates a further correction 
was made, using a growth coefficient [g] defined as the fractional OD600 in YPD relative to the wild type, for 
each strain and time point of the analysis (C). 
 
Following optimisation of experimental and normalisation protocols the screen was 
repeated, this time including all previously characterised Δrim mutants and respective 
pWL86URA clones (Fig. 7.13). The ∆rim101-like phenotype, in comparison with the 
parental strain BY4741 in YPD pH 7.4 200 mM LiCl, clearly emerged for all of the Δrim 
mutants (Fig. 7.13A). In addition, rescue of cation hypersensitivity was reproducibly 
quantificable in each of three biological replicates (1
st
 rep, 2
nd
 rep and 3
rd
 rep, respectively 
Fig. 7.13B.1, B.2 and B.3) as well for averaged data (Fig. 7.13C). Thus, in support of the 
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phenotypic screening performed on solid media for mutant library screening (Fig. 7.3-7.9 and 
Table 7.3) cation sensitivity is measurable in liquid media, and moreover, expression of 
constitutively active Rim101p rescues cation hypersensitivity in YPD pH 7.4 200 mM LiCl 
selective media.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7.13: Cation sensitivity profiles of Δrim101 and other previously characterised Rim pathway 
mutants in YPD pH 7.4 200 mM LiCl. To facilitate direct comparisons of media- and strain-specific growth 
profiles sequential normalisations to OD600 of BY4741 at time-zero [BY4741(T0)] and OD600, at time-zero, on a 
strain-specific basis [∆(T0)] were performed. To adjust for strain-specific differences in growth rates a further 
correction was made, using a growth coefficient [g] defined as the fractional OD600 in YPD relative to the wild 
type. The resulting value ([OD600/(BY4741(T0)x∆(T0)]xg) is plotted on the Y-axis. Cation sensitivity was 
measured in YPD pH 7.4 200 mM LiCl liquid culture, relative to YPD, for each mutant (A) and three respective 
pWL86URA clones (B.1, B.2 and B.3) at eight independent time points (0, 2, 4, 6, 8, 10, 12, 24 hrs) (X-axis).  
Panel (C) shows data averages for the 3 biological replicates B.1, B.2 and B.3).   
 
 In all instances, and as indicated in Fig. 7.13, the greatest detectable divergences of 
∆rim101-like and wild type phenotypes were measurable at 24 hours. Onward data 
representations therefore considered only this time point of the analyses. Adopting this 
procedure Fig. 7.14A depicts background subtracted, normalised values for three replications 
of the epistacy screen using Δrim101 and all other characterised Rim pathway mutants. 
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Having averaged the data for three biological replicates (B), Δrim101-like phenotypes clearly 
emerge from this analysis for all of the mutants tested (blue bars). Rescue of the cation 
hypersensitive phenotype was visible to different extents for each of the three replicates of 
each mutant (red, green and purple line in A respectively for 1
st
, 2
nd
 and 3
rd
 replicate) but 
undoubtedly evident for the average of the three replicates (red line in B). 
 
Fig. 7.14: Relative cation hypersensitivity of BY4741 and Rim pathway mutants following 
pWL86URA transformation. ([OD600/(BY4741(T0)x∆(T0)]xg) values (on the Y-axis) were calculated following 
24 hours growth in YPD and YPD pH 7.4 200 mM LiCl. 1
st
 rep, 2
nd
 rep and 3
rd
 rep biological replicate values 
for each transformants were compared to the respective KO (A) and average values for the 3 replicates were 
calculated (B).   
 
Fig. 7.15 shows the complete panel of results from the epistacy screening of Δrim101 
and the 80 ∆rim101-like mutants. The data are also summarised in Table 7.4 which lists 
normalised, corrected OD600 values for each mutant, plus corresponding, averaged values for 
pWL86URA transformants. Values in the table are colorimetrically graded whereby darker 
red or blue represents higher or lower adjusted OD600 value, relative to BY4741. On face 
value a closer examination of the behaviour of the 80 mutants confirmed cation 
hypersensitivity (normalised, corrected OD600 values in the range 0.0-2.6), relative to the wild 
type, for only 42 of the mutants. 15 of the mutants showed a weak (normalised, corrected 
OD600 values in the range 2.6-4.6) Δrim101-like phenotype and 24 displayed no cation 
sensitivity phenotype in YPD pH 7.4 200 mM LiCl. The Δrim101-like phenotype was 
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considered as rescued for cation hypersensitivity where an OD600 increment of at least +1.0, 
relative to the mutant phenotype was observed in averaged values obtained from three 
independent pWL86URA transformants. According to these criteria, among the 57 mutants 
retaining a ∆rim101-like phenotype in liquid media, rescue of cation hypersensitivity was 
measurable in 40 mutants following pWL86URA transformation. 15 ∆rim101-like mutant 
phenotypes were unaltered following transformation with WL86URA, whereas in two cases 
(Δcrz1 and Δdls1) an extreme value was registered. In particular, for Δcrz1 a weak Δrim101-
like phenotype was detected which, after transformation, led to increase of cation 
hypersensitivity. In contrast, for Δdls1 a strong Δrim101-like phenotype was observed and as 
a consequence of the transformation with pWL86URA, cation tolerance was increased. 24 of 
the Euroscarf S. cerevisiae deletion mutants contradicted the Δrim101-like phenotype 
previously observed on solid media. For 21 of these mutants, no major phenotypic changes 
were detectable after the introduction of a constitutively active form of Rim101p. However, 
the transformation with pWL86URA increased cation sensitivity for Δscp160 and Δpet117 or 
cation tolerance for Δssq1.  
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Fig. 7.15: Relative cation hypersensitivity of BY4741 and ∆rim101-like mutants following pWL86URA transformation. Values were calculated following 24 
hours growth in YPD and YPD pH 7.4 200 mM LiCl.   
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Gene name Euroscarf S. cerevisiae 
mutant 
pWL86URA Euroscarf S. 
cerevisiae mutant 
Rescue of the cation hypersensitivity 
BY4741 5.686 3.471 no Δrim101-like phenotype 
RIM101 0.983 2.179 rescue of cation hypersensitivity 
ADH1 4.860 2.756 no Δrim101-like phenotype 
ALF1 1.027 2.552 rescue of cation hypersensitivity 
ARP5 1.085 3.069 rescue of cation hypersensitivity 
ASF1 1.961 1.997 no effects on cation hypersensitivity 
ATG15 5.581 3.337 no Δrim101-like phenotype 
BCK1 1.685 3.527 rescue of cation hypersensitivity 
CDC10 7.361 7.130 no Δrim101-like phenotype 
CKB1 4.469 3.715 no effects on cation hypersensitivity 
CRZ1 4.270 2.207 increased cation sensitivity * 
CTP1 4.240 4.392 no effects on cation hypersensitivity 
DCC1 4.460 3.821 no effects on cation hypersensitivity 
DFG16 1.347 2.561 rescue of cation hypersensitivity 
DLS1 2.412 10.222 increased cation tolerance* 
DOA4 1.801 2.069 no effects on cation hypersensitivity 
DPB3 2.406 4.558 rescue of cation hypersensitivity 
EAF7 3.009 5.371 rescue of cation hypersensitivity 
FMP21 4.026 4.108 no effects on cation hypersensitivity 
GIS4 1.342 1.675 no effects on cation hypersensitivity 
HEX3 4.862 4.182 no effects on cation hypersensitivity 
IRA2 7.750 5.523 no Δrim101-like phenotype 
KAP123 13.648 5.889 no Δrim101-like phenotype 
LSM1 2.918 5.089 rescue of cation hypersensitivity 
MAL31 1.522 3.397 rescue of cation hypersensitivity 
MAL33 6.610 4.059 no Δrim101-like phenotype 
MEH1 2.234 4.069 rescue of cation hypersensitivity 
MET22 1.844 4.313 rescue of cation hypersensitivity 
MGA2 9.025 5.196 no Δrim101-like phenotype 
MRP17 6.564 5.591 no Δrim101-like phenotype 
MRPL27 0.701 2.353 rescue of cation hypersensitivity 
MRPL37 1.234 3.086 rescue of cation hypersensitivity 
MSC7 2.999 3.009 no effects on cation hypersensitivity 
NCL1 0.742 3.340 rescue of cation hypersensitivity 
PCA1 5.197 4.617 no Δrim101-like phenotype 
PET117 5.505 2.514 increased cation sensitivity* 
PHO80 8.765 5.255 no Δrim101-like phenotype 
PMP1 4.977 5.264 no Δrim101-like phenotype 
RBK1 3.961 3.069 no effects on cation hypersensitivity 
RHB1 1.483 4.095 rescue of cation hypersensitivity 
RIM13 1.403 3.216 rescue of cation hypersensitivity 
RIM16 2.761 5.140 rescue of cation hypersensitivity 
RIM20  1.564 4.429 rescue of cation hypersensitivity 
RIM21 1.221 4.569 rescue of cation hypersensitivity 
RIM8 0.753 3.157 rescue of cation hypersensitivity 
RIM9 1.420 3.149 rescue of cation hypersensitivity 
RMD8 1.688 2.869 rescue of cation hypersensitivity 
RPH1 8.808 3.908 no Δrim101-like phenotype 
RPL20B 0.640 2.008 rescue of cation hypersensitivity 
RPL43A 0.647 2.620 rescue of cation hypersensitivity 
SCP160 4.957 2.464 increased cation sensitivity* 
SDC1 1.352 3.756 rescue of cation hypersensitivity 
SIS2 1.152 2.295 rescue of cation hypersensitivity 
SLT2 1.109 2.369 rescue of cation hypersensitivity 
SNF2 3.299 5.400 rescue of cation hypersensitivity 
SRO7 5.903 2.604 no Δrim101-like phenotype 
SSQ1 5.890 6.464 increased cation tolerance* 
SWR1 1.486 3.767 rescue of cation hypersensitivity 
TUF1 9.405 4.658 no Δrim101-like phenotype 
VPS20 0.427 1.475 no effects on cation hypersensitivity 
VPS4 2.694 1.965 no effects on cation hypersensitivity 
VPS71 2.698 3.122 no effects on cation hypersensitivity 
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VRP1 1.282 3.448 rescue of cation hypersensitivity 
YBR277C 5.533 3.482 no Δrim101-like phenotype 
YBR281C 2.967 3.138 no effects on cation hypersensitivity 
YBR284W 1.450 3.207 rescue of cation hypersensitivity 
YCL001W-A 0.951 2.351 rescue of cation hypersensitivity 
YCR025C 1.778 3.522 rescue of cation hypersensitivity 
YCR026C 1.535 3.352 rescue of cation hypersensitivity 
YCR045C 20.350 4.216 no Δrim101-like phenotype 
YCR050C 1.795 3.545 rescue of cation hypersensitivity 
YCR061W 2.794 3.240 rescue of cation hypersensitivity 
YCR085W 1.737 4.282 rescue of cation hypersensitivity 
YCR087C-A 6.484 6.239 no Δrim101-like phenotype 
YCR087W 1.124 3.744 rescue of cation hypersensitivity 
YDR042C 18.045 7.124 no Δrim101-like phenotype 
YGR122W 0.668 2.975 rescue of cation hypersensitivity 
YJL120W 14.198 7.667 no Δrim101-like phenotype 
YKR073C 0.596 2.906 rescue of cation hypersensitivity 
YLR334C 11.601 3.686 no Δrim101-like phenotype 
YMR031W-A 1.744 1.981 no effects on cation hypersensitivity 
YPR044C 1.797 2.724 rescue of cation hypersensitivity 
YPR045C 7.646 3.912 no Δrim101-like phenotype 
 
Table 7.4: Summary of cation sensitivity data from epistacy screen of Δrim101-like mutants. 
Table lists normalised, corrected OD600 values for each mutant, plus corresponding, averaged values for 
pWL86URA transformants. Values in the table are colorimetrically graded whereby darker red or blue 
represents higher or lower adjusted OD600 value, relative to BY4741.  
 
7.3.3 Use of a synthetic Rim101p promoter to identify novel regulators of Rim101p 
processing and/or transcriptional activity 
 
Phenotypic screening of the Euroscarf S. cerevisiae ORF deletion library identified 80 
∆rim101-like mutants. To identify which of these Δrim101-like mutants suffer aberrant 
Rim101p processing and transcriptional activity, they were transformed with the plasmid 
pAED39, containing a synthetic Rim101p promoter fused to a lacZ reporter. For the purpose 
of the study, the β-galactosidase assay was adapted to a 96-well plate format as graphically 
represented in Fig. 7.16. The parental strain BY4741, Δrim101 and 80 other Δrim101-like 
mutants were transferred in 96-well plate format (Grid KOs), together with three replicates 
for each strain, obtained after the transformation with the plasmid pAED39 (1 rep, 2 rep and 
3 rep). The four plates were grown overnight in YPD and subsequently used to inoculate 
three plates each, one with YPD pH 6.5, one with YPD pH 4.5 and one with YPD pH 8.0. As 
before, the cultures were grown to an OD660 approximately of 0.6 and the measurements of 
the OD660 were recorded. 100 μL of working solution (50 μl 2X ONPG and 50 μl Y-PER 
Reagent) was added to each well. After 20 minutes, the absorbance at 420 nm was measured 
and the β-galactosidase activity (in Millers units) was calculated applying the appropriate 
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formula: (1000xA420)/(TxVxOD660)=β-galactosidase activity, where T is the reaction time 
(minutes), V corresponds to the reaction volume (ml) and A420 is the absorbance at 420 nm. 
 
Fig. 7.16: Experimental scheme for assessment of β-galactosidase activity in a 96-well plate 
format. BY4741, Δrim101, 80 ∆rim101-like mutants (Grid KOs) and three independent pAED39 transformants 
(resulting from transformation of ∆rim101-like mutants with the plasmid pAED39: 1 rep, 2 rep and 3 rep), were 
arrayed in 96-well plates. Following overnight culture in YPD three further plates (YPD pH 6.5, YPD pH 4.5 
and YPD pH 8.0) were inoculated. The 96-well plates were grown to OD660 of 0.6 prior to β-galactosidase 
assay.  
 
A pilot screen was initially performed using the parental BY4741, and Δrim101 
strains. The two strains were transformed with the plasmid pAED39, carrying the synthetic 
Rim101p promoter fused to a lacZ reporter. Two colonies obtained from these 
transformations were analysed. The overnight inoculum in YPD of each of these cultures was 
diluted (1/10) to prepare three cultures in different media, to approximate neutral (YPD pH 
6.5), acidic (YPD pH 4.5) and alkaline conditions (YPD pH 8.0). Following growth to OD660 
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of approximately 0.6, β-galactosidase assay was performed. For the β-galactosidase assay, 
100 μl of working solution was added to 100 μl of culture. After 20 minutes, the absorbance 
at 420 nm was measured. Values of OD660 and A420 were background subtracted for the OD660 
and A420 of the respective media and the β-galactosidase activity (in Millers units) was 
calculated by applying the following formula: (1000xA420)/(TxVxOD660)=β-galactosidase 
activity, where T is the reaction time (minutes), V corresponds to the reaction volume (ml) 
and A420 is the absorbance at 420 nm. Values for the two replicates were averaged. The 
results are shown in Fig. 7.17, plotting the β-galactosidase activity for the strains (BY4741 
and Δrim101) in the three different growth conditions (pH 4.5, 6.5 and 8.0). In the parental 
strain BY4741, β-galactosidase activity is unaltered under all tested conditions. This is as 
expected, given that processed Rim101p, which functions as a repressor, is appropriately 
represented in the wild type genetic background and sets a baseline for the assay. When 
RIM101 is deleted, however, derepression of lacZ expression is observed with increasing pH, 
reflecting defective Rim101p-mediated repression of the synthetic promoter at alkaline pH, 
and revealing pH-dependent repressor activity for Rim101p at promoters having Rim101p 
binding sites.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7.17: β-galactosidase activity in BY4741 and Δrim101 strains expressing a synthetic 
Rim101p-regulated promoter. Strains expressed a synthetic Rim101p-regulated promoter (fused to a lacZ 
reporter). The β-galactosidase activity (in Millers units) has been calculated on the basis of OD600 and A420 
measurements and averaged for two biological replicates.   
 
7.3.4 Analysis of the ∆rim101-like null mutants using a synthetic Rim101p-regulated 
promoter  
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In order to identify which of the Δrim101-like mutants suffer aberrant Rim101p 
processing and/or transcriptional activity, the parental strain BY4741 of the Euroscarf S. 
cerevisiae ORF deletion library, Δrim101 and 80 other ∆rim101-like mutants were 
transformed with the plasmid pAED39. In each case three independent clones were selected 
and β-galactosidase activity was measured. In this analysis, if the ORF in question is a 
regulator of Rim101p, depression of lacZ gene expression is expected. For genetic screening 
the optimised protocol was performed in 96 well-plate format. The results are shown in Fig. 
7.18, which plots β-galactosidase activity, measured at three pHs for all of the ∆rim101-like 
null mutants. Fig. 7.19 summarises those showing derepression of lacZ gene expression, 
presumably occurring as a consequence of aberrant Rim101p processing and/or 
transcriptional activity at alkaline pH. 
Fig. 7.18: β-galactosidase activity in BY4741 and Δrim101-like mutants expressing a synthetic 
Rim101p-regulated promoter. Strains expressed a synthetic Rim101p-regulated promoter (fused to a lacZ 
reporter). The β-galactosidase activity (in Millers units) has been calculated on the basis of OD660 and A420 
measurements and averaged for three replicates.   
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Fig. 7.19: Summary of β-galactosidase activity in BY4741 and Δrim101-like mutants highlighting 
mutants showing derepression of lacZ gene expression. Strains expressed a synthetic Rim101p-regulated 
promoter (fused to a lacZ reporter). The β-galactosidase activity (in Millers units) has been calculated on the 
basis of OD660 and A420 measurements and averaged for three replicates.   
 
7.4 Discussion  
 
In a neutropenic model of IPA, virulence of A. nidulans is acutely attenuated when the 
PacC transcription factor is deleted or unprocessed (Bignell et al., 2005). Attenuation of pacC 
null mutants is also observed in the major pathogen A. fumigatus (Chapter III); it therefore 
follows that proteins regulating A. fumigatus PacC activity will impact upon virulence and 
may represent novel therapeutic targets. Rim101p, the S. cerevisiae homologue of Aspergillus 
PacC transcription factors participates, not only in environmental pH adaptation but also in 
the positive regulation of sporulation, invasive growth, ion tolerance and acquisition, and 
certain cell wall-related activities (Denison, 2000; Hayashi et al., 1998; Lamb et al., 2001; 
Lamb and Mitchell, 2003; Li and Mitchell, 1997). Considering the wide spectrum of actions 
demonstrated for Rim101p and the documented overlaps in functionality of the 
Rim101p/PacC regulatory systems in S. cerevisiae and in the Aspergillus species, S. 
cerevisiae presents an ideal, and methodologically advanced, model platform upon which to 
base assays for identification of novel upstream components of the Rim101p/PacC pathway.    
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7.4.1 ∆rim101-like phenotypes  
 
A global phenotypic screen of the Euroscarf S. cerevisiae ORF deletion library had 
revealed that a Δrim101 mutant shows cation hypersensitivity compared to the parental strain 
BY4741 (Bignell, unpublished). This cation hypersensitivity profile was also observed for 80 
other ORF deletions including all of the S. cerevisiae homologues of A. fumigatus Pal pH 
signalling proteins. To identify which of the 80 ∆rim101-like proteins act upstream of 
Rim101p, an epistacy screen was performed to identify mutants having cation sensitivity 
profiles which could be complemented by the introduction of an activated RIM101 allele, 
thereby strongly suggesting a Rim101p-regulating role for the protein products of these 
genes. The initial phenotypic screen was repeated (Figs. 7.3-7.9 and Table 7.3) to verify 
cation-sensitive phenotypes and optimise the culturing conditions for the subsequent epistacy 
screen. The growth of the null mutants in comparison to the parental isolate BY4741 was 
analysed in different conditions, including YPD pH 8 (100 mM Tris-HCl), YPD pH 4 (100 
mM glycolic acid), YPD pH 4 (100 mM glycolic acid) 200 mM LiCl, YPD 100 mM LiCl, 
YPD 200 mM LiCl, YPD pH 4.5 (100 mM glycolic acid) 800 mM NaCl, and YPD pH 7.4 
(100 mM Tris-HCl) 200 mM LiCl. At this stage of the experimentation, no significant 
differences were visually discerned between any of the strains when grown on YPD. 
Alkalinisation of the media to pH 8 resulted in a reduction of growth for all strains tested, 
including the wild type strain BY4741 (Fig 7.3), whereas no effect was noted upon 
acidification of the media to pH 4 (Fig. 7.4). This confirmed  the previously noted 
observation that yeast cells grow faster at acidic than neutral or alkaline pH (Lamb et al., 
2001). In contrast with the wild type BY4741, addition of LiCl reduced or prevented growth 
of the ∆rim101-like strains analysed; in particular, the effect was observed as more 
pronounced with increasing concentration of LiCl and/or increased pH. Coherent with this 
observation, growth for the yeast null mutants was almost completely prevented in YPD pH 
7.4 mM 200 LiCl (Fig. 7.9). Previous screenings of the S. cerevisiae deletion library (Giaever 
et al., 2002; Serrano et al., 2004) have identified 216 mutants with defective growth at 
alkaline pH, highlighting the widespread effect of environmental alkalinisation on yeast 
physiology. In comparison to the parental isolate BY4741, a reduction or a complete 
inhibition of growth were here demonstrated for the ∆rim101, other Δrim mutants and many 
∆rim101-like mutants of the Euroscarf S. cerevisiae ORF deletion library in the presence of 
lithium chloride at pH 7.4. This cation hypersensitivity profile offered a powerful tool to 
investigate functions acting upstream of the transcription factor Rim101p to cooperate in its 
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activation. The compound phenotype exhibited by these strains is likely attributable to the 
heightened requirement for tight ionic homeostatic control in alkalinised media which is 
supported by Rim101p pathway control. Alkaline conditions impact dramatically upon 
membrane proton gradients, which supply energy for transmembrane transport of nutrients 
and ions. Accordingly, among the principal targets of Rim101p regulatory control are PMA1, 
ENA1 and VMA1 (Lamb et al., 2001). PMA1 encodes the plasma membrane H
+
-ATPase, 
which hydrolyses ATP to provide energy for proton extrusion, thereby neutralizing the 
cytoplasm (van der Rest et al., 1995). This protein represents the most abundant plasma 
membrane protein and is responsible for generating the proton gradient necessary for all 
secondarily active symporters and antiporters acquiring solutes from the extracellular 
environment, in particular those transporting amino acids, nucleotide bases, phosphate and 
other molecules. ENA1 encodes a Na
+
-ATPase which extrudes Na
+
 generating a gradient 
utilised for the uptake of other cations (Rodriguez-Navarro et al., 1994). A further contributor 
to cytosolic pH homeostasis is encoded by VMA1, a vacuolar H
+
-ATPase (Stevens and 
Forgac, 1997). The importance of these transporters for cellular homeostasis at high pH is 
affirmed by the inability of corresponding null mutants to grow in alkaline conditions and/or 
in the presence of a high concentration of extracellular cations  (Lamb and Mitchell, 2003).  
Mutants having ∆rim101-like phenotypes might represent functions which impact 
upon Rim101p processing. This hypothesis is indeed supported by the observation that in all 
cases lack of a Rim pathway component results in a ∆rim101-like phenotype and that this 
phenotype can be rescued in the epistacy screen (Figs. 7.13 and 7.14). The functional 
classification of genes in which deletions resulted in ∆rim101-like phenotypes reveals many 
ORFs involved in vacuolar organisation and biogenesis (ARP5, VPS20, VPS4, VPS71), 
vesicle transport (DOA4, SRO7), transmembrane transport (MAL31, RHB1), intra organelle 
transport (CTP1, KAP123), cell polarity and cell wall biogenesis (CDC10, SLT2), stress 
response and cation homeostasis (BCK1, DFG16, GIS4, IRA2, MET22, PCA1, PHO80, 
PMP1, YGR122W). Interestingly, several ORFs are likely to participate in chromatin 
modification (ASF1, DCC1, DLS1, DPB3, MSC7, RPH1, SCP160, SDC1, SNF2, SWR1). 
Other represented functions include metabolism and energy (ADH1, PET117, RBK1), protein 
degradation, synthesis and modification (ALF1, HEX3, MRP17, MRPL27, MRPL37, 
RPL20B, RPL43A) and transcription and RNA processing (CRZ1, LSM1, MAL33, MGA2, 
NCL1, SSQ1, TUF1). The genes ATG15, VRP1, CKB1 and SIS2 are involved respectively in 
autophagy (ATG15), structure (VRP1) and cell cycle (CKB1 and SIS2). Numerous genes are 
thus far of unknown biological function (EAF7, FMP21, MEH1, RMD8, YBR277C, 
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YBR281C, YBR284W, YCL001W-A, YCR025C, YCR026C, YCR045C, YCR050C, YCR061W, 
YCR085W, YCR087C-A, YCR087W, YDR042C, YJL120W, YKR073C, YLR334C, YMR031W-
A, YPR044C, YPR045C). However, it is important to underline the fact that the Euroscarf S. 
cerevisiae ORF deletion library used for this study covers only 95% of the non-essential yeast 
genome. Some exclusions are particularly relevant to this study. For example, none of the 
ENA gene deletants (ENA1, ENA2 and ENA5) is present in the library, because of the 
technical limitations involved in designing unique primers due to high similarity between the 
members (Giaever et al., 2002).    
 
7.4.2 For several null mutants, the Δrim101-like phenotype depends on whether the 
assessment is performed on solid media or in liquid culture 
 
In a time course analysis comprising nine time points (0, 2, 4, 6, 8, 10, 12 and 24 
hours), the parental strain BY4741, Δrim101, 80 Δrim101-like mutants, and respective 
pWL86URA transformants were screened for cation sensitivity in a 96-wells plate format. 
The normalised, corrected OD600 [OD600
NC
] values for growth in liquid YPD and YPD pH 7.4 
200 mM LiCl reproducibly detected differential cation sensitivity among ∆rim101-like and 
wild type strains, most specifically at the 24 hour time point. In subsequent liquid culture 
assays ∆rim101-like phenotypes were assigned according to baseline values obtained for the 
parental strain BY4741 (OD600
NC
 = 5.686) and for Δrim101 (OD600
NC
 = 0.983). In agreement 
with the Δrim101phenotype all other Δrim mutants displayed equivalent cation sensitive 
phenotypes (Fig. 7.14 and Table  7.4) in the range OD600
NC
 = 0.0-2.6, this included deletions 
in genes encoding more recently identified components of the Rim101p pathway, DFG16 and 
YGR122W (Barwell et al., 2005; Rothfels et al., 2005). Although the ∆rim101-like phenotype 
was initially identified on solid media adaptation of the screening protocol to 96-wells plate 
format created some discrepancy of phenotype among the 81 mutants screened, whereby 
cation hypersensitivity was retained for only 57 of the 81 mutants. Referring to the previous 
classification according to biological functions, the ORFs resulting in a strong Δrim101-like 
phenotype retain functions such as vacuole organisation and biogenesis (ARP5, DOA4, 
VPS20), transport (MAL31, RHB1), cell polarity, cell wall biogenesis (SLT2), stress response 
and cation homeostasis (BCK1, DFG16, GIS4, MET22, YGR122W), protein degradation, 
synthesis and modification (ALF1, MRPL27, MRPL37, RPL20B, RPL43A), transcription and 
RNA processing (NCL1), chromatin modification, architecture and transcription (ASF1, 
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DLS1, DPB3,  SDC1, SNF2, SWR1), cell cycle (SIS2), and structure (VRP1). Strong 
Δrim101-like phenotype ORFs also include candidates with an unknown function i.e. MEH1, 
RMD8, YBR284W, YCL001W-A, YCR025C, YCR026C, YCR050C, YCR085W, YCR087W, 
YKR073C, YMR031W-A, YPR044C. 24 ORF deletants grew normally in YPD pH 7.4 200 
mM LiCl. These ORFs include members of all the categories previously introduced, such as 
vacuole organisation and biogenesis (SRO7), metabolism and energy (ADH1, PET117), 
transport to other organelles (KAP123), cell polarity and cell wall biogenesis (CDC10), stress 
response and cation homeostasis (IRA2, PCA1, PHO80), protein degradation, synthesis and 
modification (HEX3, MRP17), transcription and RNA processing (MAL33, MGA2, SSQ1, 
TUF1), chromatin modification, architecture and transcription (RPH1, SCP160), and 
autophagy (ATG15). It seems therefore that cation sensitivity of the mutants becomes 
exacerbated on solid medium likely reflecting the difficulty associated with colony counts 
and/or colony measurements, and also demonstrating the partial lack of sensitivity it 
introduces when screening phenotypes of gene knockouts lacking proteins only partially 
contributing to the specific pathway or phenotype investigated  (Toussaint et al., 2006). 
Phenotypic analyses in liquid culture are expected to be more accurate and sensitive, and 
permit temporal analyses to be conducted. The differences observed between solid media and 
liquid culture screens are likely due to various factors such as heightened availability of 
nutrients, ion and oxygen in liquid culture which are of limited availability on the surface of a 
solid agar plate.  
  
7.4.3 Identification of putative novel regulators of Rim101p  
 
Among the 57 mutants retaining ∆rim101-like phenotypes, the cation hypersensitivity 
was rescued by expression of a constitutively active form of Rim101p in 40 mutants. 
Importantly, this included all of the null mutants for known components of the Rim101p 
pathway (including RIM16, DFG16 and YGR122W), as well as the following mutants: ARP5 
(vacuole organisation and biogenesis), MAL31, RHB1 (transport), SLT2 (cell polarity, cell 
wall organisation and biogenesis), BCK1, MET22 (stress response and cation homeostasis), 
ALF1, MRPL27, MRPL37, RPL20B, RPL43A (protein degradation, synthesis and 
modification), LSM1, NCL1 (transcription and RNA processing), DPB3, SDC1, SNF2, SWR1 
(chromatin modification, architecture and transcription), SIS2 (cell cycle) and  VRP1 
(structure). For 15 ∆rim101-like mutants cation sensitivity was unaltered, whereas in two 
cases (Δcrz1 and Δdls1) extreme values were registered whereby for Δcrz1 a weak ∆rim101-
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like phenotype became increased for cation hypersensitivity, and for Δdls1 a strong ∆rim101-
like phenotype became cation tolerant following expression of activated Rim101p. Of the 24 
Euroscarf S. cerevisiae deletion library mutants showing contradictory phenotypes to those 
detected upon solid media, 21 were unchanged by introduction of a constitutively active form 
of Rim101p. However, transformation with pWL86URA increased cation sensitivity for 
Δscp160 and Δpet117 and cation tolerance for Δssq1.  
 
7.4.4 Diverse functional classes of proteins govern Rim101p functionality 
 
The diverse functional categories contributing to Rim101p activation may reflect the 
extreme demands high pH stress places upon cellular physiology. Alkalinisation promotes 
dramatic remodelling of gene expression, through simultaneous activation, of various stress-
related signalling pathways (including but not limited to Rim101p signalling) such as that 
regulating cell wall integrity (CWI) (Levin, 2005), Wsc1-Pkc1-Slt2 MAP kinase signalling 
(Castrejon et al., 2006), and the calcium-activated calcineurin pathway (Serrano et al., 2002).  
These, and other regulatory mechanisms contribute to nutrient and ion acquisition in alkaline 
environments by moderating iron/copper, phosphate, zinc, and glucose uptake and 
mobilisation (Arino, 2010). Global modulation of gene expression in response to alkaline 
stress shows a different timing according to the specific pathway(s) involved in the regulation 
of specific subsets of genes. Accordingly(Arino, 2010)documented the observation that of 
about 400 genes whose expression is induced by exposing yeast cells to high pH (7.6-8.2) in 
a variety of DNA microarray experiments (Causton et al., 2001; Lamb et al., 2001; Lamb and 
Mitchell, 2003; Serrano et al., 2002; Viladevall et al., 2004) the expression of some subsets 
of genes varies very quickly (10–15 minutes), whereas others varies at later stages (after 30–
45 min). 
The multivesicular body (MVB) pathway. The three protein complexes ESCRT-I, -
II, and –III, composed of “class E” vacuolar protein sorting (VPS) gene products are 
components of the endosomal trafficking machinery, involved in the formation of, and 
trafficking through multivesicular bodies (MVBs) (Katzmann et al., 2002). MVB sorting 
requires a pH gradient across the endosomal membranes and efficient functioning of vacuolar 
protein sorting is affected in alkaline conditions (Klionsky et al., 1992). Recent work in S. 
cerevisiae has shown an unexpected role in pH signal transduction for most, but not all, the 
ESCRT components. The function of receptor endocytosis was initially attributed to down-
regulation of plasma membrane receptors. However, plasma membrane receptors do not 
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always reach the vacuole, instead remaining in the endosome and thereby suggesting that 
endocytosis could promote, rather than prevent, signalling, as shown by a growing number of 
examples. Among these, there is the Rim101p/PacC pH-signalling pathway, where the 
positive-acting association between endocytosis and signalling putatively connects two 
spatially separated complexes, located at the plasma membrane and on endosomal 
membranes (Di Fiore PP, 2001; Katzmann et al., 2002). The proposed endosomal membrane 
complex comprises Rim101p/PacC, a cysteine protease of the calpain family Rim13p/PalB 
(Denison et al., 1995), a scaffold Rim20p/PalA (Peñalva and Arst Jr, 2004) and endosomal 
components. PalC, the last component of the ambient pH signalling pathway to be 
characterised in A. nidulans (Galindo et al., 2007), is distantly related to Saccharomyces 
cerevisiae pheripheral endosomal sorting complexes required for transport III (ESCRT-III) 
protein Bro1p. As shown by two-hybrid interaction assays, PalC contains a Bro1-like domain 
supporting its interaction with Vps32 and this interaction has been demonstrated to be 
essential for pH signalling (Tilburn et al., 1995; Galindo et al., 2007). From its ability to 
localise in cortical puntate structures and to bind to Vps32, PalC has the expected requisites 
to link the two complexes involved in pH regulation. As demonstrated by PalC-GFP 
localisation experiments, in alkaline conditions PalC is recruited and assembled in punctate 
structures associated with the plasma membrane; these cortical punctate structures have been 
shown to be dependent on the presence of PalH but not of PalA and therefore hypothesised to 
be the sites of PalH-PalF signal-dependent interactions (Galindo et al., 2007). PalC is 
therefore likely to act later in the pH signalling pathway than PalH but earlier, or in 
concomitance, with PalA action. As recently suggested in Peñalva et al., 2008, an attractive 
hypothesis is that, after PalF-mediated internalisation, the plasma membrane complex recruits 
PalC, which functions as a guide to the endosomal membranes containing PalA and PalB. 
The other Bro1-like domain is Rim20p/PalA (Davis et al., 2000b; Xu and Mitchell, 2001; Xu 
et al., 2004), like its mammalian homologue AIP1/Alix, interacts also with Vps4p and 
Vps32p/Snf7p (Bowers et al., 2004; Ito et al., 2001; Vincent et al., 2003), the latter of which 
is a component of the endosomal complex required at a late stage in the multivesicular body 
pathway (Vincent et al., 2003). Work with S. cerevisiae suggests a role for this protein in the 
pH signal transduction pathway. PalA might serve as an adapter to link PacC to a 
multiprotein complex on the cytosolic side of the endosomal membrane (Xu and Mitchell, 
2001; Xu et al., 2004). Rim13p/PalB is a cysteine protease of the calpain family, most likely 
the signalling protease, which removes the negatively acting C-terminus to form PacC
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(Denison et al., 1995) (Mingot et al., 1999). In S. cerevisiae, a demonstrated interaction 
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between Vps32p and the yeast PalB homologue Rim13p (Ito et al., 2001) suggests that 
Vps32p might act like a scaffold in the protein complex in which Rim20p/PalA recruit the 
protease Rim13p/PalB to its Rim101/PacC substrate (Ito et al., 2001). Several null mutants 
for components of the MVB pathway show the same sensitivity to alkaline pH and LiCl as 
the null mutants for members of the Rim101p pathway (Bowers et al., 2004; Giaever et al., 
2002; Lamb et al., 2001). In this study, the null mutants for the genes VPS20 and VPS4 
demonstrated cation hypersensitivity which was not rescued by constitutive activation of 
Rim101p. Genetic analysis of the respective mutants has indicated that Vps20p but not Vps4p 
is required for Rim101p processing (Xu et al., 2004). Vps20 is a myristoylated subunit of 
ESCRT-III and in collaboration with Vps32p recruits various proteins, including Rim20p, 
Bro1p, and Vps2-24 (Bowers et al., 2004). Vps4p is an AAA-ATPase involved in 
multivesicular body (MVB) protein sorting, localised to endosomes and catalyzing ESCRT-
III disassembly and membrane release. The role of Vps4 in Rim101p processing is 
controversial, because, despite its indispensability for Rim101p processing (Xu et al., 2004), 
two-hybrid analyses have demonstrated its interaction with Rim20p (Bowers et al., 2004; Ito 
et al., 2001). Nonetheless, the Δrim101-like phenotype for the Δvps20 and Δvps4 mutants 
validates the involvement of the MVB pathway in the response to alkaline stress. Moreover, 
the failure to rescue cation hypersensitivity after transformation with a constitutively active 
form of Rim101p highlights, in the case of VPS20, the diversity of MVB pathway functions 
and, in the case of VPS4, the differentiation of functions for the different components within 
the pathway itself. Hence, screening for suppressors of Δrim9 and Δrim21 
mutations,(Hayashi et al., 2005)found that mutations in DID4/VPS2, VPS24, and VPS4p, 
suppress LiCl sensitivity of Δrim8, Δrim9, and Δrim21 but not Δrim13 or Δrim20, indicating 
that Rim8, Rim9, and Rim21 act upstream of Rim13 and Rim20 in the pathway. The deletion 
of VPS4,  DID4 and VPS24 causes the constitutive activation of Rim101p (Hayashi et al., 
2005), and uncouples pH sensing from Rim101 processing, leading to constitutive Rim101 
activation. This scenario is the opposite of that observed for other mutants of the MVB 
pathway (except SRN2), which are acidic-mimicking (Xu et al., 2004). Defects in Vps20p 
and Snf7p and in other components of the ESCRT-I and -II prevent their loading onto the 
endosomal membranes (Babst et al., 2002); therefore, the model from(Hayashi et al., 
2005)proposes that either formation or loading onto the endosomal membranes of the 
Vps20/Snf7 subcomplex is responsible for the activation of Rim101p processing, whereby a 
Rim20p-Snf7p-Rim13p complex catalyses the processing. Rim20p and Rim13 are both 
recruited by an interaction with Snf7, therefore doubting the degree of involvement of Vps20 
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in Rim101p processing, which has been mostly argued by two-hybrid analysis (Bowers et al., 
2004), which as extensively discussed in Chapter V and VI, identify close proximity rather 
than actual direct interaction. Vps4p function is instead to catalyse ESCRT-III disassembly 
and membrane release. It therefore acts consequently to Rim101p processing, explaining the 
failure to rescue cation hypersensitivity after transformation with a constitutively active form 
of Rim101p. The Vps20p/Snf7 subcomplex is not released from the endosomal membrane, 
therefore vps4 mutants likely exhibit constitutive processing of Rim101 (Hayashi et al., 
2005). 
The cell wall integrity (CWI) pathway. Tolerance to cell wall stress is mediated by 
the cell wall integrity (CWI) pathway, a phosphorylative cascade initiated with the activation 
of the protein kinase C Pkc1p. This kinase activates three other protein kinases Bck1p, and 
the redundant couple of MAPK kinases, Mkk1p and Mkk2p, and Slt2p MAPK kinase 
(Heinisch et al., 1999; Lagorce et al., 2003). Activation of Slt2p results in the 
phosphorylation of several cytosolic and nuclear targets, which modulates functions essential 
for growth and tolerance to cell wall damaging agents, including the transcription factors 
Rlm1p, Swi4p and Swi6p. Interestingly, previous publications indicate a significant overlap 
between gene expression modulation as a consequence of the alkalinisation of the 
environment, and resulting from exposure to cell wall damaging agents (Garcia et al., 2004; 
Lagorce et al., 2003) whereby cell wall damage induces genes involved in metabolism, 
energy production and stress response (such as chaperones), but decreases the expression of 
transcription factors and of genes involved in protein synthesis and cell growth. In this study 
both the Δbck1 and Δslt2 mutants from the Euroscarf S. cerevisiae ORF deletion library 
display strong cation hypersensitivity, which is rescued by complementation with a plasmid 
expressing a constitutively active form of Rim101p. In addition, on the basis of genetic 
manipulation and phenotypic analysis of the Δrim101 and Δslt2 in response to cell wall 
damaging compounds, it has been demonstrated that the Rim101p pathway contributes to cell 
wall remodelling in parallel with the CWI pathway or if the latter pathway is impaired 
(Castrejon et al., 2006). Based on the phenotypic analysis of the Δslt2 mutant in response to 
various types of stresses, various conditions have been identified as activators of the CWI 
pathway, among which is alkaline pH, likely to effect cell wall damage. According to its 
main function, i.e. to maintain cell morphology and to protect cells from the external factors 
challenging the cell internal homeostasis, the cell wall is a dynamic structure, which needs to 
adapt to support cell growth, but also to face environmental changes. The importance of cell 
wall adaptation to alkaline pH has been indeed demonstrated in the present study (Chapter 
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IV) by the abundance of A. fumigatus PacC targets, which are involved in cell wall 
organisation and biogenesis. The convergence between the CWI and the Rim101 pathway in 
S. cerevisiae is underlined by the observation that the Slt2p-mediated transcriptional response 
is crucial for the yeast tolerance to alkaline pH (Giaever et al., 2002). Studying the effect of 
osmotic stress in S. cerevisiae mutants by addition of 1M NaCl, which disturbs ion 
homeostasis and is toxic to yeast cells,(Giaever et al., 2002)highlighted that several genes 
critical for growth under ionic stress are also sensitive to high pH, indicating an overlap in the 
cellular response to these conditions. Interestingly, this overlap includes the calcineurin-
dependent transcription factor Crz1p, the proteins involved in ion transport Npr1p and Sat4p, 
Rim101p and Rim13p from the Rim101p pathway and Sro7p. The impairment of the 
Rim101p pathway results in cell wall defects (Castrejon et al., 2006). Δrim21 and Δrim101 
are in fact synthetically lethal with Δslt2 and this synthetic lethality decreases by osmotic 
stabilisation of the media. The double mutants however, when growing in media, which was 
osmotically stabilised, still remain extremely hypersensitive to the cell wall damaging agent 
zymolyase and possess thicker cell walls, with decreased abundance of mannoproteins. On 
the basis that mutations in members of the CWI pathway confer sensitivity to alkaline 
conditions,(Serrano et al., 2006)indicated by DNA microarray analysis that several genes 
involved in cell wall organisation and biogenesis are induced by alkaline pH, at least 
partially, in a Slt2-dependent manner (Serrano et al., 2006), proposing an essential role for 
the Slt2-mediated MAPK pathway in alkaline adaptation. However, recent studies on the 
Δrim101 Δslt2 double synthetic mutant have suggested Slt2p and Rim101p may act in an 
independent way, in particular in the context of the assembly of the chitin ring at S. cerevisiae 
bud necks (Gomez et al., 2009). According to Gomez et al., 2009, deletion of SLT2 would 
impact its iteraction with Glc7p (Andrews and Stark, 2000; Garcia-Gimeno et al., 2003), 
which functions with Bni4p at the bud neck (Kozubowski et al., 2003; Larson et al., 2008). 
Defects in BNI4 are associated with altered septin assembly (Gladfelter et al., 2005). Deletion 
of RIM101 would instead act on RSB1, which has been demonstrated to be  downregulated in 
the Δrim101 mutant (Lamb and Mitchell, 2003), and is required for maintainance of lipid 
symmetry (Ikeda et al., 2008). Both Δrim101 and Δrsb1 mutants show delocalised chitin 
deposition, whereas the Δrim101 Δslt2 double mutant displays a significant degree of lysis, 
therefore suggesting the effect may be due to misregulation of RSB1 (Gomez et al., 2009). 
Showing the direct involvement in the Rim101p pathway for Bck1p and Slt2p, the rescue of 
the cation-sensitive phenotype for the Δbck1 and Δslt2 mutants after the transformation with 
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a constitutively active form of Rim101p in this study suggest a rather integrated model of 
action between the Slt2-mediated MAPK pathway and the Rim101p pathway.  
 The calcineurin pathway. In S. cerevisiae several distinct stresses, including alkaline 
pH prompt the rapid cytoplasmic entry of calcium from the extracellular media or from 
internal stores, such as the vacuole. Initially using an aequorin luminescence reporter to 
monitor the rise of intracellular calcium within the cell as a consequence of the alkalinisation 
of the media, and then by DNA microarray analysis in S. cerevisiae, calcium-mediated 
signalling has been demonstrated as involved in gene expression remodelling in the context 
of responses to alkalinisation of the media (Viladevall et al., 2004). Increase of cytosolic 
calcium activates the protein phosphatase calcineurin, a heterodimer composed of a catalytic 
and a regulatory subunit, respectively encoded by CNA1 and CNA2 (Cyert, 2003), and CNB1 
(Kuno et al., 1991). Activated calcineurin dephosphorylates the transcription factor Crz1p, 
permitting its entrance to the nucleus to activate target gene expression through binding to 
calcineurin-dependent responsive elements (CDREs) in their promoters. By DNA microarray 
analysis of the transcriptional response to the alkalinisation of the media in calcineurin-
deficient (Δcnb1) and Δcrz1 mutants, two transcription factors, Crz1p and Rim101p, have 
been demonstrated to regulate a distinct, but partially overlapping set of target genes involved 
in the response to alkaline stress (Viladevall et al., 2004).(Serrano et al., 2002)also showed 
that the calcineurin pathway mediates, at least in part, the activation of ENA1, crucial for 
adaptation to alkaline pH (Serrano et al., 2002). From the cited studies, it has been inferred 
that the calcineurin-mediated transcriptional response has a relatively minor role for survival 
at high pH, which it integrates with several other regulatory pathways, including that of 
Rim101p. Accordingly, in the epistacy screen performed in this study, a Δcrz1 mutant 
showed only a weak ∆rim101-like phenotype, reflecting a likely partial requirement for the 
calcineurin pathway in adaptation to alkaline conditions, and moreover, uncoupling from the 
Rim101p pathway. Furthermore, growth of crz1 mutants has previously been reported to be 
unaffected (Stathopoulos and Cyert, 1997) or only marginally affected by alkaline conditions 
(Arino, 2010). After transformation with a constitutively active Rim101p, a Δcrz1 mutant 
shows increased cation-sensitivity, thereby strengthening the hypothesis that calcineurin and 
Rim101p pathways are uncoupled in the response to alkalinisation of the media. According to 
the repressor role of Rim101p in S. cerevisiae, the introduction of a constitutively active 
Rim101p would lead to a scenario where the repressive action of Rim101p on the nrg1 gene 
is restored, therefore exacerbating the cation hypersensitivity phenotype, if the deleted ORF 
is involved in Rim101p processing. However, if the two pathways function independently to 
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mediate adaptation to alkaline conditions, the introduction of a constitutively active Rim101p 
may lead to the unbalancing of the equilibrium between the two cooperative pathways, 
resulting in increased cation hypersensitivity. A crucial point of convergence between the 
calcineurin and the Rim101p pathways is the independent modulation of the expression of 
ENA1 (Mendoza et al., 1994), which represents a major element in alkaline adaptation and 
detoxification of sodium and lithium and whose expression is dramatically induced by 
alkaline, saline and osmotic stress. Deleting both CRZ1 and RIM101, does not completely 
abolish the expression of ENA1, suggesting the participation of additional signalling 
pathways for the adaptation to alkaline pH (Serrano et al., 2002). Besides, at alkaline pH, the 
induction of the ENA1 gene is completely abolished in a snf1 rim101 double mutant in the 
presence of FK506, which is an inhibitor of the calcineurin pathway (Platara et al., 2006). 
Demonstrating the integration of different signalling pathways to integrate alkaline adaptation 
response, ENA1 has been described as modulated in response to alkaline stress by three main 
pathways (Platara et al., 2006).     
 
7.4.5 Novel regulators of Rim101p functionality 
 
Functional categorisation of the null mutants of the Euroscarf S. cerevisiae ORF 
deletion library, whose cation sensitive phenotype is rescued after the transformation with a 
constitutively active form of Rim101p, retrieves several biological functions commonly 
associated with the Rim101p pathway and likely related to dealing with the physiological 
implication of a sudden alkalinisation of the environment.  
Transport. As extensively discussed in the introduction to the present study and 
supported by evidence in Chapter IV and VI, the ability to regulate transport systems under 
alkaline pH is crucial to maintain pH homeostasis and ensure the supply of nutrients, 
otherwise limited by the environment. In the present assay, two transporter null mutants 
exhibited a Δrim101-like phenotype and the rescue of cation hypersensitivity when 
transformed with a constitutively active form of Rim101p. These gene deletants are MAL31, 
a high-affinity maltose transporter, belonging to the 12-TMD superfamily of sugar 
transporters driven by the electrochemical gradient across the plasma membrane, and RHB1, 
a putative Rheb-related GTPase involved in regulating canavanine resistance and arginine 
uptake and a member of the Ras superfamily of G-proteins.  
Chromatin modification, architecture and transcription. This category, including 
ARP5, represents the most highly populated functional category amongst mutants whose 
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cation hypersensitivity was rescued by constitutively active Rim101p. DPB3 encodes for the 
third-largest subunit of the DNA polymerase II (DNA polymerase ε), required to maintain 
fidelity of chromosomal replication and for inheritance of telomeric silencing. SDC1 encodes 
for a subunit of the COMPASS (Set1C) complex, which methylates lysine 4 of histone H3 
and is required for chromatin silencing at telomeres. As described extensively in Chapter IV 
and VI, histone and chromatin remodelling have gained credit as contributing to the 
regulation of transcription in the past few years (Buck and Lieb, 2006), with the discovery 
that these complexes alter nucleosome structure in different ways, such as by covalent 
modification of N-terminal histone tails or by ATP-dependent perturbation of histone-DNA 
interactions (Fyodorov and Kadonaga, 2001). The latter mechanism in particular is executed 
by the SWI/SNF family of protein complexes, interestingly representing two of the genes in 
the present study, whose deletion resulted in a Δrim101-like phenotype and whose cation 
hypersensitivity was rescued by the introduction of an active Rim101p. These two genes are 
SWR1, a Swi2/Snf2-related ATPase, exchanging histone variant H2AZ (Htz1p) for 
chromatin-bound histone H2A, and SNF2, the catalytic subunit of the SWI/SNF chromatin 
remodelling complex. In addition, Arp5 has been demonstrated to be part of numerous 
chromatin-modifying enzyme complexes, not only structural, but also enzymatic functions 
(Shen et al., 2003; Vignali et al., 2000). The experimental evidence presented in this study 
supports the involvement of the SWI1/SNF2 group in pH sensing and regulation. 
Cell cycle. Two genes belonging to this category have been demonstrated as having a 
Δrim101-like phenotype when deleted i.e. CKB1 and SIS2, but only for the latter one cation 
hypersensitivity was rescued after transformation with a constitutively active form of 
Rim101p. CKB1 is an highly conserved Ser/Thr protein kinase involved in cell polarity and 
cell cycle proliferation (Bidwai et al., 1995; Glover, 1998), whose role in salt tolerance in S. 
cerevisiae has been has been extensively studied as part of the Trk1-Trk2 transport system 
(de Nadal et al., 1999). The TRK system controls the uptake of K
+
 and Na
+
; in particular it 
prevents the entry of Na
+
 when the cation is present in high concentrations in the media 
(Arino et al., 2010b). However, the role of Cbk1p in salt tolerance has been shown to be 
independent from the regulation of Ena1p. Indeed, high salinity stress induces the transition 
from mitosis to the G1 stage (Melamed et al., 2008; Reiser et al., 2006). The link between 
cell cycle control and ion homeostasis is validated by the involvement in both pathways of 
Hal3p, otherwise called Sis2p (Ferrando et al., 1995). When over-expressed this gene confers 
resistance to high concentrations of NaCl and rescues the salt sensitivity of a calcineurin null 
mutant. In addition to its function in yeast growth arrest, HAL3 is therefore thought to be 
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involved in the regulation of expression of ENA1, in concert with the calcineurin pathway. In 
the current literature, however there is no indication of the possible involvement of HAL3 
and/or CBK1 in other environmental stresses such as alkalinisation of the pH.  
Structure. The Δrim101-like phenotype of the Δvrp1 mutant was rescued for cation 
sensitivity in the epistacy screen. The gene VRP1 encodes a proline-rich actin-associated 
protein involved in cytoskeleton organisation and cytokinesis and related to mammalian 
Wiskott-Aldrich syndrome protein (WASP)-interacting protein (WIP). In addition, this gene 
has been demonstrated to be essential for endocytosis (Thanabalu et al., 2007), although the 
relationship between actin organisation and endocytosis is still not well understood. 
However, the link of VRP1 with pH signalling might correspond to the crucial role the 
endocytic pathway has in Rim101p processing and activation.  
 
  7.4.6 Use of a synthetic Rim101p-regulated promoter for identification of null 
mutants suffering aberrant Rim101p processing and/or transcriptional activity 
 
Using the same set of 80 ∆rim101-like mutants from the Euroscarf S. cerevisiae ORF 
deletion library, the use of a synthetic Rim101p-regulated promoter fused to a lacZ reporter 
permitted identification of mutants likely suffering aberrant Rim101p processing and/or 
transcriptional activity. The synthetic Rim101p promoter, constructed by Lamb and Mitchell, 
2003 was initially used to study Rim101p-mediated repression of the genes NRG1 and SMP1 
to direct ion tolerance and cell differentiation (Lamb and Mitchell, 2003). In fact, in a wild-
type scenario, as in the case of the parental strain BY4741, Rim101p functions as a repressor 
of the general repressor functions Nrg1 and Smp1. Deletion of NRG1 and SMP1 suppresses 
the defects in ion tolerance, haploid invasive growth and sporulation of a Δrim101 mutant, 
therefore indicating the two proteins Nrg1p and Smp1p function as Rim101p-mediated 
repressors of alkaline pH responses. Interestingly, one of the targets of Rim101p via Nrg1p is 
the Na
+
 pump gene ENA1. This study finds that, following transformation with a synthetic 
Rim101p promoter fused to a lacZ reporter, β-galactosidase activity is repressed, under all 
environmental pH conditions studied. However, when RIM101 is deleted, thereby removing 
processed Rim101p from the cell, β-galactosidase activity becomes derepressed at high pH 
(Fig. 7.16) as a consequence of removing Rim101p-mediated repression, according to the 
functioning as a repressor demonstrated by Lamb and Mitchell, 2003. According to this 
model, if the ORF deletants studied regulate Rim101p promoter binding, derepression of β-
galactosidase activity is expected. β-galactosidase activity for the various transformed strains 
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was assayed and compared in normal, alkaline and acidic conditions, to identify, among all 
the Δrim101-like null mutants of the Euroscarf S. cerevisiae ORF deletion library, those 
showing derepression of the lacZ gene occurring as a consequence of aberrant Rim101p 
processing and/or transcriptional activity at alkaline pH. As in the case of the previous 
epistacy screen, all of the previously identified Δrim mutants showed the expected phenotype. 
Agreeing with the results of the epistacy screen, among all Δrim101-like mutants screened, 
derepression of the lacZ gene indicates a regulatory role for Arp5p and Mrpl27p. ARP5 is 
involved in chromatin modification, architecture and transcription, one of the most highly 
populated functional category amongst mutants whose cation hypersensitivity was rescued by 
constitutively active Rim101p (see above). This protein has been demonstrated to be part of 
numerous chromatin-modifying enzyme complexes, having not only structural but also 
enzymatic functions (Shen et al., 2003; Vignali et al., 2000). Also the Δvps20 mutant, whose 
cation sensitivity was not rescued by transformation with a constitutively active form of 
Rim101p in the prior experiment, was positive in this second assay, confirming the 
association between the yeast MVB pathway and Rim101p-mediated regulation to 
environmental pH, as discussed above. Surprisingly, the gene RPH1, whose deletion mutant 
did not exhibit a Δrim101-like phenotype, was also identified. This gene is a histone 
demethylase which can specifically demethylate H3K36 tri- and dimethyl modification states; 
and is involved in damaged DNA repair. This supports the hypothesised role of histone and 
chromatin remodelling as regulators of pH-responsive gene expression.   
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CHAPTER VIII 
 
CONSTRUCTION OF A. FUMIGATUS STRAINS EXPRESSING 
LUCIFERASE FOR BIOLUMINESCENCE DETECTION 
 
8.1 Overview 
 
Bioluminescence imaging (BLI) of microorganisms allows the study of 
establishment, manifestation and progression of infection in real time. This technique has 
already been successfully applied to a multitude of microorganisms, such as bacteria 
(Glomski et al., 2007; Karsi and Lawrence, 2007; Sjolinder and Jonsson, 2007), viruses 
(Hutchens and Luker, 2007) and eukaryotic parasites like Toxoplasma, Leishmania, and 
Plasmodium species (Dellacasa-Lindberg et al., 2007; Franke-Fayard et al., 2006; Hutchens 
and Luker, 2007; Saeij et al., 2005); it would indeed represent a significant innovation for 
the imaging of Aspergillus species during infection, providing real time data on location and 
distribution of infectious particles, which is currently unobtainable. In addition, repetitive 
imaging of single mice would dramatically reduce the number of animals required for certain 
experiments. 
For the ultimate purpose of transposing protein interaction assays into tissue culture 
and murine models of infection, an A. fumigatus strain expressing firefly luciferase under the 
control of the glyceraldehde-3-phosphate dehydrogenase gene (gpdA) promoter was 
constructed and characterised. Firefly luciferase (FLuc) is a single polypeptide (550 aa; 62 
kDa), derived from Photinus pyralis, one of the most famous bioluminescent organisms 
which utilises bioluminescence as a way to attract potential mates (Wood et al., 1989). In this 
chapter the development and initial characterisation of A. fumigatus strains expressing firefly 
luciferase is reported. A. fumigatus bioluminescence imaging would facilitate understanding 
of the dynamics of infection and ultimately the development of protein interactions assays in 
vivo.   
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8.2 Methods 
 
8.2.1 A. fumigatus strains  
 
A. fumigatus strains used in this study are the wild type strain CEA10, and the PyrG 
Δku80, which has a non-homologous end joining deficiency (da Silva Ferreira et al., 2006), 
as listed in Appendix A. Recipes for solid and liquid media are described in Chapter II. To 
select and propagate the transformant strains, AMM (- aneurin) was supplemented with 0.5 
μg/ml Pyrithiamine (Takara).    
 
8.2.2 Plasmid pSK379 for the construction of the bioluminescent A. fumigatus CEA10 
and Δku80 strains  
 
 To construct the A. fumigatus strains expressing firefly luciferase the plasmid pSK379 
from Sven Krappman (Julius-Maximilians-University Würzburg, Germany), shown in Fig. 
8.1, was utilised. pSK379 contains a pyrithiamine resistance cassette (ptrA) for selection in A. 
fumigatus. A unique restriction site for the enzyme PmeI is positioned between the sequence 
of the constitutively-expressed promoter of A. fumigatus gene (gpdA) and the sequence his2A 
which drives targeted insertion of the plasmid in the A. fumigatus genome. For selection and 
maintenance in bacterial cells, the plasmid carries the ampicillin resistance marker (amp) and 
a bacterial origin of replication.  
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Fig. 8.1: pSK379. The plasmid contains a pyrithiamine resistance marker (ptrA). A PmeI restriction, 
positioned between the gpdA promoter, and the sequence his2A facilitates fusion of the bioluminescence cassette 
to the constitutive promoter. In addition, the plasmid carries the ampicillin resistance marker (amp) and a 
bacterial origin of replication.  
 
To generate the plasmid pSK379Luc (Fig. 8.2) the firefly luciferase open reading 
frame was fused to the promoter of a constitutively-expressed A. fumigatus gene (gpdA) in 
the plasmid pSK379, designed to be specifically integrated into the histone 2A locus of the 
A. fumigatus genome. The vector pSK379 was digested with the restriction enzyme PmeI, a 
restriction enzyme that produces blunt ends, and dephosphorylated using the enzyme Calf 
Intestinal Alkaline Phosphatase to avoid self-ligation. The luciferase (Photinus pyralis, gene 
accession: BAF91092) was kindly supplied by Siouxsie Wiles (Imperial College London) in 
the vector, pUC19, and obtained by PCR using the Platinum Taq DNA Polymerase High 
Fidelity (Invitrogen). The firefly luciferase gene (LucF) was amplified by PCR using the 
oligonucleotides FireflyF1 and FireflyR1 (Appendix B) and treated to blunt and 
phosphorylate its ends. This involved the treatment of PCR products sequentially with two 
enzymes: DNA Polymerase I, Large (Klenow) Fragment to fill-in 5‟ overhangs and T4 
Polynucleotide Kinase (PNK) for the addition of 5´-phosphates. The ligation was performed 
using T4 DNA Ligase and plasmids purified from 20 selected colonies was checked by PCR 
with the BIO-X-ACT-Long polymerase (Bioline) and using the oligonucleotides FireflyF1 
and FireflyR2 to confirm the presence of the LucF gene. Because blunt ended ligation was 
used, the insert could have integrated in either the forward or the reverse orientations and in 
order to establish which clones had the correct orientation, 10 of the PCR-positive clones 
were checked using the oligonucleotides FireflyF1, FireflyF2, FireflyR1, FireflyR2 and 
FireflyR3 (Appendix B).  
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 Fig. 8.2: pSK379Luc. The plasmid is a pSK379 derivative having the luciferase open reading frame 
fused to the promoter of the constitutively-expressed A. fumigatus gene (gpdA). 
 
8.2.3 Verification of the bioluminescent A. fumigatus CEA10 strains 
 
Following A. fumigatus transformation, the correct and single insertion of the firefly 
luciferase gene was verified by Southern blotting. In the case of Δku80 mutants this was 
performed by our collaborator Sven Krappman and in the case of CEA10 mutants as part of 
this study. For transformants in the CEA10 genetic background, Southern Blotting was 
performed by digesting the genomic DNA extracted from the mycelia with the enzyme EcoRI 
and using two different probes. Probe 1 was designed to verify the correct insertion of the 
plasmid carrying the luciferase gene in the genomic DNA and constructed using the 
oligonucleotides LucSBF and LucSBR, which amplify a region of 580 bp, flanking the region 
of his2A. Probe 2 was designed to verify the single insertion of the PTR cassette in the 
genome and was constructed using the oligonucleotides LucPtrAF and LucPtrAR, amplifying 
a region of 580 bp in the ptrA gene. For details about the oligonucleotides see Appendix B. 
 
8.2.4 In vitro bioluminescence imaging of A. fumigatus CEA10 strains 
 
In vitro bioluminescence imaging of selected A. fumigatus strains producing firefly 
luciferase was performed by inducing light emission following the addition of D-luciferin (50 
µg/ml, Promega) to the medium. Bioluminescence (photons s
-1
 cm
-2
 sr
-1
) was measured using 
the IVIS100 camera system (Xenogen, now part of Caliper Life Sciences). The sample shelf 
was set to position D (field of view 21.2 cm). A photograph (reference image) was taken 
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under low illumination prior to quantification of photons emitted from Aspergillus 
transformants at a binning of 8 over 1 minute (or if the signal was very weak, of 16 over 2 or 
3 minutes) using the software program Living Image (Xenogen) as an overlay on Igor 
(Wavemetrics, Seattle, WA). Bioluminescence from specific transformants was also 
quantified using the region of interest (ROI) tool in the Living Image software program 
(given as photons s
-1
). 
 
8.3 Results 
 
8.3.1 Development of the bioluminescent A. fumigatus CEA10 strains 
 
To generate the A. fumigatus strain expressing firefly luciferase, the plasmid 
pSK379Luc was constructed, fusing the firefly luciferase open reading frame to the promoter 
of a constitutively-expressed A. fumigatus gene (gpdA) in the plasmid pSK379. Once verified 
by sequencing, the plasmid was transformed into the sequenced A. fumigatus isolate CEA10 
by electroporation (see Chapter II) with selection for pyrithiamine resistance (Kubodera et 
al., 2000; Kubodera et al., 2002).  
In order to optimise the concentration of pyrithiamine and the electroporation protocol 
conditions that were varied on transferring the spores to selective plates included the 
concentration of spores plated (neat or a 1/50 dilution), the concentration of pyrithiamine in 
the media (from 0.1 μg/ml to 1 μg/ml), and spores were either plated directly on selective 
media, or alternatively overlaid with selective media following overnight incubation on plates 
without selection. For this genetic background and selective drug, the following conditions 
were established to be optimal: plating the transformed spores directly after the 
electroporation, without dilution, on AMM (-aneurin) supplemented with 0.5 μg/ml 
Pyrithiamine (Takara). To increase the probability of the correct insertion of the LucF gene in 
the appropriate genomic location (his2A) the transformation was performed using the 
undigested constructs (pSK379 was used as positive control to calculate the transformation 
efficiency), requiring therefore only one single event of homologous recombination with the 
homologous genomic locus for insertion of the entire vector.  
Having optimised the conditions, many transformants were obtained (around 150) and 
20 colonies were purified growing them in the same selective media used for the 
transformation to extract the genomic DNA from spores. The clones were checked by PCR 
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using the oligonucleotides FireflyF1 and FireflyR2 and six of them presented a PCR product 
of 1.1 Kb, corresponding to the LucF size, and were therefore considered for further analysis. 
An immediate screen was performed to judge functionality of the luciferase cassette and 
assesses detection ability. These transformants were grown in the same selective media used 
for the transformation adding 50 µg/ml luciferin (Doyle et al., 2004) to induce light emission 
and assess the bioluminescence using the IVIS100 camera system. Fig. 8.3 shows the results 
obtained. Two of the transformants (11 and 19) negative for bioluminescence, whereas the 
other four were positive to different extents.  
 
Fig. 8.3: In vitro bioluminescence imaging of purified A. fumigatus CEA10 strains producing 
firefly luciferase. Six clones obtained from the transformation of A. fumigatus CEA10 with pSK379 containing 
Luc and resulted positive by PCR were tested for light emission (Clone 3, Clone 7, Clone 11, Clone 12, Clone 
16 and Clone 19) compared to the wild type CEA10.  
 
These six transformants (Luc strains) were further investigated to verify the correct 
and single insertion by Southern Blotting with two different probes, designed according to the 
predicted mode of integration of pSK379Luc in the targeted genomic locus as shown in 
Figure 8.4. The plasmid pSK379Luc is designed to specifically integrate after the histone 2A 
locus of the A. fumigatus genome because of the presence his2A 3‟ flanking region, called 
his2At. The predicted mode of integration involves the recombination of pSK379Luc and the 
his2A region in the A. fumigatus genome via single crossing over. The genomic DNA was 
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extracted from the mycelia and digested with the enzyme EcoRI. Probe 1 was designed to 
verify the correct insertion of the plasmid carrying the luciferase gene into the genome and 
was obtained by PCR using the oligonucleotides LucSBF and LucSBR (Fig. 8.4, orange 
square). The expected signal is 3.6 Kb for the wild type. Following single homologous 
integration the size expected would be 4.7 Kb. Probe 2 was designed to verify the single 
insertion of the pyrithiamine cassette in the genomic DNA and constructed using the 
oligonucleotides LucPtrAF and LucPtrAR (Fig. 8.4, red square), amplifying a region of 580 
bp in the ptrA gene. No signal is expected for the wild type CEA10 while for the Luc strains 
the expected signal is 4.7 Kb. 
  
Fig. 8.4: Scheme representing the predicted mode of integration of pSK379Luc in the targeted 
genomic locus and the adopted Southern bloting strategy. The plasmid pSK379, used for construction of 
pSK379Luc, is designed to specifically integrate into the histone 2A locus of the A. fumigatus genome because 
of the presence his2A 3‟ flanking region, called his2At. The predicted mode of integration involves the insertion 
of pSK379Luc and the his2A region in the A. fumigatus genome via single crossing over.  
 
The CEA10 Luc strains were also screened using the BD-advantage polymerase and 
two sets of oligonucleotides (Appendix B) However, as indicated by the previous 
experiments, the six Luc strains screened were positive for the integration of the Luc gene, 
but the recombination event appeared not to have occurred in the appropriate genetic locus. 
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The plasmid pSK379, used as a basis for these experiments, is designed to specifically 
integrate into the histone 2A locus of the A. fumigatus genome. It would therefore be 
necessary to repeat the transformation to achieve insertion of the construct into the 
appropriate A. fumigatus genomic locus.  
The transformation was repeated, this time using the same plasmid pSK379Luc and 
the same conditions, and a non-homologous end rejoining mutant Δku80 strain (da Silva 
Ferreira et al., 2006). As before, among the many transformants obtained (around 150), 20 
colonies were purified by growing them in the same selective media used for the 
transformation prior to extracting the genomic DNA from spores. The clones were checked 
by PCR using the oligonucleotides FireflyF1 and FireflyR2 and eleven of them produced a 
PCR product of 1.1 Kb, corresponding to the LucF size. For these strains, the correct and 
single insertion of the firefly luciferase gene and the pyrithiamine marker in the genomic 
DNA to gene was verified by Southern blotting (by our collaborator Sven Krappman). Two 
clones were revealed positive for the correct insertion of the Luc gene in the appropriate A. 
fumigatus genomic locus.  
  
8.3.2 Preliminary testing of the bioluminescent A. fumigatus CEA10 strains 
 
Various in vitro experiments were performed to evaluate experimental parameters 
relating to detection of bioluminescence in A. fumigatus. Questions to be addressed included 
whether the strains would be detectable in mice, at which stage of growth the 
bioluminescence would become detectable and whether the light emission correlated with the 
concentration of spores inoculated, giving a quantitative measurement for the fungal biomass.  
Initially the luminescence of all available Luc Strains was tested. 1 x 10
4
 conidia of each one 
were plated in AMM (-aneurin) adding 50 µg/ml luciferin to induce light emission and the 
bioluminescence was measured after 2 days of incubation using the IVIS100 camera system. 
Fig. 8.5 shows the comparison between the different transformants in analysis and the wild 
type CEA10. 
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Fig. 8.5: In vitro bioluminescence imaging of purified A. fumigatus CEA10 strains producing 
firefly luciferase. 1 x 10
4
 conidia of each Luc strain obtained from the transformation of A. fumigatus CEA10 
with pSK379 containing the luciferase gene (Clone 3, Clone 7, Clone 11, Clone 12, Clone 16 and Clone 19) 
compared to the wild type CEA10.  
 
To determine the effect of spore number, growth stage of the fungus and the quantity 
of D-luciferin required for successful detection, several concentrations of conidia, for both 
the wild type CEA10 and the Luc strains (1x10
4
, 1x10
5
 and 1x10
6
) were grown in AMM (-
aneurin), as shown in Fig. 8.6. The serial dilutions were incubated at 37°C for different times 
aiming to obtain a representation of conidia (0h), germlings (8h) and hyphae (16h) for each 
sample (A). Growth did not appear to be affected by the density of conidia inoculated in the 
media. For each sample, 10 μl of D-luciferin (20 mM) was added to induce light emission 
and measure the bioluminescence (B). The bioluminescent signal started to become visible 
after 8 hours in the 1x10
5
 and 1x10
6
 inocula, and was weakly detectable also after 16 hours in 
the 1x10
4 
inoculum. To determine if a delay in measuring bioluminescence would impact 
upon light emitted, luminescence was measured 20 minutes after the D-luciferin was added. 
No significant decrease of the signal was detectable (data not shown). To test the effect of an 
increasing dose of substrate, the luminescence was assessed after the addition of a single and 
a double extra dose of D-luciferin. The signal doubled in response to the single extra dose of 
D-luciferin, but no significant improvement in the detection of the fungi was recorded when a 
double extra dose was added (data not shown). 
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Fig. 8.6: In vitro bioluminescence imaging of purified A. fumigatus strains producing firefly 
luciferase. 1x10
4
, 1x10
5
 and 1x10
6
 conidia for the wild type CEA10 and the Luc strains (Clone 3, Clone 7, 
Clone 11, Clone 12, Clone 16 and Clone 19) were grown in AMM (-aneurin). Each serial dilution was plated 3 
times and they were incubated at 37°C. Developmental growth (conidia, 0h; germlings, 8h; hyphae, 16h) was 
assessed by light microscopy (A). For each sample, 10 μl of D-luciferin (20 mM) was added to induce light 
emission and measure the bioluminescence for varying spore concentrations (B.1 to B.3) in triplicate for each 
strain. Quantification of light emission (photons per second) for the luminescent clones identified (C).   
 
8.4 Discussion  
 
Successful imaging of fungal species during infection provides real time data on 
location and distribution of infectious particles, which is currently unobtainable for A. 
fumigatus.  In addition, repetitive imaging of single mice will dramatically reduce the number 
of animals required for the experiments. The use of an internal biological source of light, 
called luciferase, to tag cells or pathogens or genes represents a versatile approach to supply 
in vivo indicators that can be detected externally. This technique for the study of animal 
models of infectious disease provides not only insights into disease processes but also reveals 
new methods used by the pathogens to avoid host defences during the infection. 
Bioluminescence (Doyle et al., 2004; Tannous et al., 2005; Verhaegent and Christopoulos, 
2002; Wiles et al., 2006) is a naturally occurring enzyme reaction whereby light is produced 
by enzyme-mediated chemical conversion of a substrate usually through an intermediate 
highly energised state. This process occurs in a number of organisms from a variety of 
different genera, to facilitate location of food or for identifying mates. Independent evolution 
has originated different luciferases and substrates with different colours of emission but in 
general, these enzymes require energy, oxygen and a specific substrate (commonly known as 
luciferin) and may also require cofactors for light production.  
For the ultimate purpose of transposing protein interaction assays into tissue culture 
and murine models of infection, an A. fumigatus strain expressing firefly luciferase under the 
control of the glyceraldehde-3-phosphate dehydrogenase gene (gpdA) promoter has been 
constructed and preliminarily characterised for its use in future infection assays. The A. 
fumigatus strain expressing firefly luciferase will aid understanding of the dynamics of 
infection and possibly fungal protein interactions during murine infection in real time, and 
permit analysis of disease parameters such as levels of tissue colonisation and invasion. 
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8.4.1 The A. fumigatus strain expressing firefly luciferase represents a promising 
tool for A. fumigatus bioluminescence detection purposes 
 
A plasmid to drive luciferase gene expression within A. fumigatus was constructed, 
fusing the promoter of a constitutively-expressed A. fumigatus gene (gpdA) to the luciferase 
open reading frame of the well-characterised bioluminescent organism Photinus pyralis 
(Firefly). The gpdA promoter was chosen because it is constitutively active, with some 
variations depending on the carbon source, but is actively expressed when the mycelium is 
growing invasively in the host tissue. The firefly luciferase (FLuc) is a single polypeptide 
(550 aa; 62 kDa) which uses a benzothiazole, luciferin, as substrate along with ATP and 
oxygen to generate light and Mg
2+
 as cofactor. Cells expressing this enzyme, when provided 
with luciferin, will emit a yellow-green light with an emission peak at 560 nm ca using 
cellular ATP as the energy source (Doyle et al., 2004; Wiles et al., 2006).  
Once a suitable plasmid had been constructed and verified, it was fundamental to 
optimize the concentration of the selective drug pyrithiamine and the protocol for the 
transformation using the clinical isolate A. fumigatus CEA10. The transformation of A. 
fumigatus by electroporation has the advantage of being quick and simple but suffers from 
growth of background colonies with certain selective agents, particularly pyrithiamine, due to 
the extremely high numbers of colony forming units electroporated. Once the selection 
conditions had been optimised, transformants were screened to verify functional, targeted and 
single insertion of the Luc gene by PCR, by the assessment of bioluminescence and by 
Southern Blotting. Taken together, the results of these experiments indicate the six Luc strains 
screened are positive for the integration of the Luc gene, but the recombination event had not 
occurred in the appropriate genetic locus. The integration site of the plasmid into the A. 
fumigatus genome is very important because it directs the stable expression of the luciferase 
gene while ensuring that the integration does not disrupt any other important gene. Thus, for 
the CEA10 genetic background repetition of the transformation will be required to target the 
insertion of the gene of interest in the appropriate A. fumigatus genomic locus. In the 
meantime, use of the Δku80 mutant, which has a non-homologous end joining deficiency (da 
Silva Ferreira et al., 2006) provided a single, targeted, integrant which could be used, 
alongside the CEA10 ectopic integrants, to optimise certain aspects of onward 
experimentation.   
In this respect the strains were comparatively analysed for bioluminescent signal, its 
dependency upon spore concentration and kinetics of expression during developmental 
growth. These preliminary results validated the suitability of the Luc gene as a reporter for 
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subsequent murine experiments, given that the bioluminescent signal is visible within the 
range of infectious doses normally given to mice (Fig. 8.5).   
In parallel with our study, another group has developed and recently published the use 
of BLI for A. fumigatus, using the firefly luciferase under the control of the gpdA promoter 
(Brock et al., 2008), providing additional information on the potential use of the 
methodology in murine models of pulmonary aspergillosis (Ibrahim-Granet et al., 2010). As 
shown by our results, the study confirmed a good correlation between the bioluminescent 
signal generated by the A. fumigatus engineered strain during infection, and fungal biomass. 
This correlation is fundamental for permitting the evaluation of fungal burden in infected 
tissues and for providing a means of testing antifungal treatments for efficacy. In addition, 
light emission can be directly correlated with the copies of luciferase gene present in the 
engineered strain (Brock et al., 2008). The same study demonstrated that the A. fumigatus 
strain expressing firefly luciferase is a powerful tool for drug efficacy testing and in vivo 
monitoring of IPA, allowing the assessment of infection parameters such as the levels of 
tissue colonisation and invasion (Brock et al., 2008). In addition, the A. fumigatus strain 
expressing firefly luciferase has been used to monitor fungal progression and location during 
the infection in mice with different types of immunosuppressive regimens, affecting either 
macrophages or neutrophils functions. In particular bioluminescent imaging of infected mice 
and histopathological analysis have correlated light emission and fungal invasion for the 
cyclophosphamide-treated murine model, where neutrophils function is depleted (Ibrahim-
Granet et al., 2010). This murine model is currently in use in our laboratory, and indeed 
formed the basis of experimentation described in Chapters III and IV). 
 
8.4.2 Future perspectives and applications for BLI 
 
Engineering A. fumigatus to express luciferase has been demonstrated as a very 
powerful option for tracking A. fumigatus murine infection in real time with bioluminescence 
assays and to assess infection parameters such as tissue colonisation and invasion. Besides, 
repetitive imaging of single mice will dramatically reduce the number of animals required for 
the experiments. Interestingly it would also represent an innovative tool for the ultimate 
purpose of studying Aspergillus protein-protein interactions during infection. Many attractive 
possibilities for the use of the Luc marker gene are reported in the literature. For example, 
adaptation of methodology such as Bioluminescence Resonance Energy Transfer (BRET) or 
similar approaches could permit the discovery and monitoring of protein-protein interactions 
not only at the cell level, but in the living model animal.   
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Chemioluminescence Resonance Energy Transfer (CRET), also known as 
Bioluminescent Resonance Energy Transfer (BRET) or Luminescence Resonance Energy 
Transfer (LRET) requires the transfer of emitted energy from a luciferase to the GFP in the 
same species. The luciferase emits light in a broad but low-intensity spectrum; part or all of 
the energy is absorbed by the GFP, which consequently emits in a narrow bandwidth peak 
but with higher intensity and higher wavelength. Thus, if two interacting partners are fused, 
the emitted light shifts from the luciferase to that of the GFP. Gene fusions between GFP and 
Renilla luciferase have been successfully performed in a variety of studies, showing that cells 
expressing this fusion can similarly be detected in animals after administration of the 
coelenterazine substrate (Wang et al., 2001; Wang et al., 2002; Xu et al., 1999; Xu et al., 
2002; Xu et al., 2003; Yu and Szalay, 2002). However, the wavelengths of emission of these 
fusions remain a limiting factor for this potentially powerful approach to study protein–
protein interactions. Alternatively, the firefly luciferase has been expressed under the control 
of a modified NF-kappaB promoter to detect eventual protein-protein interactions resulting in 
transcriptional activation (Ray et al., 2002).  
The most promising applications reported in the literature for the use of the Luc 
marker for in vivo protein-protein assays are represented by the use of the split-luciferase in 
an intein-mediated reporter gene assay (Kanno et al., 2006; Ozawa et al., 2000; Ozawa et al., 
2001a; Ozawa et al., 2001b). This methodology represents an improvement of the recent 
systems utilising the split GFPs and the split firefly luciferase as reporter to investigate 
protein-protein interactions (Ozawa et al., 2000; Ozawa et al., 2001a; Ozawa et al., 2001b). 
For example, Ozawa and collaborators tested the ability of the split-luciferase to report in vivo 
protein-protein interactions, using the known insulin-induced interaction of the insulin 
receptor substrate 1 (IRS-1) and the N-terminal SH2 domain of the PI 3-kinase and 
demonstrated a direct correlation between the addition of insulin and luciferin, and light 
emission (Ozawa et al., 2001a). The intein-mediated reporter gene assay has been applied by 
Kanno and his collaborators to monitor the epidermal growth factor (EGF)-induced 
interactions between the two known partners, the oncogenic product Ras and its target Raf-1 
(Kanno et al., 2006). The intein-mediated reporter gene assay has the advantage compared to 
the split-ubiquitin that it can assess interactions between membrane and/or cytoplasmic 
proteins and or nuclear proteins. This methodology is based on the protein splicing of 
transcription factors with DnaE inteins, where DnaE stands for the catalytic α subunit of DNA 
polymerase III and inteins represent segments of the protein. Protein splicing is a 
posttranslational autocatalytic processing in which an intein is excised out with the 
concomitant ligation of the flanking exteins. DnaE are connected with mLexA and VP16AD 
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and the proteins tested for interaction are linked to the ends of DnaEs. When the two proteins 
tested interact, the DnaEs are brought into proximity and undergo correct folding, which 
induces protein splicing and the connection of the DNA-binding protein (mLexA) with the 
transcription activation domain of a Herpes simplex protein (VP16AD) by a peptide bond. 
Until mLexA is ligated with VP16AD, the firefly luciferase reporter gene is not transcribed. 
As a result, the protein-protein interaction is measured by the luminescence intensity 
originating from firefly luciferase translated from the mRNA.  
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CHAPTER IX  
 
SUMMARY AND CONCLUSIONS 
 
In all circumstances where metabolism is active, a steady flux of protons enters and 
leaves the cytoplasm of cells, which have therefore evolved multiple mechanisms to maintain 
ion balance and guarantee optimal activity of major metabolic pathways, whose functionality 
would be damaged by large deviations of intracellular pH. Clear benefits are associated with 
having a means with which to modulate gene expression according to the ambient 
environment, and thereby secure rapid adaptations to environmental change. Such adaptation 
is particularly important for pathogenic microorganisms in withstanding multiple stresses 
exerted by the host niche.  
Due to the existence of sexual and parasexual stages in the A. nidulans life cycle, this 
Aspergillus species has long been exploited as a model organism for the genus. The 
importance of the A. nidulans PacC-mediated pH response in the pathogenesis of murine 
pulmonary aspergillosis was first shown using mutational analysis which demonstrated that 
murine virulence is acutely attenuated if the A. nidulans transcription factor PacC is deleted, 
becomes (mutationally) resistant to processing or does not receive the pH signal (Bignell et 
al., 2005).  
This study describes the characterisation of A. fumigatus ΔPacC mutants in terms of 
phenotype, virulence and histopathology, and infection-related, genome-wide transcriptional 
defects, assigning roles for PacC in mammalian virulence (Chapter III) and infection-related 
gene expression (Chapter IV).   
In each of two, genetically distinct, A. fumigatus pacC null mutants, aberrant 
conidiation and inability to adapt to alkaline pH in vitro was demonstrated (Fig. 3.2). Survival 
analyses in a neutropenic murine model of infection (Figs. 3.3-3.5) confirmed that this growth 
defect manifests also in murine lungs where a ΔpacC mutant is unable to progress beyond 
primary hyphal morphotypes during early stages of infection (Fig 3.6). Relative to the 
parental isolate, therefore, the mutant appears to be blocked in development and is unable to 
invade host tissues. 
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Although the phenotypes are likely to be due to the combinatorial impairment of 
several functions involved in A. fumigatus growth, on the basis of transcriptional profiling of 
A. fumigatus ATCC46645 and the isogenic ΔpacC mutant during initiation of murine 
infection (Chapter IV), several hypotheses may be formulated to explain the apparent 
developmental block of the ΔpacC mutant and its attenuation of virulence.  
In A. nidulans a protein, believed to be necessary for synthesis of a small diffusible 
factor, and encoded by the fluG gene has been demonstrated as necessary for the induction of 
asexual sporulation in air-exposed colonies (Lee and Adams, 1994). A. nidulans FluG is 
constantly produced and when a specific quantity threshold is surpassed development is 
induced. Mutations in fluG, therefore, impair fungal ability to transit from a vegetative state to 
one in which conidiophores develop. The fluG mutant phenotype is rescued by over-
expression of flbA, which is therefore believed to act downstream of FluG. Thus far however, 
in the context of A. nidulans developmental regulation, FluG has been studied soley for its 
role in controlling conidiophore development whereas, on the basis of the aconidial 
phenotype associated with an flbA mutant, FlbA has been hypothesised to act to a broader 
extent upon colony development. The observation that fluG and flbA are respectively up- and 
down-regulated during murine infection by a wild-type strain represents therefore an 
interesting finding, and points towards a role for this developmental pathway in A. fumigatus 
development in the host. The relevance of this observation, with respect to virulence, is 
strengthened by finding that fluG expression is highly down regulated in the ΔpacC mutant, 
during initiation of infection (Table 4.3).       
During infection, A. fumigatus satisfies its requirement for proteinaceous substrates by 
destructing host tissues by means of several proteases (Ibrahim-Granet et al., 2008; Kogan et 
al., 2004; Rementeria et al., 2005). Proteases appear to have a crucial role among the 
multitude of hydrolytic enzymes secreted by A. fumigatus, given the huge number of genes 
encoded by its genome, which is estimated to be over 100 (Nierman et al., 2005). In terms of 
the relevance of this category of secreted enzymes during virulence, particular difficulty is 
associated with identifying pathologically significant enzymes due the redundancy of function 
among them. A recent example is provided by the transcription factor ptrT, which represents a 
conserved regulator of the expression of several secreted proteases. Although ptrT null 
mutants are defective, relative to the wild type in protease secretion, deletion of  ptrT appears 
not to affect virulence (Bergmann et al., 2009), indicating the likely compensatory action of 
other secreted proteases. Three major A. fumigatus proteases have been previously 
demonstrated to be secreted during infection (Monod et al., 1999), namely the Alp alkaline 
serine protease (Afu4g11800), the Mep metalloprotease (Afu8g07080), and the Pep aspartic 
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protease (Afu5g13300). The induction of several other proteases has been reported from 
infection studies (Markaryan et al., 1994; Moutaouakil et al., 1993; Reichard et al., 1990; 
Reichard et al., 1994). Scrutiny of the ATCC46645 data, and comparative analysis of pacC 
null transcription during initiation of murine infection, permits unprecedented insight with 
respect to the temporal programming of transcription of such enzymes during early infection. 
Relative to the wild type, pacC deletion impacts heavily upon protease expression, as 
indicated by the down-regulation of at least six proteases (Afu4g11800, Afu6g12420, 
Afu3g00650, afu2g15950, Afu6g09650, Afu8g07080), among which Alp1 (Afu4g11800) and 
Mep (Afu8g07080) are included. An impairment of secreted protease secretion may, therefore 
be one of the impediments suffered by the ΔpacC mutant, possibly exacerbated by secretory 
defects given the stunted growth of the mutant in the host, and its non-invasive phenotype. 
The cellular function, most significantly impaired by pacC deletion is transport. 
Down-regulated genes in the ΔpacC mutant predominantly include those involved in the 
uptake and mobilisation of metal ions such copper, zinc, sodium, and calcium, phosphate, 
amino acids and various nutrients (Table 4.18). These transporters are likely essential for 
supporting growth at alkaline pH, and given their normally positive regulation by PacC and 
their plasma membrane locations, they represent potential targets for further study, both of 
their role in A. fumigatus virulence, and their use as therapeutic targets, an aim which could 
be facilitated using the, now optimised, split-ubiquitin MYTH system (Chapter V). In the 
absence of PacC, upregulated transport functions are predominantly involved in sugar 
transport (Table 4.17). This might be explained in different ways. Considering the bilateral 
regulatory activity of PacC (which can function to activate and repress transcription) an 
immediate assumption is that genes which are up-regulated in the mutant should normally be 
subject to PacC-mediated repression. Given that sugars are commonly transported in symport 
with protons, carbohydrate uptake might simply represent a compensatory mechanism 
mounted by the mutant in an attempt to neutralise the cytoplasm of the cell. A. nidulans PacC 
null mutants have been frequently described as acidity-mimicking, implying that the cells 
(regardless of extracellular pH) are locked in an acid-responsive state, thus under acidic 
conditions such a hypothesis would make physiological sense, however, in the alkaline 
environment of the murine lung such activities would be counterproductive and therefore 
contribute to pH sensitivity of the ΔpacC mutant. Whether this response is under the direct 
regulatory control of PacC remains unclear but might be addressed by ChIP-Chip analysis. 
ChIP-chip combines chromatin immunoprecipitation with microarray technology, to 
investigate interactions between proteins and DNA in vivo. This would allow the 
identification, on a genome-wide basis (Aparicio et al., 2004), of PacC binding, but would 
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still be subject to sample size limitation in disease settings. In particular, according the 
hypothesised role of epigenetic mechanisms in PacC regulatory action, such techniques would 
serve a multiple function.  
Differentially-regulated genes did not exclusively contain PacC binding sites in fact, 
87% of the genes less abundantly expressed in the ΔpacC mutant during the infection do not 
have a PacC consensus sequence. This may suggest a predominantly indirect (i.e. non cis- 
acting) mechanism(s) of gene regulation during infection. It is certainly likely that PacC 
regulation of gene expression is achieved via multiple mechanisms, and the down-regulation 
of genes likely to be involved in transposition might be significant in this respect.  
Recent work in the Bignell laboratory has demonstrated developmentally-linked 
mobilisation of LINE-1 retrotransposable elements on the basis of such transcriptional 
profiles in a LaeA methylase-deficient mutant (Bignell, unpublished). Taken together, the 
regulatory impact of TEs upon gene cluster regulation (Shaaban et al., 2010) and non-
expression of the entire gliotoxin gene cluster in the PacC null mutant (Table 4.22) lend 
support to the hypothesis that PacC operates, at least partially through an epigenetic 
mechanism. Furthermore, in addition to their role in the activation of TEs, epigenetic 
mechanisms might however act in this instance as modulators of gene expression per se, 
according to recent evidence showing the chromatin-mediated specification of transcriptional 
factor targets (Buck and Lieb, 2006). In S. cerevisiae, targets of the regulator of yeast 
metabolism, Rap1p, are modulated by the chromatin regulator Tup1p and associated partners, 
which modify genome architecture itself, altering the targeting of the transcription factor and 
ultimately biological responses. In A. nidulans, the COMPASS complex member Bre1, which 
acts by modulating chromatin-mediated processes by methylation of lysine 4 of histone 3 
(H3K4) (Mueller et al., 2006; Sims and Reinberg, 2006), has been demonstrated to be 
involved in the activation of the expression of an otherwise cryptic secondary metabolite 
cluster (Bok et al., 2009).  
Membrane protein-protein interactions play key roles in the organisation of living 
cells, yet they have been among the most difficult aspects of biology to be studied (Ozawa et 
al., 2000; Ozawa et al., 2001a; Ozawa et al., 2001b). The specificity of these interactions 
could be exploited to interfere and block specific sensory pathways, such as the protein 
interactions (studied here for pH sensing) in the plasma membrane which are formative in A. 
fumigatus environmental sensing and may provide a means to prevent host-adaptation.  
Sensory deprivation might provide a valid means of inhibiting infectious fungal growth, since 
in the absence of either PalH or PalI pH signalling is blocked and PacC is not proteolytically 
processed (Denison, 2000; Negrete-Urtasun et al., 1999). Environmental-sensing proteins are 
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particularly interesting from a therapeutic perspective because they act at the interface 
between host and pathogen and they are more accessible to inhibitory agents due to their 
membrane localisation.  
During pH signalling in Aspergillus nidulans a protein complex, hypothesised to 
initiate the ambient pH signal, is composed of: the 7-TMD protein PalH, the arrestin PalF and, 
very likely, the 3-TMD protein PalI (Calcagno-Pizarelli et al., 2007; Herranz et al., 2005; 
Negrete-Urtasun et al., 1999). PalH has been identified as one, perhaps the only, pH plasma 
membrane receptor and interacts with the arrestin-like protein PalF. palF and palH mutations 
preventing this interaction also prevent pH signalling (Herranz et al., 2005). Based upon the 
observation that, unlike null mutants of other pal genes, null palI mutants grow, though 
poorly, at alkaline pH (Denison et al., 1995), PalI function has been hypothesised as assisting 
the plasma membrane localisation of PalH (Calcagno-Pizarelli et al., 2007). This would 
require an interaction, either direct or indirect, and has not yet been demonstrated between 
PalH and PalI. To overcome difficulties in studying membrane proteins several methods have 
been reported, including the split-ubiquitin MYTH system (Fetchko and Stagljar, 2004; 
Johnsson and Varshavsky, 1994; Stagljar et al., 1998). The MYTH system has here been 
demonstrated as a useful methodology for the analysis of A. fumigatus protein-protein 
interactions in yeast.  
In this study (Chapter V), the MYTH system was used to test the interaction network 
for the three components of the A. fumigatus plasma membrane pH signalling complex, PalH, 
PalI and PalF, whose role in pH signalling has been extensively studied. Initial investigations 
confirmed topology of the two plasma membrane proteins PalH and PalI (Fig. 5.12), 
confirming previous reports and also in silico predictions by SignalP 3.0 and TMpred 
(Appendix F). The hypothesised model of topology implies that PalH and PalI are 
respectively a 7-TMD protein and a 3-TMD protein with extracellular N-termini and 
intracellular C-termini. PalF was demonstrated to interact with PalH, confirming that findings 
in A. nidulans (Herranz et al., 2005) remain relevant in the pathogen. In A. nidulans, the 
hydrophilic C-terminus of PalH interacts with the arrestin-like protein PalF and this 
interaction is required for PalF ubiquitination and phosphorylation, leading to the 
internalisation of PalF and its 7-TMD protein receptor associate, PalH. Additionally a novel 
finding (Fig 5.11) was the identification of PalH-PalH interaction, suggesting that PalH pH 
reception has further parallels with G-protein coupled receptor signalling, whereby 
homodimerisation of PalH is likely involved in pH signalling. S. cerevisiae Rim21p and 
Dfg16p and A. nidulans PalH have been predicted to be seven transmembrane domain 
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proteins with hydrophilic C-termini and therefore they have been hypothesised to form a G-
protein coupled receptor (Barwell et al., 2005; Herranz et al., 2005).  
The structure, topology and interaction partners for PalH resemble findings for GPCR 
proteins. Novel parallels identified in this study include PalH dimerisation (Chapter V) and 
possible N-glycosylation, requiring Pho88p and/or a lectin-like protein (Chapter VI). N-
glycosylation is crucial for the proper folding of GPCRs, their intracellular folding, their 
delivery to the plasma membrane and appropriate protein-protein interactions (Lanctot et al., 
1999; Ray et al., 1998; Wheatley and Hawtin, 1999). Moreover, GPCRs are now known to 
form dimers and/or higher-order oligomeric complexes (as reviewed in(Milligan et al., 2003; 
Milligan et al., 2006; Milligan, 2007; Milligan, 2010) and such oligomerisation is associated 
with various functions, including quality control of protein folding for plasma membrane 
delivery (as reviewed in(Milligan, 2007). Taken together this evidence supports a model in 
which appropriate targeting of the GPCR-like protein PalH requires homodimer formation, 
possibly in a glycosylation-dependent manner. Although no direct involvement of G-protein 
has been demonstrated in PacC-mediated pH signalling, mammalian GPCRs have been shown 
to activate non-G-protein signaling pathways from endosomes, mostly by interaction with β-
arrestins, which create a bridge with MAPK signaling molecules, thereby establishing spatial 
and temporal control for signalling (Reiter and Lefkowitz, 2006).  
No interaction was demonstrated in the present study (Chapter V) between PalH and 
PalI. PalI has been hypothesised to assist plasma membrane localisation of PalH which would 
require interaction between PalH and PalI, either direct or indirect in manner, but this has not 
been demonstrated (Peñalva et al., 2008). The results presented here do not definitively rule 
out the participation of PalI in the plasma membrane signalling complex but do cast doubt 
upon a direct mode of interaction between the two proteins.  
The most interesting application of the DUAL membrane system is that, using a 
membrane-associated protein for the screening, it allows the isolation of novel protein 
interactors from expression libraries (Chapter VI). The A. fumigatus cDNA library 
constructed for this study used Invitrogen proprietary technology, a Gateway-adapted 
DUALmembrane prey vector (pPR3N-GW) and A. fumigatus RNA isolated from a range of 
growth conditions. The MYTH system was adapted, and optimised for high-throughput 
identification of novel PalH interaction partners. Implementation of the system for large-scale 
screening involved the evaluation of expression level achieved from PalH bait plasmids, 
which was crucial for optimal functioning of the MYTH system. To limit bait self-activation, 
media was supplemented with 3-AT, competitive inhibitor of the HIS3 gene product, which 
enhances the stringency of HIS3 selection. The candidates for PalH putative interactors 
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identified using the high-throughput MYTH system are the phosphate transporter Pho88 
(Afu5g01960), the COMPASS complex subunit Sdc1 (Afu7g05270), the lectin family 
integral membrane protein (Afu2g12180), the MFS glucose transporter (Afu3g13980), the 
polyubiquitin UbiD/Ubi4 (Afu4g10350) and the acyl-CoA binding protein (Afu2g11060). 
Further validation of the putative interactions is absolutely required, and could be pursued 
using co-immunoprecipitation or fluorescence microscopy.  
In S. cerevisiae, Rim101p, the yeast homologue of Aspergillus species PacC, has been 
associated with various biological functions, not simply in environmental pH adaptation, but 
also in positive regulation of sporulation, invasive growth, ion tolerance and acquisition, and 
certain cell wall activates (Denison, 2000; Hayashi et al., 1998; Lamb et al., 2001; Lamb and 
Mitchell, 2003; Li and Mitchell, 1997). Considering the wide spectrum of actions 
demonstrated for Rim101p and the overlap between the functioning of the regulatory system 
in S. cerevisiae and in the Aspergillus species, the budding yeast represented an ideal platform 
in which to screen for novel upstream components of the Rim101p/PacC pathway. A global 
phenotypic screen of the Euroscarf S. cerevisiae ORF deletion library had previously revealed 
a highly characteristic ∆rim101 cation hypersensitivity phenotype which was identified in the 
case of 80 other ORF deletants. To identify which of these might act upstream of Rim101p, 
reversal of lithium toxicity in the presence of an activated RIM101 was tested (Chapter VII). 
Those mutants where cation sensitivity could be rescued in this manner are lacking gene 
functions having plausible significance for alkaline stress resistance, such as cell wall 
maintenance and vesicle transport. In addition, the data suggest the novel involvement of 
histone modifications and/or chromatin remodelling in pH sensing and regulation. This was 
further supported by the findings of a second screen (Chapter VII) which used a synthetic 
Rim101p-regulated promoter to identify rim101-like mutants suffering Rim101p-dependent 
defects.   
The two reporter assays identified overlapping cohorts of deletion mutants which 
varied markedly in size. This difference might be attributable to the different nature of the 
experiments performed. In Chapter VII, a constitutively active form of Rim101p (Castrejon et 
al., 2006) was transformed into the ∆rim101-like mutants to rescue cation hypersensitivity, 
most likely via up-regulation of transcription of the Na
+
-ATPase Ena1p (Rodriguez-Navarro 
et al., 1994). Given that Rim101p is thought to achieve Ena1 activation, at high pH, by lifting 
Nrg1-mediated repression (Lamb and Mitchell, 2003) which requires Rim101p processing, 
mutants deficient in Rim101 processing, nuclear localisation, or perhaps Nrg1 promoter 
accessibility might be among those identified. The functional variety among those identified 
as having Rim101p-rescuable phenotypes is pleasing but requires further scrutiny given the 
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indirect nature of the reporter assay and possible contribution of other ion transporters in 
restoring cation tolerance. Regulation of ENA1 has been demonstrated to integrate at least 
three different signalling pathways in alkaline adaptation response (Platara et al., 2006). It 
would therefore be interesting to repeat the epistacy screen on the same rim101-like mutants 
but in a Δnrg1 background.  
The use of a synthetic Rim101p-regulated promoter provided a more restricted result. 
Having shown that Rim101p represses reporter activity exclusively in alkaline conditions a 
small number of mutants were identified where activated Rim101p could not derepress 
promoter activity. Although likely to be a more direct route for finding Rim101p-specific 
regulators a necessary next step of investigation for these mutants requires that the role of 
Nrg1p or Smp1p be addressed.  It would be interesting, for example, to repeat the experiment 
on the same rim101-like mutants but in a Δnrg1 or Δsmp1 background, to identify those 
mutants in which the Rim101-regulated gene activation is mediated by the repression of the 
two repressors Nrg1p or Smp1p.  
The Split-ubiquitin MYTH assay cannot provide information on the dynamics of 
protein interactions in the native organism A. fumigatus, or on the relevance of tested 
interactions during infection. In this respect, bioluminescence imaging (BLI) might 
ultimately prove invaluable. BLI allows the study of establishment, manifestation and 
progression infection in real time. An A. fumigatus strain expressing firefly luciferase, under 
the control of the gpdA promoter, was constructed and preliminarily tested (Chapter VIII), for 
the ultimate purpose of transposing protein interaction assays into tissue cultures and murine 
models of infection. The CEA10 Luc strains developed in this study have answered several 
questions regarding the potential use of the firefly luciferase in tissue culture and murine 
models of infection. The luminescence of the Luc Strains available was compared and was 
analysed to determine the effect on the bioluminescent signal of the concentration of spores 
inoculated, of the growth stage of the fungus considered and of the quantity of D-luciferin 
added. These preliminary results have indicated the suitability of the Luc gene as a reporter 
for subsequent murine experiments, considering the bioluminescent signal is already visible 
with the concentration of A. fumigatus spores usually injected in mice. Engineering A. 
fumigatus to express the luciferase has been demonstrated to be a very powerful option to 
follow A. fumigatus murine infection in real time with bioluminescence assays and to assess 
infection parameters such as tissue colonisation and invasion (Doyle et al., 2004). Besides, 
repetitive imaging of single mice will dramatically reduce the number of animals required for 
the experiments. Interestingly it would also represent an innovative tool for the ultimate 
purpose of studying Aspergillus protein-protein interactions during infection. Many attractive 
347 
 
possibilities for the use of the Luc marker gene are reported in the literature, such as the use 
of the split-luciferase in an intein-mediated reporter gene assay (Kanno et al., 2006; Ozawa et 
al., 2000; Ozawa et al., 2001a; Ozawa et al., 2001b).  
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APPENDIX A  
 
STRAINS  
 
Name Genotype Phenotype Organism Application 
XL-10 F- mcrA ∆(mrr-hsdRMS-
mcrBC) Φ80lacZ∆M15 
∆lacΧ74 recA1 araD139 
∆(araleu) 7697 galU galK 
rpsL (StrR) endA1 nupG 
 E. coli For general 
molecular cloning 
techniques 
CEA10 Wild type clinical isolate  A. fumigatus  Chapter III 
ATCC46645 Wild type clinical isolate  A. fumigatus Chapter III, IV 
ATCC46645 ΔpacC ΔpacC::ptr
R
 Alkaline pH 
sensitive 
A. fumigatus Chapter III, IV 
CEA10 ΔpacC  ΔpacC::ptr
R
 Alkaline pH 
sensitive 
A. fumigatus Chapter III 
PyrG Δku80 Δku80::pyrG
+
   A. fumigatus Chapter IX 
NMY51 MATa his3delta200 trp1-901 
leu2-3,112 ade2 
LYS2::(lexAop)4-HIS3 
ura3::(lexAop)8-lacZ 
(lexAop)8-ADE2 GAL4) 
 S. cerevisiae Chapter V, VI 
BY4741 MATa his3_1 leu2_0 met15_0 
ura3_0 
 S. cerevisiae Chapter VII 
 
 Table AA.1: Strains used for this study.  
 
 
 
 
 
 
 
 
 
349 
 
APPENDIX B  
 
OLIGONUCLEOTIDE PRIMER SEQUENCES 
 
Name Sequence  Reference 
pF-PacCint1 acgttcctctgaagcctcata Chapter III 
pR-PacCint1  tcggccatcgtggttgat Chapter III 
PacCSB1 cttggtctttcctgtcgg   Chapter III 
PacCSB2 cttttcttgggagcagcg   Chapter III 
LucPtrAF cttcctgttgatggaatgg   Chapter III 
LucPtrAR gacggcgcatgaccatag   Chapter III 
SHF nnnnnnnnggccattacggccatgggggatgatgctcgtct Chapter V, pBT3-STE PalH,  pBT3-SUC – 
PalH 
SHR nnnnnnnnggccgaggcggccgtgtcgtctcgactggg Chapter V, pBT3-STE PalH, pBT3-SUC – 
PalH, pPR3-STE – PalH, pPR3-N – PalH 
SIF nnnnnnnnggccattacggccatgttactcaagcctgcaa Chapter V, pBT3-STE – PalI, pBT3-SUC – 
PalI, pPR3-N – PalI 
SIR nnnnnnnnggccgaggcggccggcaaagggtatcgtgag Chapter V, pBT3-STE – PalI, pBT3-SUC – 
PalI 
PSHLEUF nnnnnnnnggccattacggcctgatgggggatgatgctcgtct Chapter V, pPR3-STE – PalH 
PSHGLNF nnnnnnnnggccattacggccagatgggggatgatgctcgtct Chapter V, pPR3-STE – PalH 
PSHARGF nnnnnnnnggccattacggccgaatgggggatgatgctcgtct Chapter V, pPR3-STE – PalH 
PSFLEUF nnnnnnnnggccattacggcctgatgtccgtcaattcctttac Chapter V, pPR3-STE – PalF 
PSFGLNF nnnnnnnnggccattacggccagatgtccgtcaattcctttac Chapter V, pPR3-STE – PalF 
PSFARGF nnnnnnnnggccattacggccgaatgtccgtcaattcctttac Chapter V, pPR3-STE – PalF 
SFR nnnnnnnnggccgaggcggcccgctggtaacgcggtaatga Chapter V, pPR3-STE – PalF 
PSILEUF nnnnnnnnggccattacggcctgatgttactcaagcctgcaa Chapter V, pPR3-STE – PalI 
PSI GLNF nnnnnnnnggccattacggccagatgttactcaagcctgcaa Chapter V, pPR3-STE – PalI 
PSI ARGF nnnnnnnnggccattacggccgaatgttactcaagcctgcaa Chapter V, pPR3-STE – PalI 
NHR nnnnnnnnggccgaggcggccgtgtgtcgtctcgactg Chapter V, pPR3-N – PalH 
NFF nnnnnnnnggccattacggccatgtccgtcaattcctttac Chapter V, pPR3-N – PalF 
NFR nnnnnnnnggccgaggcggccgtcgctggtaacgcggtaat Chapter V, pPR3-N – PalF 
NIR nnnnnnnnggccgaggcggccgtggcaaagggtatcgtg Chapter V, pPR3-N – PalI 
PalHF1 atgggggatgatgctcgt Chapter V 
PalHF2 tcattccgggtcgctgag Chapter V 
PalHF3  tacctacatacgatgggt Chapter V 
PalHF4 tatgagacaggtcagctg Chapter V 
PalHF5 gccgctccgtggagcata Chapter V 
PalHR1 tcatgtgtcgtctcgact Chapter V 
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PalHR2 aagcatctgcgtcgcgtt Chapter V 
PalHR3 gacgtcgcacatcggaac Chapter V 
PalHR4 gaacagcacacaaggata Chapter V 
PalHR5 acggccttccacccaacgc Chapter V 
PalIF1 atgttactcaagcctgca Chapter V 
PalIF2  ttccctccttgccttctt Chapter V 
PalIF3  tgatattcctgcgccaga Chapter V 
PalIF4  tctacaggcctcaatcct Chapter V 
PalIF5  catgctcttggagaaaat Chapter V 
PalIR1  tcatggcaaagggtatcg Chapter V 
PalIR2 agcatgcgaggctgtatg Chapter V 
PalIR3  cgtagttgtaggcatcat Chapter V 
PalIR4 gtggccgcgtgcagcata Chapter V 
PalIR5 aaaagaagaatgtccacc Chapter V 
PalFF1  atgtccgtcaattccttt Chapter V 
PalFF2  atccacactcaccaaacc Chapter V 
PalFF3 ttatcgtcacgttatacc Chapter V 
PalFF4 gaaaagggagttgtagct Chapter V 
PalFF5 gagtcggtgcagactgta Chapter V 
PalFR1 ccgcgttaccagcgataa Chapter V 
PalFR2 ccgctcagcactaccaat Chapter V 
PalFR3 tgtctttcctacgattac Chapter V 
PalFR4 tagtccggcccccagtaat Chapter V 
PalFR4 agaacacagtgccttcgg Chapter V 
pPR3-NF gtcgaaaattcaagacaagg Chapter VI 
pPR3-NR aagcgtgacataactaattac Chapter VI 
UraNot2F nnnnnngcggccgcagcttttcaattcaatt  Chapter VII 
UraNot2R nnnnnngcggccgcagctttttctttcc Chapter VII 
UraF1 ttccatggagggcacag Chapter VII 
UraF2 ctgacattattattgttgg Chapter VII 
UraR1 gcttttcgtgcatgatat Chapter VII 
UraR2 aaaggcctctaggttcct Chapter VII 
FireflyF1 atggaagacgccaaaaaca Chapter VIII 
FireflyR1 gcaggttacaatttgg Chapter VIII 
FireflyR2 ggttacaatttggactttccgc Chapter VIII 
FireflyF2 cccgcgaacgacatttataa Chapter VIII 
FireflyR3  aatatcgattccaattcagcg Chapter VIII 
pSK379F1  catattttcctgctctcccca Chapter VIII 
pSK379R1  aaccgtctagccgttgcaca Chapter VIII 
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LucSBF   gtaactacgctcaacgtgtt   Chapter VIII 
LucSBR gaaagctgtcggtatcattc   Chapter VIII 
 
 Table AB.1: Oligonucleotides used in this study. 
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APPENDIX C 
 
PLASMIDS FOR THE SPLIT-UBIQUITIN MYTH SYSTEM 
 
Table AC.1: Plasmids used in this study for the split-ubiquitin MYTH system.  
 
 
 
 
 
 
 
 
 
 
 
Vector Auxotrophic 
Marker 
(yeast) 
Origin of 
replication 
(yeast) 
Resistance 
Marker  
(E. coli) 
Origin of 
replication  
(E. coli) 
Reference  
pBT3-SUC LEU2 CEN/ARS (1-2 
copies/ cell) 
Kan (select with 
30 μg/ml 
kanamycin) 
High copy 
 
Chapter V,VI 
pBT3-STE LEU2 CEN/ARS (1-2 
copies/cell) 
Kan (select with 
30 μg/ml 
kanamycin) 
High copy 
 
Chapter V,VI 
pBT3-N LEU2 CEN/ARS (1-2 
copies/cell) 
Kan (select with 
30 μg/ml 
kanamycin) 
High copy 
 
Chapter V,VI 
pPR3-SUC TRP1 2micron (20-50 
copies/cell) 
 
Amp (select with 
100 μg/ml 
ampicillin) 
High copy 
 
Chapter V,VI 
pPR3-STE TRP1 2micron (20-50 
copies/cell) 
 
Amp (select with 
100 μg/ml 
ampicillin) 
High copy 
 
Chapter V,VI 
pCCW-Alg5 LEU2 CEN/ARS (1-2 
copies/ cell) 
Kan (select with 
30 μg/ml 
kanamycin) 
High copy 
 
Chapter V,VI 
pAL-Alg5 TRP1 2micron (20-50 
copies/cell) 
 
Amp (select with 
100 μg/ml 
ampicillin) 
High copy 
 
Chapter V,VI 
pDl-Alg5 TRP1 2micron (20-50 
copies/cell) 
 
Amp (select with 
100 μg/ml 
ampicillin) 
High copy 
 
Chapter V,VI 
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pBT3-SUC. The bait vector pBT3-SUC (Figure AC.1) is specifically designed for 
type I integral membrane proteins, which have a single TMD, an N-terminal cleavable signal 
sequence and topology with Nout/Cin. The vector supplies a yeast signal sequence derived from 
the SUC2 (invertase) gene of S. cerevisiae. The Cub-LexA-VP16 cassette is fused to the 
cytosolic C-terminus of the protein of interest.  
 
 
 Fig. AC.1: pBT3-SUC. This vector contains a yeast signal sequence derived from the SUC2 
(invertase) gene of S. cerevisiae. The Cub-LexA-VP16 cassette is fused to the cytosolic C-terminus of the 
protein of interest. Map generated by DNADynamo, www.bluetractorsoftware.co.uk. 
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pBT3-STE. The vector pBT3-STE (Figure AC.2) is recommended for multispan 
integral membrane proteins (i.e. those having multiple transmembrane domains) with a 
Nout/Cin topology, because it contains the STE2 leader sequence derived from the S. cerevisiae 
Ste2 protein (a G protein coupled receptor). It does not have any targeting function but only 
serves as a short leader sequence to optimize expression of the desired bait. The Cub-LexA-
VP16 cassette is fused to the C-terminus of the bait.  
 
 
Fig. AC.2 pBT3-STE. The STE2 leader sequence contained in this plasmid derives from the S. 
cerevisiae STE2p. It does not have any targeting function but only serves as a short leader sequence to increase 
the expression of the protein of interest. The Cub-LexA-VP16 cassette is fused to the C-terminus of the bait. 
Map generated by DNADynamo, www.bluetractorsoftware.co.uk. 
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pBT3-N. On the other hand, if the protein has a lumenal C-terminus, the use of pBT3-
N (Figure AC.3) is recommended to fuse the LexA-VP16-Cub module to the cytosolic N-
terminus of the protein of interest.  
 
 
Fig. AC.3: pBT3-N. This vector fuses the LexA-VP16-Cub module to the cytosolic N-terminus of the 
protein of interest. Maps generated by DNADynamo, www.bluetractorsoftware.co.uk. 
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pPR3-N. Preys and cDNA libraries can be constructed in an orientation expressing 
fusion proteins with N-terminal NubG using the vector pPR3-N (Figure AC.4).  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Fig. AC.4: pPR3-N. This vector fuses the NubG domain to the cytosolic N-terminus of the protein of 
interest. Map generated by DNADynamo, www.bluetractorsoftware.co.uk. 
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pPR3-STE. Preys and cDNA libraries can be constructed in an orientation expressing 
fusion proteins with C-terminal NubG using the vector pPR3-STE (Figure AC.5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. AC.5: pPR3-STE. As previously described the STE2 leader sequence from the S. cerevisiae 
STE2p does not have any targeting function but only serves to increase the expression of the protein of interest. 
The NubG domain is fused to the C-terminus of the bait. Map generated by DNADynamo, 
www.bluetractorsoftware.co.uk. 
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pCCW-Alg5. The plasmid pCCW-Alg5 (Figure AC.6) has been used as a control bait 
and expresses a fusion of the yeast ER protein Alg5 to the Cub-LexA-Vp16 cassette.  
 
Fig. AC.6: pCCW-Alg5. The plasmid is the control bait expressing a fusion of the yeast ER protein 
Alg5 to the Cub-LexA-Vp16 cassette. Map generated by DNADynamo, www.bluetractorsoftware.co.uk. 
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pAL-Alg5. The plasmid pAL-Alg5 (Figure AC.7) has been used as a control prey and 
expresses a fusion of the yeast ER protein Alg5 to the wild type Nub portion of the yeast 
ubiquitin.  
 
Fig. AC.7: pAL-Alg5. The plasmid is one of the control preys and expresses a fusion of the yeast ER 
protein Alg5 to the wild type Nub portion of the yeast ubiquitin. Map generated by DNADynamo, 
www.bluetractorsoftware.co.uk. 
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pDL-Alg5. The plasmid pDL-Alg5 (Figure AC.8) has been used as a control prey and 
expresses a fusion of the yeast ER protein Alg5 to the mutated Nub portion of the yeast 
ubiquitin.  
 
Fig. AC.8: pDL-Alg5. The plasmid is one of the control preys and expresses a fusion of the yeast ER 
protein Alg5 to the mutated Nub portion of the yeast ubiquitin. Map generated by DNADynamo, 
www.bluetractorsoftware.co.uk. 
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APPENDIX D 
 
LIST OF GENES DIFFERENTIALLY EXPRESSED IN THE 
MICROARRAY DATASETS 
 
The tables listed in this appendix are contained on the Supplementary Data CD 
attached, which also include the complete heat maps for the differentially expressed genes in 
the ATCC46645 time course, in the ATCC46645 ΔpacC time course and in the ATCC46645 
ΔpacC/ATCC46645 dataset. Genes shown in red were up-regulated; genes shown in green 
were down-regulated. Black boxes represent the cases where the gene is not differentially 
expressed or has not been detected. Each column corresponds to a time point versus the 
reference. Analysis was performed using Genespring GX 11.02. The Supplementary Data CD 
also includes the file reporting the extended GO annotation for STEM analysis described in 
Chapter IV. 
 
AD.1 A. fumigatus ATCC46645 transcript profile during initiation of murine infection 
 
Table AD.1.1: List of up-regulated genes in the ATCC46645 time course. Genes significantly up-
regulated were included if showing a fold change of +2 on a log2 scale at least in one of the time point datasets. 
T0 vs T4 = 4 hrs, T0 vs T8 hrs = 8 hrs, T0 vs T16 = 16 hrs.   
 
Table AD.1.2: 30 ORFs with the highest log2 values between the up-regulated genes unique to the 
4 hrs time point of the ATCC46645 time course. 
 
Table AD.1.3: 30 ORFs with the highest log2 values between the up-regulated genes unique to the 
8 hrs time point of the ATCC46645 time course. 
 
Table AD.1.4: 30 ORFs with the highest log2 values between the up-regulated genes unique to the 
16 hrs time point of the ATCC46645 time course. 
 
Table AD.1.5: List of down-regulated genes in the ATCC46645 time course. Genes significantly 
down-regulated were included if showing a fold change of -2 on a log2 scale at least in one of the time point 
datasets. T0 vs T4 = 4 hrs, T0 vs T8 hrs = 8 hrs, T0 vs T16 = 16 hrs.   
  
Table AD.1.6: 30 ORFs with the lowest log2 values between the down-regulated genes unique to 
the 4 hrs time point of the ATCC46645 time course. 
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Table AD.1.7: 30 ORFs with the lowest log2 values between the down-regulated genes unique to 
the 8 hrs time point of the ATCC46645 time course. 
 
Table AD.1.8: 30 ORFs with the lowest log2 values between the down-regulated genes unique to 
the 16  hrs time point of the ATCC46645 time course. 
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Fig. AD.1.1: STEM clustering analysis of the differentially expressed genes in the ATCC46645 time course during initiation of murine infection ordered on the basis of the 
Af293 infection clusters (McDonagh et al., 2008a). The two values at the bottom of each profile indicate the number of specific genes (in this case genes previously identified in 
the Af293 infection clusters) present in the profile and the significance of the intersect size, based upon the hypergeometric distribution of dataset genes in the respective model 
profiles. 
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Fig. AD.1.2: STEM clustering analysis of the differentially expressed genes in the ATCC46645 time course during initiation of murine infection ordered on the basis of the 
subtelomeric location (McDonagh et al., 2008a). The two values at the bottom of each profile indicate how many specific genes (in this case genes with subtelomeric location) are 
present in the profile and the significance of the intersect size, based upon the hypergeometric distribution of dataset genes in the respective model profiles. 
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Fig. AD.1.3: STEM clustering analysis of the differentially expressed genes in the ATCC46645 time course during initiation of murine infection ordered on the basis of the 
involvement on secondary metabolite production (Perrin et al., 2007). The two values at the bottom of each profile indicate how many specific genes (in this case genes involved 
on secondary metabolite production) are present in the profile and the significance of the intersect size, based upon the hypergeometric distribution of dataset genes in the respective 
model profiles. 
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Fig. AD.1.4: STEM clustering analysis of the differentially expressed genes in the ATCC46645 time course during initiation of murine infection ordered on the basis of the 
in vitro up-regulated genes in response to an alkaline pH shift (Loss, unpublished). The two values at the bottom of each profile indicate how many specific genes (in this case 
up-regulated genes in response to an alkaline pH shift) are present in the profile and the significance of the intersect size, based upon the hypergeometric distribution of dataset 
genes in the respective model profiles. 
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Fig. AD.1.5: STEM clustering analysis of the differentially expressed genes in the ATCC46645 time course during initiation of murine infection ordered on the basis of the 
in vitro down-regulated genes in response to an alkaline pH shift (Loss, unpublished). The two values at the bottom of each profile indicate how many specific genes (in this 
case down-regulated genes in response to an alkaline pH shift) are present in the profile and the significance of the intersect size, based upon the hypergeometric distribution of 
dataset genes in the respective model profiles. 
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AD.2 A. fumigatus ATCC46645 ΔpacC mutant transcript profile during initiation of 
murine infection 
 
Table AD.2.1: List of up-regulated genes in the ATCC46645 ΔpacC time course. Genes 
significantly up-regulated were included if showing a fold change of +2 on a log2 scale at least in one of the time 
point datasets.  T0 vs T4 = 4 hrs, T0 vs T8 hrs = 8 hrs, T0 vs T16 = 16 hrs.   
 
Table AD.2.2 30 ORFs having the highest log2 among up-regulated genes unique to the 4 hrs time 
point of the ATCC46645 ΔpacC time course. 
 
Table AD.2.3: 30 ORFs with the highest log2 values between the up-regulated genes unique to the 
8 hrs time point of the ATCC46645 ΔpacC time course. 
 
Table AD.2.4: 30 ORFs with the highest log2 values among up-regulated genes unique to the 16 
hrs time point of the ATCC46645 ΔpacC time course. 
 
Table AD.2.5: List of down-regulated genes in the ATCC46645 ΔpacC time course. Genes 
significantly down-regulated were included if showing a fold change of -2 on a log2 scale at least in one of the 
time point datasets. T0 vs T4 = 4 hrs, T0 vs T8 hrs = 8 hrs, T0 vs T16 = 16 hrs.   
 
Table AD.2.6: 30 ORFs with the lowest log2 values among down-regulated genes unique to the 4 
hrs time point of the ATCC46645 ΔpacC time course. 
 
Table AD.2.7: 30 ORFs with the lowest log2 values among down-regulated genes unique to the 8 
hrs time point of the ATCC46645 ΔpacC time course. 
 
Table AD.2.8: 30 ORFs with the lowest log2 values between the down-regulated genes unique to 
the 16 hrs time point of the ATCC46645 ΔpacC time course. 
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Fig. AD.2.1: STEM clustering analysis of the differentially expressed genes in the ATCC46645 ΔpacC time course during initiation of murine infection ordered on the basis 
of the Af293 infection clusters (McDonagh et al., 2008a). The two values at the bottom of each profile indicate the number of specific genes (in this case genes previously 
identified in the Af293 infection clusters) present in the profile and the significance of the intersect size, based upon the hypergeometric distribution of dataset genes in the respective 
model profiles. 
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Fig. AD.2.2: STEM clustering analysis of the differentially expressed genes in the ATCC46645 ΔpacC time course during initiation of murine infection ordered on the basis 
of the subtelomeric location (McDonagh et al., 2008a). The two values at the bottom of each profile indicate how many specific genes (in this case genes with subtelomeric 
location) are present in the profile and the significance of the intersect size, based upon the hypergeometric distribution of dataset genes in the respective model profiles. 
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.  
 
Fig. AD.2.3: STEM clustering analysis of the differentially expressed genes in the ATCC46645 ΔpacC time course during initiation of murine infection ordered on the basis 
of the involvement on secondary metabolite production (Perrin et al., 2007). The two values at the bottom of each profile indicate how many specific genes (in this case genes 
involved on secondary metabolite production) are present in the profile and the significance of the intersect size, based upon the hypergeometric distribution of dataset genes in the 
respective model profiles. 
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Fig. AD.2.4: STEM clustering analysis of the differentially expressed genes in the ATCC46645 ΔpacC time course during initiation of murine infection ordered on the basis 
of the in vitro up-regulated genes in response to an alkaline pH shift (Loss, unpublished). The two values at the bottom of each profile indicate how many specific genes (in this 
case up-regulated genes in response to an alkaline pH shift) are present in the profile and the significance of the intersect size, based upon the hypergeometric distribution of dataset 
genes in the respective model profiles. 
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Fig. AD.2.5: STEM clustering analysis of the differentially expressed genes in the ATCC46645 ΔpacC time course during initiation of murine infection ordered on the basis 
of the in vitro down-regulated genes in response to an alkaline pH shift (Loss, unpublished). The two values at the bottom of each profile indicate how many specific genes (in 
this case down-regulated genes in response to an alkaline pH shift) are present in the profile and the significance of the intersect size, based upon the hypergeometric distribution of 
dataset genes in the respective model profiles. 
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Fig. AD.2.6: STEM clustering analysis of the differentially expressed genes in the ATCC46645 ΔpacC time course during initiation of murine infection ordered on the basis 
of the involvement in transposition. The two values at the bottom of each profile indicate how many specific genes (in this case genes involved in transposition) are present in the 
profile and the significance of the intersect size, based upon the hypergeometric distribution of dataset genes in the respective model profiles. 
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AD.3 A. fumigatus ATCC46645 ΔpacC/ATCC46645 log2 ratio comparison during 
initiation of murine infection 
 
Table AD.3.1: List of up-regulated genes in the ATCC46645 ΔpacC/ATCC46645 dataset. Genes 
significantly up-regulated were included if showing a fold change of +1.5 on a log2 scale at least in one of the 
time point datasets. T0 vs T4 = 4 hrs, T0 vs T8 hrs = 8 hrs, T0 vs T16 = 16 hrs.   
 
Table AD.3.2: 30 ORFs with the highest log2 values between the up-regulated genes unique to the 
4 hrs time point of the ATCC46645 ΔpacC/ATCC46645 comparison. 
 
Table AD.3.3: 23 up-regulated ORFs unique to the 8 hrs time point of the ATCC46645 
ΔpacC/ATCC46645 comparison. 
 
Table AD.3.4: 30 ORFs with the highest log2 values between the up-regulated genes unique to the 
16 hrs time point of the ATCC46645 ΔpacC/ATCC46645 comparison. 
 
Table AD.3.5: List of down-regulated genes in the ATCC46645 ΔpacC/ATCC46645 dataset. 
Genes significantly down-regulated were included if showing a fold change of -1.5 on a log2 scale at least in one 
of the time point datasets. T0 vs T4 = 4 hrs, T0 vs T8 hrs = 8 hrs, T0 vs T16 = 16 hrs.   
 
Table AD.3.6: 30 ORFs with the lowest log2 values between the down-regulated genes unique to 
the 4 hrs time point of the ATCC46645 ΔpacC/ATCC46645 comparison. 
  
Table AD.3.7: 11 down-regulated ORFs unique to the 8 hrs time point of the ATCC46645 
ΔpacC/ATCC46645 comparison. 
 
Table AD.3.8 30 ORFs with the lowest log2 values between the down-regulated genes unique to 
the 16 hrs time point of the ATCC46645 ΔpacC/ATCC46645 comparison. 
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APPENDIX E 
 
OPTIMISATION OF THE SPLIT-UBIQUITIN MYTH SYSTEM 
USING PBT3-STE A. NIDULANS PALH BAIT 
 
Initially, the optimisation of the split-ubiquitin MYTH system was performed using A. 
nidulans PalH as bait in the vector pBT3-STE and A. nidulans PalI as prey in the vectors 
pPR3-N and pPR3-STE. These vectors were kindly provided by Ana Maria Calcagno-
Pizarelli (Herb Arst‟s Laboratory, Imperial College London).  
As explained in the experimental procedure in CHAPTER V and VI, the sequence-
verified constructs were transformed into the yeast strain provided, NMY51, for expression 
tests and control assays. The expression of the genes of interest was verified by western 
blotting analysis of total yeast extracts using an antibody directed against the LexA domain of 
the fusion protein for the baits and an antibody directed against the HA epitope of the fusion 
protein for the preys. As shown in Fig. AE.1, the expression of A. nidulans PalH as bait in the 
vector pBT3-STE was confirmed. Considering the size of A. nidulans PalH protein (83.7 
KDa) and the size of the Cub-LexA-VP16 fusion (38 KDa) the size of the expected product 
was 121.7 KDa, whereas the positive control‟s size, derived from the yeast transformed with 
the plasmid pCCW-Alg5, was 77.5 KDa. The construct pCCW-Alg5, used as positive control 
for the detection of the LexA epitope, expresses a fusion of the yeast ER protein Alg5 to the 
wild type Cub portion of yeast ubiquitin. A. nidulans PalI was expressed as prey only when 
cloned in the orientation fusing the NubG domain at the C-terminal (pPR3-STE). The 
plasmid pPR3-N was used as positive control for the detection of the HA epitope. 
Considering the size of A. nidulans PalI protein (44.3 KDa) and the size of the NubG-HA 
fusion (7 KDa) the size of the expected product was 52.3 KDa, whereas the positive control 
size, derived from the yeast transformed with the plasmid pPR3-N, was 15 KDa.  
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Fig. AE.1: Western blotting analysis to verify the expression of A. nidulans bait and preys. A. 
nidulans PalH bait (A) was expressed. (B) A. nidulans PalI as a prey was properly expressed only in the 
orientation fusing the NubG domain at the C-terminal (pPR3-STE).  
 
According to the structure of the two prey vectors used for the expression of A. 
nidulans PalI as prey, the verification of preys expression by western blotting provided 
additional evidence of the presence in A. nidulans PalI of a signal peptide, as previously 
predicted (Calcagno-Pizarelli et al., 2007) by SignalP 3.0 (Bendtsen et al., 2004). Expression 
of A. nidulans bait was also verified using the control preys supplied with the kit. The control 
assay is an important step to determine whether the bait is functional in the assay and whether 
it displays any non-specific background. In order to assay the expression of A. nidulans PalH 
bait protein in yeast, the bait plasmid was co-transformed with the control plasmids pAI-Alg5 
and pDL2-Alg5. The construct pAI-Alg5 expresses a fusion of the yeast ER protein Alg5 to 
the wild type Nub portion of yeast ubiquitin, whereas pDL2-Alg5 expresses a fusion of the 
same protein to the mutated Nub portion (NubG). Co-expression of the bait together with 
pAI-Alg5 should result in reconstitution of split-ubiquitin through the strong affinity of wild 
type Nub for Cub and the concurrent activation of the reporter genes, if the bait tested is 
properly inserted into the membrane of yeast and the Cub-LexAVP16 part is located on the 
cytosolic side of the membrane. Co-expression of the bait of interest together with pDL2-
Alg5 should instead not lead to split-ubiquitin formation, because the mutated Nub has no 
affinity for Cub. Fig. AE.2 shows the result of this experiment for A. nidulans PalH bait 
indicating that this bait is appropriately localised in the membrane of yeast and the Cub-
LexAVP16 part is located on the cytosolic side of the membrane. Transformation efficiency 
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is confirmed by the growth in SD-trp-leu media. Growth of yeast expressing the tested bait 
and the Alg5-NubI control in the selective media SD-trp-leu-his-ade signifies that A. nidulans 
PalH bait is functional in the DUALmembrane system. Co-expression of the baits together 
with pDL2-Alg5 should not activate the reporter genes, as the mutated NubG moiety has no 
affinity for Cub. In addition, if a bait and prey interact, as in the case of the co-transformation 
with A. nidulans with the positive control prey plasmid pAI-Alg5, the ade2 reporter gene is 
activated and the adenine synthesis pathway is unblocked, leading to the disappearance of the 
red colour.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. AE.2: Verification of the expression and functionality of A. nidulans PalH bait (pBT3-STE) 
by co-transformation with the control preys in yeast. The baits tested are (A) the positive control bait 
pCCW-Alg5 and (B) pBT3-STE A. nidulans PalH. Each of these baits was co-transformed with the positive 
control prey pAI-Alg5 and the negative control prey pDL2-Alg5 and for each co-transformation the total 
transformants (TT) in SD-leu-trp (indicative of the transformation efficiency) and the prototrophic transformants 
(PT) in SD-leu-trp-his-ade (indicative of interaction between bait and prey) are shown. With lack of interaction, 
yeast colonies turn pink during the incubation.  
 
Appropriate expression of A. nidulans PalH bait and A. nidulans PalI and A. fumigatus 
PalF (see Chapter V) preys, as confirmed by the previous western blotting, provided an 
opportunity to further optimize the split-ubiquitin methodology. Having demonstrated the 
functionality of A. nidulans PalH bait, the direct interaction of A. nidulans PalI and A. 
fumigatus PalF preys was addressed by co-expression with A. nidulans PalH bait, using the 
same method described above, as shown in Fig. AE.3.  
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Fig. AE.3: Co-transformation of the expression-verified A. nidulans PalH pBT3-STE bait with A. 
fumigatus PalI pPR3-STE (A) and A. fumigatus PalF pPR3-N (B) preys to test direct interactions. For each 
co-transformation the total transformants (TT) in SD-leu-trp (indicative of the transformation efficiency) and the 
prototrophic transformants (PT) in SD-leu-trp-his-ade (indicative of interaction between bait and prey) are 
shown. With lack of interaction, yeast colonies turn pink during the incubation.  
 
As demonstrated by the degree of growth on SD-trp-leu-his-ade media and by the 
colour of the transformant colonies, an interaction was detectable between A. nidulans PalH 
and A. nidulans PalI and between A. nidulans PalH and A. fumigatus PalF. However, only 
few colonies were obtained from the co-transformation with A. nidulans PalH and A. 
nidulans PalI and this might indicate the proteins are localised in close proximity in the 
plasma membrane signalling complex, but do not directly interact. Although the interaction 
between PalH and PalF has already been demonstrated in A. nidulans (Herranz et al., 2005), 
this co-transformation experiment confirmed interaction, even if the two proteins were 
heterologous in species origin, suggesting the potential use of A. nidulans PalH bait to screen 
the full length A. fumigatus cDNA library for possible interactors.  
The first step for the screening of the full-length A. fumigatus cDNA library with A. 
nidulans PalH bait was a pilot screen to determine whether the bait displays any self-
activation when transformed together with empty library vector. For this, the bait construct 
was co-transformed with an aliquot of the empty library vector pPR3-N and assayed on 
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selective SD-trp-leu-his-ade plates of increasing stringency, supplemented with different 
amounts of 3-AT. Since the bait is co-expressed with unfused mutated Nub (expressed from 
an the empty library vector), any colonies obtained from the screening plates must be 
background and the pilot screen helps to adjust the screening conditions to obtain in the 
following library screen the absolute minimum of false positives possible. The efficiency of 
the pilot screen was verified calculating the total number of transformants and the 
transformation efficiency from the number of colonies on SD-trp-leu media. The total 
number of transformants should be greater than 8x10
5
 for the assay to deliver meaningful 
results (the background on selection plates is directly proportional to the total number of 
transformants, i.e. the total number of yeast transformants containing a bait and prey 
plasmid). In this case, the total number of transformants was 3.85x10
6
 with a transformation 
efficiency of 1.8x10
5
 clones/μgDNA. SD-trp-leu-his-ade media was supplemented with 0, 1, 
2.5, 5, 7.5 and 10 mM 3-AT and the optimal conditions for the screening resulted as be SD-
trp-leu-his-ade supplemented with 10 mM 3-AT.  
The full-length A. fumigatus cDNA library was transformed into NMY51 expressing 
A. nidulans PalH bait and interactors were selected using the stringency conditions 
determined in the pilot screen. The high-efficiency protocol described should yield 
transformation efficiencies in the range of 5x10
5
 to 2x10
6
 clones/μgDNA, in this case 2.7x10
6
 
clones/μgDNA.  
200 possible interactions were detected with this screening and positive colonies were 
purified on the same selective media used in the library screen. Library plasmids encoding 
putative interactors were isolated from yeast, culturing each interactor strain in liquid media, 
lysing the yeast cells and purifying the bait and library plasmids. The plasmid mix was 
subsequently transformed into E. coli and the library plasmid was selectively propagated, 
since the library plasmids carry an ampicillin marker, whereas the bait plasmid carries a 
kanamycin marker. As yeast can take up several plasmids during the transformation 
procedure, two E. coli colonies were analysed from each transformation.  
To assess the composition of the putative interactors, a set of 85 putative interactors 
was analysed by sequencing using the oligonucleotides pPR3-NF and pPR3-NR (Appendix 
B). Among these 85, 10 were represented by a single colony in E. coli, so the total set of E. 
coli clones analysed was composed of 160 samples. All the sequences were examined using 
the software BLAST (http://blast.ncbi.nlm.nih.gov/) for the research of similarity in the 
available sequence databases. Among the samples, 29 had no similarity with any A. fumigatus 
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genes, but with S. cerevisiae genes, probably representing false positives. 12 of the putative 
interactors with two available clones out of 75 contained more than one library plasmid.  
All the clones showing similarity with an A. fumigatus gene were further analysed to 
determine if the A. fumigatus gene was in frame with the mutated Nub domain of the library 
vector and if its sequence was complete. The results, summarised in Figs. AE.4 and AE.5, 
excluded from subsequent screening another 24 clones: 9 of them where the A. fumigatus 
gene was not in frame with the NubG, 6 because the A. fumigatus gene carried by the library 
plasmid was inverted, and another 9 containing only a partial sequence of the A. fumigatus 
gene (less than 100 nucleotides). The remaining 107 E. coli clones were in frame, 35 of these 
clones contained the complete sequence of the A. fumigatus gene whereas 72 contained only 
a part of the A. fumigatus gene (more than 100 nucleotides).  
    
 
 
Fig. AE.4: Scheme showing the preliminary analysis of 85 of the 200 putative interactors 
identified by the screening of the full length A. fumigatus cDNA library with A. nidulans PalH bait. The 
total set of E. coli clones analysed was composed of 160 samples: samples showing no similarity with any A. 
fumigatus genes (blue), samples where the A. fumigatus gene was not in frame with the NubG (red), samples 
carrying an inverted A. fumigatus gene (green), samples with a partial sequence of the A. fumigatus gene 
(purple), samples in frame (light blue).  
 
18%
5%
4%
6%
67%
Putative interactors
No similarity
Genes not in frame 
Genes inverted 
Genes only partial
Genes in frame 
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Fig. AE.5: Scheme showing the composition of the 107 E. coli clones containing an A. fumigatus 
gene in frame with the NubG of the library vector identified by the preliminary analysis of 85 of the 200 
putative interactors obtained by the screening of the full-length A. fumigatus cDNA library with A. 
nidulans PalH bait. Clones containing the complete sequence of the A. fumigatus gene (light blue) and clones 
containing only a part of the A. fumigatus gene (red) (more than 100 nucleotides).  
 
Table AE.1 summarises the clones identified as putative interactors and where the A. 
fumigatus gene identified is in frame with the NubG domain of the library vector to allow the 
expression of a functional fusion protein. As annotated in the last column, 10 A. fumigatus 
genes were identified in more than one sample and significantly, in most of the cases each 
sample encoding the same A. fumigatus gene carries a different sub-terminal fragment of the 
gene itself. This could inform upon which part of the confirmed interactor is fundamental for 
the interaction with A. nidulans PalH. One example is the A. fumigatus gene encoding the 
UPF0136 domain protein (Afu1g03720) identified 8 times among the clones analysed and 
belonging to the poorly characterised UPF0136 family of short transmembrane proteins. The 
portion of this gene present in these 8 clones is in a range between 93% and 57% of the entire 
ORF, calculating the lengths from the 3‟ end. Interestingly, A. fumigatus PalF was not 
identified among the clones analysed, suggesting the possibility that palF is poorly 
represented in the full length A. fumigatus cDNA library.  
 
A. fumigatus ORF Description Complete Multiple Id 
Afu6g09740 thioredoxin reductase GliT no  
 Afu1g03720  UPF0136 domain protein no 8 (93%) 
Afu4g09360 ATP synthase subunit ATP9 yes  
Afu5g07450 conserved hypothetical protein no  
33%
67%
Genes in frame
Complete genes
Incomplete genes
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 Afu1g03720 UPF0136 domain protein no 8 (90%) 
Afu1g14240 Golgi membrane protein (Coy1) yes  
Afu3g07570 conserved hypothetical protein no  
Afu1g03720 UPF0136 domain protein no 8 (74%) 
 Afu2g11060 Acyl CoA binding protein family no 2 (93%) 
Afu5g09330 CipC-like antibiotic response protein yes 2 (100%) 
Afu6g04110  CLPTM1 domain protein no  
Afu1g03720 UPF0136 domain protein no 8 (83%) 
Afu1g04315 integral membrane protein yes 2 (100%) 
 Afu6g11270  synaptobrevin-like protein Sybl1 no  
Afu1g09100 60S ribosomal protein L9 yes  
 Afu1g03720 UPF0136 domain protein no 8 (82%) 
Afu2g00180  neutral amino acid permease no 2 (30%) 
 Afu2g11550  ergosterol biosynthesis protein Erg28 no 3 (97%) 
Afu2g11550 ergosterol biosynthesis protein Erg28 no 3 (96%) 
 Afu2g09870 eukaryotic translation initiation factor 3 no 2 (70%) 
 Afu7g05730  conserved hypothetical protein no  
Afu4g03595 conserved hypothetical protein no  
Afu6g10700 chaperonin no 2 (78%) 
Afu3g06597 conserved hypothetical protein yes  
Afu4g07435  60S ribosomal protein L36 no  
 Afu1g17350 CP2 transcription factor no  
Afu1g02290  conserved hypothetical protein yes  
Afu4g03630  sterol 24-c-methyltransferase no  
 Afu2g01010  myo-inositol-phosphate synthase no  
Afu1g04315 integral membrane protein yes 2 (100%) 
 Afu2g11550  ergosterol biosynthesis protein Erg28 yes 3 (100%) 
Afu5g07340 DnaJ domain protein Psi no  
Afu2g00180  neutral amino acid permease no 2 (28%) 
Afu3g11710 saccharopine dehydrogenase Lys1 yes  
Afu7g00280 conserved hypothetical protein no  
Afu2g11060 Acyl CoA binding protein family no 2 (94%) 
Afu1g15820  fatty acid hydroxylase yes  
Afu3g01900 conserved hypothetical protein no 2 (90%) 
Afu1g03720 UPF0136 domain protein no 8 (82%) 
Afu6g10700 chaperonin no 2 (89%) 
Afu5g10560  cytochrome c oxidase subunit V no  
Afu1g05720 c-14 sterol reductase yes  
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Afu1g01870 presequence translocase-associated motor yes  
Afu2g05060  alternative oxidase AlxA yes  
Afu1g13430 conserved hypothetical protein no   
Afu5g01960  phosphate transporter (Pho88) yes 2 (100%) 
Afu1g14200 mitochondrial processing peptidase beta no  
Afu2g04610 DUF967 domain protein yes  
Afu2g09870 eukaryotic translation initiation factor 3 no 2 (77%) 
Afu5g09330  CipC-like antibiotic response protein no 2 (96%) 
Afu5g08100  conserved hypothetical protein yes  
 Afu5g01960 phosphate transporter (Pho88) yes 2 (100%) 
 Afu1g03720 UPF0136 domain protein no 8 (83%) 
Afu3g01900  conserved hypothetical protein yes 2 (100%) 
 Afu7g00540  integral membrane protein no  
Afu5g02700  MFS multidrug transporter no  
 Afu2g04710  cytochrome b5 no  
 Afu1g03720 UPF0136 domain protein no 8 (57%) 
 
Table AE.1: Summary of the clones identified as putative interactors of A. nidulans PalH because 
containing an A. fumigatus gene in frame with the NubG domain of the library vector to allow the 
expression of a functional fusion protein. For each putative interactors are reported the A. fumigatus ORF, a 
general description and the number of times it has been identified in the analysis.  
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APPENDIX F  
 
IN SILICO STUDIES OF A. FUMIGATUS PACC/RIM101P 
PATHWAY MEMBERS  
 
AF.1 Alignments of A. nidulans and A. fumigatus PacC/Rim101p pathway members  
Alignments were performed using the A. fumigatus protein sequence of interest as 
query for the FASTA alignment tools available at www.ebi.ac.uk with the default settings. In 
each alignment therefore the top sequence represents the A. fumigatus protein sequence, 
whereas the bottom sequence the A. nidulans one.  
 
Smith-Waterman score: 3013; 69.1% identity (83.0% similar) in 689 aa overlap  
 
               10        20        30        40        50        60 
Sequen MSEHQDTATNNNTTASPSATAAPMPAPISQEQPSSQPAATTPAPVSTSTPPASVTATAAA 
                            ::. .: .::::.:::::   : :.: : : :::::::: 
UNIPRO            MLGAMAEEAVAPVAVPTTQEQPTSQPAA---AQVTTVTSP-SVTATAAA 
                          10        20           30         40      
 
               70                   80        90       100          
Sequen ATAAVSAPQANGT------PPSD-----EQLSCLWQGCSEKCPSAEALYDHICERHVGRK 
       :::::..:::::.      : :.     :.:.:.::::::: :. :.::.:.:::::::: 
UNIPRO ATAAVASPQANGNAASPVAPASSTSRPAEELTCMWQGCSEKLPTPESLYEHVCERHVGRK 
          50        60        70        80        90       100      
 
     110       120       130       140       150       160          
Sequen STNNLNLTCQWGSCRTTTVKRDHITSHIRVHVPLKPHKCEFCGKAFKRPQDLKKHVKTHA 
       :::::::::::::::::::::::::::::::::::::::.:::::::::::::::::::: 
UNIPRO STNNLNLTCQWGSCRTTTVKRDHITSHIRVHVPLKPHKCDFCGKAFKRPQDLKKHVKTHA 
         110       120       130       140       150       160      
 
     170       180       190       200       210       220          
Sequen DDSVLVRSPEPGARNPDMMFHGAGKGYAAAAHYFEPSLNAVPSQGYAHGAPQYYSSHPPH 
       ::::::::::::.::::::: : ::::::: :::::.:: ::::::::: ::::..:    
UNIPRO DDSVLVRSPEPGSRNPDMMFGGNGKGYAAA-HYFEPALNPVPSQGYAHGPPQYYQAHHAP 
         170       180       190        200       210       220     
 
     230       240       250        260       270       280         
Sequen QPSNPSYGNVYYALNHGHDGH-ASYESKKRGYDALNEFFGDLKRRQFDLHSYAAVGQRLL 
       ::::::::::::::: : . : :::::::::::::::::::::::::: .:::::::::: 
UNIPRO QPSNPSYGNVYYALNTGPEPHQASYESKKRGYDALNEFFGDLKRRQFDPNSYAAVGQRLL 
          230       240       250       260       270       280     
 
      290       300       310        320       330       340        
Sequen GLQNLSLPILTGGPLPEYQPMPAPVAVGGG-YGPGGHGAPVYHLPPMSNIRTKNDLINID 
       .:::::::.::..:::::: :::::::..: :: : : ::.::::::::.:::::::::: 
UNIPRO SLQNLSLPVLTAAPLPEYQAMPAPVAVASGPYGGGPHPAPAYHLPPMSNVRTKNDLINID 
          290       300       310       320       330       340     
 
       350       360       370       380       390       400        
Sequen QFLQQMQDTIYENDDHVAAAGVAQPGAHYVHGGMSYRTTHSPPTQLPPSHAVATTSASTS 
       :::::::::::::::.:::::::::::::.:.:.::::::::::::: .::.. :.:.   
386 
 
UNIPRO QFLQQMQDTIYENDDNVAAAGVAQPGAHYIHNGISYRTTHSPPTQLPSAHATTQTTAGPI 
          350       360       370       380       390       400     
 
       410       420       430       440       450       460        
Sequen MSNPATHSPPTGTPALTPPSSAQSYTSARSPISISSAHRVSPPHHDGGSGMYPRLPSTTM 
       .:: ..::: ..:::::::::::::::.:::::. ::::::::: ..::.:::::::.:  
UNIPRO ISNTSAHSPSSSTPALTPPSSAQSYTSGRSPISLPSAHRVSPPH-ESGSSMYPRLPSAT- 
          410       420       430       440        450       460    
 
       470       480       490        500       510       520       
Sequen ADSLAGGYPTASSAAPPSTLSGIFDDD-RRRYTGGTLQRARPEERRPSIQMDTSHDGKED 
        :....:: .::::::::::.::::.: ::::::::::::::  :  : .:: : : ::. 
UNIPRO -DGMTSGYTAASSAAPPSTLGGIFDNDERRRYTGGTLQRARPASRAASESMDLSSDDKES 
             470       480       490       500       510       520  
 
        530       540       550       560       570       580       
Sequen GERTPTGKARSSGSDSPVRISANLIDPALHSSSPSDAEAALRTAQAATEVADRAD--SQW 
       :::::             .:::.::::::::.::.. ... :::.::::::.:.:  :.: 
UNIPRO GERTPK------------QISASLIDPALHSGSPGEDDVT-RTAKAATEVAERSDVQSEW 
                         530       540        550       560         
 
          590       600       610                          620      
Sequen VEKVRLLEYLRSYIASRLERGEYDSDSDDHAS-------------------AAASPVIKH 
       ::::::.::::.:::.::::::...::... .                   .. ::: :  
UNIPRO VEKVRLIEYLRNYIANRLERGEFSDDSEQEQDQEQEQDQEQEQDQEQGQDRVSRSPVSKA 
      570       580       590       600       610       620         
 
         630       640       650        660       670       
Sequen DGHMDGVESSHKPITAEETSAPPAAKAESNH-GVMYPTLHGLDGDEDTKMHH 
       :  :.::: .  : . .  ..:  . .:: . .::::::.::: : :.::   
UNIPRO DVDMEGVERDSLPRSPR--TVPIKTDGESAEDSVMYPTLRGLDEDGDSKMPS 
      630       640         650       660       670    
 
Fig. AF.1: Alignment between A. nidulans PacC (AN2855) and A. fumigatus PacC (Afu3g11970). 
 
Smith-Waterman score: 3374; 67.1% identity (84.2% similar) in 767 aa overlap 
 
               10        20        30        40        50        60 
Sequen MGDDARLTPRQIWANPTTTTSKSYSPGCTPFLLPSDGYVYFNRSFAITLTENAVFEPVCT 
       : ::.::.:::::: ::.::..:: :::::::::::::::.::...:.: :::...:.:: 
UNIPRO MEDDGRLAPRQIWARPTSTTTRSYVPGCTPFLLPSDGYVYLNRTYSISLGENAIYDPACT 
               10        20        30        40        50        60 
 
               70        80        90       100       110       120 
Sequen SQPTDTRQPSPLLDTRDPFYSSVTPQLYAIGCATVVSYLLVIILLITPRTFYVGGPGGGA 
       : :: :.. .  :: .::::.:::: :::.:::::::::::::::::::::::::::::: 
UNIPRO STPTTTEHAGAALDIHDPFYASVTPLLYAMGCATVVSYLLVIILLITPRTFYVGGPGGGA 
               70        80        90       100       110       120 
 
              130       140       150       160       170       180 
Sequen NFLGRHGMISGSYSGNSSVVGVGGRPWLQKVAAILVAVSLTIASADSFRVAERQYNYGYS 
       ::::::::.:::::.::::::::::::::::::.:::.:::::.::::::::.::..::: 
UNIPRO NFLGRHGMVSGSYSNNSSVVGVGGRPWLQKVAALLVAISLTIATADSFRVAEKQYDHGYS 
              130       140       150       160       170       180 
 
              190       200       210       220       230       240 
Sequen DAEALTEEVIDGTEIRVVRVISSTFLWLAQVQTLIRLFPRHKEKIMIKWAGFALIVLDTI 
       :::::: ::::::::.:::.::::::::::::::::::::::::.::::::::::::::: 
UNIPRO DAEALTSEVIDGTEIKVVRIISSTFLWLAQVQTLIRLFPRHKEKVMIKWAGFALIVLDTI 
              190       200       210       220       230       240 
 
              250       260       270       280       290       300 
Sequen FSILDKFLVKTNTTRPRLYDDAIPALSYLFELALNLLYAAWVIFYSLSKHRYAFFHPKMR 
       :.:::::::::::::::::.:::::::::::::::::::::::::::::::.:::::::: 
UNIPRO FAILDKFLVKTNTTRPRLYEDAIPALSYLFELALNLLYAAWVIFYSLSKHRFAFFHPKMR 
387 
 
              250       260       270       280       290       300 
 
              310       320       330       340       350       360 
Sequen NICLVALLSLCAVLIPVIFFVLDIAKEEIAGWGTYIRWVGSAAASVVVWEWVERIEALER 
       :::::::::::::::::.:::::::: ::::::::::::::::::::::::::::::::: 
UNIPRO NICLVALLSLCAVLIPVVFFVLDIAKPEIAGWGTYIRWVGSAAASVVVWEWVERIEALER 
              310       320       330       340       350       360 
 
              370       380       390       400       410       420 
Sequen DERKDGILGRELFDGDEMLEVTPSEEVDWPRQTYGGGDRDGGSGTSSGWGGVMGLANRPL 
       :::::::::::.::::::.::::::::::::: . : :: ::.: ::.::::::::.::: 
UNIPRO DERKDGILGREVFDGDEMIEVTPSEEVDWPRQQFHGHDRGGGTGMSSAWGGVMGLAHRPL 
              370       380       390       400       410       420 
 
              430          440       450       460       470        
Sequen RTRVGLPRGNRKPDKQRKT---VSSDVRRHGAGRPTPPPAATTPVSRADTTSAASTVYNV 
       :     :::.:  . ::..   ...  :.. ..::::::::.:::::::::::::::::: 
UNIPRO R-----PRGGRITQTQREAEGATAAKSRKRRSARPTPPPAAVTPVSRADTTSAASTVYNV 
                   430       440       450       460       470      
 
       480       490       500       510       520       530        
Sequen HYHPVSSPTPPVVMPHMEEEDEYETGQLKEMTMRTEDGGGDVGQPRLSAQQTREESPQIV 
       ::.:::::::::.:: ::::::   :. ..    ...  ...      ..  :..::::: 
UNIPRO HYYPVSSPTPPVAMPFMEEEDEGSDGDGEKELAVVQNQQSSLPTQDTYTEPRRQNSPQIV 
         480       490       500       510       520       530      
 
       540       550       560       570       580         590      
Sequen NMDGRWRTLLNPFRKRRASLPREVASAQADEDPSTAQEDLYGDEGDR--PRAACSKQGYL 
       :.:.::: .::::..:.:.::::::::::.:.   . .:    .::.  :. .  ..: : 
UNIPRO NVDNRWRFILNPFKNRHAALPREVASAQAEEEGFLSPDDQAPRQGDEENPHYTPRHRG-L 
         540       550       560       570       580       590      
 
         600       610         620       630       640       650    
Sequen FPFNFRIRPGSDKRD--ADASLPVTVIPARRRGQNTWSPQWLNDANILEPTPNRVVRSNR 
       : :.  .  :...:.  ::  :::::::::::::.::::::....:... . .: . :   
UNIPRO FSFH-PMSDGASRRQSGADQPLPVTVIPARRRGQDTWSPQWFTNSNLVDRSSSRRTASRP 
           600       610       620       630       640       650    
 
           660       670       680       690          700       710 
Sequen SNLPVRVIQPQTRTAAPWSIPEGDTILGNGNYELRYDPETAALI---VPDGHQAQQRTAA 
        .  ..:::::...::::.  . .. ... .::::::::.:::.   .:: :.  : : : 
UNIPRO RDQRMKVIQPQVQSAAPWTAADMEASFSSMDYELRYDPEAAALVSEDIPDHHS--QPTQA 
           660       670       680       690       700         710  
 
                  720        730       740       750       760      
Sequen SSTAH----NGDGQPVDEA-TAGPAGHDAPDMLRESQISAPPEQPPSSTPSRQDGQRSPT 
       .: ::    .:.:    :. .:  .:      . :...   ::.  :              
UNIPRO DSPAHPTMSGGNGPSGGETQSALDTGPGIEGSVNEGSVIEGPEESHSQR            
             720       730       740       750       760            
 
         770         
Sequen HPSLGGDPSRDDT 
 
Fig. AF.2: Alignment between A. nidulans PalH (AN6886) and A. fumigatus PalH (Afu5g13270). 
 
Smith-Waterman score: 2184; 59.9% identity (75.6% similar) in 594 aa overlap  
 
               10        20        30        40        50        60 
Sequen MLLKPATPLTILLLAAFVLLLLSVLSTPIIQGIPLATFNHVDYGVFGFCKAGQCTNIHIG 
       :::::::::::::: :::::::::.::::...::::::..:.:::::.:::: :: :::: 
UNIPRO MLLKPATPLTILLLIAFVLLLLSVISTPIVKSIPLATFDNVEYGVFGYCKAGTCTAIHIG 
               10        20        30        40        50        60 
 
               70          80        90       100       110         
Sequen YTTDEISNTD--NSEFDLPSSTRRSLSSILIVHPVAAFLTLVCLCLAAAAHLHAPSHSPR 
388 
 
       :::.:: ::   .:.:.:::..::::::::::::.::::::.:::::::::::::::::: 
UNIPRO YTTEEIENTGSTDSDFNLPSDARRSLSSILIVHPIAAFLTLICLCLAAAAHLHAPSHSPR 
               70        80        90       100       110       120 
 
      120       130       140       150       160       170         
Sequen YLLALLILLLPTLLVSLLAFLVDILLFVPHLGWGGWIVLGATILLVISGVVTCAMRRTLV 
       :::::::::::::::::::::::::::::::.:::::::.:::.::  :::::::::::: 
UNIPRO YLLALLILLLPTLLVSLLAFLVDILLFVPHLSWGGWIVLAATIILVTCGVVTCAMRRTLV 
              130       140       150       160       170       180 
 
      180       190       200       210       220       230         
Sequen SRKARKRRIAENAEMSGENYYNRQNAAVPVVASGFTGPRSAALNAETKEAIITTSPNSES 
       :::::::::::::::::.:::::::::. ..       .:  .  :.::...... .::: 
UNIPRO SRKARKRRIAENAEMSGQNYYNRQNAAAAALN------ESKPIAPEAKETFVAATQSSES 
              190       200       210             220       230     
 
      240       250       260       270       280       290         
Sequen GPMFATFRTTTHSSDDDQTPLNTQGAPTDIPAPDSQYAARGHGDRMPSGAPFDESRNHPY 
       :: ::::::.:.:::::.::::... :.   : :. : .:  :: .: .:: :.  :    
UNIPRO GPTFATFRTNTRSSDDDRTPLNNHSDPS---AQDAGYQSRIPGDPVPYNAPRDDFGNPLP 
          240       250       260          270       280       290  
 
      300        310            320       330       340       350   
Sequen AGSYGPGPRMR-PGPGDP-----RLRPQYSDGSMGSRRGPPPPGFAPRGRGGYPPRGGYG 
        :.:. .:::: :::  :     :.: ::::     :::::  ::::::::::::::::: 
UNIPRO PGAYNSAPRMRTPGPPGPPPPDSRVRDQYSD----PRRGPPT-GFAPRGRGGYPPRGGYG 
             300       310       320            330       340       
 
            360           370       380       390       400         
Sequen RGGPYGGPRGP----PPNGRGGPMGPMRGAPSGMMGRGQRGPNPAGYGYGPVSTGLNPGY 
       :::::::: ::    : .:::: ::::::.:.: :.::   :.::. :::           
UNIPRO RGGPYGGPYGPNSRAPLTGRGGYMGPMRGGPAGPMARGGYRPQPAAGGYGN--------- 
        350       360       370       380       390                 
 
      410       420       430       440       450       460         
Sequen DAYNYGPGPRPSQRFGENGIDYHGPSPVETARRPSPGPIGMAVSPPETAPIGQAIEMTSQ 
                  .. .::.   :.:::    .:. .:::..  ..:   .: ::::::  : 
UNIPRO -----------ARAMGEDEYGYRGPS----SRQRTPGPMAAPAAP---GPAGQAIEMMPQ 
                  400       410           420          430          
 
      470       480       490       500       510       520         
Sequen PRHTDSAVELGPNAVPEEEQPHAVSNDGHPEPVSPSSLYSRSASYIPPRAGWTPADLRVG 
       :::  .:     . :::..: ::.: :.. :::::.:::::. ::.::: .: :   ..  
UNIPRO PRHEPDA----QDEVPEQQQLHAISIDNQHEPVSPTSLYSRTQSYVPPRRNWGP---QAY 
     440           450       460       470       480          490   
 
      530       540       550       560       570       580         
Sequen HSPSPVHALGENHTASHARSNSGDSYYEDVDPRFAEPHQPPAGNRALPSALTPGAGELKL 
       .:  :      :.   ::::.::. :::: :: ..  ..  .:: ..::.::::       
UNIPRO QSSEPNLPYQPNQP-RHARSQSGSMYYEDEDPVYTSRNESAVGNSGVPSVLTPGNSAK   
            500        510       520       530       540            
 
      590       600       610       620       630       640         
Sequen TDDLAETPGSPTTSEISHFTSISERPINPRWRPPPPPALPAQQRQNVLLENNPDFDLRAG 
 
 
Fig. AF.3: Alignment between A. nidulans PalI (AN4853) and A. fumigatus PalI (Afu3g07530). 
 
Smith-Waterman score: 3538; 70.6% identity (86.5% similar) in 769 aa overlap  
 
                        10        20        30        40        50  
Sequen          MSVNSFTSPSAPSPLGRNRSSLLSKFRAPFGHRNRSIADFYIEPDDPWRSY 
                :::: ... .. :::.:::::::::::. .:.:::.:.::::::::::::: 
UNIPRO MVRATCSCVMSVNPLSAQTSASPLSRNRSSLLSKFRTQLGQRNRAITDFYIEPDDPWRSY 
               10        20        30        40        50        60 
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              60        70        80        90       100       110  
Sequen FPGDVVKGTVALTVVRPVRITHLVVCLHGYVKVFKNTVPSGETDPDLGFLGPGRGRRGPE 
       :::::.::::.:::::::::::::. ::: ::::::.::.::: ::.: ::::::::: : 
UNIPRO FPGDVIKGTVSLTVVRPVRITHLVISLHGIVKVFKNNVPAGETPPDVGSLGPGRGRRGAE 
               70        80        90       100       110       120 
 
             120       130       140       150       160       170  
Sequen YLGNGLATLFEDEVVLCGEGRLKEGIYKFRFEMCFPPYALPSSISFERGTISYMLTSTLT 
       :::::.::::::::::::::::::::::::::: :::: ::::::::::::::::::::: 
UNIPRO YLGNGVATLFEDEVVLCGEGRLKEGIYKFRFEMSFPPYPLPSSISFERGTISYMLTSTLT 
              130       140       150       160       170       180 
 
             180       190       200       210       220       230  
Sequen KPTTMNPTVSCRRRVNFLENIDIAPFPAPKARIVTLEPVTRRSKPKGKAKSVESDAAADV 
       ::::::::.:::::.:.::::::: ::::: :.:::::...:::::::.:..  ::  :. 
UNIPRO KPTTMNPTLSCRRRINLLENIDIAAFPAPKPRVVTLEPISKRSKPKGKTKAAGFDAP-DT 
              190       200       210       220       230           
 
             240       250       260       270       280            
Sequen QSREPSLNGSGAVGDNRPPLSPAPSNVSSSSRLSNSSQSFQLASDPSSSAGTGVRNG--- 
        : ::: .:. .: ..:::::::::::::::::::::::::...::.:.:..::::.    
UNIPRO ASLEPSASGGITVPEHRPPLSPAPSNVSSSSRLSNSSQSFQIVTDPGSTASSGVRNSEAR 
     240       250       260       270       280       290          
 
      290       300       310       320       330       340         
Sequen SITPSIADKTITAKTELLRAGVLPGETLPIVITINHCKQVRSAHGIIVTLYRQGRIDLHP 
       : :::..:  ::::.:.::::::::.:::: ::::: ::::::::::.::::.::::::: 
UNIPRO SNTPSVTDGIITAKAEVLRAGVLPGDTLPIKITINHTKQVRSAHGIIITLYRSGRIDLHP 
     300       310       320       330       340       350          
 
      350       360       370       380       390       400         
Sequen AIPIGTTANGKKPVYEDYYPRSRTGLGGLTLGTSRTSSVFRKDLAQTFAPLVVDPATMTA 
       :::.:.:::::::.:::::::::::::::::::::.::::::::.::::::.:::.:.:: 
UNIPRO AIPMGSTANGKKPIYEDYYPRSRTGLGGLTLGTSRASSVFRKDLSQTFAPLIVDPTTLTA 
     360       370       380       390       400       410          
 
      410       420       430       440       450       460         
Sequen VVKTSIRIPEDVFPTITRTPGSMINFRYYVEVVVDLRGKLTSPERFLPRFNMVSSGSNFS 
        .:::::::::.:::::::::::::::::::::::::::::::::::::::.:::: ::: 
UNIPRO DIKTSIRIPEDAFPTITRTPGSMINFRYYVEVVVDLRGKLTSPERFLPRFNLVSSGRNFS 
     420       430       440       450       460       470          
 
      470       480       490       500       510       520         
Sequen PSGQVLNPSDANGNSITTNWAGNILDTAQIRREKGVVAVAFEVVIGTRDSQRHKEKTERT 
        .:....:.:.::..::.::. ::::: ::::::::::: :::::::.:.::.: ...:  
UNIPRO SNGKIVHPADTNGSAITANWGDNILDTDQIRREKGVVAVIFEVVIGTQDTQRRKSEARRM 
     480       490       500       510       520       530          
 
      530       540          550       560       570       580      
Sequen HSVAAVSDISPPQAHPAAESD---HWQNGYSPMPTTNSEYLPQTDYGFPEESQWPMYEDE 
        :.:  .... : .. ....:   :  .:    :  .   : .: :: :.. .:: : .. 
UNIPRO SSTAEEAEFQQP-VENSVDGDYAGHDYQGSMAGPEPGYAPLENTAYG-PDQIRWPDYPEQ 
     540       550        560       570       580        590        
 
          590       600       610       620       630        640    
Sequen TA-QHYQSLGGMVATPQVEEPTDEKARLRHAEQTLLPSRPPDDSEPGPSAG-HLAMPTAP 
       .  .::    : . .:: .:: :::::::.::::::::.:: : : :::.. . :::::: 
UNIPRO SEHEHYPFQPGTLPSPQPDEPMDEKARLRRAEQTLLPSQPPCDPEAGPSSAVEAAMPTAP 
       600       610       620       630       640       650        
 
           650       660          670       680       690       700 
Sequen VLPEDDHINGYHHLPSPVENCLPH---TLGSAESVQTVVASSSVAEPNGSTAPPGEDKQE 
       :::::::.: :::::: . : .     .: ::::::::.:.:: :  .. . :  ::::: 
UNIPRO VLPEDDHLNDYHHLPSTTVNGMTGMAPALMSAESVQTVIAGSSSAPLTSPSRPSEEDKQE 
       660       670       680       690       700       710        
 
              710       720       730       740        750        
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Sequen LERRRLMMEASAPEDMDAHTDNSAMDGPSAPVFHDDHDEQ-LVGGAAHGDESLPRYQR 
       :::.::::::::: : ::. .. : ::::::.:::: :.: ::::::.::: :::::: 
UNIPRO LERQRLMMEASAPGDPDARHNDRADDGPSAPIFHDDDDDQQLVGGAANGDELLPRYQR 
       720       730       740       750       760       770      
 
Fig. AF.4: Alignment between A. nidulans PalF (AN1844) and A. fumigatus PalF (Afu4g09650). 
 
AF.2 In silico prediction topology for A. fumigatus PalH and PalI 
 
-----> STRONGLY prefered model: N-terminus outside 
 7 strong transmembrane helices, total score : 10996 
 # from   to length score orientation 
 1   88  105 (18)    2291 o-i 
 2  150  168 (19)    1215 i-o 
 3  197  219 (23)     614 o-i 
 4  225  244 (20)    1520 i-o 
 5  268  287 (20)    1520 o-i 
 6  301  322 (22)    2692 i-o 
 7  333  352 (20)    1144 o-i 
 
------> alternative model 
 7 strong transmembrane helices, total score : 9974 
 # from   to length score orientation 
 1   89  108 (20)    1989 i-o 
 2  147  165 (19)    1252 o-i 
 3  200  218 (19)    1032 i-o 
 4  225  244 (20)    1135 o-i 
 5  270  287 (18)    1324 i-o 
 6  302  322 (21)    2528 o-i 
 7  334  352 (19)     714 i-o 
 
 
 Fig. AF.5: TMpred prediction for the topology of the A. fumigatus plasma membrane PalH 
(Afu5g13270). 
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>Sequence              length = 70 
# Measure  Position  Value  Cutoff  signal peptide? 
  max. C    62       0.114   0.32   NO 
  max. Y    15       0.109   0.33   NO 
  max. S     1       0.402   0.87   NO 
  mean S     1-14    0.166   0.48   NO 
       D     1-14    0.138   0.43   NO 
 
 
>Sequence 
Prediction: Non-secretory protein 
Signal peptide probability: 0.000 
Signal anchor probability: 0.000 
Max cleavage site probability: 0.000 between pos. 37 and 38 
 
 
 Fig. AF.6: Signal P3.0 prediction for the presence of a signal peptide in the A. fumigatus 
plasma membrane PalH (Afu5g13270). 
  
-----> STRONGLY prefered model: N-terminus inside 
 4 strong transmembrane helices, total score : 9856 
 # from   to length score orientation 
 1    8   26 (19)    2427 i-o 
 2   87  108 (22)    2263 o-i 
 3  119  146 (28)    2493 i-o 
 4  153  170 (18)    2673 o-i 
 
------> alternative model 
 4 strong transmembrane helices, total score : 9032 
 # from   to length score orientation 
 1    9   25 (17)    2502 o-i 
 2   86  110 (25)    1897 i-o 
 3  119  140 (22)    2494 o-i 
 4  151  168 (18)    2139 i-o 
 
  
 Fig. AF.7: TMpred prediction for the topology of the A. fumigatus plasma membrane PalI 
(Afu3g07530). 
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>Sequence              length = 70 
# Measure  Position  Value  Cutoff  signal peptide? 
  max. C    27       0.516   0.32   YES 
  max. Y    27       0.547   0.33   YES 
  max. S    12       0.997   0.87   YES 
  mean S     1-26    0.982   0.48   YES 
       D     1-26    0.765   0.43   YES 
# Most likely cleavage site between pos. 26 and 27: VLS-TP 
 
 
>Sequence 
Prediction: Signal peptide 
Signal peptide probability: 0.991 
Signal anchor probability: 0.009 
Max cleavage site probability: 0.836 between pos. 26 and 27 
 
 Fig. AF.8: Signal P3.0 prediction for the presence of a signal peptide in the A. fumigatus 
plasma membrane PalI (Afu3g07530). 
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